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INTRODUCTION 
 
 
 
General background 
 
Since the discovery and development of the first antibiotics prior to the Second World War, these 
drugs have played an important role in curing disease in humans and animals. In 1946 experiments 
showed that low, sub-therapeutic levels of antibiotics could improve feed conversion and growth in 
animals, and the addition of various antibiotics to feed for livestock was initiated. These antibiotics, 
supplemented to the diet at nutritional levels (<100 mg/kg), were designated as antimicrobial 
growth-promoters (AMGP), since they improved animal performance. However, they can be 
considered more to be growth permitting rather than growth promoting in the sense that they can only 
permit the animal to grow to its genetic potential given the diet it is fed. There has been widespread 
incorporation of AMGP into animal feeds in many countries (e.g. Cromwell, 2002). Feeding pigs 
with sub-therapeutic levels of antibiotics has been documented to increase weight gain by 3.3–8.8% 
and improve feed conversion by 2.5–7.0% in a nearly consistent way (Doyle, 2001). The effect of 
AMGP is most pronounced in young growing animals especially under unfavourable hygienic and 
management conditions. When animals get older, the beneficial effect is reduced and can often not be 
observed in the finishing period (Wenk, 2003). At weaning, piglets are exposed to a range of 
stressors, including changes in social settlement, diet composition, environment and bacterial 
challenges, contributing to digestive upsets and depressions in growth rate. The AMGP have proven 
to be very effective in counteracting the negative effects manifested around weaning of pigs (Visek, 
1978). 
 
The exact mechanisms by which this occurs are not completely understood. Since AMGP provide a 
relatively greater improvement in farms with poor hygiene, their effectiveness is at least partially due 
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to suppression of some pathogenic bacteria and related gut infections/growth-depressing toxins. It is 
also believed that the antibiotics alter the normal, non-pathogenic bacteria of the gut and these 
changes have a beneficial effect on digestive processes and the utilization of nutrients in feed 
(reviewed by Anderson et al., 1999; Corpet, 2000; Gaskins et al., 2002 and Visek, 1978), since:  
- a reduction and/or metabolic inactivation of the gut bacteria diminishes the competition for 
(essential) nutrients and losses by conversion of nutrients to components with lower 
nutritional value (SCFA – short chain fatty acids, lactic acid) in the proximal regions of the 
gut. It has been estimated that as much as 6% of the net energy in a pig’s diet may be lost due 
to microbial fermentation in the stomach and SI (Vervaeke et al., 1979); 
- gut bacteria inactivate pancreatic digestive enzymes and bile salts (deconjugation and 
dehydroxylation; impairment of lipid digestion and production of toxic degradation products) 
(Eyssen, 1973) and 
- gut bacteria metabolize dietary protein with the production of harmful and growth-depressing 
deamination metabolites like ammonia, irreversible decarboxylation products (biogenic 
amines) such as cadaverine (e.g. Dierick et al. 1986ab) and phenolic compounds such as 
phenol and p-cresol. 
Antibiotics inhibit these activities and thus increase the digestibility of dietary nutrients. Most AMGP 
target G+ bacteria, and it is well established that G+ bacteria are predominant in the SI and are 
mainly responsible for the above mentioned competitive effects. Antibiotics also appear to prevent 
irritation of the intestinal lining and may enhance uptake of nutrients from the intestine by thinning of 
the mucosal layer. A lower turnover rate of enterocytes and a lower stimulation of the GALT (gut-
associated lymphoid tissue) (inflammation) has been documented as well. The consequence of this is 
that more nutrients are available for animal growth and a lower maintenance costs are needed to 
assure the absorptive and immunological functions of the gut. Dierick et al. (2002a) stated that 
growth promotion by feed antibiotics is related and proportional to the inhibition of the total 
microbial load in the stomach and the jejunum. A reduction of the general bacterial growth in SI and 
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pathogen proliferation should be major targets to improve animal performance and/or health 
(Apajalahti & Kettunen, 2006). The involvement of gut microbiota in the mode of action of AMGP is 
most well substantiated by studies with germ-free animals, carried out as early as in the 60’s. For 
example, feeding AMGP did not improve animal performance in germ-free animals, while animals 
infected with gut microbiota from conventional animals resulted in growth-depression. AMGP are 
able to partially reverse this depression in growth (see review by Anderson et al., 1999). In opposite, 
others believe that the growth-promoting effect of the AMGP cannot be attributed to an antibiotic 
effect on the microbes of the GIT (gastro-intestinal tract), but rather to a direct effect on host cells, in 
particular inflammatory cells (Niewold, 2007). Certain antibiotics can accumulate in inflammatory 
cells (macrophages and PML, polymorphonuclear leukocytes) and inhibit their function (e.g. 
Schoevers et al., 1999). Niewold (2007) suggests that as a consequence the levels of pro-
inflammatory cytokines like IL-1 (interleukin-1) would be lower in AMGP-fed animals as compared 
to control animals, which would result in a lower catabolic stimulus and appetite depression (Klasing 
et al., 1987). The release of these cytokines triggers an acute phase response which is associated with 
metabolic expenses. Furthermore, it has been described that the GIT is in a state of constant 
controlled inflammation. Hence, it is assumed that AMGP reduce this inflammation and subsequently 
spare energy for production. Finally, experiments with chlortetracycline, penicillin, and 
sulfamethazine as growth-promoters have shown that treated pigs have higher serum levels of IGF-1 
(insuline-like growth factor 1) (Hathaway et al., 1996). Thus the effects of sub-therapeutic antibiotics 
may extend beyond digestion in the intestine and stimulate metabolic processes throughout the 
animal.  
 
The use of AMGP would not have become under debate if antibiotic resistance did not show up. As 
soon as in 1947, penicillin resistance was documented. The presence of an antibiotic may kill most of 
the bacteria in an environment but the resistant survivors (resistance genes by mutation) can 
eventually re-establish themselves and pass their resistance genes on to their offspring and, often, to 
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other bacteria of the population or bacteria of a different species (horizontal transfer of resistance 
genes). These genes may confer resistance to one or several different antibiotics. Both medical and 
veterinary uses of antibiotics have resulted in the appearance of resistant strains of bacteria. Resistant 
bacteria which are human pathogens (e.g.  Campylobacter spp., Salmonella spp.) may cause diseases 
that are difficult to treat. Even if the resistant bacteria are not human pathogens, they may still be 
dangerous because they can transfer their resistance genes to other bacteria that are pathogenic. There 
is strong, but not conclusive evidence that the use of AMGP in livestock has contributed significantly 
to the selection for antibiotic resistance (e.g. Mathew et al., 1998) and that these resistant bacteria 
have spread from farm animals to human through animal products (zoonotic pathogens) (e.g. 
Seyfarth et al., 1997), compromising treatment of infectious diseases. Although resistance may 
develop very quickly, nutritional antibiotics, were and are still, where allowed (e.g. USA) very 
efficacious in animal production (Cromwell, 2002). Another concern are possible residues of these 
substances in animal products and the environment. Moreover, the consumer demand is for safer 
food, without reliance on antibiotics as feed additives. These concerns resulted in a number of 
government initiatives, among them measures to reduce veterinarian prescription of antibiotics 
(therapeutic use) and measures against use of certain antibiotics as growth-promoters. Already in 
1969, The Swann Committee in the UK recommended restrictions in the use of antibiotics for growth 
promotion in order to mitigate the risk of resistance. In Europe, this led to a progressive withdrawal 
of several substances from the list of authorised additives because of a decision to restrict certain 
antibiotics to therapeutic use (Dibner & Richards, 2005). Finally, the EU decided to ban the four 
remaining authorised AMGP (avilamycin, flavophospholipidol, monensin and salinomycin) by 
January 2006 (Regulation 1831/2003, EC). In the rest of the world, AMGP are under debate as well 
and approvals for their use are disappearing. 
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It is difficult to evaluate the effect of the withdrawal of AMGP in the EU, since comparable data on 
animal performances and health before and after the ban are hard to find. However, field data 
indicate that young pigs still suffer from a range of gastro-intestinal disorders (e.g. post-weaning 
diarrhoea), that hereby ‘theurapeutic’ antibiotics (e.g. colistin) are widely used and that some ‘old’ 
pathogens, like Brachyspira hyodysenteriae (Vangroenweghe, 2008), are re-emerging fastly. This 
was also observed in Sweden and Denmark, where a voluntary ban was set in the late 90’s which was 
accompanied with a sharp increase in theurapeutic use of antibiotics (in review by Casewell et al., 
2003). Moreover, in the EU antimicrobial levels of copper for pigs younger than 12 w (170 mg/kg) 
are foreseen to be reduced in the near future, this for reasons of resistance development and 
accumulation in agricultural soils. Hence, there was and still is an urgent need for new ways to 
guarantee performance and to protect the health status of animals, especially in the more vulnerable 
stages of production, such as the weaning period of piglets. This target can be attained by good 
housing or climate conditions along with a fine selection of feedstuffs and well balanced feeds.  
 
‘Alternative’ feed additives can also play a prominent role. Long before the ban on AMGP research 
groups came up with new substances and tested their efficacy as replacers for the AMGP. The 
following list of the so called ‘alternative’ feed additives is by no means exhaustive: enzymes, 
probiotics, prebiotics (fermentable carbohydrates), antibodies, spray-dried porcine plasma, cytokines, 
metals like Zn and Cu, acidifiers (organic acids), medium-chain fatty acids, fermented liquid feed, 
herbs, plants extracts and bateriophages (for reviews see: Close, 2000; Gill et al., 2005; Roselli et al., 
2005; Thomke & Elwinger, 1998; Wenk, 2003 and many others). Not all mentioned alternatives 
mimic the presumed mode of action of antibiotics, but can act at different sites of the GIT and relay 
on different targets such as modifying the intestinal microbial balance in favour of potentially 
beneficial bacterial strains (competitive exclusion by probiotics and stimulating the growth of 
desirable bacteria by prebiotics), competitive colonization of the mucosa by adhering non-pathogens 
(probiotics), occupation of specific receptors on mucosal surface (prebiotics), stimulation/priming of 
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intestinal immune response (pro- and prebiotics, herbs and plant extracts), altering intestinal physico-
chemical conditions to suppress pathogenic bacteria (acidifiers, Cu and metabolic products from 
fermentation of prebiotics), production of bacteriocins (probiotics), alleviation of inflammatory 
response (Zn, herbs and plant extracts), improving nutrient digestibility and consequently lowering 
nutrient availability for opportunistic bacteria (enzymes) and antioxidant activity (herbs and plant 
extracts). Some of the alternatives described may be part of an overall adapted strategy in pig raising 
or may be combined. The use of AMGP is evidenced by their consistent positive impact on animal 
growth, feed efficiency and disease susceptibility. The recent alternatives do not always include these 
benefits, but are generally aiming at healthier pigs which can better overcome the post-weaning 
growth check and show a more balanced gut health status. Up to date, no product has been successful 
in replicating the relatively consistent and robust effects on performance of the AMGP (Dibner & 
Buttin, 2002).  
 
Herbs, plants extracts and essential oils (EO) have been used for food preservation, 
pharmaceuticals, alternative medicine and natural therapies for many years (Jones, 1996). They also 
have been proposed and reviewed as alternatives for the antibiotics in pig raising (Doyle, 2001; 
Kamel, 2001; Lis-Balchin, 2003; Rodehutscord & Kluth, 2002; Turner et al., 2001; Wenk, 2003; 
Westendarp, 2005 and Windisch et al., 2008). However, different modes of action (e.g. antioxidant, 
antimicrobial, coccidiostatic, anti-inflammatory, immuno-modulating effects and enhancement of 
endogenous secretions) are described depending on the product considered. A large quantity of 
compounds from herbal origin are well known for their antimicrobial properties (for review see Burt, 
2004; Cowan, 1999; Hulin et al., 1998 and Nychas & Skandamis, 2003) with the EO and their 
components being a very interesting and promising group. EO are the odorous components found in 
various plant parts. Because they evaporate when exposed to the air at ambient temperatures, they are 
also called volatile oils or ethereal oils. As a rule, they are immiscible with water, however, they are 
soluble in ether, alcohol and most organic solvents. EO in plants, form a very complex mixture which 
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can contain about 20-60 or more components at quite different concentrations. Components are 
mostly hydrophobic with a terpene, terpenoid or phenylpropene nature. EO are characterized by two 
or three major components at fairly high concentrations (20-80%) in addition to others present in 
trace amounts. Generally, these major components determine the biological properties of the EO.  
 
In this research 5 pure EO components were selected, based on their antibacterial properties found in 
literature and studied for their possible application as alternative for the AMGP. The EO are the 
terpenoids carvacrol and thymol and the phenylpropenes anethole, eugenol and 
cinnamaldehyde. These compounds can be isolated from plant extracts; however the ones used in 
this research were synthetically derived (‘natural identical’) (see Chapter 1 for biological and 
synthetic synthesis and isolation). Carvacrol is antibacterial. It is added to different products, e.g. 
baked good (15.75 mg/kg), non-alcoholic beverages, chewing gum (Ultee et al., 1999), as fragrance 
in cosmetic products and is also used in organic syntheses (Andersen, 2006). Thymol is an antifungal 
and antibacterial agent. It is widely used to treat the Varroa mite in honey bee cultures (Imdorf et al., 
1999). It is included in topical antiseptic and analgesic preparations in concentrations ranging from 
0.1 to 1%, in personal-care products, and in mouthwashes (in conjunction with chlorhexidine) for its 
antiseptic action (Robbers et al., 1996) and added to food products as flavouring and adjuvant 
(Andersen, 2006). Thymol is added as a stabilizer to several therapeutic agents, including halothane. 
Further, it is also used for inhalation in respiratory disorders. Its veterinary use includes the treatment 
of bronchitis, laryngitis, infections of the upper respiratory system, pleuritis and pneumonia with a 
recommended dose of 10 mg per animal for 5 consecutive days, irrespective of species (Anonymous, 
1996). At one time, thymol was much used in hookworm (Ancylostoma duodenale) treatment (Evans, 
2002). Anethole is widely used by industry to enhance the flavour of foods and alcoholic beverages, 
and as an odorant in perfumes (Soares et al., 2007). Eugenol, as a component of clove oil, is used to 
relief toothache due to its anaesthetic and antiseptic properties. Further, it is widely used as a 
component of zinc oxide eugenol cement in dental filling and in cosmetic and food products. The 
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average maximum used levels in food products, such as beverages, ice cream, baked goods, gelatins 
and puddings, and chewing gums, range from 1.4 to 500 mg/kg. Eugenol is the starting material in 
the synthesis of vanillin. Cinnamaldehyde is a major flavouring agent and it is extensively used in 
beverages, ice creams, confectionery, baked foods, chewing gums, condiments and meat preparations 
at concentrations from 8 mg/kg in ice cream to 700 mg/kg in boiled sweets. Its main application is as 
fragrance material in cosmetics, shampoos, toilet soaps and other toiletries as well as in non-cosmetic 
products such as household cleaners and detergents. It is also used as animal repellent, insect 
attractant and antifungal agent. Cinnamaldehyde is extensively studied as a model molecule for the 
selective hydrogenation of α,β-unsaturated aldehydes. More recently, all these compounds have 
gained interest as antimicrobial inclusion agent in edible coatings (e.g. Ben Arfa et al., 2007; Du et 
al., 2008 and Rojas-Grau et al., 2007) and their effects towards various invertebrates (nematodes, 
snails, insects …) and weed seedlings are  intensively investigated. 
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Objectives and outline of the thesis 
 
The specific objectives of the present study are: 
[1] to characterise the antimicrobial activities of EO against piglet intestinal bacteria; 
[2] to study the stability and kinetics of EO in the GIT of piglets and 
[3] to study the effect of EO on the functionality of the gut in piglets. 
Improved insight into the biological effects and kinetics of EO should allow to better evaluate the 
potential of EO as replacers of the AMGP in pig nutrition. 
 
Concerning the experimental work, effects were mainly quantified related to the weaning period of 
pigs, because in current pig production systems, the weaning period is one of the main critical points 
for growth and survival of the animal. 
 
In Chapter 1, a literature review is presented. It comprises relevant data of carvacrol, thymol, 
anethole, eugenol and cinnamaldehyde, with special emphasis on the antimicrobial activities and the 
reported effects on pig gut bacteria and physiology and pig performance. Data on effects in birds 
(poultry) are not included, since a lot of dissimilarities in digestive anatomy and function between 
mammals and birds exist. 
 
Chapter 2 describes experimental work dealing with the antimicrobial activity against the main 
culturable components of the pig gut bacteria. In vitro incubations, simulating the fermentation in 
different sections of the GIT, to study the effects of added EO on the bacteria were carried out. 
Firstly, a screening study was performed with carvacrol, thymol, eucalyptol, terpinen-4-ol, E-
anethole, eugenol and E-cinnamaldehyde. Dose-response relations were established and 
combinations were tested in a second study with the most promising EO. 
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Data on the stability and kinetics of carvacrol, thymol, eugenol and E-cinnamaldehyde in the GIT of 
pigs were determined in a subsequent study (Chapter 3). Samples of in vitro incubations were 
analysed for their EO content, and the recovery was calculated as a measure for stability/degradation. 
A single dose of each of these EO mixed with feed was given to piglets. Following euthanasia at 
different times post-prandial, digesta and body fluids were sampled to obtain kinetic data in vivo. 
 
A choice-feeding trial was done in which weaned piglets could freely choose between a control and 
an experimental diet. The objective was to determine whether a diet supplemented with thymol 
would be preferred or not, and this in relation to the dose applied. Further, flavours were added to 
mask thymol and tested. This work is reported in Chapter 4A. 
 
Two in vivo trials with carvacrol and thymol for newly-weaned piglets are described in Chapter 4B. 
Doses of 500 and 2000 mg/kg feed and different formulations were tested. Effects on gut bacteria and 
functionality were gathered by microbiological and biochemical analysis of digesta and body fluids 
and histological examination of the gut tissue. 
 
Chapter 5 presents a detailed study of the effects of thymol, E-anethole and E-cinnamaldehyde on 
active epithelial absorption of D-glucose and L-alanine and stimulated chloride secretion. For that 
purpose, the Ussing chamber technique was used. 
 
Finally, a general discussion (Chapter 6) relates all data. Data are viewed in the perspective of these 
EO as alternatives for the AMGP and future prospects are discussed.  
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ESSENTIAL OILS AS FEED ADDITIVES IN PIG NUTRITION 
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CHAPTER 1  
 
ESSENTIAL OILS AS FEED ADDITIVES IN PIG NUTRITION 
 
 
1. FATE OF SELECTED ESSENTIAL OILS IN PLANTS AND PROPERTIES 
1.1. Biosynthesis 
 
EO are the odorous, volatile products of an aromatic plant’s secondary metabolism, normally 
formed in special cells or groups of cells, found in many leaves and stems. The production of plant 
secondary constituents is dependent on the fundamental metabolic cycles of the living plant tissues. 
A number of recent reports suggest that secondary metabolites, rather than constituting waste 
products of metabolism, are biosynthesized to aid to the producer’s survival (Evans, 2002). Recently, 
considerable attention has been directed to the possible ecological implications of secondary 
metabolites not only in relation to plant-plant interaction but also concerning the interrelationship of 
plants and animals. 
 
Carvacrol and thymol (Table 1) are classified as monoterpenoids and their biosynthesis in plants 
follows the general scheme of terpenoid synthesis (Robbers et al., 1996). Terpenoids are composed 
of isoprene units; monoterpenoids having two units. The isoprene units arise from acetate via 
mevalonic acid and are branched-chain, five carbon units containing two unsaturated bonds (Fig 1.). 
Isopentenyl-5-pyrophosphate (IPP) is termed active isoprene. Geranyl pyrophosphate serves as the 
substrate for the various monoterpenoid synthases (mainly cyclases) and represents the key precursor 
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3-acetyl-CoA
(3S)-3-hydroxyl-3-methylglutaryl-CoA
(3R)-mevalonic acid
5-pyrophosphomevalonic acid
ATP
ADP + Pi
CO2
isopentenyl-5-pyrophoshate (IPP) (= active isoprene)
3,3-dimethylallyl pyrophosphate
IPP
PPi
geranyl pyrophosphate
gamma-terpinene
(aromatisation)
p-cymene
(hydroxylation)
carvacrol          thymol
of monoterpenoid biosynthesis. Geranyl pyrophosphate itself cannot cyclize directly to form a six-
membered ring because of the trans-geometry of the double bond at C-2. However, the 
monoterpenoid synthases isomerize it to a bound intermediate with the cis-geometry, which is then 
able to cyclize. After initial cyclizations, these compounds can undergo a variety of subsequent 
enzymatic transformations including oxidations, reductions … The synthesis of carvacrol and thymol 
follows the aromatization of their precursor γ-terpene to p-cymene and finally the hydroxylation of 
the latter. Carvacrol and thymol, although aromatic in structure, are thus terpenoid in origin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Biosynthesis in plants of carvacrol and thymol follows the general scheme of terpenoid 
synthesis (adapted from Robbers et al., 1996). 
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Anethole, eugenol and cinnamaldehyde (Table 1) are phenylpropanoids formed in plants via the 
shikimic acid-phenylpropanoid route (Fig. 2) (Robbers et al., 1996). Phenylpropanoids contain the 
C6 phenyl ring with an attached C3 propane side chain. Shikimic acid, through a series of 
phosphorylated intermediates, yields chorismic acid, which is an important branch-point 
intermediate. One branch leads to prephenic acid that can be aromatized in two ways. The first 
proceeds by dehydration and simultaneous decarboxylation to yield phenylpyruvic acid, the direct 
precursor of L-phenylalanine. Cinnamic acid, is then formed by direct enzymatic deamination of 
phenylalanine. The acid may then undergo a number of elaboration reactions to generate many of the 
phenylpropanoids; for example cinnamic acid is reduced to the corresponding aldehyde, 
cinnamaldehyde. The second occurs by dehydrogenation and decarboxylation to yield p-
hydroxyphenylpyruvic acid, the precursor of L-tyrosine. P-hydroxycinnamic acid (p-coumaric acid) 
can originate from tyrosine or by hydroxylation of cinnamic acid at the para position. Anethole and 
eugenol are derived from p-hydroxycinnamic acid. The principal precursors for phenylpropanoids are 
therefore cinnamic acid and p-hydroxycinnamic acid, which arise in turn from the aromatic amino 
acids L-phenylalanine and L-tyrosine. For anethole and cinnamaldehyde two enantiomeric forms 
exist, E (=trans) and Z (=cis). However, in nature E is the predominant isomer (>99%) for both 
compounds (Aromatic Consortium, 2005). 
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phosphoenolpyruvate + D-erythrose-4-phosphate
3-deoxy-D-arabinoheptulo sonic acid-7-phosphate
3-dehydroquinic acid
shikimic acid
chorismic acid
prephenic acid
(dehydration + decarboxylation)     (dehydrogenation + decarboxylation)         
phenylpyruvic acid p-hydroxyphenyl pyruvic acid
L-phenylalanine L-tyrosine
cinnamic acid
p-hydroxycinnamic acid
cinnamaldehyde
anethole eugenol
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Biosynthesis in plants of anethole, eugenol and cinnamaldehyde via the shikimic acid-
phenylpropanoid route (adapted from Robbers et al., 1996). 
 
1.2. Presence in plants and synthetic analogues 
 
The production of secondary constituents of plants are influenced by three principal factors: genetic 
composition (chemotypes), ontogeny (stage of development) and environment (soil, climate, 
associated flora and methods of cultivation) (Robbers et al., 1996). For many EO containing plant 
species, distinct chemotypes are described. Chemotypes are defined as chemically distinct 
populations within a species and have similar phenotypes but different genotypes and as such are 
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identical in external appearance but differ in their constituents of the isolated plant EO (Evans, 2002). 
Genetic effects induce both quantitative and qualitative changes, but those caused by environmental 
influences are primarily quantitative. Stage of development depends on harvesting time. To conclude, 
it means that the composition of the plant EO is variable and this should be taken into account, when 
exploiting an EO. In practice, EO are commonly extracted from plant material by pressure, 
extraction, steam distillation or supercritical carbon dioxide and compose of an often quite complex 
mixture of mostly hydrophobic chemicals with a terpene, terpenoid, phenylpropene or 
phenylpropanoid nature. Only a few posses a single component in a high percentage (e.g. clove oil 
contains no less than 85% of phenolic substances, chiefly eugenol). However, it is not uncommon for 
a EO to contain over 200 components. 
 
Carvacrol is present in the EO obtained from several species of the genus Origanum, e.g. O. vulgare, 
O. intercedens, O. ornites and O. marjoram. This genus belongs to the Lamiaceae family. The 
flowering plant is harvested and the carvacrol content is different for leaves and flowering tops. 
Carvacrol is the major component of oregano oil, principally 50 to 80%. Oregano oil contains also 
thymol and the precursors γ-terpinene and p-cymene to varying concentrations (e.g. Sivropoulou et 
al., 1996). Carvacrol is present in thyme oil (9-60%), as well in many other plant species; e.g. 
Coridothymus capitatus (70%), Satureja montana (22-40%) (Peňalver et al., 2005). Carvacrol is 
synthetically derived from p-cymene by sulfonation followed by alkali fusion (Andersen, 2006).  
 
Thymol is obtained from thyme oil (Thymus vulgaris L. and Thymus zygis; both are included in the 
European Pharmacopoeia - EP and British Pharmacopoeia - BP), from horsemint oil (Monarda 
punctata L.), from Oswego tea oil (Monarda didyma L.), from ajowan oil (Carum copticum B. et B.) 
and many others. A number of chemical varieties, e.g. ‘thymol’ and ‘carvacrol’ types, are known for 
Thymus. The genus Thymus belongs to the family Lamiaceae. Thyme oil is obtained from the leaves 
and flowering tops of the plant and commonly contains 20-55% thymol, accompanied by lower 
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amounts of carvacrol, γ-terpinene and p-cymene. The thyme oil may be treated in two ways to isolate 
thymol crystals: [1] it may be subjected to freezing temperatures causing the thymol to crystallize or 
[2] it may be treated with sodium hydroxide solution, the aqueous solution of sodium thymol being 
separated and decomposed with acid, thus liberating the thymol, which is subsequently purified. 
Thymol may be prepared synthetically from m-cresol and isopropyl chloride by the Fiedel-Crafts 
method at -10°C or more efficiently from m-cresol and propene at elevated temperatures (Andersen, 
2006). 
 
It is increasingly evident that both carvacrol and thymol also occur in plants in the glycoside form. 
Both were found in T. vulgaris L. as glucosides and galactosides (Evans, 2002) and carvacrol and 
thymol glycosides were also detected in S. montana (Mastelic & Jerkovic, 2003) and O. vulgare 
(Milos et al., 2000). These glycosides are translocated from leaves to flowers as aroma precursors 
and serve as a means of translocation/storage within the plant. Glycosides are water soluble, non-
volatile and flavourless and offer therefore some advantages compared to the parent compound. A 
reliable differentiation of natural from synthetic carvacrol and thymol is feasible by multi-element 
GC-IRMS (Gas Chromatography – Isotope Ratio Mass Spectrometry) on 2H/1H, 13C/12C and 18O/16O 
ratios relative to international standards (Nhu-Trang et al., 2006; Greule et al., 2008). Determination 
of the isotope ratios (only 2H/1H ratios are practicable) of the actual compound allows a 
discrimination between natural (isolated from plants) or synthetic (with synthetic compounds as 
starting material) origin, thus assessing its authenticity. 
 
Pimpinella anisum L. (aniseed, Apiaceae) and Illicium verum Hook (star-anise, Illiciaceae) are 
important sources of anethole (both included in EP and BP). Aniseed oil is obtained from the dried, 
ripe fruits of the plant and yields commonly 2-5% of EO. The Pimpinella oil is said to have a slightly 
superior flavour than the Illicium oil, but most of the aniseed oil used is that obtained from the star-
anise. Anethole is the principal constituent in the oil (80-90%). The oil is sensitive to atmospheric 
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oxidation and both anisic aldehyde and anisic acid are normally present. This change is said to 
diminish the tendency of the oil to solidify, which it normally does on cooling to about 15°C. Oil of 
anise is used as a flavouring agent and carminative (a herb or preparation that is able to combat 
flatulence). Anethole is also the major compound of fennel oil (Foeniculum vulgare), about 60%. All 
these oils are components of popular Mediterranean beverages such as anisette, ouzo and raki. 
Besides isolation from the mentioned plant EO, anethole can be obtained by isolation from crude 
sulphate turpentine or chemically derived by treatment of anisole with propionic acid derivates or 
propionaldehyde (Terpene Consortium, 2002).  
 
Clove is the dried flower bud of Eugenia caryophyllata B. et H. (Syzygium aromaticum), family 
Myrtaceae, and is the main source of natural eugenol. Clove oil is the EO distilled with steam from 
the dried flower buds (yield 14-21%, >80% eugenol) (official in EP and BP). Oils with a particularly 
high content of eugenol are used in the commercial production of vanillin. Eugenol is usually 
prepared from clove oil by shaking with a 10% solution of sodium hydroxide to form sodium 
eugenolate (Robbers et al., 1996). The mixture is washed with ether, and the sodium eugenolate is 
then decomposed with sulphuric acid. Eugenol is separated by steam distillation. It has a strong 
aromatic odour of clove and a pungent spicy taste. Cinnamon leaf oil contains 70-95% of eugenol as 
well. Eugenol occurs as glucoside in Melissa officinalis (Evans, 2002). Eugenol can be synthetically 
derived from benzoic acid. 
 
Cinnamaldehyde is present in different species of the genus Cinnamomum (Lauraceae). Ceylon 
cinnamom refers to Cinnamomun zeylanicum B. (Cinnamomun verum), the dried inner bark of shoots 
of coppiced trees is used for the production of the Ceylon cinnamon oil (yield 0.5-1%). The principal 
constituent of the oil is cinnamaldehyde (60-95%), the remainder consists of terpenes such as 
limonene, p-cymene, (-)-linalool and β-caryophyllene and other compounds such as eugenol. 
Cinnamon oil is used as a flavouring agent; it is also a carminative and pungent aromatic. It has 
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antiseptic properties. Cassia oil is derived from Cinnamomun cassia N. Cassia yields 1-2% of EO 
which, when pure, contains no eugenol but rarely less than 85% of cinnamaldehyde. Cinnamaldehyde 
can be isolated by sequential fractionation with various solvents and silica gel column 
chromatography. On a commercial scale, cinnamaldehyde is prepared almost exclusively from the 
alkaline condensation of benzaldehyde and acetaldehyde (Aromatic Consortium, 2005). 
 
1.3. Physico-chemical properties and stability 
 
An overview of the physico-chemical properties of the pure forms of the EO is shown in Table 1. All 
compounds contain a benzene unit which provides their aromatic nature. In general, they are 
volatile and are prone to volatilization. Carvacrol and thymol are isomers bearing the hydroxyl group 
at a different position. Both are phenolic compounds with a moderate solubility in water and a pKa 
value of 10.4. Si et al. (2006b) found that pre-incubation of carvacrol and thymol in a pH 2.0 medium 
at 37°C for 4h did not alter the efficacy of antimicrobial activity. Thymol was susceptible to 
ozonation (Nakada et al., 2007). Anethole and eugenol have both a methoxy moiety. Anethole has a 
much lower water solubility than the other EO used in this research. When water is added to anise 
containing drinks (anisette, ouzo …), a cloudy white suspension results which is attributable to a 
decrease in solubility of this phenylpropanoid as it is much more soluble in ethanol than in water. 
Anethole should be stored air- and light-protected to avoid oxidation. The calculated half-life value 
for E-anethole has been reported to be as short as 2.0 h; it contains a reactive allylic hydrogen 
capable of ready reaction with hydroxyl and peroxy radicals (Terpene Consortium, 2002). Oxidation 
of anethole and eugenol was effected under photochemical conditions using hydrogen peroxide to 
obtain either epoxy or hydro-epoxy derivates (Elgendy & Khayyat, 2008). Eugenol has a phenol 
moiety as well and typically its density exceeds that of water. Eugenol was resistant to degradation 
when exposed to temperatures up to 200°C (Friedman et al., 2000) and its antimicrobial properties 
were not affected by pre-incubation at pH 2.0 (Si et al., 2006b). 
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Cinnamaldehyde contains an oxidizable α,β-unsaturated aldehyde function. The calculated 
photodegradation half life is around 3 h, the α,β-unsaturated aldehyde function being susceptible to 
attack by hydroxyl radical species in the gas phase (Aromatic Consortium, 2005). No hydrolysis is 
possible for cinnamaldehyde, so it is expected to be stable in an aqueous medium, although it may be 
slowly oxidized to cinnamic acid (Aromatic Consortium, 2005). Yuan et al. (1992) did not find any 
oxidation of cinnamaldehyde to cinnamic acid in aqueous solutions. However, in commercial 
applications (as flavouring agent) antioxidants are added as stabilizers (Aromatic Consortium, 2005). 
Temperature-dependent and non-enzymatic oxidation and further decomposition to benzaldehyde and 
glyoxal has been reported by Friedman et al. (2000) and Gholivand & Ahmadi (2008), occurring at 
temperatures above 60-70°C. Benzaldehyde itself has the bitter almond odor. Interestingly, Friedman 
et al. (2000) found also that cinnamaldehyde was not heat degraded when present in cinnamon oil or 
when mixed with eugenol. Basketter (2000) reviewed the quenching effect of eugenol towards the 
skin sensitizing activity of cinnamaldehyde in human. Due to its electrophilic groups, 
cinnamaldehyde can react directly with proteins via two different mechanisms: Schiff base 
intermediates to lysine residues and Michael addition to sulfhydryls (Elahi et al., 2004). Pre-
incubation of cinnamaldehyde in a pH 2.0 medium at 37°C for 4h did not alter the efficacy of 
antimicrobial activity (Si et al., 2006b). 
 
Systematic research on the stability of these compounds during feed processing (for example 
pelletizing) and feed storage conditions has rarely been done. However, considering the available 
data above mentioned, adequate research might be necessary; especially for E-anethole and E-
cinnamaldehyde. Wald (2002) found that 20 to 24% of carvacrol and thymol within OEO (oregano 
essential oil) was lost by pelletising the feed at 70 and 90°C. It was shown that losses of carvacrol 
(18%) and eugenol (18-27%) were not due to the pelletising step (81 to 86°C) but caused by the 
preceding steam treatment (48 to 55°C) (Bauerman, 2006). During storage of pelleted feed 
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containing app. 44.4 mg/kg carvacrol for 7 weeks, there was no loss of this compound, in contrast to 
γ-terpene and p-cymene (Westendarp et al., 2006). 
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Table 1. Physico-chemical properties of selected essential oils 
Compound 
(IUPAC; CAS No.) 
Carvacrol 
(2-methyl-5-propan-2-
ylphenol; 499-75-2) 
Thymol 
(5-methyl-2-
isopropylphenol; 89-83-8) 
Anethole 
(1-methoxy-4-(1-
propenyl)benzene; 104-46-1) 
Eugenol 
(4-allyl-2-methoxyphenol; 
97-53-0) 
Cinnamaldehyde 
(3-phenylprop-2-enal; 104-
55-2) 
Chemical structure  
OH
 
 
OH
 
OMe
 
OH
OMe
 
O 
Formula C10H14O C10H14O C10H12O C10H12O2 C9H8O 
Molecular weight (D) 150.2 150.2 148.2 164.2 132.2 
Density (g/cm3) 0.976 0.969 0.988 1.067 1.050 
Melting point (°C) 0-2 49-52 23 -12 - -10 -7.5 
Boiling point (°C) 234-238 232-233 234-237 253 246-251 
Vapour pressure at 20°C 
(Pa) 
35 250 (50°C) - 133 (64°C) 4.9 133 (78°C) 3.85 
Sol. in water (g/L) 0.83-1.10 0.85-1.01 to 1.4 (40°C) 0.11 0.80-2.41 1.42-1.45 
Sol. in ethanol (g/L) good 1000 good 500 (in 70%), good 150 (in 60%), good 
Octanol/water partition  
coefficient (log Kow) 
3.38-3.64 3.30 - 2.99 1.9 
pKa value 10.4 10.4 - - - 
Physical appearance at 
room temperature 
colourless to pale yellow 
liquid 
white crystalline powder or 
large colourless crystals 
colourless liquid colourless or pale yellow, 
thin liquid 
clear yellowish liquid 
Source: Andersen, 2006; Anonymous, 2000; Aromatic Consortium, 2005; Cocchiara et al., 2005; Griffin et al., 1999; Helander et al., 1998; Knobloch et al., 1989; Lee et 
al., 2004; Terpene Consortium, 2002; Ultee et al., 2002 and MSDS of product nr. 282197, T0501, 117870, E51791 and 96320 (Sigma-Aldrich, Bornem, Belgium)
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2. ANTIMICROBIAL ACTIVITY OF SELECTED ESSENTIAL OILS 
2.1. Mode of action 
 
The mode of action of the phenolics carvacrol and thymol involves several target sites, mainly acting 
on the bacterial cell membranes. Important to note is that the cytoplasmic membrane of bacteria has 
two principal functions: [1] barrier function and energy transduction, which allow the membrane to 
form ion gradients that can be used to drive various processes, and [2] formation of a matrix for 
membrane-embedded proteins (Sikkema et al., 1995). The first effort was done by Juven et al. (1994) 
who examined the working of thymol against Salmonella Typhimurium and Staphylococcus aureus. 
These authors hypothesised that thymol binds to membrane proteins hydrophobically by means of 
hydrogen bonding, thereby changing the permeability characteristics of the membrane. Further, they 
stated that carvacrol and thymol sensitize the membranes and when saturation of the site(s) of action 
occurs, there is a gross damage and sudden collapse of the integrity of the bacterial cytoplasmic 
membrane and leakage of vital intracellular constituents. Secondly, as a result of their lipophilic 
structure, these components will partition easily into the bacterial membranes (between the fatty acid 
chains) and make the membranes to expand and become more fluid. These two actions lead to 
membrane expansion, fluidization, destabilization and permeabilization, followed by release of 
membrane-associated and cell material, which has been reported in several studies (Cristani et al., 
2007; Gill & Holley, 2006a; Helander et al., 1998; Rhayour et al., 2003; Trombetta et al., 2005; 
Ultee et al., 2002; Veldhuizen et al., 2006; Walsh et al., 2003 and Xu et al., 2008). Knobloch et al. 
(1989) showed that carvacrol and thymol had an inhibitory effect on enzymatic reactions catalyzed 
by cell-free bacterial membranes. The studies of Ultee et al. (1999) and Ultee et al. (2002) on the 
action of carvacrol on Bacillus cereus led to the hypothesis of the ‘proton exchanger model’ (Fig. 3), 
whereby carvacrol acts as a trans-membrane carrier of monovalent cations by exchanging its 
hydroxyl proton for another ion such as a potassium ion (thus acting like an ionophore) leading to 
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dissipation of the pH gradient and electrical potential over the membrane, loss of the proton motive 
force and depletion of intracellular ATP pools, which is the onset to impairment of essential cell 
processes. Loss of potassium is problematic as well, since it plays a role in the activation of 
cytoplasmatic enzymes, in maintaining osmotic pressure and in the regulation of cytoplasmic pH.  In 
most cases, bacteria can counterbalance these effects by using ionic pumps and cell death does not 
always occur, but large amounts of energy are diverted to this function and bacterial growth is slowed 
down. Furthermore, a 2 h treatment of several bacteria with bactericidal levels of carvacrol and 
thymol induced a decrease in the proportion of unsaturated fatty acids (UFA) in the membrane (Di 
Pasqua et al., 2007). We conclude that the primary mechanism of action for carvacrol and thymol 
is therefore clearly related to its effect on the cytoplasmic membranes and energy generation. 
 
 
Fig. 3. Schematic overview of the hypothesized activity of carvacrol. Undissociated carvacrol 
diffuses through the cytoplasmic membrane towards the cytoplasm and dissociates, thereby releasing 
its proton to the cytoplasm. It then returns undissociated by carrying a potassium ion or other cation 
from the cytoplasm to the external environment (Ultee et al., 2002). 
cytoplasmic membrane 
in out 
OH OH 
K+ 
 +   H+ 
O-     
OK OK 
O-     
     H+ 
+   K+ 
 - 28 - 
Nevertheless, secondary effects of these phenolics, necessary for the bactericidal activity cannot be 
discounted. Gill & Holley (2006b) found that significant inhibition of ATPase activity of Escherichia 
coli and Listeria monocytogenes by carvacrol occurs at concentrations within the same range required 
for membrane disruption (> 750 mg/L), and suggested that this is a secondary cause of cell death. 
Helander et al. (1998) and Trombetta et al. (2005) stated that carvacrol and thymol might cross the 
cell membranes, penetrating the interior of the cell and interacting with intracellular sites probably 
critical for antibacterial activity. It has been demonstrated that highly lipophilic and low molecular 
weight compounds penetrate relatively easily through the outer membrane of several G- bacteria 
(Sikkema et al., 1995) and moreover carvacrol and thymol were also able to disintegrate the outer 
membrane of two G- bacteria (S. Typhimurium and E. coli O157:H7) thereby releasing 
lipopolysaccharides (Helander et al., 1998). A sharp decrease (80%) in B. cereus diarrheal toxin 
production was observed in the presence of 0.06 mg/mL carvacrol (Ultee & Smid, 2001). Overnight 
incubation with carvacrol induced production of heat shock protein 60, but not heat shock protein 70, 
and inhibited the synthesis of flagellin in E. coli rendering the bacterium non-motile and less 
infective (Burt et al., 2007b). To study further the mode of action of thymol, Shapira & Mimran 
(2007) constructed E. coli mutans exhibiting altered response to thymol. Essentially, they 
demonstrated that the antimicrobial activity of this compound cannot be attributed solely to 
depolarization of the membrane (membrane effect). 
 
For eugenol which has a phenolic functional group, membrane effects have been reported causing 
potassium leakage from E. coli  (500 mg/L) and S. aureus (1000 mg/L) (Walsh et al., 2003) and 
depletion of intracellular ATP of E. coli (Gill & Holley, 2006a) and are considered the primary 
mechanism of action. Gill & Holley (2004) suggested that depletion of intracellular ATP by eugenol 
could be primarily due to ATPase inhibition, more likely than by membrane effects dissipating the 
proton motive force. Eugenol and cinnamaldehyde induced a decrease of UFA in the bacterial 
membrane after a 2 h treatment (Di Pasqua et al., 2007).  Nevertheless, secondary effects are here 
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more important and diverse. Despite the vast data about the antimicrobial activity of 
cinnamaldehyde, the mode of action of this substance is much less understood and current knowledge 
points out that a range of independent and likely species-dependent targets sites are involved. 
Helander et al. (1998) found that cinnamaldehyde did not exhibit outer membrane disintegrating 
activity nor depletion of intracellular ATP, but suggested that cinnamaldehyde gain access to the 
periplasm and deeper parts of the cell through porin proteins. Becerril et al. (2007) retrieved this 
compound in dead E. coli cells, so the compound must penetrate the bacteria before cell disruption 
takes place. Electron microscopic observations revealed that the bacterial cells treated with the 
cinnamaldehyde also suffered from severe damages in their surface structure (Kim et al., 2004), but 
the membrane permeabilization observed by Gill & Holley (2006a) was clearly not as definitive as 
for eugenol and carvacrol. For compounds with an aldehyde group conjugated to a carbon to carbon 
double bond (α,β-unsaturated aldehyde) resulting in a highly electronegative arrangement like 
cinnamaldehyde, it is known that they may interfere in biological processes involving electron 
transfer and react with vital nitrogen components, e.g. functional groups on proteins and nucleic acids 
and therefore inhibit the growth of micro-organisms (Lis-Balchin, 2003) or form Schiff’s bases with 
membrane proteins and so prevent cell wall biosynthesis (Friedman, 1996). Treatment of 
cinnamaldehyde to B. cereus exponential phase cells resulted in no significant protein leakage but 
strong inhibition of cell separation (Kwon et al., 2003). Gill & Holley (2004) hypothesized that the 
mechanisms of the observed rapid inhibition of energy generation of cinnamaldehyde against L. 
monocytogenes and of eugenol against L. monocytogenes and Lactobacillus sakei at bactericidal 
concentrations could be due to the inhibition of glucose uptake or utilization and effects on 
membrane permeability. Gill & Holley (2006b) found that significant inhibition of ATPase activity 
of E. coli and L. monocytogenes by eugenol and cinnamaldehyde occurs at concentrations within the 
same range required for membrane disruption (> 750 mg/L) and suggested that this is rather a 
secondary cause of cell death. Sub-lethal concentrations of eugenol inhibited the production of 
amylase and proteases by B. cereus. Cell wall deterioration and a high degree of cell lysis were also 
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noted (Thoroski et al., 1989). Cinnamaldehyde and eugenol were found to be very effective inhibitors 
of histidine decarboxylase activity of Enterococcus aerogenes at sublethal levels (Wendakoon & 
Sakaguchi, 1995). The hydroxyl group of eugenol and the carbonyl group of cinnamaldehyde are 
thought to bind to proteins, preventing the action of amino acid decarboxylases in E. aerogenes. 
Finally, cinnamaldehyde binds to the FtsZ protein and inhibited subsequently cell division of B. 
cereus (Domadia et al., 2007). 
 
2.2. Evidence for antimicrobial activity and structure relationship 
 
Numerous studies have been performed to investigate the antimicrobial activities of plant EO against 
many different types of microbes, mainly foodborne pathogens and bacteria present in the oral cavity. 
Test methods used, include standardised broth dilution or disc and agar well diffusion assays. 
However, problems associated with the assessment of the antimicrobial activity by these diffusion 
methods are that the method in itself is highly dependent on water solubility and the ability of test 
components to diffuse through agar (Southwell et al., 1993) and on the effect on bacteria of oil 
vapours that may be released. As outlined above, EO are moderately to highly lipophilic, so this 
characteristic will influence results obtained in these tests. Turbidimetry (measurements of optical 
density) used in broth dilution assays detects only the upper part of growth curves (> 6 log10 
CFU/mL) (CFU, colony forming units), is influenced by the size of the bacterial cells, and requires 
calibration in order to correlate the results with viable counts obtained on agar media (plate counting) 
(Nychas & Skandamis, 2003). Therefore, results reported can differ a lot and are difficult to 
compare directly, also because different measures of bactericidal activity, broth media, redox 
potentials, NaCl content in the media, temperatures, pH, aw values, bacterial strains, enumeration 
techniques and sources of essential oils are used. Many of these factors can greatly affect the 
antibacterial activity of a compound as illustrated by Santiesteban-Lopez et al. (2007). 
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Table 2 lists data on Minimal Inhibition Concentration (MIC) and Bactericidal Activity 50% (BA50), 
depicted from numerous studies, but by no means complete. The table displays a high number of 
different species tested. Data of distinct species strains/serovars are taken together since Friedman et 
al. (2002) showed that the activities of a variety of compounds appeared to be relatively similar for 
various strains represented within a species. Nevertheless, in other studies strain/serovar difference in 
susceptibility were great, e.g. Si et al. (2006b). From Table 2, it is hard to make firm conclusions, 
because the range of antimicrobial activity listed for each bacterium is in some cases very wide (for 
reasons specified above) making a meaningful comparison impossible. Individual reports were 
studied in detail in an attempt to answer to the following questions: [1] can the EO be ranked in order 
of antimicrobial activity? and [2] are G- bacteria less susceptible than G+ bacteria? Bypassing the 
outer membrane is a prerequisite for any solute to exert bactericidal activity towards G- bacteria. The 
outer membrane represents an additional barrier to lipophilic compounds. Therefore, it is generally 
speculated that G- bacteria will be less susceptible than G+ bacteria (as is illustrated for a high 
number of plant EO by Chao et al. (2000) and Smith-Palmer et al. (1998)). However, from the 
studies presented in Table 2 no decisive difference in susceptibility between G- and G+ bacteria was 
seen. Ranking of the EO varied according to the bacterium considered. Generally, it can be stated 
that:  
[1] many pathogenic bateria (e.g. Clostridium perfringens, E. coli, S. enterica, S. aureus), 
including antibiotic resistant strains, were more or less susceptible to several EO 
indicating their huge potential in the control of pathogen proliferation; 
[2] Pseudomonas aeruginosa is the most resistant bacterium which is due to an active 
efflux mechanism and the barrier function of the outer membrane (Cox & Markham, 
2007); 
[3] cinnamaldehyde shows a more selective antimicrobial spectrum compared to the 
other compounds, and 
[4] anethole has weaker antimicrobial activities than the other EO.  
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Carvacrol and thymol exhibit similar activities against all of the species tested. Typically, both 
compounds do not show a progressive increase in antibacterial effect with increased concentration, 
but rather a sudden significant reduction in viable counts or bacterial metabolic activity once a certain 
(critical) concentration is applied (Juven et al., 1994; Macheboeuf et al., 2008). Sub-MIC levels 
increased the lag phase as was observed for thymol (Walsh et al., 2003 and Falcone et al., 2007). 
Both phenols are amongst the most powerful monoterpenes and this may be due to the acidity of their 
OH-group along with their lipophilic character (Knobloch et al., 1989). Ultee et al. (2002) argued 
that the OH-group and the presence of a system of delocalized electrons (benzene ring) are important 
for the antimicrobial activity of carvacrol, evidenced by the fact that structure analogues lacking 
these features have no or minor antimicrobial activities, which was confirmed by the study of Ben 
Arfa et al. (2007).  However, Veldhuizen et al. (2006) disagreed and stated that the OH-group is not 
essential for activity but does have special features that add to the antimicrobial mode of action of 
carvacrol. Cluster analysis based on the antimicrobial activities against 4 different species grouped 
carvacrol and thymol in a group of non-selective terpenoids whose main discriminating molecular 
properties were a higher water solubility and H-bonding capacity compared to a high number of other 
terpenoids (Griffin et al., 1999). In a disk diffusion assay both components showed clear inhibition 
zones towards E. coli, S. Typhimurium, Rhizobium leguminosarum, S. aureus and Bacillus subtilis, 
but were not effective against Pseudomonas aeruginosa (Sivropoulou et al., 1996), this is in 
agreement with data from Table 2. The precursors γ-terpinene and p-cymene did not reduce the 
growth of these bacteria as was shown by Knobloch et al. (1989) and Juven et al. (1994). 
Interestingly, Nostro et al. (2004) found no difference in susceptibility to carvacrol and thymol 
between methicillin-susceptible and methicillin-resistant staphylococci. 
 
Si et al. (2006b) found that Lactobacillus plantarum, Lactobacillus acidophilus and Bifodobacterium 
spp. were less sensitive to carvacrol (200-300 mg/L), thymol (200-300 mg/L) and eugenol (300-400 
mg/L) than the pathogenic bacteria E. coli and S. Typhimurium. This selective activity was most 
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clear for eugenol, although its bactericidal effect against the G- bacteria was weaker compared to 
carvacrol and thymol. Thymol showed moderate inhibition against the G+ bacteria and its activity 
was highest under aerobic conditions. Eugenol-isoeugenol and anethole-estragole are isomers, each 
of which differ only with regard to the position of the double bond in the aliphatic side chain. 
Eugenol and estragole have the double bond at the 2-position and isoeugenol and anethole at the 1-
position. Friedman et al. (2002) showed that eugenol was more active than isoeugenol and that 
anethole was less active than estragole. Apparently, these differences can be related with the position 
of the double bond. Methyl- and acetyl-eugenol were less effective than eugenol indicating the 
importance of a free OH-group (Knobloch et al., 1989). Obligate anaerobes were generally more 
sensitive to thymol and eugenol than facultative anaerobes (Shapiro et al., 1994). 
 
Lee & Ahn (1998) showed that cinnamaldehyde had a pronounced inhibitory activity in human C. 
perfringens and Bacillus fragilis, while it had no or a moderate effect against Bifodobacterium 
longum and L. acidophilus. Eugenol had in the same disk diffusion assay no effect against these 
bacteria. In humans, clostridia are associated with a variety of diseases, while bifodobacteria are 
considered beneficial. Therefore, this selective inhibition by cinnamaldehyde may have a 
beneficial role in balancing the intestinal microbiota. In an impregnated paper disk method, Lee et 
al. (2001) compared the antibacterial activity of several cinnamic acid derivates against human 
intestinal bacteria. Against E. coli, the order was 4-hydroxy-3-methoxy cinnamic acid > 
cinnamaldehyde > 3,4-dihydroxycinnamic acid > (cinnamic acid and others; not active); showing the 
importance of the methoxyl group. These three compounds were equally active against C. 
perfringens, but only cinnamaldehyde was (moderately to strong) active against the G+ bacteria B. 
bifidum, B. acidophilus and L. acidophilus. 
 
Interestingly, both carvacrol and cinnamaldehyde exhibited clear antimicrobial activity against both 
antibiotic-resistant and non-resistant Campylobacter jejuni strains, at concentrations ≥ 0.1% 
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(Ravishankar et al., 2008). Furthermore, in the studies of Inouye et al. (2001), Krist et al. (2007), 
Lopez et al. (2007) and Burt et al. (2007a) it was demonstrated that carvacrol, thymol, eugenol and 
cinnamaldehyde were very effective antibacterial compounds in the vapour phase against respiratory 
tract pathogens (Streptococcus spp., S. aureus), airborne microbes, foodborne microbes and carcass 
contaminants, respectively. Therefore, further applications could be the use in inhalation therapies to 
threat respiratory infections or to disinfect carcasses. Cinnamaldehyde was also found to prevent 
biofilm formation by E. coli and Pseudomonas spp., which was probably due to the ability of sub-
inhibitory concentrations of cinnamaldehyde to interfere with the quorum sensing (Niu et al., 2006). 
Further, cinnamaldehyde at sub-inhibitory concentrations (100 µmol/L) interfered with AI-2 based 
quorum sensing in various Vibrio spp. by decreasing the DNA-binding ability of LuxR resulting in 
marked phenotypic changes of the bacterium including reduced virulence and increased susceptibility 
to stress (Brackman et al., 2008). Nostro et al. (2007) demonstrated that carvacrol and thymol were 
able to inhibit formation and to eradicate biofilm of several strains of S. aureus and Staphylococcus 
epidermis; however the required concentration was twofold to fourfold greater than the concentration 
needed for inhibition of planktonic growth. Karpanen et al. (2008) found that thymol efficacy against 
S. epidermis in both suspension or in biofilm was different amongst two strains of the bacterium. But 
up to date, evidence for quorum sensing mechanisms of bacteria in the pig intestine has not been 
demonstrated. 
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Table 2. Minimal Inhibition Concentration (MIC) and Bactericidal Activity 50% (BA50) of selected essential oils tested in vitro in standardised 
assays against various bacteria 
MIC BA50 Essential oil Species of bacteria 
(approximate range; µg/mL) 
(1) 
Reference (2) 
Carvacrol 
 
Acrobacter butzleri 
Acrobacter cryaerophilus 
Acrobacter skirrowi 
Bacillus cereus 
Campylobacter coli 
Campylobacter jejuni 
Clostridium perfringens 
Enterobacter cloacae 
Enterobacter sakazakii 
Enterococcus faecalis 
Escherichia coli 
 
Haemophilus influenza 
Heliobacter pylori 
Klebsiella pneumoniae 
Listeria monocytogenes 
Mycobacterium avium (3) 
Pseudomonas aeruginosa 
 
Salmonella enterica 
 
64-128 
64 
128 
188-900 
500 
 
500 
750 
188 
225 
100-980 
 
63 
40 
250-500 
375-500 
72 
300-3900 
 
150-500 
 
 
 
 
 
 
110 
 
 
 
 
570 
 
 
 
 
860 
 
 
 
540 
 
Cervenka et al. (2008) 
Cervenka et al. (2008) 
Cervenka et al. (2008) 
Cosentino et al. (1999), Pol & Smid (1999) 
Kamel (2001) 
Friedman et al. (2002) 
Kamel (2001) 
Aligiannis et al. (2001) 
Lee & Jin (2008) 
Cosentino et al. (1999) 
Cosentino et al. (1999), Didry et al. (1993), Friedman et al. (2002), Griffin et al. (1999), Helander et al. 
(1998), Kamel (2001), Kim et al. (1995), Olasupo et al. (2003), Si et al. (2006b), Veldhuizen et al. (2006) 
Didry et al. (1993) 
Bergonzelli et al. (2003) 
Aligiannis et al. (2001), Didry et al. (1993) 
Cosentino et al. (1999), Friedman et al. (2002), Kim et al. (1995), Pol & Smid (1999) 
Wong et al. (2008) 
Aligiannis et al. (2001), Cosentino et al. (1999), Cox & Markham (2007), Didry et al. (1993), Griffin et 
al. (1999), Lambert et al. (2001) 
Cosentino et al. (1999), Friedman et al. (2002), Helander et al. (1998), Kamel (2001), Kim et al. (1995), 
Nazer et al. (2005), Olasupo et al. (2003), Si et al. (2006b) 
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Staphylococcus aureus 
 
Streptococcus pneumoniae 
Yersinia enterocolitica 
100-980 
 
125 
225 
 
 
 
 
Aligiannis et al. (2001), Cosentino et al. (1999), Didry et al. (1993), Griffin et al. (1999), Lambert et al. 
(2001), Nostro et al. (2007), Veldhuizen et al. (2006) 
Didry et al. (1993) 
Cosentino et al. (1999) 
Thymol 
 
Acrobacter butzleri 
Acrobacter cryaerophilus 
Acrobacter skirrowi 
Bacillus cereus 
Campylobacter jejuni 
Enterobacter sakazakii 
Enterococcus faecalis 
Escherichia coli 
 
Haemophilus influenza 
Heliobacter pylori 
Klebsiella pneumoniae 
Listeria monocytogenes 
Prevotella nigrescens 
Pseudomonas aeruginosa 
 
Salmonella enterica 
 
Selenomonas artemidis 
Staphylococcus aureus 
 
Streptococcus pneumoniae 
Streptococcus sanguis 
Treponema vincentii 
32 
64 
>256 
450 
 
188 
225 
100-1000 
 
125 
100 
500 
304-450 
300 
385-2000 
 
57-500 
 
200 
140-1000 
 
125 
1100 
300 
 
 
 
 
240 
 
 
600 
 
 
 
 
770 
 
 
 
340 
 
 
 
 
 
 
 
Cervenka et al. (2008) 
Cervenka et al. (2008) 
Cervenka et al. (2008) 
Cosentino et al. (1999) 
Friedman et al. (2002) 
Lee & Jin (2008) 
Cosentino et al. (1999) 
Cosentino et al. (1999), Didry et al. (1993), Falcone et al. (2007), Friedman et al. (2002), Griffin et al. 
(1999), Helander et al. (1998), Olasupo et al. (2003), Si et al. (2006b), Walsh et al. (2003) 
Didry et al. (1993) 
Bergonzelli et al. (2003) 
Didry et al. (1993) 
Cosentino et al. (1999), Falcone et al. (2007), Friedman et al. (2002) 
Shapiro (1994) 
Cosentino et al. (1999), Didry et al. (1993), Griffin et al. (1999), Lambert et al. (2001), Walsh et al. 
(2003) 
Cosentino et al. (1999), Friedman et al. (2002), Helander et al. (1998), Karapinar & Aktug (1987), Nazer 
et al. (2005), Olasupo et al. (2003), Si et al. (2006b) 
Shapiro (1994) 
Cosentino et al. (1999), Didry et al. (1993), Falcone et al. (2007), Griffin et al. (1999), Karapinar & Aktug 
(1987), Lambert et al. (2001), Nostro et al. (2007), Walsh et al. (2003) 
Didry et al. (1993) 
Shapiro (1994) 
Shapiro (1994) 
 - 37 - 
Vibrio parahaemolyticus 
Yersinia enterocolitica 
75 
155-225 
Karapinar & Aktug (1987) 
Cosentino et al. (1999), Falcone et al. (2007) 
Anethole 
 
Bacillus subtilis 
Campylobacter jejuni 
Escherichia coli 
Enterobacter aerogens 
Listeria monocytogenes 
Micrococcus leteus 
Pseudomonas aeruginosa 
Salmonella enterica 
Staphylococcus aureus 
Vibrio parahaemolyticus 
400 
 
>1600 
>1600 
 
>1600 
>1600 
100 
500, >1600 
500 
 
1200 
>6700 
 
>1600 
 
 
>6700 
Kubo et al. (2008) 
Friedman et al. (2002) 
Friedman et al. (2002), Kubo et al. (2008) 
Kubo et al. (2008) 
Friedman et al. (2002) 
Kubo et al. (2008) 
Kubo et al. (2008) 
Friedman et al. (2002), Karapinar & Aktug (1987) 
Karapinar & Aktug (1987), Kubo et al. (2008) 
Karapinar & Aktug (1987) 
Eugenol 
 
Acrobacter butzleri 
Acrobacter cryaerophilus 
Acrobacter skirrowi 
Bacillus subtilis 
Campylobacter coli 
Campylobacter jejuni 
Clostridium perfringens 
Enterobacter sakazakii 
Escherichia coli 
 
Heliobacter pylori 
Listeria monocytogenes 
Prevotella nigrescens 
Pseudomonas aeruginosa 
Salmonella enterica 
 
256 
128 
256 
800 
500 
 
500 
821 
300-2100 
 
100 
>1000 
1000 
600-2130 
100-500 
 
 
 
 
 
 
220 
 
 
1100 
 
 
810 
 
 
870 
 
Cervenka et al. (2008) 
Cervenka et al. (2008) 
Cervenka et al. (2008) 
Kubo et al. (2008) 
Kamel (2001) 
Friedman et al. (2002) 
Kamel (2001) 
Lee & Jin (2008) 
Friedman et al. (2002), Griffin et al. (1999), Kamel (2001), Kim et al. (1995), Kubo et al. (2008), Olasupo 
et al. (2003), Si et al. (2006b), Walsh et al. (2003) 
Bergonzelli et al. (2003) 
Friedman et al. (2002), Kim et al. (1995) 
Shapiro (1994) 
Cox & Markham (2007), Griffin et al. (1999), Kubo et al. (2008), Walsh et al. (2003) 
Friedman et al. (2002), Kamel (2001), Karapinar & Aktug (1987), Kim et al. (1995), Nazer et al. (2005), 
Olasupo et al. (2003), Si et al. (2006b) 
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Selenomonas artemidis 
Staphylococcus aureus 
Streptococcus sanguis 
Treponema vincentii 
Vibrio parahaemolyticus 
900 
75-2100 
2000 
800 
50 
 
 
 
Shapiro (1994) 
Karapinar & Aktug (1987), Kubo et al. (2008), Griffin et al. (1999), Walsh et al. (2003) 
Shapiro (1994) 
Shapiro (1994) 
Karapinar & Aktug (1987) 
Cinnamaldehyde Acrobacter butzleri 
Acrobacter cryaerophilus 
Acrobacter skirrowi 
Campylobacter coli 
Campylobacter jejuni 
Clostridium perfringens 
Escherichia coli 
Haempohilus influenza 
Klebsiella pneumoniae 
Listeria monocytogenes 
Mycobacterium avium (3) 
Pseudomonas aeruginosa 
Salmonella enterica 
Staphylococcus aureus 
Streptococcus pneumoniae 
32 
32-64 
64 
1000 
 
1000 
250-1000 
31 
250 
 
26 
<200-1400 
400-1000 
125 
125 
 
 
 
 
28 
 
570 
 
 
190 
 
 
330 
 
 
Cervenka et al. (2008) 
Cervenka et al. (2008) 
Cervenka et al. (2008) 
Kamel (2001) 
Friedman et al. (2002) 
Kamel (2001) 
Didry et al. (1993), Friedman et al. (2002), Helander et al. (1998), Kamel (2001) 
Didry et al. (1993) 
Didry et al. (1993) 
Friedman et al. (2002) 
Wong et al. (2008) 
Cox & Markham (2007), Didry et al. (1993) 
Friedman et al. (2002), Helander et al. (1998), Kamel (2001) 
Didry et al. (1993) 
Didry et al. (1993) 
(1) In the references MICs have been reported in the units mg/mL, % (v/v), µg/mL and mmol/L; for ease of comparison these have been converted to µg/mL, whereby it was assumed that EO 
have the same density as water; (2) MIC was determined as MBC, minimum bactericidal concentration in Bergonzelli et al. (2003), Cosentino et al. (1999) and Si et al. (2006b); (3) subspecies 
paratuberculosis 
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2.3. Synergism of mixtures of selected EO and other compounds 
 
Carvacrol and thymol were found to give an additive effect when tested against S. aureus and P. 
aeruginosa (Lambert et al., 2001). Synergism between carvacrol and its biological precursor p-
cymene has been noted when acting on B. cereus vegetative cells. P-cymene, not antimicrobial to 
itself, swells bacterial cell membranes to a greater extent than carvacrol does, enhancing the 
membrane associated action of carvacrol (Ultee et al., 2000a). Using a fractional inhibitory 
concentration index for the evaluation of the antimicrobial effect against respiratory pathogens of 
mixtures, Didry et al. (1993) found that only the combination carvacrol + thymol out of all binary 
mixtures of cinnamaldehyde, carvacrol and thymol showed synergism. On the contrary, Zhou et al. 
(2007a) showed that 7 out of 12 binary combinations of these 3 compounds were acting 
synergistically against S. Typhimuruim. In addition, demonstrating synergism is a hard task, different 
methodologies exist, and test conditions likely also influence the results to a great extent. To 
summarize, up to now hard evidence for synergism between EO components is lacking. 
 
Due to their strong flavour, application of these EO in food products is limited (to certain products). 
The use of hurdle technology to reduce concentrations and to use the advantages of combinations of 
preservation systems could be a solution for this problem (Ultee et al., 2000b). In this respect, a lot of 
combinations with other (antimicrobial) compounds have been tested. Nisin, which is not active 
against G- bacteria, combined with carvacrol or thymol showed a synergistic effect on the viability of 
B. cereus cells (Periago et al., 2001; Pol & Smid, 1999) and L. monocytogenes (Yamazaki et al., 
2004; Pol & Smid, 1999) and Bacillus subtilus (Ettayebi et al., 2000) and combined with eugenol 
against L. monocytogenes (Yamazaki et al., 2004). It can be speculated that EO might act 
synergistically with other bacteriocins that are produced by intestinal (endogenous or exogenous) 
bacteria. Cinnamaldehyde was synergistic with the antibiotic clindamycin to combat Clostridium 
difficile (Shahverdi et al., 2007). In an extensive study, using S. Typhimurium inoculated broth media 
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in microplate wells, Nazer et al. (2005) did not find clear synergistic antimicrobial effects for binary 
and triple combinations of carvacrol, thymol, acetic acid, lactic acid, pyropolyphosphoric acid and 
citric acid. Numerous dose combinations of carvacrol and thymol with either acetic acid, citric acid 
and EDTA against S. Tyhimurium have been tested by Zhou et al. (2007b) as well. Their results 
indicate that 9 out of 22 combinations were synergistic and that there were similar synergistic effects 
when carvacrol and thymol were combined with acetic acid or citric acid. The synergistic effect of 
thymol with EDTA was stronger than that of carvacrol with EDTA; the chelator EDTA alters the 
outer membrane permeability. Walsh et al. (2003) also showed that EDTA potentiated the 
antimicrobial activity of thymol and eugenol against both G- and G+ bacteria. Blaszyk & Holley 
(1998) found that sodium citrate and monolaurin could increase the inhibitory action of eugenol 
against 6 organisms to various degrees. In a study of Santiesteban-Lopez et al. (2007) synergistic 
binary mixtures with fractional inhibitory concentration index < 0.6 included 100 or 200 mg/kg 
potassium sorbate with 50 or 100 mg/kg thymol, carvacrol or eugenol against different foodborne 
pathogens. To conclude, there seems to be some evidence that these EO can act synergistically 
with organic acids. The mechanism for this potential synergism is, however, not clear. It can be 
argued that either the organic acids potentiate the effects of EO or that the EO potentiate the 
detrimental effects of organic acids. EO are more undissociated and lipophilic in an acidic 
environment (e.g. caused by organic acids), which is assumed to enhance their penetration in the 
bacterial membrane and permeabilization of the latter, hence in support of the former hypothesis. On 
the other hand, in line with the latter hypothesis is that stress on intracellular pH homeostasis caused 
by organic acids becomes lethal when EO further destabilize membrane pumps necessary for this 
homeostasis. 
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2.4. Factors interacting with the antimicrobial efficacy 
 
MIC values are determined by diffusion methods and in microtiter plates, using low organic matter 
broth media. It is well established that in more complex media (higher content of organic matter), 
higher doses are needed to have an equal inhibition of the bacterium. Plenty of direct and indirect 
evidence can be found in literature. For example; Shelef et al. (1984) reported that resistance to sage 
EO increased with decrease in water content and increase in protein and fat in food. 
 
Varel (2002) recovered more than 75% of carvacrol and thymol in the solid fraction and the 
remainder in the liquid fraction of the medium in a swine waste incubation experiment, indicating 
that these compounds can bind to organic matter. Pol (2001) stated that proteins are a limiting factor 
in the antibacterial activity against B. cereus in milk. Protein content has also been put forward as a 
factor inhibiting the action of clove oil on Salmonella Enteritidis in diluted low-fat cheese (Smith-
Palmer et al., 2001). Addition and condensation reactions can be involved, resulting in less active EO 
in the medium. The in vitro effect of thymol (175 mg/L) against S. Typhimurium was abolished by 
adding bovine serum albumine (9 mg/L) to the medium (Juven et al., 1994). In the beginning of the 
past century Sollmann (1919) already found that carvacrol precipitated proteins more actively than 
other compounds, including thymol. When a pig starter diet was added to the broth medium, the 
antibacterial effect of a mixture of carvacrol, thymol, eugenol and cinnamon oil was completely 
abolished (Si et al., 2006a). Cinnamaldehyde is known to react with proteins as stated elsewhere. Fat 
is another nutrient compromising antimicrobial activity in food matrices. If the EO dissolves in the 
lipid phase of the matrix, there will be relatively less available to act on bacteria present in the 
aqueous phase (Lis-Balchin, 2003). In opposite, carbohydrates in foods do not appear to protect 
bacteria from the action of EO (Shelef et al., 1984). Smith-Palmer et al. (2001) showed that the lower 
water content of food compared to laboratory media may hamper the progress of antibacterial agents 
to the target site in the bacterial cell. Gutierrez et al. (2008) found contradictory results concerning 
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the effect of protein and carbohydrates (starch). It can be stated that when predicting the 
antimicrobial activity of an EO, the amount and type of organic compounds in the medium should be 
taken in account, although the relevance and consequences of this for application in animal feed with 
the GIT as target site is less clear since digesta herein are liquid and thoroughly mixed. 
 
Thymol was found to be more effective against S. aureus and S. Typhimurium under anaerobic than 
in aerobic conditions and in lower pH conditions (Juven et al., 1994). The latter is explained by the 
fact that thymol is a weak acid and thereby more lipophilic in an acidic environment. 
Cinnamaldehyde was more inhibitory for the germination of Alyciclobacillus acidoterrestris spores at 
low pH (Bevilacqua et al., 2008). The maximum water solubility according to Knobloch et al. (1989) 
for carvacrol, thymol, eugenol and cinnamaldehyde is 1.1, 1.0, 0.8 and 1.4 g/L, respectively. 
Generally, it is assumed that when using hydrophobic substances only molecules dissolved in the 
aqueous phase can interact with the bacteria (Sikkema et al., 1995). Gill & Holley (2006a) found that 
bacterial cells in proximity of suspended droplets of the EO were fastly stained with propidium 
iodide. Several authors questioned if the addition of emulsifiers and/or stabilizers, in order to [1] 
avoid separation of the hydrophobic EO from the aqueous phase, and [2] to emulsify suspended 
droplets to smaller particles; could improve antibacterial efficacy. In vitro research with oregano oil, 
thyme oil, carvacrol, thymol, eugenol and cinnamaldehyde in combination with several emulsifiers 
and/or stabilizers (agar, lecithine, carrageenan, Surfynol 465W, Surfynol 485W, gums, 
methylcellulose …) gave inconsistent results (Burt & Reinders, 2003; Burt et al., 2005; Gaysinsky 
et al., 2005a; Gaysinsky et al., 2005b and Si et al., 2006a). Burt & Reinders (2003) assumed that the 
reduced antibacterial activity of oregano and thyme oil against E. coli O157:H7 in the presence of 
lecithine could be explained by the fact that the emulsifier orientated itself between the oil micelles 
and the aqueous phase and thereby physically hindering the interaction between the compound and 
the bacterium or that, as it is an additional source of phospholipids, neutralized the action on the 
bacterial membranes. 
 - 43 - 
All the former observations were done in ‘closed’ systems (for example food matrices). However the 
GIT is a dynamic and open system and therefore the conclusions made above should be taken with 
care when applied to animals. Indeed, the GIT is characterised by a (continuous) supply/transit of 
feed and endogeneous secretions and an intense interaction between digesta, gut physiology and gut 
microbiota. 
 
2.5. Tolerance and resistance of bacteria against EO 
 
Various studies highlighted the potential for induced bacterial tolerance in the presence of sub-
lethal doses of several EO. Adaptation of the foodborne pathogen B. cereus to carvacrol after in vitro 
growth in the presence of non-lethal concentrations (60 µg/mL) was observed (Ultee et al., 2000a). 
The mechanism behind this induced tolerance was a lowering of the bacterial membrane fluidity due 
to a change in the fatty acid and head-group composition of the phospholipids. Di Pasqua et al. 
(2006) found similar results for E. coli O157:H7 in the presence of cinnamaldehyde and for S. 
Typhimurium in the presence of carvacrol and eugenol. Various Heliobacter pylori strains did not 
acquire resistance to eugenol and cinnamaldehyde at sub-inhibitory concentrations even after 10 
passages, in contrast to amoxicillin and claritromycin (Ali et al., 2005). Pumbwe et al. (2007) found 
that, among other compounds, pre-treated with sub-lethal concentrations, cinnamaldehyde could 
induce multiple antibiotic resistance in Bacteriodes fragilis. Cardozo et al. (2004) found that in 
continuous ruminal in vitro incubations, cinnamon, anise and oregano extracts (all extracts at 7.5 
mg/kg dry matter) affected the molar proportion of acetate, propionate and butyrate from day 2 to 6, 
but these differences disappeared after day 6. Similarly, in a pig caecal continuous culture the 
antimicrobial effects of 500 mg/L carvacrol on all microbial groups and S. Typhimurium MB2184 
was not seen anymore 5 days after the addition of the EO (Report, 2006). In both cases it seems that 
the microbiota can adapt to the addition of EO. However, it is generally accepted that it takes at least 
two to three weeks for the anaerobic ruminal or caecal microbial community to establish a new 
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equilibrium following altered conditions. So, results from these investigations have to be interpreted 
with caution. 
 
Evidence points at possible adaptation mechanisms by bacteria, but this has not yet been clearly 
demonstrated for complex bacterial communities. Nevertheless, no doubt that this issue is of major 
importance regarding the efficacy and safety for use of these EO, and further research is urged in 
this area. 
 
2.6. In vitro antimicrobial activity against bacteria in the GIT of pigs 
 
Table 2 shows data on the activity of the selected EO against a variety of bacteria in standardised 
assays. However, if one is considering the use of the compounds in animal feeds aiming at a 
modulation of the GIT bacteria, the relevance of these data becomes less obvious. Indeed, physico-
chemical conditions along the GIT of pigs vary considerably and are hardly comparable with the 
conditions in these standardised methods. In addition, the EO have been tested mostly against pure 
cultures while the microbial ecology in the pig gut is characterised by a high diversity and a 
vulnerable stability. Therefore, one should test the effects of EO under gut-like conditions and 
against a mixed microbial gut population. In vitro models, simulating the gut fermentation and in 
vivo experiments should give more reliable data.  
 
Several reports present data on the antimicrobial activity of these EO in in vitro simulations of the 
fermentation prevailing in the pig gut, whether carried out as batch incubations or in continuous 
cultures. In a 24 h batch caecal fermentation, the number of Enterobacteriaceae and gas production 
was lowered with 24 and 21%, respectively, by 400 mg/L carvacrol (Piva et al., 2002). Si et al. 
(2006b) carried out 6 h caecal incubations and tested the effect of 300 mL/L carvacrol, 400 mL/L 
eugenol, 100 mL/L cinnamon oil and 200 mg/L thymol on the endogenous bacteria and introduced E. 
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coli O157:H7. All tested oils reduced E. coli O157:H7 counts by at least 2.5 log10 CFU/mL, E. coli 
counts by 1.25 log10 CFU/mL, and coliforms by 1.25 log10 CFU/mL. Only thymol reduced the 
number of lactobacilli (> 1 log10 CFU/mL). Manzanilla (2005) performed a series of gas production 
measurements in a closed in vitro system with pig intestinal contents. The results are summarized in 
Table 3. The dose range needed for antimicrobial activity of the EO in these incubations falls 
within (Si et al., 2006b) or is much higher (Manzanilla, 2005) than the range of MIC values 
from Table 2. 
 
Caco-2 cells and enteroinvasive E. coli EcK 262/75 were co-cultured to test the effectiveness of some 
EO in reducing the negative effects of the strain on cell viability (Dusan et al., 2006). Carvacrol, 
thymol and eugenol at 55.6, 25.5 and 85.4 mg/L were beneficial, while at the higher dose (274.9, 
120.2 and 410.5 mg/L, respectively) the EO, except for carvacrol, led to more damage of the cells 
(due to cytotoxicity of the EO). Roselli et al. (2007) did not find any protective effect of carvacrol 
and cinnamaldehyde against IPEC-1 membrane damage caused by enterotoxigenic E. coli K88. 
 
The EO can interfere with the adhesion of gut pathogens. The aggregation of a pig E. coli strain was 
reduced in a Salt Aggregation Test in the presence of cinnamon and thyme oil (Kamel, 2001). 
Percentage aggregation is negatively related to the hydrophobicity of the bacterium and the latter is 
assumed to be indicative to the ability to adhere to mucosal cells of the host. Dal Sasso et al. (2006) 
found that thymol at sub-MIC levels, diminished the adherence of E. coli and S. aureus to human 
vaginal epithelial cells. Moreover, the haemaglutinaton of E. coli was abolished.  
 
More recently, a great deal of effort has been made to investigate the effects of these EO on ruminal 
fermentation patterns (for reviews see Benchaar et al., 2008 and Calsamiglia et al., 2007). 
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Table 3. Effect of carvacrol and cinnamaldehyde (mg/kg fresh weight) on gas production 
measurements and bacterial counts (only B) in a closed in vitro incubation model with pig intestinal 
contents (after Manzanilla, 2005) (3) 
Stomach Jejunum Caecum 
B 
Treatment 
A (1) 
GP 
B (2) 
LB 
A 
GP GP EB LB 
B 
GP 
Carvacrol 
  100 
  500 
  1000 
  2000 
  3000 
  4000 
  10000 
 
0 
 
0 
 
 
 
++ 
 
 
 
0 
 
 
+ 
 
0 
 
+ 
 
 
 
++ 
 
 
0 
+ 
++ 
++ 
 
 
 
 
0 
 
 
0 
 
 
 
0 
 
 
+ 
 
 
 
0 
0/+ 
+ 
++ 
 
Cinnamaldehyde 
  100 
  500 
  1000 
  2000 
  3000 
  5000 
  10000 
 
0 
 
+ 
 
 
 
+ 
 
 
 
0 
 
 
+ 
 
0 
 
+ 
 
 
 
++ 
 
 
+ 
++ 
++ 
++ 
 
 
0 
 
 
+ 
 
 
+ 
 
 
+ 
 
 
 
0 
+ 
+ 
++ 
 
(1) intestinal contents of 1-week old animals; (2) intestinal contents of 5-weeks old animals; (3) 0 = no reduction, + = 
moderate reduction, ++ = total reduction of GP = gas production, EB = Enterobacteria and LB = Lactobacilli 
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3. FATE OF SELECTED ESSENTIAL OILS IN MAMMALS 
3.1. Pharmacokinetics and residues 
 
Numerous data have been reported on the pharmacokinetics of EO in humans and rodents. Carvacrol 
and thymol and their metabolites were found to be rapidly excreted in urine after oral 
administration (for review see Andersen (2006) and Kohlert et al. (2000)). Different oxidation 
products (e.g. propan-1-ol derivate and thymohydroquinone) and phase-II metabolites (glucuronide 
and sulphate conjugates) were detected in rats, rabbits and humans. Unchanged compounds could be 
detected only in small amounts in 24-h urine. Abid et al. (1995) demonstrated that thymol (and many 
other xenobiotics) could be glucuronidated by cultured Caco-2 cells, indicating that this compound 
could be partly detoxified in intestinal epithelial tissue. In a clinical trial, 12 volunteers received a 
single dose of a preparation of a thyme extract equivalent to 1.08 mg thymol (Kohlert et al., 2002). 
No thymol could be detected in plasma or urine, however thymol sulphate and thymol glucuronide 
were found in urine and only thymol sulphate was detected in plasma, suggesting the presence of 
UDP-glucuronyltransferase activity in kidney microsomes. Peak plasma concentrations were reached 
after 2.0 ± 0.8 h. In this study thymol was absorbed quickly, considerable plasma concentrations 
could already be detected after 20 min. Kohlert et al. (2000) suggested that residues in fat and muscle 
tissue will be limited, but literature data with pigs are scarce. In a trial with weaned piglets 
supplemented with thyme herb (0.1 to 1.0%), thymol was detected in the plasma (50 to 480 µg/L) but 
could no longer be find in plasma 3 days after the end of supplementation (Hagmuller et al., 2006). 
Stoni et al. (2005) could not detect carvacrol (15.1 mg/kg feed for weaned piglets) in different 
tissues, including muscle and abdominal fat, but it was detected in kidney and plasma (106-171 
ng/mL). In addition, a sensory panel was unable to detect a flavour/aroma difference between control 
and treated (500 mg/kg oregano oleoresin in diet) pork (Janz et al., 2007). Oswald et al. (2007) 
showed that carvacrol and thymol could be transferred from the sow’s diet (27.8 and 0.4 mg/kg, 
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respectively) to the milk, however the estimated recovery was very low, respectively 0.1 and 2%. 
Sensory characteristics of meat of lamb was not affected by diet supplementation with either 200 
mg/kg carvacrol or 200 mg/kg cinnamaldehyde (Chaves et al., 2008). Data on the stability in the GIT 
are scarce. Broudiscou et al. (2007) found no degradation of thymol in a 24 h in vitro caprine ruminal 
fermentation at a dose of 2000 mg/L, neither was degradation observed when the ruminal microbes 
were previously exposed to thymol . 
 
In rats and mice, given single doses of 250 mg/kg BW (body weight) more than 95% of C-14 
anethole was recovered with the majority in the 24-h urine (Bounds & Caldwell, 1996). Eighteen 
urinary metabolites were identified, the unchanged compound was not found in urine, which was in 
accordance to earlier work of Sangster et al. (1984ab, 1987) in humans. The pattern of metabolites in 
human urine differed only quantitatively from that seen in rodent urine. Anethole undergoes three 
primary oxidation pathways: O-demethylation, ω-side chain oxidation, and side chain epoxidation; 
followed by a variety of secondary pathways of oxidation and hydration, the products of which are 
extensively conjugated with sulfate, glucuronic acid, glycine, and glutathione (for further details, see 
Terpene Consortium, 2002). Some of the metabolites can have toxicological consequences or can 
result in a greater antimicrobial efficacy when applied in vivo compared to in vitro assays with the 
parent compound (Pauli & Schilcher, 2004). Appearance in human breast milk peaked 2 h (peak 
concentration; 23.3 µg/L) after a single administration of 100 mg E-anethole and returned to baseline 
after 8 h (Hausner et al., 2008). 
 
Few data are available on the pharmacokinetics of eugenol. Concentrations of eugenol in rat blood 
and plasma peaked rapidly following oral administration, but elimination half-lives in blood and 
plasma were long (> 14 h) (Guenette et al. 2007). Metabolization occurred principally in the liver via 
conjugation of the phenolic hydroxy group with sulphate or glucuronic acid or reduction of the 
double bond (Sutton et al., 1985 and Guenette et al., 2006).  
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In studies with humans and rodents it was shown that cinnamaldehyde was rapidly and completely 
absorbed from the gut and subsequently oxidized to cinnamic acid by NAD-dependent 
aldehyde dehydrogenases, followed either by conjugation and excretion or by further β-
oxidation, conjugation and excretion (with hippuric acid as major urinary metabolite) (for review 
see Bickers et al., 2005 and Cocchiara et al., 2005 and Fig. 4). The bioavailability (AUC – area under 
the curve - of time-response curve in plasma after oral gavage relative to AUC after i.v. injection) of 
cinnamaldehyde was calculated to be less than 20% at dose levels 250 and 500 mg/kg BW in rats, 
plasma levels were less than 1 and 10 µg/mL respectively (Yuan et al., 1992). In a study of Sapienza 
et al. (1993) with male F344 rats, the major urinary metabolite for doses 5 and 50 mg/kg BW (8 
consecutive days) was hippuric acid, accompanied by small amounts of cinnamic and benzoic acid. 
At the high dose (500 mg/kg BW), benzoic acid was the major metabolite, suggesting that saturation 
of the glycine conjugation pathway occurs at repeated dose levels of cinnamaldehyde. After 24 h, 
more than 80% of the radioactivity of a single dose was recovered in the urine and less than 7% in 
the faeces from all groups of rats, regardless of dose level. A second pathway of cinnamaldehyde 
metabolism, involving conjugation with reduced glutathione to form mercapturic acid derivates was 
described by Peters & Caldwell (1994). Regardless of dose or species, the β-oxidation pathway is the 
predominant pathway of metabolic detoxification of cinnamaldehyde. In many studies it was shown 
that orally administered cinnamaldehyde was principally cleared by urinary excretion and the sum of 
recoveries in urine and faeces exceeded always 85%. However, it remains a matter of debate whether 
the compound or its metabolites can lead to appreciable residues in the animal’s body. For example, 
24 h after oral administration of a single dose of 14C-labelled (β-carbon atom) cinnamaldehyde (5-
500 mg/kg BW) in rats, between 0.31 and 0.90% and between 0.13 and 0.26% of radioactivity was 
recovered in fat and muscle respectively (Sapienza et al., 1993). 
 - 50 - 
 
Fig. 4. Metabolism of cinnamaldehyde and derivates in mammals (Aromatic Consortium, 2005) 
 
These data indicate rapid metabolization and clearance of these compounds/metabolites with 
laboratory animals and therefore residues are primarily not anticipated. However, no or limited 
data are available in the literature concerning the possible retention of these compounds/metabolites 
in pig tissues, expecially when higher doses of these EO are applied in the feed. So caution is 
recommended. Thymol is included in Annex II of Council Regulation (EEC) No 2377/90, which 
means that it is assumed not necessary to establish a Maximum Residue Limit (MRL) in animal 
species for this compound (Anonymous, 1996), indicating its presumed safety for the consumer. 
However, its recommended veterinary use hereby is limited to 50 mg per animal (accumulated dose); 
which is a very low dose, for example, in comparison with the applied doses in our in vivo trials 
reported in Chapter 4B (500 and 2000 mg/kg feed). No MRL’s are available for the other EO. 
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3.2. Pharmacodynamics 
 
Various body functions and tissues are responsive to EO. There is a plethora of literature data dealing 
with their pharmacodynamic activities in vertebrates. Most observations were done using in vitro 
models and in vivo confirmation is lacking many times. Some data, that have particular relevance in 
the context of this thesis are presented here.  
 
3.2.1. EFFECTS ON SMOOTH, CARDIAC AND SKELETAL MUSCLE 
 
Boskabady & Jandagh (2003) described the dose-dependent (≤ 0.52 mmol/L) relaxant 
(bronchidilatory) effect of carvacrol on contracted guinea-pig tracheal chains. Carvacrol showed in 
vivo cardiac hyposensitive effects in rats (Aydin et al., 2007). Thymol was inhibitory for smooth 
(Beer et al., 2007) and cardiac (Szentandrassy et al., 2004) muscle contraction. On isolated blood 
vessels, anethole induced contraction at lower doses, mediated via opening of voltage-dependent 
Ca2+-channels, but relaxant effects at higher concentrations  (>10-2 mmol/L) (Soares et al., 2007). In 
several studies it was shown that eugenol had a relaxant effect on either smooth (Nishijima et al., 
1999 and Leal-Cardoso et al., 2002), cardiac (Damiani et al., 2004) and skeletal muscle (Damiani et 
al., 2003). The derivate methyl-eugenol showed equal antispasmodic actions (Lima et al., 2000). 
From the studies of Leal-Cardoso et al. (2002), Magyar et al. (2002), Magyar et al. (2004), Nishijima 
et al. (1999), Sarkozi et al. (2007), Szentandrassy et al. (2004) and Damiani et al. (2004) it can be 
concluded that the mechanism behind the inhibitory activity of carvacrol, thymol and eugenol was 
largely independent of the membrane potential and participation of the enteric nervous system, but 
was due to interference with calcium handling. Cinnamaldehyde was found to induce the release of 
noradrenaline in isolated guinea-pig ileum nerve terminals in a concentration dependent manner from 
5 to 50 µmol/L (Cheng et al., 2000). Cinnamaldehyde can depolarize the membrane resulting in a 
Ca2+-dependent and cAMP-related release of the neurotransmitter. This neurotransmitter is known to 
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induce intestinal relaxation, indirectly by the inhibition of acetylcholine release. The inhibitory action 
upon smooth muscle contraction has been reported for cinnamaldehyde (i.v. administration in rat) by 
Harada & Yano (1975) and on isolated rat aorta by Yanaga et al. (2006). So far, there is a body of 
evidence concerning the inhibitory effects on (smooth) muscle contraction, but it remains 
questionable if these effects can affect the digestive physiology of animal (e.g. gut motility) or 
other body functions. No data are available yet for pig. 
 
3.2.2. ANTIOXIDANT PROPERTIES 
 
The phenolic compounds carvacrol, thymol and eugenol have shown dose-dependent 
antioxidant properties in various in vitro systems (Table 4). It was stated that EO mainly owe their 
antioxidant activity to the H-donating capacity (Aeschbach et al., 1994). The H-donating capacities 
can be reasonably predicted from comparisons between bond dissociation energies of their most 
labile H-atoms. Surprisingly, the most labile H-atom of thymol, carvacrol and eugenol was the H-
atom of the isopropyl or allyl group and not the phenolic H-atom (Chemat et al., 2007). From Table 4 
it can be noted that there is some discrepancy for data in DPPH-scavenging (diphenylpicryl hydrazyl 
radical) test and inhibition of lipid peroxidation (CDi - conjugated diene method). Normally, good 
inhibitors of lipid peroxidation must rapidly scavenge the lipid peroxyl radicals (LOO•) and this is 
reflected at least by a substantial ability to reduce the much less reactive DPPH radical. Here, data 
indicate that these compounds inhibit lipid peroxidation somewhat less efficiently than could be 
anticipated from their strong DPPH-scavenging activities. Probably, this is due to their lipophilic 
character that results in a reduced access to LOO• (Chemat et al., 2007). Mastelic et al. (2008) 
constructed derivates of carvacrol, thymol and eugenol which showed better antioxidant properties 
than the parent compound. Table 4 aims to illustrate their distinctive antioxidant properties, as it was 
demonstrated in in vitro models.  
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Table 4. Antioxidant activities of selected EO in in vitro systems 
In vitro tests of antioxidant activity (1) Reference Essential oil 
  (reference 
compounds) 
DPPH TBARS CDi  
Carvacrol 
 (BHT, α-tocopherol) 
 
 (α-tocopherol) 
 
 (propyl gallate) 
 (-) 
 (trolox) 
 (α-tocopherol) 
 
 
Thymol 
 (BHT, α-tocopherol) 
 
 (α-tocopherol) 
 
 (propyl gallate) 
 (-) 
 (trolox) 
 (α-tocopherol) 
 
 
Eugenol 
 (α-tocopherol) 
 
 (-) 
 (trolox) 
 (trolox) 
 (-) 
 (-) 
 (α-tocopherol) 
 
 
Anethole 
 (α-tocopherol) 
 
IC50; 400 (18, 
8.6) 
 
 
 
 
 
 
 
 
 
IC50; 500 (18, 
8.6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IC50; >130 
(34.4) 
 
In % at 1000; 52.8 
(68.6, 90) 
In % at 1000; 69.9 
(93.5) 
In % at 100; 80 (86) 
In % at 400; 64 
IC50; 10.5 (59.0) 
In % at 1000; 52.8 
(90.0) 
 
 
In % at 1000; 41.5 
(68.6, 90) 
In % at 1000; 55.7 
(93.5) 
In % at 100; 82 (86) 
In % at 400; 73 
IC50; 6.6 (59.0) 
In % at 1000; 52.8 
(90.0) 
 
 
In % at 1000; 81.2 
(93.5) 
IC50; 100 
IC50; 13.1 (-) 
IC50; 2.2 (59.0) 
IC50; 1.85 (Fe2+) 
IC50; 12.2 (Fe3+) 
In %  at 10.3; 43 (97) 
 
 
 
In % at 1000; 41.9 
(93.5) 
 
 
 
In % at 1500; 
89.9 (94.8) 
 
 
 
 
 
 
 
 
 
In % at 1500; 
91.7 (94.8) 
 
 
 
 
 
 
 
In % at 1500; 
93.6 (94.8) 
 
Kulisic et al. (2004) 
 
Ruberto & Baratta (2000) 
 
Aeschbach et al. (1994) 
Youdim & Deans (2002) 
Prieto et al. (2007) 
Radonic & Milos (2003) 
 
 
 
Kulisic et al. (2004) 
 
Ruberto & Baratta (2000) 
 
Aeschbach et al. (1994) 
Youdim & Deans (2002) 
Prieto et al. (2007) 
Radonic & Milos (2003) 
 
 
 
Ruberto & Baratta (2000) 
 
Dorman et al. (2000) 
Ito et al. (2005) 
Chericoni et al. (2005) 
Priyadarsini et al. (1998) 
Priyadarsini et al. (1998) 
Ogata (2008) 
 
 
 
Ruberto & Baratta (2000) 
 
(1) DPPH test expressed as either percentage of DPPH reduced (%) at a defined concentration (mg/L) or as IC50 
value (mg/L); TBARS method, values are percentage of antioxidant index (%) at a defined concentration (mg/L) or 
as IC50 value (mg/L); CDi, conjugated diene method expressed as percentage of inhibition of lipid peroxidation 
(control without added antioxidant=0%) (%) at a defined concentration (mg/L) 
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In vivo, thymol (42.5 mg/kg BW) was beneficial for the ageing rat brain as it maintained significant 
higher antioxidant enzyme activities (superoxide dismutase and gluthathione peroxidase) and total 
antioxidant status (Youdim & Deans, 2000). The proportion of 22:6n-3 (DHA) in brain phospholipids 
was also higher in the supplemented rats compared to control. It is unclear whether this can be related 
to retention of this compound or metabolites in the respective tissue and a biological activity thereof.  
Eugenol reduced TBARS, increased GSH (reduced gluthatione) and L-ascorbate, but did not affect 
catalase, gluthatione peroxidase and SOD (superoxide dismutase) in the striatum of mouse (Kabuto et 
al., 2007). After 7 and 14 days administration of carvacrol (30 and 60 mg/kg/day and 15 and 30 
mg/kg/day respectively) to the drinking water of rats, it was found that DNA isolated from 
hepatocytes and testicular cells of treated animals was significantly more resistant to the damaging 
effects of hydrogen peroxide than DNA of control animals (Slamenova et al., 2008). The gastro-
protective effect of eugenol against indomethacin-induced ulcers in rats was partially attributed to its 
radical scavenging properties (Morsy & Fouad, 2008). An increase in intracellular GSH and GST 
(gluthatione S-transferase) was attributed to anethole (cited by Chainy et al. (2000)) and the same 
compound reduced TNF (tumor necrosis factor) induced lipid peroxidation and ROS (reactive 
oxygen species) generation (Chainy et al., 2000). Cinnamaldehyde showed no antioxidant activity in 
a lipid peroxidation model (Chericoni et al., 2005). In contrast Gowder & Devaraj (2006) found a 
dose-dependent effect of this compound on antioxidative status of rat kidney. It can be concluded that 
these EO are promising tools to alleviate diseases in which the uncontrolled proliferation of free 
radicals is very damaging, although the balance between an anti- and pro-oxidant effect (likely dose-
dependent) by these EO has been debated by several authors (Fujisawa et al., 2002 and Bakkali et al., 
2008). 
 
Related to this thesis, it has not been shown that these EO can protect the intestinal mucosa from 
oxidative damage. If so, it could be of great benefit for fast growing animals. EO with antioxidant 
activity could also be used indirectly as feed additives, in order to improve quality and shelf-life of 
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meat. However, as stated above, residues (and thus retention in meat) are primarily not anticipated or 
not fully proven. Hence, Vichi et al. (2001) found that back fat of pigs fed oregano extracts did not 
show a higher antioxidant activity than that of control animals. A tendency towards reduction of lipid 
oxidation was noted in oregano-fed pork (500 mg/kg oregano oleoresin in diet) (Janz et al., 2007). 
 
3.2.3. EFFECTS ON THE IMMUNE SYSTEM 
 
Carvacrol and eugenol triggered dose-dependently the Ca2+ mobilization in Jurkat T-cells and THP1 
monocytic cells (Chan et al., 2005). As intracellular Ca2+ mobilization is an important factor in the 
signalling ways for the recruitment and activation of blood monocytes and therefore the control of 
inflammation, both compounds can aid the immune response. Carvacrol, thymol and related 
compounds found in Nigella sativa seeds were evaluated for their effect on COX-1 (cyclooxygenase) 
and COX-2 activity (Marsik et al., 2005; Marsik et al., 2006; Landa et al., 2009). Carvacrol and 
thymol showed non-selective inhibition of both enzyme isoforms, with an inhibitory activity that was 
comparable to that of indomethacin. Thymoquinone and thymohydroquinone exhibited the strongest 
inhibitory effect on COX-2. Notably, the latter compound was also a phase-I metabolite of thymol 
found in rat plasma (Austgulen et al., 1987). Previously, it was demonstrated that thymol inhibited 
prostaglandin synthesis (cited by Anonymous, 2000). On the contrary, Huss et al. (2002) found no 
COX-2 inhibition by thymol. Braga et al. (2006) showed that thymol inhibited the release of elastase 
by human PML in a dose-dependent manner, which was correlated to the inhibition of calcium 
mobilization. Eugenol in rat diets (1700 mg/kg) reduced carrageenan-induced oedema (inflammation) 
in foot pads (Reddy et al., 2004). Prasad et al. (2004) showed that eugenol (IC50, 26 µmol/L) and 
cinnamaldehyde (35 µmol/L) inhibited 5-lipoxygenase in PML, the key enzyme involved in 
biosynthesis of leukotrienes which has been implicated in several inflammatory diseases in humans. 
Both phenylpropenes are also potent inhibitors of COX-2 activity (IC50, 125 and 245 µmol/L for 
eugenol and cinnamaldehyde respectively) (Huss et al., 2002), but for eugenol this was contrary to 
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Murakami et al. (2007) and also eugenol did not inhibit COX-2 gene expression (Okada et al., 2005). 
Concerning cinnamaldehyde, Guo et al. (2006) demonstrated that cinnamaldehyde reduced, in a 
dose-dependent manner, IL-1β-induced (interleukin 1 beta) COX-2 activity, but not IL-1β-induced 
COX-2 mRNA expression, and consequently inhibits production of PGE2 (prostaglandin E2) in 
cultured rat cerebral microvascular endothelial cells. Anethole and eugenol inhibited TNF induced 
NF-κB (nuclear factor kappa-light-chain-enhancer) activation (Chainy et al., 2000). Eugenol was 
shown to block the release of the bone resorbing mediators, including IL-1β, TNFα, and PGE2 from 
LPS (lipopolysaccharides) stimulated macrophages (Lee et al., 2007b). Cinnamaldehyde was able to 
inhibit LPS-induced DNA binding activity of NF-κB in addition to NF-κB transcriptional activity 
(Reddy et al., 2004) and age related NF-κB activity (Kim et al., 2007). NF-κB is a transcription 
factor that regulates the expression of inflammatory and immune genes. Youn et al. (2008) found that 
cinnamaldehyde suppressed the oligomerization of Toll-like receptor 4 induced by LPS, resulting in a 
downregulation of NF-κB activation. Further, cinnamaldehyde has been reported to inhibit activation 
of proliferation of T cells and to modulate their differentation (Koh et al., 1998) and to inhibit pro-
inflammatory cytokine secretion from monocytes/macrophages (Chao et al., 2008). Taking together, 
these compounds show to some extent anti-inflammatory/anti-pyretic (and anti-carcinogenic) 
properties. Most of the effects, especially for cinnamaldehyde, are mediated by modulation of 
intracellular signalling pathways. Their potential and relevance in practical pig raising are yet to be 
established. Since immune response activation represents a great deal of the animal’s energy budget 
(Klasing et al., 1987; Klasing, 2004); their properties to downregulate the inflammatory responses 
could be of benefit to healthy animals (for example in high health status herds) under conditions of 
exposure to low level immune stimulation (for example by commensal gut microbiota; without the 
presense of a serious virulent pathogen) or in cases of excessive inflammation wherein this reaction is 
not appropriate in defending the menacing threat (for example coccidiosis; Klasing, 2007). 
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3.2.4. EFFECTS ON TRANSIENT RECEPTOR POTENTIAL CHANNELS 
 
Among the five senses, the sense of touch (mechanical forces, chemical stimuli and temperature) is 
one of the most varied and least understood. The distinct touch stimuli are sensed by dorsal root 
ganglia and trigeminal neurons in the soma and head, respectively. These neurons convey 
information about the environment through specialized neuritis that extend from cell bodies. The 
transient receptor potential A1 (TRPA1) is member of the well-studied thermosensitive TRP 
channels that are present at the end of these extensions. TRPA1 is a Ca2+-permeable non-selective 
cation channel that depolarizes the plasma membrane and causes Ca2+ influx. TRPA1 is activated by 
noxious cold temperature and several irritant synthetic and natural compounds like mustard oil and 
garlic, which induces a burning sensation. Cinnamaldehyde is also a very potent, but selective 
agonist of TRPA1 through covalent modification of N-terminal cysteine residues (Bandell et al., 
2004). It induces a cold-sensation and was found to elicit nociceptive behaviour in mice (Bandell et 
al., 2004) and to evoke significant spontaneous pain, heat and mechanical hyperalgesia, cold 
hypoalgesia and a neurogenic axon reflex erythema by applying on the forearm in study participants 
(Namer et al., 2005). Cinnamaldehyde has been shown to provoke a heat sensation and burning pain, 
as exemplified on the human tongue (Albin et al., 2008). Basically, cinnamaldehyde causes a burning 
sensation, and whether the same stimulus is interpreted as hot, cold or otherwise depends on the 
activity of other TRP channels and neurons. For example, TRPA1 is invariably co-expressed with 
TRPV1 in sensory neurons. Activation results in burning heat, because TRPA1 causes a burning 
sensation and TRPV1 is a heat sensitive channel. Thymol (Lee et al., 2007a) and carvacrol (Xu et al., 
2006) were also found to be activators of TRPA1 (concentration-dependent, reversible and rapidly 
desensitized) and the activity of thymol was blocked by camphor. Camphor and menthol are known 
blockers of TRPA1, but activate other TRP channels (Macpherson et al., 2006). More recently, 
Macpherson et al. (2007), Andersson et al. (2008) and Cruz-Orengo et al. (2008) found evidence that 
TRPA1 displays broad specificity to endogenous molecules produced during tissue damage and 
 - 58 - 
oxidative stress and that are involved in anti-inflammatory processes. It is questioned if TRPA1 can 
function as a central chemical ‘hub’ nocisensor. TRPV3 is a warm-sensitive Ca2+ cation channel and 
is highly expressed in skin, tongue and nose. It was found to be a target for carvacrol, thymol and 
eugenol (Xu et al., 2006; Vogt-Eisele et al., 2007). Hereby, they elicit a warm sensation. Activation 
of TRP-channels can help explain the pungent, irritant and aversive properties of these 
compounds. Besides, recently a high number of publications on TRP functioning appeared showing 
their physiological role beyond their involment in the sense of touch. 
 
3.2.5. EFFECTS ON ABSORPTIVE, SECRETORY AND BARRIER FUNCTION OF 
EPITHELIAL TISSUE 
 
Kreydiyyeh et al. (2000) showed that eugenol and cinnamaldehyde were strong inhibitors of the 
in vitro activity of rat basolateral jejunal and kidney Na+-K+-ATPase, similarly to the action of 
cinnamon and clove oil (not for aniseed oil). In a rat perfusion study, they also found that the L-
alanine absorption was reduced significantly by 850 mg/L eugenol and 1000 mg/L cinnamaldehyde. 
This reduction was attributed to the inhibition of basolateral Na+-K+-ATPase, the driving force for 
secondary active transport. It also includes that these compounds can permeate the apical membrane 
and reach the serosal side. The opposite was found for aniseed oil. Kreydiyyeh et al. (2003) 
demonstrated in a rat perfusion study that aniseed oil (P. anisium L.; 76.7% E-anethole; 0.05% of oil 
in first perfusate; in second perfusate 180 µmol/L glucose was added) significantly increased jejunal 
glucose absorption and this was in line with the stimulation of the Na+-K+-ATPase activity in 
jejunal homogenates. Anethole also reduced urine output, the Na+-K+-ATPase activity in kidney 
homogenates was elevated. Boudry & Perrier (2008) found a dose-dependent (0-0.1 mmol/L) 
increase in Isc (short-circuit current) after addition of thymol and cinnamaldehyde in the Ussing 
chamber model. An increase in Isc means that these compounds induced transport of ions. They also 
found that the ionic basis was different; thymol induced Cl- and HCO3- secretion via a nervous 
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pathway, likely by nicotinic receptor stimulation and cinnamaldehyde induced only HCO3- secretion, 
probably by direct activation of epithelial nicotinic receptors. 
 
3.2.6. OTHER EFFECTS 
 
Mice, fed thymol and carvacrol (200 mg/kg BW) for 7 successive days were found to have higher 
levels of phase-I (e.g. GST) and phase-II enzymes, meaning that these compounds are bi-functional 
inducers of xenobiotic metabolism (Sasaki et al., 2005). Carvacrol has been investigated for its 
application in cancer therapy due to its inhibitory effects on different cancer cell types (Chan et al., 
2005) and in the prevention of cancer due to its anti-mutagenic activity (Ipek et al., 2005). Thymol 
inhibited bone resorption by a direct inhibitory effect on osteoclast activity (Mühlbuer et al., 2003). 
Carvacrol and thymol have inhibitory properties against acetylcholinesterase; carvacrol was ten times 
more potent than thymol (Jukic et al., 2007; Orhan et al., 2008). Inhibition of this enzyme leads to a 
prolonged activation of cholinergic receptors. Priestley et al. (2003) showed that thymol potentiates 
GABAA (gamma-aminobutyric acid) receptors. Many biological actions of eugenol have been 
reported. For example, eugenol induces central nervous system effects in mammals, such as 
hypothermia, a decrease in spontaneous motor activity, and anticonvulsant and general anaesthetic 
effects (cited by Leal-Cardoso et al., (2002)). Eugenol is a potent depressant of peripheral nervous 
activity and excitation–contraction coupling in skeletal muscle. At concentrations of 0.3 mmol/L or 
greater, both eugenol and cinnamaldehyde stimulated the activity of mitochondrial F0F1-ATPase, 
further they reduced the mitochondrial membrane potential and inhibited NADH oxidase, which 
would lower ATP levels and ultimately may influence cell function and growth (Kreydiyyeh et al., 
2000). The authors assumed that eugenol, as it is a lipophilic weak acid, may release a proton into the 
matrix, thus dissipating the gradient across the membrane and turning the mitochondrial ATP 
synthase enzyme, into an ATPase. On the other hand, a number of in vitro and in vivo experiments 
have demonstrated that cinnamaldehyde targets the thiols of cysteine residues on protein molecules. 
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For cinnamaldehyde, several biological activities such as peripheral vasodilatory, anti-platelet-
aggregration, antitumor, antifungal, cytotoxic and mutagenic/anti-mutagenic activities were reported 
(cited by Ka et al. (2003) and Huang et al. (2007)). Subash Babu et al. (2007) showed that 
cinnamaldehyde had dose-dependent (up to 20 mg/kg BW) hypoglycaemic and hypolipidemic effects 
in diabetic rats and that this was caused by a stimulation of insulin secretion of pancreatic β-cells. 
Already in 1998, Imparl-Radosevich et al. (1998) have found that cinnamon aqueous extracts 
improved insulin receptor function by activating insulin receptor kinase and inhibiting insulin 
receptor phosphates, leading to increased insulin sensitiviy. Later research showed that polyphenols 
were mainly responsible for this effect (e.g. Anderson et al., 2004). The use cinnamon oil for relief of 
diabetic complications is recommended. In addition, cinnamaldehyde (not eugenol) inhibited the 
activity of rat lens aldose reductase and consequently the conversion of glucose to sorbitol (Lee, 
2002). Intracellular accumulation of the latter compound has been implicated in the chronic 
complications of diabetes (e.g. cataract). However, reports from clinical trials gave conflicting results 
and a recent meta-analysis of several clinical trials showed that cinnamon did not alter glycosylated 
haemoglobin, fasting blood glucose or lipid parameters in patients with type 1 or type 2 diabetes 
(Baker et al., 2008). 
 
3.3. Toxicity 
 
Acute oral toxicity (LD50 – lethal dose 50%) of carvacrol and thymol have been found to be 810 and 
640-1800 mg/kg BW for rodents respectively, 100 and 750 mg/kg BW for rabbits and 250 mg/kg 
BW for cat (only thymol) (toxicity reviewed by Andersen (2006)). Cytotoxic effects for intestinal 
tissue have been reported as well. Carvacrol, thymol and eugenol at 55.6, 25.5 and 85.4 mg/L had no 
cytotoxic effects after 24 h against differentiated Caco-2 cells, while at the higher dose (274.9, 120.2 
and 410.5 mg/L, respectively) the EO, except for thymol led, to general damage of the cells and loss 
of monolayer adhesion (Dusan et al., 2006). Roselli et al. (2007) found that the highest non-toxic 
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concentration of carvacrol towards pig intestinal IPEC-1 cells was 750 mg/L (assessed by cell 
permeability), while more recently, Bimczok et al. (2008) found that the IC50 of carvacrol towards 
the same cell line amounted to 78.9 mg/L (MTT assay). Carvacrol caused apoptosis in porcine 
lymphocyte cultures (IC50; 27.3 mg/L) as determined by annexin V-binding and caspase-3 activation 
(Bimczok et al., 2008). Apoptosis could be a result of the effect of EO on mitochondrial membranes 
resulting in an impairment of the electron chain reactions and a pro-oxidant activity; as proposed by 
Bakkali et al. (2008). Acute oral LD50 for anethole was between 2090 and 3050 mg/kg BW in 
rodents (MSDS nr. A8638, Sigma-Aldrich, Bornem, Belgium). The determined NOEL (no 
observable effect level) of 300 mg/kg BW for anethole exceeds by far the estimated daily human 
intake in Europe (0.4 µg/kg BW), when used as a flavouring agent (Anonymous, 2004). Eugenol has 
a low acute oral toxicity, with a LD50 value ranging from 1930 to 3000 mg/kg BW (cited by Leal-
Cardoso et al. (2002)). A NOEL of 500 mg/kg BW in rats was determined (Steele, 1997). 
 
Oral acute LD50 for cinnamaldehyde in rodents was between 1160 and 2220 mg/kg BW, 
demonstrating that the oral acute toxicity of this substance is also rather low (Bickers et al., 2005). 
The highest non-toxic concentration towards pig intestinal IPEC-1 cells (assessed by cell 
permeability) for cinnamaldehyde was 660 mg/L (Roselli et al., 2007). Further details on 
toxicological studies with cinnamaldehyde are reviewed by Bickers et al. (2005) and Cocchiara et al. 
(2005). In summary; in oral chronic studies, NOAEL (no observable adverse effect level) were 
identified as 200 and 550 mg/kg BW in rats and mice respectively; this compound does not pose a 
risk for mutagenic and genotoxic activity, but cinnamaldehyde is a skin sensitizer in humans with a 
NOEL for induction of sensitization at 0.5%. Transformation of skin proteins into immunogenic 
entities through Michael addition reactions are thought to be responsible for the skin hypersensitizing 
reactivity. Surprisingly, this hypersensitivity was abolished in the presence of eugenol (quenching 
effect) (Basketter, 2000). Interestingly, Boyland & Chasseaud (1970), Raveendran et al. (1993) and 
Janzowski et al. (2003) showed that cinnamaldehyde was able to deplete GSH in rat liver in vivo and 
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in Chinese hamster V79 cells, respectively. Raveendran et al. (1993) and Gowder & Devaraj (2006) 
reported further effects of cinnamaldehyde (73.5 mg/kg BW, 30-90 days) on the rat liver and kidney 
antioxidant status and they concluded that cinnamaldehyde acted as a pro-oxidant. These results give 
evidence for cinnamaldehyde-mediated oxidative stress possibly contributing to cytotoxic/genotoxic 
cell damage. Additionally, cinnamaldehyde can inhibit the activity of enzymes involved in 
antioxidant defence, e.g. Van Iersel et al. (1997) found that cinnamaldehyde inhibited GST π-1 
activity (but this occurred at 2.5 mmol/L and was not complete and reversible) and Vander Jagt et al. 
(1997) demonstrated that this compound inhibited gluthation reductase in a cell-free system. These 
biological functions help explain why cinnamaldehyde can be used as an anticancer agent. Depletion 
of GSH renders the cell more sensitive to apoptosis and therefore inhibits tumor cell proliferation. Ka 
et al. (2003) demonstrated that cinnamaldehyde induced apoptosis through a reactive oxygen species- 
and caspase-dependent mechanism, which was abolished with pre-treatment with vitamin E (Wu et 
al., 2004). Further, cinnamaldehyde has been reported to have antitumor activity mediated by the 
inhibition of farnesyl protein transferase activity in vitro (Koh et al., 1998). 
 
Concluding, acute oral toxicity (cited LD50 values) for these compounds is variable according to 
species tested, but in most cases rather low. So it is expected that they will not pose major 
toxicological riks (for example with regard to current human exposure), but this has not been 
confirmed in pigs. Further, Stammati et al. (1999) reported that cinnamaldehyde, carvacrol and 
thymol had a variety of toxic effects at the cellular level and that these effects can be rather different 
between even chemically very closely related compounds, such as the isomers carvacrol and thymol. 
However, these authors concluded that in contrast to their cytotoxic effects, these compounds 
generally showed no or moderate toxicity for the animal (at least at dose levels many orders of 
magnitude greater than estimated levels of human exposure). The same conclusion was drawn for 
cinnamaldehyde by the Aromatic Consortium (2005).  
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4. FATE OF SELECTED ESSENTIAL OILS IN ENVIRONMENT 
 
4.1. Distribution and fate in the environment 
 
In vitro, carvacrol and thymol were stable in swine waste under anaerobic conditions for 62 days with 
90 to 95% of the compound being recovered in the waste solids, suggesting that mixed microbial 
populations in swine waste do not metabolize carvacrol or thymol under anaerobic conditions (Varel, 
2002). However, carvacrol and thymol were found to be biodegraded under aerobic (Chamberlain & 
Dagley, 1968) and anaerobic conditions (Gibson & Harwood, 2002) mainly by soil bacteria and by a 
diverse array of pathways. Dissipation half-lives of thymol in water and soil were respectively 16 and 
5 days (Hu & Coats, 2008). Over time, a considerable volatilization loss of thymol was found in the 1 
month study under the experimental conditions used. Less than 6% of thymol were detected as bound 
residues, and less than 3% were mineralized during the 30 day study. Anethole demonstrated ready 
and ultimate biodegradability (OECD Guideline 301B) with a biodegradation around 91.0% (Terpene 
Consortium, 2002). The soil bacterium Arthrobacter aurescens was able to degrade E-anethole, using 
this compound as the sole carbon source (Shimoni et al., 2002). Microbial degradation of both 
anethole and eugenol involves oxidation of the side chain to carboxylic acid prior to hydroxylation 
and cleavage of the benzene ring (Shimoni et al., 2002). For example, eugenol is microbially 
degraded to yield coniferyl alcohol, ferulic acid, vanillin and vanillic acid as intermediates (Tadasa, 
1977). Cinnamaldehyde has shown to be readily biodegradable (Haarmann & Reimer, 2001). It was 
100% biodegraded after 21 days in an OECD 301B test. Bock et al. (1988) described the reduction of 
cinnamaldehyde to corresponding alcohols by the fungus Botrytis cinerea. Microbial degradation of 
cinnamaldehyde is analogues to that of eugenol (Shimoni et al., 2002). The transport, distribution and 
persistence in the environment were modelled using the EQC Fugacity Model III. Cinnamaldehyde 
was distributed mainly to soil and water with a short persistence in the environment (279 h) 
(Aromatic Consortium, 2005). Vokou & Liotiri (1999) concluded that EO are used as carbon and 
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energy source by ubiquitously occurring soil micro-organisms and they would not accumulate in 
soil if environmental conditions favour growth of these micro-organisms. 
 
4.2. Ecotoxicity 
 
Few ecotoxicological data were found in literature. EC50 (half maximum effective concentration) in 
acute toxicity for Daphnia magna and LC50 (lethal concentration) for fish Pimephales promelas of 
thymol was 1.7-3.2 and 3.2-4.2 mg/L, respectively (MSDS nr. T0501, Sigma-Aldrich, Bornem, 
Belgium). The acute toxicity of cinnamaldehyde in Zebra fish was determined in a 96 h semi-static 
test. The measured NOEC (no observable effect concentration) was 2.8 mg/L, the LC50 4.3 mg/L 
and the LC100 5.5 mg/L. Two tests described the acute toxicity for Daphnia magna. Under semi-
static conditions the 48 h NOEC, EC50 and LC50 were 1.91, 3.86 and 4.22 mg/L, respectively and 
under static conditions EC50 equaled 11.5 mg/L. Green algae, exposed to various concentrations of 
cinnamaldehyde exhibited a 72 h EC of 6.87 mg/L based on average specific growth rate. Based 
upon the number of cells/mL, the 72 h NOEC and EC50 were 2.00 and 4.07 mg/L. Another study 
indicates that a 6.61 mg/L solution of cinnamaldehyde inhibits the growth of green algae by 35% 
after 80 h and 5% after 160 h (Aromatic Consortium, 2005). 
 
On average, their ecotoxicological toxicity is in the mg/L (ppm) range. Since data on 
environmental exposure based on current usage are lacking, an ecological risk assessment cannot 
be made. Their limited persistence in the environment (see previous section) is however in favour of 
their environmental safety. It is not anticipated that in-feed use of these EO use will pose ecological 
problems. If residues are to be found in pig slurries, they are expected to be biodegraded once 
deposited on agricultural soils or during other manure treatment (e.g. composting). 
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5. EFFECTS OF SELECTED ESSENTIAL OILS ON GUT BACTERIA AND 
FUNCTIONALITY AND PIG PERFORMANCE 
 
5.1. Effects on palatability in pigs 
 
The sensorial qualities of a feedstuff are mainly defined by its aroma, texture and flavour (Laitat et 
al., 2003) and determine in part its palatability (reflected by ingestive response). Aroma is 
appreciated by olfactive (smell) and nasal sensations, while flavour perception can be ascribed to 
taste and olfactive and thermo-mechanical stimulation, like hot or from chemical origin (e.g. spicy). 
The pig’s sense of smell is very performant and 2000 times superior to that of human. Generally, pigs 
accept well acidified feed, are indifferent for salt content, reject feedstuffs with a bitter taste and have 
a strong preference for sweet substances, in particular sucrose. It has been shown that pigs have 
preference for specific flavours, and which, when added to feed  were able to enchance feed intake in 
the first weak post-weaning (not in the following weeks) (McLaughlin et al., 1983). However, it is 
still a matter of debate to what extent flavours can positively influence feed intake and hence growth. 
 
Due to their aromatic chemical structure and volatility, EO have a reminiscent and characteristic 
(for humans mostly pleasant) aroma/flavour. Hence, EO may affect the palatability of feedstuffs 
or at least the animal’s preference when offered choice between either an aromatised and a non-
aromatised feed. For example, they could be of great help to overcome post-weaning anorexia 
usually observed in commercial practice. To test palatability, choice-feeding studies are to be 
compiled (Windisch et al., 2007). Indeed, increased feed intake in growth trials can simply reflect the 
higher consumption capacity of animals grown larger due to a better nutrient utilization compared 
with untreated controls. The number of choice-feeding studies with herbs/EO is very limited. They 
show dose-related depression of palatability in pigs fed EO from fennel and caraway (Schöne et al., 
2006) as well as from the herbs thyme and oregano (Jugl-Chizzola et al., 2006). 
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5.2. Effects on gut bacteria and functionality and animal performance 
 
Table 5 represents a summary of published data on the effects of the EO and related products on 
performance in weaned piglets. This Table may not represent all trials that have been carried out 
with these EO. It is believed that numerous trials, frequently without any positive effect, have 
probably not been published. In addition, the results of many trials carried out or (financially) 
supported by the industry are not accessible. Furthermore, a number of trials were not selected here, 
since: 
[1] a huge number of ‘products’, often extracts or mixtures of active components, sometimes 
ill defined for their exact composition, have been tested; 
[2] protocol details are sometimes lacking making comparison of results irrelevant, and 
[3] confirmation by analysis of the intended dose of active components in the feed is rarely 
done. 
Tests with single, pure and well defined compounds are very scarce. In the Table, treatment effects 
on animal performance are given as percentage difference compared to control. The reference control 
treatment is the negative control, which means a diet without AMGP. In some studies, a positive 
control was included as well, this is further described in the text below. In fact, both a negative and 
positive control should be used to fully understand the economical potential of these additives as 
alternatives. 
 
Several trials with OEO and other plant EO have been performed as early as in the 90’s. Kyriakis et 
al. (1998) and Tsinas et al. (1998a,b) found an increased ADG (average daily gain) and a reduced 
mortality, diarrhoea score and FCR (feed conversion ratio) by supplementation of OEO (Table 5). 
These trials were carried out on commercial pig farms with respectively a history of ETEC 
(enterotoxigenic E. coli), PE (proliferative enteropathy) and minor disease problems. Feed 
supplemented with 2000 mg/kg of an oregano preparation (WG Ropa, RopaFarm, The Netherlands; 
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containing 5% OEO of which was 81% carvacrol and 2% thymol) did not affect any of the bacterial 
counts and metabolites in the small and large intestine, neither it had an effect when piglets were 
experimentally orally infected by ETEC-O139:K82 (Gössling, 2001). The apparent digestibility of 
crude nutrients and the N-balance of the weaned piglets was not influenced by feeding piglets 
restrictively with this additive (Möller, 2001). In opposite, organic matter, crude protein and fat 
digestibility was improved in pigs supplemented with the same additive in a previous experiment 
(Günther & Bossow, 1998). In a recent trial with OEO (80 mg/kg, containing thymol and carvacrol), 
piglets were challenged with ETEC-O149K91+K88ac+(F4ac) at day 7 post-weaning (Jongbloed et 
al., 2007). OEO fed pigs showed a better faeces consistency and a lower faecal E. coli shedding post-
inoculation compared to control, while their were no differences in caecal bacterial counts at day 22 
post-weaning. Further, in preliminary results of a trial by Pérez et al. (2007) no significant effect of 
OEO (150 mg/kg) on total ileal microbes post-weaning was found. 
 
In contrast to obvious in vitro results by disk diffusion, 10 g/kg thyme herb (1.66 v/w EO with 39% 
p-cymene and 32% thymol) did not reduce shedding of haemolytic E. coli, nor it had an effect on 
animal performance of weaned piglets (Jugl-Chizzola et al., 2005). Pigs fed fennel oil showed similar 
and reduced performance compared to the negative and positive (formic acid, 7.5 mg/kg and copper, 
150 mg/kg) control, respectively (Schöne et al., 2006) (Table 5). 
 
In the trial of Namkung et al. (2004) (Table 5), ADG was reduced by 9.5% while the ileal pH, 
number of coliforms and lactobacilli in distal SI, intestinal morphology, white blood cell profile and 
plasma IL-1β, TNF-β, IgG, protein and albumin were not affected by the herbal extract mixture. 
PCR-DGGE (polymerase chain reaction – denaturing gradient gel electrophoresis) analysis revealed 
that microbiota diversity was not affected, but the number of ileal lactobacilli was increased (Gong et 
al., 2008). A mixture containing 5% carvacrol, 3% cinnamaldehyde and 2% capsicum oleoresin in a 
fatty acid carrier (Xtract, Pancosma, Switzerland) dosed at 150 and 300 mg/kg had no significant 
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effect on animal performance, neither it had on many gut parameters like villus/crypt architecture in 
weaned pigs (Manzanilla et al., 2004 and Nofrarias et al., 2006) (Table 5). Supplementation 
increased weight and pH of stomach content. At 300 mg/kg it tended to increase jejunal lactobacilli 
and to decrease enterobacteria when determined by direct plating; these results could not be 
confirmed by quantitative PCR analysis of the digesta (Castillo et al., 2006). Further, this 
supplementation reduced significantly the number of IEL (intra-epithelial lymphocytes) in jejunum 
and lymphocytes in ileocolic lymph nodes; however blood monocytes and the density of LPL (lamina 
propria lymphocytes) were increased. The higher stomach content reflects a lower gastric emptying 
rate and the authors argued that this was due to the direct effect of capsaicin on gastric motility. 
Oetting et al. (2006b) found a dose-dependent rise in apparent dry matter and energy digestibility 
when animals were supplemented with a herbal extract mixture, but this was not in line with animal 
performance in a growth trial (Table 5). The 2100 mg/kg treatment gave intermediate performance 
results between the negative and positive control (zinc bacitracin, 50 mg/kg; olanquindox, 50 mg/kg 
and colistin, 50 mg/kg), although it has to be stressed that in this trial growth rates were low. 
Histological parameters for this treatment compared to negative control were not altered, improved 
and worse in duodenum, jejunum and ileum respectively. Herbal treatments had no effects on 
microbial plate counts in SI (Oetting et al., 2006a). PRC-DGGE analysis of the bacterial population 
showed higher similarity, due to sampling site, than to treatments applied (Pedroso et al., 2005). 
Cluster analysis of V3 region of 16S rDNA amplicon showed that, within each small intestinal 
sampling site, distances within herbal treatments were smaller than compared to negative and 
positive controls. Piglets supplemented with a mixture of CEO (clove essential oil), eugenol, OEO 
and carvacrol showed similar performance as the positive control treatment (colistin, 75 mg/kg and 
tiamulin, 75 mg/kg), while other treatments performed less (Costa et al., 2007) (Table 5). 
 
Microencapsulated thymol did not change bacterial counts in different sections of the GIT (Piva et 
al., 2007b) (Table 5). However, in this abstract, the applied dose was not mentioned. Thymol at a 
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dose of 10000 mg/kg was applied in the trial of Trevisi et al. (2007) (Table 5). Additionally, half of 
the piglets were challenged with S. Typhimurium at day 5 post-weaning. Thymol reduced feed intake 
in the first days post-weaning and thereafter, had no effect on S. Typhimurium excretion, neither on 
tissue weights, digesta pH, salivary IgA, saliva production, ATPase gene expression, gastric TNF 
expression, number of parietal cells for each oxyntic gland and the depth of this gland. Serum IgA 
and IgM was significantly increased at day 5 by the thymol addition. In a subsequent publication, a 
molecular analysis (PCR-DGGE of the V6-V8 region of 16S rRNA) of the jejunal microbiota was 
presented (Janczyk et al., 2008). No effect of challenge or thymol supplementation on the bacterial 
diversity could be observed. Clustering of the objects revealed the presence of distinct clusters 
according to challenge and thymol supplementation; showing a shift in the jejunal bacterial 
community caused by treatment. In thymol treated animals, the G- bacterium Actinobacillus minor 
was absent and in contrast, the G- enterobacterium Citrobacter freundii was present in most animals 
fed thymol. Cinnamaldehyde, supplemented at 175 mg/kg, did not improve ADG, nor it had an effect 
on FCR and histology of jejunum (Andrés Elias et al., 2007). 
 
Several trials (Table 5) indicate that OEO at a particular low dose (range between 12.5 and 345 
mg phenolic compounds per kg feed) is able to significantly improve ADG and reduce FCR. 
Besides, OEO was able to ameliorate faeces consistency and lower diarrheoa incidence and ETEC 
shedding (after inoculation), without affecting gut microbial counts. However, in the studies of 
Gollnisch & Halle (2001) and Wald et al. (2001) OEO (100 mg/kg) did not improve animal 
performance, neither did a range of other plant EO. Probably, this inconsistency can partially be 
related to the hygiene status of the animals and hence performance of the control animals. 
‘Antimicrobial’ feed additives are expected to be more beneficial for challenged animals, housed 
under low hygienic conditions. Mixtures were tested by several groups, but firm conclusions cannot 
be made. Surprisingly, in some of these trials direct plating and molecular analysis of microbes 
gave conflicting results. These discrepancies can explained by the agglomeration of colonies on the 
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plates, the presense of a high number of viable but not culturable bacteria in the digesta, the 
amplification and quantification of free DNA from dead bacteria in the digesta and the multiplicity of 
16S rDNA genes per genome in prokaryriotic organisms (Castillo et al., 2006). Few trials have been 
conducted with pure compounds. A general observation is that in none of these studies the total 
number of bacteria in the GIT was reduced. Effects on histo-morphological and immune 
parameters were mostly lacking or variable. 
 
Fewer trials with growing and finishing pigs have been reported compared to weaned pigs. In the trial 
of Tsinas et al. (1998b) (see above and Table 5) the pigs were reared until slaughter weight. Animal 
performance and health status was equally improved as in the weaner period, and prevelance of 
Lawsonia intracellularis was markedly reduced. Walter & Bilkei (2004) studied the effect 3000 
mg/kg of Orepig (Oregpig GnbH, Pecs, Hungary) on the proportions of leukocyte sub-populations in 
growth-retarted growing-finishing pigs subject to various infectious agents. Orepig is the dried leaf 
and flower of O. vulgare, enriched with 500 g/kg cold-pressed EO of the leaf and flower of the plant, 
equivalent to 60 mg carvacrol and 55 mg thymol per kg. The proportion of CD4+, CD8+, MHC class 
II antigen and γδ-T cells in peripheral lymphocytes and double positive CD4+CD8+ in peripheral 
blood and mesenteric lymph nodes showed significantly higher values in the supplemented pigs from 
4 weeks supplementation on. As well, ADG and FCR was significantly better, but it has to be 
mentioned that the trial was conducted with severe growth-retarded and diseased animals.  
 
A significant reduced sow mortality and marked improved reproductive performance (significant 
decreased weaning-to-oestrus interval and increased farrowing rate) was observed after application of 
1000 mg/kg Oregpig in the pre-farrowing diet and lactation diet (from parturition throughout 
lactation and from weaning to mating) (Allan & Bilkei, 2005; Amrik & Bilkei, 2004; Kis & Bilkei, 
2003 and Mauch & Bilkei, 2004). However, also in these studies the performance of the control 
group was low compared to EU standards. Ilsley et al. (2003) found that sow and piglet performances 
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from day 15 to 21 were better with a diet supplemented with 100 mg/kg of a mixture of 5% 
carvacrol, 3% cinnamaldehyde and capsicum oleoresin 2% in a fatty acid carrier (Xtract, Pancosma, 
Switzerland) compared to control. 
 
Varel (2002) and Varel & Miller (2004) investigated the applicability of carvacrol, thymol and 
eugenol to reduce odour emissions and pathogen proliferation in swine waste (here added directly to 
swine slurries). Carvacrol or thymol at 2500 mg/L and eugenol at 2680 mg/L completely inhibited 
the production of the offensive odour compounds; isobutyrate, valerate, isovalerate and cresol, and 
significantly reduced other SCFA and gas emissions from swine waste. Fecal coliforms were reduced 
from 6.3 106 to 1.0 103 cells per mL 2 days after treatment with carvacrol (2000 mg/L) and were not 
detectable within 14 days. Notably, lactate accumulated only when carvacrol, thymol or eugenol 
were added and not in the control treatment. As mentioned before, carvacrol and thymol were stable 
in swine waste under anoxic conditions for 62 days. In conclusion, carvacrol and thymol are not 
metabolized in anoxic swine waste and they are potentially useful in controlling odor emissions and 
pathogens in swine waste. Thymol (2000 mg/L)  reduced E. coli and S. Typhimurium proliferation in 
swine slurries (Wells & Varel, 2008). 
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Table 5. Effect of plant extracts and essential oils and related plant extracts on production performance in weaned piglets (4) 
Treatment effect (% difference 
from untreated control) (1) 
Plant extracts and essential oils 
(intented dose of additive as fed; 
mg/kg / formulation type) 
Intended dose of active ingredient(s) 
(mg/kg) 
Basal diet Weaning age 
(d) / weight 
(kg) 
Dura-
tion of 
trial (d) ADFI ADG FCR 
Reference 
Oregano oil (Ropadiar) (500 / ICA) 
Oregano oil (Ropadiar) (500 / ICA) 
Oregano oil (Ecodiar) (250 / ICA) 
                                     (500 / ICA) 
Oregano oil (Ecodiar) (250 / ICA) 
                                     (500 / ICA) 
Oregano oil (Ecodiar) (250 / ICA) 
                                     (500 / ICA) 
Oregano (Oregpig) (1000 / -) 
                                (2000 / -) 
                                (3000 / -) 
Oregano oil (500 / ICA) 
                     (1000 / ICA) 
                     (2000 / ICA) 
Oregano oil (Royal P. ) (1500 / DC) 
Oregano oil (Royal N.) (500 / DC) 
                                      (1000 / DC) 
                                      (1500 / DC) 
Oregano oil (- / -) 
Clove oil (- / -) 
Cassia oil (- / -) 
Oregano oil, clove oil (- / -) 
OEO, 25 (81%  CAR, 2% THY) 
OEO, 25 (81%  CAR, 2% THY) 
OEO, 12.5 
OEO, 25 
OEO, 12.5 
OEO, 25 
OEO, 12.5 
OEO, 25 
OEO, 500 (CAR, 60; THY, 55) 
OEO, 1000 (CAR, 120; THY, 110) 
OEO, 1500 (CAR, 180; THY, 165) 
OEO, 25 
OEO, 50 
OEO, 100 
OEO, 112.5 
OEO, 37.5 
OEO, 75 
OEO, 112.5 
OEO, 100 
CEO, 100 
CAEO, 100 
OEO, 50; CEO, 50 
cereals, SBM 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
corn, SBM 
corn, SBM 
corn, SBM 
corn, SBM 
- 
- 
- 
- 
20 / 7.78 
28 / 7.5 
25 / - 
25 / - 
25 / - 
25 / - 
25 / - 
25 / - 
28 / 8.1 
28 / 8.1 
28 / 8.1 
21 / 5.4 
21 / 5.4 
21 / 5.4 
17 / 5.6 
21 / 5.2 
21 / 5.2 
21 / 5.2 
 - / 7 
- / 7 
- / 7 
- / 7 
42 
14 
21 
21 
37 
37 
37 
37 
21 
21 
21 
28 
28 
28 
35 
35 
35 
35 
35 
35 
35 
35 
-2.6 
+4.3 
0.9 
+11.3* 
-6.9 
-5.9 
-1.8 
-6.6* 
0 
+6.4* 
+4.9* 
+1.1 
+2.0 
+2.4 
-7.1* 
-3.1* 
-3.8* 
+4.2* 
+3.0 
+1.0 
+4.9 
+3.0 
+7.1* 
+16.6* 
+9.4* 
+18.5* 
+3.4 
+5.9* 
+6.6* 
+8.2* 
+2.1 
+8.9* 
+8.8* 
-0.2 
-0.8 
+0.3 
-6.2* 
-5.5* 
+1.1 
+10.7* 
+2.3 
-1.5 
+2.3 
+0.5 
-9.1* 
-12.0* 
-7.3* 
-9.3* 
-9.8* 
-10.7* 
-7.9* 
-13.7* 
-2.1* 
-2.1* 
-3.7* 
+0.8 
+1.6 
+0.8 
+1.2* 
+6.5* 
-3.0* 
-3.0* 
+0.7 
+2.7 
+2.7 
+2.7 
Günther & Bossow (1998) 
Van Krimpen et al., 2001) 
Kyriakis et al. (1998) 
Kyriakis et al. (1998) 
Tsinas et al. (1998b) 
Tsinas et al. (1998b) 
Tsinas et al. (1998a) 
Tsinas et al. (1998a) 
Molnar & Bilkei (2005) 
Molnar & Bilkei (2005) 
Molnar & Bilkei (2005) 
Neill et al. (2006) 
Neill et al. (2006) 
Neill et al. (2006) 
Ragland et al. (2007) 
Ragland et al. (2007) 
Ragland et al. (2007) 
Ragland et al. (2007) 
Gollnisch & Halle (2001) 
Gollnisch & Halle (2001) 
Gollnisch & Halle (2001) 
Gollnisch & Halle (2001) 
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Oregano oil, cassia oil (- / -) 
Clove oil, cassia oil (- / -) 
Clove oil (- / -) 
Oregano oil (- / -) 
Thyme oil (- / -) 
Cassia oil (- / -) 
Fennel oil (100 / -) 
Cinnamon, thyme, oregano 
  (7500 / ICA) 
Carvacrol, cinnamaldehyde and 
capsicum oleoresin (Xtract) 
                                (150, ICA) 
                                (300, ICA) 
Herbal extract mixture (700, ME) 
 
                                      (1400, ME) 
 
                                      (2100, ME) 
 
Herbal extract mixture (- / ME) 
                                      (- / ME) 
                                      (- / ME) 
 
Thymol (- / ME) 
Thymol (10000 / - ) 
OEO, 50; CAEO, 50 
CEO, 50; CAEO, 50 
CEO, 100 
OEO, 100 
TEO, 100 
CAEO, 100 
FEO, 100 (62.5% ANE) 
- 
 
 
 
CAR, 7.5; CIN, 4.5 
CAR, 15; CIN, 9 
TEO, 46.6; CEO, 23.3; OEO, 23.3; 
EUG, 23.3; CAR, 23.3 
TEO, 93.2; CEO, 46.6; OEO, 46.6; 
EUG, 46.6; CAR, 46.6 
TEO, 186.4; CEO, 93.2; OEO, 93.2; 
EUG, 93.2; CAR, 93.2 
CEO, 210; EUG, 210 
OEO, 210; CAR, 210 
CEO, 105; EUG, 105; OEO, 105; 
CAR, 105 
THY, - 
THY, 10000 
- 
- 
cereals, SBM 
cereals, SBM 
cereals, SBM 
cereals, SBM 
cereals, SBM 
corn, SBM 
 
 
 
corn, barl., SBM 
corn, barl., SBM 
corn, SBM 
 
corn, SBM 
 
corn, SBM 
 
corn, SBM 
corn, SBM 
corn, SBM 
 
- 
- 
- / 7 
- / 7 
- / 8.2 
- / 8.2 
- / 8.2 
- / 8.2 
21 / 7.0 (2) 
16-19 / 4.90 
 
 
 
20 / 6.0 (3) 
20 / 6.0 (3) 
21 / - 
 
21 / - 
 
21 / - 
 
24 / 7.2 
24 / 7.2 
24 / 7.2 
 
22 / 6.7 
24 / - 
35 
35 
35 
35 
35 
35 
21 
28 
 
 
 
21 
21 
35 
 
35 
 
35 
 
35 
35 
35 
 
42 
25 
+3.7 
+1.3 
- 
- 
- 
- 
+2.7 
-16.7 
 
 
 
-6.9 
-6.9 
-1.2 
 
-9.9 
 
+1.7 
 
-9.8 
-3.6 
+6.0 
 
+12.6* 
-12.9* 
-0.3 
-1.8 
+6.5 
+5.4 
-4.3 
+0.2 
+3.9 
-9.5 
 
 
 
-10.8 
-6.4 
-3.4 
 
-11.0 
 
+0.6 
 
-12.9* 
-10.8* 
+5.7* 
 
- 
-7.6 
+4.0 
+2.7 
-3.7 
-4.9 
-1.8 
-4.9 
-1.5 
-7.4 
 
 
 
+3.2 
-1.5 
+3.4 
 
+1.1 
 
+0.6 
 
+11.0 
+8.4 
+3.2 
 
- 
-6.4* 
Gollnisch & Halle (2001) 
Gollnisch & Halle (2001) 
Wald et al. (2001) 
Wald et al. (2001) 
Wald et al. (2001) 
Wald et al. (2001) 
Schöne et al. (2006) 
Namkung et al. (2004) 
 
 
 
Manzanilla et al. (2004) 
Manzanilla et al. (2004) 
Oetting et al. (2006b) 
 
Oetting et al. (2006b) 
 
Oetting et al. (2006b) 
 
Costa et al. (2007) 
Costa et al. (2007) 
Costa et al. (2007) 
 
Piva et al. (2007) 
Trevisi et al. (2007) 
(1) * = significantly different compared to negative control (P<0.05); (2) experimental period started 5d post-weaning; weight at day 5 post-weaning; (3) experimental period started 12d post-
weaning, weight at weaning and (4) for Abbreviations, see List of Abbreviatons. 
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6. LEGAL FRAMEWORK REGARDING THE USE OF EO IN ANIMAL FEEDING IN THE 
EU 
 
Herbal extracts, flavours and EO now fall within the scope of EC Regulation 1831/2003. In general, 
unprocessed herbs would be regarded as feed materials and thus not in need for authorisation. 
Notified plant extracts or components thereof are now included in the Community Register of Feed 
Additives (accessed Dec. 2008, 
http://ec.europa.eu/food/food/animalnutrition/feedadditives/registeradditives_en.htm). This register 
has only informative purposes and does not replace Community legal acts. The Community legal acts 
concerning the authorisation of each additive entered in the Register constitute the legal basis for the 
placing on the market and use of the additive concerned. This means that before November 2010, a 
complete scientific dossier for each notified EO or component thereof shall be submitted to EFSA 
(European Food Safety Authority). After full evaluation by EFSA, with positive outcome and after 
authorisation by the Standing Committee on the Food Chain and Animal Health (SCFCAH), these 
EO can be used legally in the EU in animal nutrition. Full references on legal aspects can be found at 
http://ec.europa.eu/food/food/animalnutrition/feedadditives/index_en.htm. The actual status of the 
EFSA evaluation of the scientific dossier can be checked at the Register of Questions 
(http://registerofquestions.efsa.europa.eu/roqFrontend/questionsList.jsf). 
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CHAPTER 2  
 
IN VITRO CHARACTERISATION OF THE ANTIMICROBIAL ACTIVITY 
OF SELECTED ESSENTIAL OIL COMPONENTS AND BINARY 
COMBINATIONS AGAINST THE PIG GUT FLORA 
 
 
ABSTRACT 
 
The antimicrobial activity of selected EO components against the major culturable components of the 
pig gut flora has been characterised by means of an in vitro incubation model simulating the 
fermentation in different sections of  the pig GIT. In a first study 7 components were screened for 
their antimicrobial properties. Dose-response equations were established for the 4 components with 
the highest potential in a second study. Binary combinations were tested as well, and the interaction 
effects were evaluated following the isobole method. The results of both studies indicated that 
carvacrol, thymol, eugenol and E-cinnamaldehyde give opportunities to modulate the flora and 
fermentation pattern of the GIT of pigs. Eucalyptol, terpinen-4-ol and E-anethole were found not to 
have interesting effects on the growth of the pig gut flora. The minimum concentration for carvacrol, 
thymol, eugenol and E-cinnamaldehyde in jejunal simulations to reduce the number of total 
anaerobic bacteria compared to control with a probability of 99.7% was 255, 258, 223 and 56 mg/L 
respectively. This strong activity of E-cinnamaldehyde was due to its progressively increasing effect 
against coliform bacteria; a dose of 104 mg/L gave a reduction of 1 log10 CFU/mL vs. 371, 400 and 
565 mg/L for carvacrol, thymol and eugenol respectively. However, E-cinnamaldehyde showed 
clearly less inhibitory activity towards lactobacilli than carvacrol and thymol. Therefore, the use of 
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E-cinnamaldehyde (for example 100 mg/L) and to a lesser extent eugenol could result in a shift in the 
microbial ecology in favour of lactic acid producing bacteria and reducing the number of coliform 
bacteria. Carvacrol and thymol showed very similar and non-selective antimicrobial properties. Their 
effect was more pronounced in acidic media and demonstrated a rapidly increasing bactericidal effect 
from a certain concentration on (400-500 mg/L in jejunal simulations). The inhibition of the 
production of total SCFA in jejunal simulations by these 4 candidates was related to their effect 
against coliform bacteria, however they did not alter the lactic acid and ammonia concentrations. Few 
combinations demonstrated synergism; most mixtures showed zero interaction or antagonism. 
Carvacrol + thymol (ratio ≥1) was synergistic against total anaerobic bacteria in jejunal simulations, 
however this effect was rather small. In caecal simulations, carvacrol, thymol and E-cinnamaldehyde 
were equally effective while eugenol had only an effect on coliforms. These data on the in vitro 
antimicrobial activities of EO components give support for a better control of the gastrointestinal 
bacterial community and design of alternative growth-promoters. Their in vivo potential is discussed 
as well. 
  
KEYWORDS: in vitro antimicrobial activity, carvacrol, thymol, eugenol, E-cinnamaldehyde, pig gut 
flora, lactobacilli, coliforms  
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INTRODUCTION 
 
For reasons of public concern and legislation (regulation EC/1831/2003 banned the use of in-feed 
antibiotics – AMGP - in the EU as from January 2006) there is a need for reliable alternatives for the 
AMGP. For decades, the use of AMGP in intensive pig production demonstrated a consistent ability 
to improve growth rates and feed conversion ratios (Cromwell, 2002). Their mode of action is not 
fully understood but there is evidence that nutritional antibiotics work in part by decreasing the 
overall numbers and/or specific bacterial species or their metabolic activities in the GIT (see reviews 
by Visek, 1978; Anderson et al., 1999; Corpet, 2000; Gaskins et al., 2002; Dibner & Richards, 2005 
and Page, 2006). Dierick et al. (2002a) stated that growth promotion by in-feed antibiotics is related 
and proportional to the inhibition of the total microbial load and microbial metabolism in the stomach 
and the jejunum. A reduction of the general bacterial growth in SI and pathogen proliferation should 
be major targets to improve animal performance and/or health (Apajalahti & Kettunen, 2006). 
 
Herbs, spices, plant extracts and derived products have been proposed and reviewed as alternatives 
for AMGP in pig raising (Doyle, 2001; Kamel, 2001; Turner et al., 2001; Rodehutscord & Kluth, 
2002; Lis-Balchin, 2003; Wenk, 2003; Lee et al., 2004 and Westendarp, 2005). However, different 
modes of action (e.g. antioxidant, antimicrobial, coccidiostatic, anti-inflammatory, 
immunomodulating effects and enhancement of endogenous secretions) are described depending on 
the product considered. Here, research has been carried out concerning the antimicrobial activities of  
some specific plant-derived pure chemicals. A large quantity of chemicals of herbal origin are well 
known for their antimicrobial properties (for review see Cowan, 1999; Hulin et al., 1998; Nychas & 
Skandamis, 2003 and Burt, 2004) with the EO and their components being a very interesting and 
promising group. 
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Most of the observations of antimicrobial properties of EO and their components found in literature 
are based on standardised broth dilution or disc and agar well diffusion assays. However, problems 
associated with the assessment of the antimicrobial activity by these diffusion methods are that the 
method in itself is highly dependent on water solubility and the ability of test components to diffuse 
through agar (Southwell et al., 1993) and on the volatility of the oils. Turbidimetry (measurements of 
optical density) used in broth dilution assays detects only the upper part of growth curves (> 6 log10 
CFU/mL), is influenced by the size of the bacterial cells, and requires calibration in order to correlate 
the results with viable counts obtained on agar media (plate counting) (Nychas & Skandamis, 2003). 
Moreover, physico-chemical conditions along the GIT of pigs vary considerably and are hardly 
comparable with the conditions in these standardised methods. Finally, these EO and components 
have been tested mostly against pure cultures while the microbial ecology in the pig gut is 
characterised by a high diversity and a vulnerable stability. Therefore one should test these EO and 
components under gut-conditions and evaluate their effects against a mixed microbial gut population.  
 
The aim of the present work was therefore to characterise the antimicrobial activity against the main 
culturable components of the pig gut flora of a selected number of EO components by means of in 
vitro batch incubations simulating the fermentation in different sections of the pig GIT in order to 
fully understand their potential as an alternative for the AMGP. The EO components included the 
monoterpenes: carvacrol, thymol, eucalyptol and terpinen-4-ol and the phenylpropenes: E-anethole, 
eugenol and E-cinnamaldehyde. These hydrophobic components have MIC values ranging between 
50 and 5000 mg/L depending on the EO component, methodology and test organism. For review on 
this topic the reader is directed to Burt (2004). 
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MATERIALS AND METHODS 
 
In vitro simulations of the pig gut fermentation 
 
CHEMICALS 
 
Carvacrol (282197), thymol (T0501), eucalyptol (C80601), E-anethole (117870) and eugenol 
(E51791) were obtained from Sigma-Aldrich nv/sa (Bornem, Belgium) and E-cinnamaldehyde 
(96320) was obtained from Fluka (Bornem, Belgium). Acros Organics (Geel, Belgium) provided 
terpinen-4-ol (36002). According to the manufacturer, terpinen-4-ol was synthetically prepared and 
therefore expected to be an 1:1 mixture of both enantiomers; (+)-terpinen-4-ol and (-)-terpinen-4-ol. 
This was confirmed by GC-analysis using a chiral separation column (Restek Rt-βDEXsm; 
Bellefonte, USA). Tea tree EO was delivered by Pranarôm (Ghislenghien, Belgium) and contained 
38,7% terpinen-4-ol which was by far the most important out of 58 identified components. GC-
analysis using a chiral separation column showed that 65% and 35% of terpinen-4-ol was (+)-
terpinen-4-ol and (-)-terpinen-4-ol, respectively.  
 
SIMULATION OF THE PIG GUT FERMENTATION 
 
The antimicrobial activity against the pig gut flora was evaluated in vitro under conditions prevailing 
in vivo in the stomach, jejunum and caecum of pigs. The in vitro batch incubation medium was 
composed of 2 g of an artificial substrate (Table 1), 20 mL of a buffer, 1 mL of a suspension of pig 
gut flora (inoculum) and 50 μL of a solution of the EO component in absolute ethanol. 
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Table 1. Composition of the artificial substrate for in vitro simulations of pig gastric, jejunal and 
caecal fermentation (mg/kg) 
Ingredient Gastric simulations Jejunal simulations Caecal simulations 
  Starch from corn (1) 650 650 100 
  Dextrose, anhydrous (2) 100 100 - 
  Casein (3) 100 100 100 
  Casein acid hydrolysate (4) 20 20 5 
  Soybean oil 30 30 10 
  Bile salts (5) - 0.65 - 
  L-cysteine hydrochloride anhydrous (6) - - 6.5 
  Fibre 
      pectine NF pure citrus medium (7) 
      alphacel (8) 
      mucine from porcine stomach, type II (9) 
 
20 
40 
10 
 
20 
40 
10 
 
105 
550 
100 
  Premix Biosow (10) 30 29.35 23.50 
(1) Sigma, S-4126, (2) Sigma, D-9434, (3) Sigma, from bovine milk, C-7078, (4) MP Biomedicals, LLC, 101291, (5) 
Sigma, B-8756 (50% sodium cholate and 50% sodium deoxycholate), (6) Sigma, C-1276, (7) Upjohn, item nr. 00 
160825 000 5, (8) MP Biomedicals, LLC, 900453, (9) Sigma, M-2378, (10) Vitamex NV, Drongen; Belgium (Vit A, 
400 IU/g, Vit D3, 80 IU/g, Vit E, 2400 mg/kg, Vit K, 40 mg/kg, Vit B1, 50 mg/kg, Vit B2, 150 mg/kg, Vit B3, 480 
mg/kg, Vit B6, 80 mg/kg, Vit B12, 950 µg/kg, Folic acid, 32 mg/kg, Choline, 8000 mg/kg, Fe, 4800 mg/kg, Cu, 
800 mg/kg, Zn, 4000 mg/kg, Mn, 3270 mg/kg, I, 45 mg/kg, Co, 45 mg/kg, Se, 15 mg/kg, antioxidants (BHT and 
ethoxyquin), 1500 mg/kg) 
 
The final concentration of ethanol in the incubation medium never exceeded 2.4 mL/L. The 
concentration of bile salts used in the jejunal simulations is rather low but within the physiological 
range of bile salts occurring in pig intestinal digesta (Campbell et al., 2004). The duration of the in 
vitro incubations was 3, 4 and 24 h for simulation of gastric, jejunal and caecal fermentation 
respectively, allowing an exponential growth of the bacteria. They were carried out in 100 mL vessels 
in a shaking water bath. The incubation system and parameters chosen resemble as closely as 
possible the in vivo conditions (Table 2). The medium and headspace in the 100 mL vessels for caecal 
simulations were gassed with a mixture of 90% N2 + 10% CO2 before starting the incubation and 
after adjusting the pH to 6.5.  
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Table 2. In vitro batch incubation conditions simulating the pig gastric, jejunal and caecal 
fermentation 
Parameter Gastric simulations Jejunal simulations Caecal simulations 
  pH 3 6.5 6.5 (adjusted after 12 h with 
1 mmol/L NaOH) 
  Medium and   
  headspace 
aerobic (free air) aerobic (free air) anaerobic (90% N2 + 10% 
CO2) 
  Duration (h) 3 4 24 
  Shaking waterbath 37°C ; f = 90 rpm 37°C ; f = 90 rpm 39°C ; f = 90 rpm 
  Buffer (mL) 20, glycine 0.2 mmol/L 20, phosphate 0.1 mmol/L 20, phosphate 0.1 mmol/L 
  Inoculum (mL) 1 1 1 
  Treatments (mg/L) 
    - first study 
    - second study 
 
0, 20, 100 and 500 
0, 100, 200, 300, 400 
and 600 
 
0, 10, 100 and 1000 
0, 100, 200, 300, 400 and 
600 
 
0, 10, 100 and 1000 
 
 
INOCULUM 
 
For practical reasons different approaches were applied for the preparation of the inoculum. For each 
gastric and jejunal incubation, a piglet fed a wheat-pea based diet without any antimicrobial growth-
promoter and weaned for 3 to 4 weeks was euthanised and the GIT was removed. The SI was divided 
into three segments of similar length. For the gastric incubations the contents of the two cranial 
segments were quantitatively collected and centrifuged (10 min, 1500 g, 5°C). The supernatant that 
contained a suspension of the luminal flora was used as inoculum. Small intestinal flora was used as 
inoculum for in vitro gastric simulations because of the ease of collection and isolation, and the fact 
that the dominant luminal indigenous flora components at both sites (stomach and jejunum) are the 
same (Vervaeke et al., 1979 and Jensen, 1998). For the jejunal incubations the content of the 
complete SI was collected and further processed in a similar way as for the gastric incubations. 
However, due to temporary unavailability of fresh flora, preservation techniques were used for the 
preparation of the inoculum for jejunal and caecal simulations in the first series of experiments. The 
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small intestinal contents of 8 slaughter pigs (ca. 105 kg BW) with known origin and feeding 
(commercial diet without any antimicrobial growth-promoting additive) were collected and mixed; 
feed particles were removed by centrifugation of these contents (10 min, 1500 g, 5°C); thereafter the 
flora was isolated by centrifugation of the supernatant (10 min, 15000 g, 5°C). This flora was then 
resuspended in a 40 g/L trehalose and 40 g/L sucrose solution and kept frozen at -80°C in 25 ml vials, 
according to Zayed & Roos (2004). For use as inoculum in jejunal simulations the frozen suspension 
was thawed, centrifuged (10 min, 15000 g, 5°C) and resuspended in a sterile 9 g/L NaCl-solution. In 
a preliminary trial we investigated the effect of this preservation technique on the bacterial groups 
used in this study. A slight reduction in the number of CFU/mL of the bacterial groups considered 
occurred. However, the ratio between the different bacterial groups remained unchanged. For caecal 
inoculum, caecal contents of 10 slaughter pigs (ca. 105 kg BW) with known origin and feeding 
(commercial diet without any antimicrobial growth-promoting additive) were sampled and freeze 
dried. A batch was made of these contents, that was suspended in a sterile 9 g/L NaCl-solution for use 
in caecal simulations (6.2 total anaerobic bacteria CFU log10/mL suspension). This method was 
satisfactory for the preparation of the caecal inoculum. 
 
Bacterial enumerations and analysis of bacterial metabolites 
 
BACTERIAL ENUMERATIONS 
 
Bacterial counts (viable counts; CFU log10/mL) on starting media (except for caecal simulations) and 
after incubation were done using the ring-plate technique (Van Der Heyde & Henderickx, 1963). 
Serial 10-fold dilutions were made from 1 g aliquots of incubated contents, using a sterilized peptone 
solution (1 g peptone + 0.4 g agar + 8.5 g NaCl in 1 L aqua destillata). Selective media were used for 
counting the following bacterial groups: total anaerobic bacteria (Reinforced Clostridial Agar, 
CM0151, Oxoid, Basingstoke, UK + 0.001% hemin), coliform bacteria (Eosin Methylene Blue Agar, 
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CM0069, Oxoid), streptococci (Slanetz & Bartley Medium, CM0377, Oxoid) and lactobacilli 
(Rogosa Agar, CM0627, Oxoid + 0.132% acetic acid). In the second study an additional selective 
medium was used for counting E. coli (Tryptone Bile X-glucuronide Medium, CM0945, Oxoid). For 
caecal incubations, all manipulations were carried out in 90% N2 + 10% CO2 atmosphere. The 
detection limits for the gastric, jejunal and caecal incubations were 1, 2 and 4 CFU log10/mL 
respectively. When no colonies could be observed on the plates after incubation, an at random 
number between 0 and the detection limit was assigned in the first study.  
 
ANALYSIS OF BACTERIAL METABOLITES 
 
In the second study samples from starting media and after incubation were taken and the fermentation 
was stopped with 2% of 6 mol/L H2SO4. Samples were stored at -20°C. SCFA and lactic acid were 
analysed by a GC-method described by Jensen et al. (1995). Ammonia was determined according to 
the method of Conway (1962). In a microdiffusion cell, ammonia is released from the sample by 
adding K2CO3 and diffuses into a H3BO3-solution. After diffusion ammonia is quantitatively titrated 
with 0.01 mol/L HCl.   
 
Experiments and statistical analysis 
 
PRELIMINARY TEST ON ETHANOL IN THE INCUBATION MEDIA AND EXPONENTIAL 
GROWTH OF BACTERIA 
 
In order to get insight into and to validate the in vitro model applied, preliminary experiments were 
carried out. To evaluate the effect of the addition of absolute ethanol on the fermentation 
characteristics, a number of gastric (n=9), jejunal (n=10) and caecal (n=5) simulations were 
performed whereby a positive control, with 2.4 mL/L absolute ethanol in the starting medium was 
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compared with a negative control (ethanol was replaced by aqua destillata). In a following 
experiment the effect of the presence of absolute ethanol on the antimicrobial activity of 1000 mg/L 
E-cinnamaldehyde in jejunal simulations (n=4) was evaluated. Therefore E-cinnamaldehyde was 
added either directly to the medium (without absolute ethanol) or as a solution in absolute ethanol 
(0.421 g/mL). Comparisons were made by a two-paired Student’s t-test using the SPSS 11.5 program 
software (SPSS Inc., Chicago IL, USA). 
To further explore the in vitro model, thymol at different concentrations (0, 100, 200, 400, 600 and 
1000 mg/L) was tested in a jejunal simulation whereby at various time points during the incubation, 
samples were taken for counting total anaerobic bacteria.  
 
FIRST SERIES OF EXPERIMENTS: SCREENING FOR ANTIMICROBIAL ACTIVITY 
AGAINST THE PIG GUT FLORA 
 
In a first series of experiments the 7 EO components were screened for their antimicrobial effects 
against the main components of the pig gut flora by in vitro simulations of the gastric, jejunal and 
caecal fermentation. EO components were tested in a dose range of 0-1000 mg/L (Table 2). In this 
series of experiments, tea tree EO was also tested but only in gastric and jejunal simulations. 
Incubations with this EO were carried out in which the final dose of terpinen-4-ol corresponded to an 
equal dose of terpinen-4-ol when used solely. Incubations were carried out per type of simulation and 
included each time two positive control treatments and all treatments with the EO components. All 
incubations were repeated three times which resulted in three independent replicates for each 
treatment. For each EO component a statistical analysis was performed per bacterial group and per 
type of simulation by the GLM ANOVA procedure with the fixed effect of treatment (concentration; 
see Table 2) and replicate as a random factor to account for variation in the inoculum using the SPSS 
11.5 program software. Means for effects of treatment (concentration) were compared using 
Duncan’s multiple range test (P<0.05). 
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SECOND SERIES OF EXPERIMENTS: DOSE-RESPONSE STUDY FOR CARVACROL, 
THYMOL, EUGENOL AND E-CINNAMALDEHYDE AND INTERACTION OF 
COMBINATIONS 
 
In vitro simulations of the gastric and jejunal fermentation were carried out in order to establish dose-
response curves for the in vitro antimicrobial activity of carvacrol, thymol, eugenol and E-
cinnamaldehyde (the components with the highest potential out of the first series of experiments) and 
to evaluate the interaction of combinations. All components and binary combinations per type of 
simulation were always tested simultaneously in the same incubation including two positive control 
treatments. There were three replicates. Components were tested individually at 0, 100, 200, 300, 400 
and 600 mg/L (Table 2). All possible binary combinations of the 4 EO components were tested in 
dose combinations of 100 + 100, 100 + 400, 250 + 250 and 400 + 100 mg/L.  
 
The antimicrobial effect of an EO component was expressed as the reduction in viable counts after 
incubation compared to the control. Dose-response curves for each EO component were fitted to the 
data points (x, y) using a quadratic function (y = bx + cx2) with GraphPad Prism 4 software 
(GraphPad Software Inc., San Diego, USA). The quadratic functions and the statistical output data 
were used to calculate additional parameters. The ‘minimum effect concentration’ (MEC) of a 
component was defined as the concentration that equals an effect that is three times the mean square 
error giving a probability of 99.7% that the effect is different from zero. A bacteriostatic 
concentration corresponds to the concentration of the EO component whereby a zero increase of CFU 
log10/mL during incubation was observed. ∆ y log10 CFU/mL stands for the concentration that gives a 
mean reduction of y log10 CFU/mL compared to control. 
 
The isobole method (Berenbaum, 1985 and Berenbaum, 1989) was used to evaluate the effect of the 
combinations. The method is based on the assumption of zero interactivity (additivity) of components 
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in a combination. A zero-interactive response for a combination of two agents can be expressed by 
the following equation : 
da/Da + db/Db = 1 
 
where da and db are known and represent values of concentrations of the two components in the 
combination. Da and Db are the concentrations of the components that individually would produce 
the same effect as the combination. On a graph of the dose-response curves of components A and B, a 
horizontal line intersects these two curves at points corresponding to Da and Db (x-axis coordinates). 
Da, Db and the combination (da, db) are iso-effective. Therefore, a solution is to find the horizontal 
iso-effective straight line (giving a y value), which would determine concentrations of A (Da) and B 
(Db) to satisfy the above equation. This y value represents the value of the expected effect of a non-
interactive combination based on the individual dose-response equations. A two-paired Student’s t-
test was used to compare the experimentally observed effect with the expected effect of the 
combination. If an experimentally observed effect of the combination is significantly different from 
the calculated expected effect, interaction can be inferred, if not, this is a zero-interaction. A second 
statistical test was performed using the interaction index. Therefore the value of the experimentally 
observed effect of a combination was inserted into the dose-response equations of each individual 
component as y to calculate the corresponding value of x (horizontal axis for concentration); Da’ and 
Db’. These values of Da’ and Db’ were inserted into the equation for zero-interaction and this was 
called the interaction index. An interaction index equal to one corresponds to zero-interaction. The 
interaction index was analysed using a one-sample Student’s t-test with a test value of one and a 
probability value of 0.05 as the level of statistical significance. Synergism was inferred if the 
interaction index was significantly lower than one; antagonism if otherwise.  
 
The analysis of bacterial metabolites was carried out in duplicate on the starting media, the control 
treatments, the treatments 0, 100, 300 and 600 mg/L for the individual components and 100 + 100 
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and 250 + 250 mg/L for the combinations. For lactic acid, total SCFA and ammonia a statistical 
analysis was performed by the GLM ANOVA procedure with the fixed effect of treatment and 
replicate as a random factor using the SPSS 11.5 program software. Means for effects of treatment 
were compared using Duncan’s multiple range test (P<0.05). 
 
RESULTS 
 
Preliminary tests on ethanol in the incubation media and exponential growth of bacteria 
 
No significant differences were found between the positive control, with 2.4 mL/L absolute ethanol 
in the starting medium and the negative control, except for the number of total anaerobic bacteria in 
caecal simulations (P<0.01). The number of total anaerobic bacteria was lowered from 9.74 to 9.31 
log10 CFU/mL. Whether E-cinnamaldehyde was added either directly to the medium (without 
absolute ethanol) or as a solution in absolute ethanol, the number of bacteria in jejunal simulations 
was not affected (P>0.05) (data not shown). 
A clear exponential increase in number of viable counts after a lag phase for the treatments 0, 100, 
200 and 400 mg/L can be seen in Fig. 1. A concentration of 1000 mg/L thymol reduced progressively 
the number of total anaerobic bacteria.  
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Fig. 1. Effect of thymol at different concentrations (mg/L) on the number of total anaerobic bacteria 
in a simulation of the jejunal fermentation in a preliminary experiment (n=1) 
 
First series of experiments: screening for antimicrobial activity against the pig gut flora 
 
GASTRIC SIMULATIONS 
 
Thymol had the highest antibacterial activity and showed significantly lower numbers for total 
anaerobic bacteria and coliforms at 100 and 500 mg/L and for streptococci and lactobacilli at 500 
mg/L (Table 3). Carvacrol significantly lowered all bacterial counts at 500 mg/L compared to control, 
but not at 100 mg/L. E-cinnamaldehyde had no effect on streptococci or lactobacilli, but reduced the 
number of coliforms from 5.83 to 4.54 log10 CFU/mL at 500 mg/L (P<0.05). Eucalyptol, terpinen-4-
ol, tea tree EO, E-anethole and eugenol had no significant effects (data not shown). 
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JEJUNAL SIMULATIONS 
 
The number of viable counts in the starting media was relatively low, but this was due to the 
preservation technique used for the inoculum. The jejunal simulations revealed that carvacrol and 
thymol had a very strong antimicrobial activity at 1000 mg/L, but no significant differences in 
bacterial counts compared to the control were found at 100 mg/L (Table 3). E-cinnamaldehyde 
significantly diminished total bacteria and coliform bacteria at 100 and 1000 mg/L. Carvacrol, 
thymol and E-cinnamaldehyde reduced significantly the number of streptococci and lactobacilli at 
1000 mg/L; however the reduction by E-cinnamaldehyde was clearly smaller than by carvacrol and 
thymol. Besides the treatment of 100 mg/L (no significant effects), the results for eugenol were 
comparable to those of E-cinnamaldehyde. Only total anaerobic bacteria were significantly reduced 
by E-anethole. Terpinen-4-ol at 1000 mg/L gave a significantly lower number of total anaerobic 
bacteria (-0.8 log10 CFU/mL) and coliform bacteria (-0.7 log10 CFU/mL). Tea tree EO and eucalyptol 
showed no significant effects within the dose range tested. 
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Table 3. Effect of EO components on different bacterial groups (log10 CFU/mL) in in vitro incubations simulating the pig gut fermentation in the 
screening experiments (data of treatments with 10 or 20 mg/L not shown) (n=3) (CAR=carvacrol; THY=thymol; ANE=E-anethole; 
EUG=eugenol and CIN=E-cinnamaldehyde) 
Bacterial group Concentration 
(mg/L) 
Gastric simulations 
 
Jejunal simulations Caecal simulations (4) 
  CAR 
(1) 
THY CIN CAR THY ANE EUG CIN CAR THY EUG CIN 
Tot.anaerobic 
bacteria 
 
 
 
 
Coliform bacteria 
 
 
 
 
 
Streptococci 
 
 
 
 
 
 
starting media 
0 
100 
500/1000 (2) 
RSD (3) 
 
starting media 
0 
100 
500/1000 
RSD 
 
starting media 
0 
100 
500/1000 
RSD 
 
 
5.09 
5.78a 
5.40a 
4.18b 
0.50 
 
4.29 
5.83a 
4.76a 
2.30b 
0.97 
 
4.82 
5.01a 
4.71a 
4.01b 
0.35 
 
 
5.09 
5.78a 
5.11b 
4.08c 
0.29 
 
4.29 
5.83a 
4.68b 
3.00c 
0.23 
 
4.82 
5.01a 
4.77a 
3.60b 
0.25 
 
 
5.09 
5.78 
5.42 
4.82 
0.44 
 
4.29 
5.83a 
5.74a 
4.54b 
0.21 
 
4.82 
5.01 
4.90 
4.80 
0.26 
 
 
4.57 
6.60a 
6.42a 
3.15b 
0.56 
 
3.58 
5.31a 
5.23a 
1.14b 
0.71 
 
2.64 
4.36a 
4.17a 
1.52b 
0.43 
 
 
4.57 
6.60a 
5.97a 
3.09b 
0.50 
 
3.58 
5.31a 
4.62a 
1.13b 
0.33 
 
2.64 
4.36a 
4.31a 
1.44b 
0.35 
 
 
3.91 
6.22a 
5.62b 
5.51b 
0.64 
 
4.11 
4.90 
4.69 
4.30 
0.25 
 
2.70 
4.17 
4.31 
3.88 
0.21 
 
 
4.57 
6.60a 
7.05a 
4.15b 
0.51 
 
3.58 
5.31a 
5.25a 
1.00b 
0.83 
 
2.64 
4.36a 
4.52a 
3.13b 
0.16 
 
 
4.57 
6.60a 
5.56b 
4.06c 
0.32 
 
3.58 
5.31a 
3.72b 
0.81c 
0.57 
 
2.64 
4.36a 
4.40a 
2.97b 
0.24 
 
 
 
9.39a 
9.65a 
6.79b 
0.82 
 
 
9.12a 
9.67a 
6.60b 
0.61 
 
 
8.80a 
8.61a 
5.30b 
0.69 
 
 
 
9.39a 
9.34a 
7.23b 
0.71 
 
 
9.12a 
9.54a 
6.94b 
0.62 
 
 
8.80a 
8.25a 
6.24b 
0.72 
 
 
 
9.69 
9.49 
9.60 
0.37 
 
 
9.32a 
9.00a 
7.49b 
0.45 
 
 
9.11 
9.08 
9.04 
0.31 
 
 
 
9.39a 
9.47a 
6.86b 
0.52 
 
 
9.12a 
9.32a 
6.43b 
0.61 
 
 
8.80a 
8.38a 
6.09b 
0.32 
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Lactobacilli 
 
starting media 
0 
100 
500/1000 
RSD 
4.87 
4.74a 
4.49a 
3.93b 
0.26 
4.87 
4.74a 
4.70a 
3.71b 
0.32 
4.87 
4.74 
4.79 
4.67 
0.19 
3.81 
4.63a 
4.54a 
1.56b 
0.66 
3.81 
4.63a 
4.48a 
2.44b 
0.36 
3.83 
4.63 
4.55 
4.43 
0.19 
3.81 
4.63a 
4.49a 
3.84b 
0.24 
3.81 
4.63a 
4.53a 
3.92b 
0.27 
 
8.13a 
7.99a 
4.68b 
0.80 
 
8.13a 
7.82a 
3.68b 
0.39 
 
8.47 
8.06 
8.28 
0.45 
 
8.13a 
7.28a 
4.11b 
0.44 
(1) Mean values per type of simulation, EO component and bacterial group bearing different superscripts are significantly different at P<0.05 (Duncan’s multiple range test), (2) 
500 mg/L for gastric simulations and 1000 mg/L for jejunal and caecal simulations, (3) RSD: Residual standard deviation, (4) Countings on starting media of caecal simulations 
were not carried out for all incubations and therefore not included in the table (see also text)
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CAECAL SIMULATIONS 
 
Bacterial countings on the starting media were only performed for 2 out of 6 incubations, due to 
practical reasons and as the same batch inoculum was used for all 6 incubations. The mean number of 
viable counts in the starting media in the 2 incubations for total anaerobic bacteria, coliforms, 
streptococci and lactobacilli were respectively 4.02, 2.86, 3.83 and 3.12 log10 CFU/mL. The results 
for carvacrol, thymol and E-cinnamaldehyde were more or less identical (Table 3). The 1000 mg/L 
treatment gave significant reductions compared to control while the 100 mg/L treatments were not 
effective. In caecal conditions, eugenol reduced only coliform bacteria. E-anethole (7.80 vs. 8.47 
log10 CFU/mL) and terpinen-4-ol (7.55 vs. 8.47 log10 CFU/mL) at 1000 mg/L had only a significant 
effect on lactobacilli. Eucalyptol again was not effective within the dose range tested. 
 
Second series of experiments: dose-response study for carvacrol, thymol, eugenol and E-
cinnamaldehyde and interaction of combinations 
 
GASTRIC SIMULATIONS 
 
In gastric simulations the MEC against total anaerobic bacteria for carvacrol and thymol was 159 and 
186 mg/L respectively (Table 4). E-cinnamaldehyde and eugenol were less effective. The cultivated 
bacteria were predominantly lactobacilli. This group was reduced with 0.5 log10 CFU/mL by 398 
mg/L carvacrol and 433 mg/L thymol, while the effect of E-cinnamaldehyde and eugenol at the 
highest concentration of 600 mg/L was still lower than 0.5. None of the tested combinations resulted 
in synergism against total anaerobic bacteria or lactobacilli, while some of the combinations showed 
a trend (P<0.1) towards antagonism. Generally, the variability between replicates for gastric 
simulations was higher than for jejunal simulations which interfered with a smooth analysis of 
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interaction. The lactic acid concentration ranged between 0.56 and 1.00 mmol/L (control treatment 
0.60 mmol/L), without significant differences between treatments.  
 
JEJUNAL SIMULATIONS 
 
The MEC for carvacrol, thymol, eugenol and E-cinnamaldehyde against total anaerobic bacteria in 
jejunal simulations was 255, 258, 223 and 56 mg/L respectively. E-cinnamaldehyde showed a strong 
effect against coliform bacteria (the most abundant group in the jejunal simulations) at low doses 
(Table 4), however the effect against coliform bacteria at 600 mg/L gave smaller differences between 
E-cinnamaldehyde, carvacrol and thymol (Fig. 2). The activity of the EO components against E. coli 
was similar to their respective activity against coliform bacteria (data not shown). For all groups of 
bacteria, the estimated parameters of the quadratic function for carvacrol and thymol were not 
different (P<0.05). This was also the case in the gastric simulations. 
Few combinations demonstrated synergism; most mixtures showed zero interaction or antagonism. 
Two combinations of carvacrol + thymol were clearly synergistic against total anaerobic bacteria: 
250 mg/L carvacrol + 250 mg/L thymol and 400 mg/L carvacrol + 100 mg/L thymol with an 
interaction index of 0.91 and 0.94 (P<0.05). Following combinations were found to have an 
antagonistic effect against both coliform bacteria and E. coli: 100 mg/L carvacrol + 400 mg/L 
thymol; 100 mg/L carvacrol + 400 mg/L eugenol; 100 mg/L thymol + 400 mg/L eugenol and 400 
mg/L eugenol + 100 mg/L E-cinnamaldehyde (P<0.05) 
Lactic acid concentrations were higher than in the gastric simulations but once again the statistical 
model did not indicate significant differences between treatments (P>0.05) (Table 5). Generally, the 
treatments with the strongest antimicrobial effects had the lowest concentration of total SCFA in the 
medium after incubation, with a lower proportion of acetic acid and higher proportions of propionic 
and butyric acid. Ammonia concentrations after incubation were relatively high (control treatment 
2.51 mmol/L). Significant differences were found between treatments, but these were considered not 
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to be physiologically relevant. Besides, none of the treatments could significantly reduce the 
concentration of ammonia compared to control. 
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Fig. 2. Quadratic curves fitting data points of effect of EO components on coliform bacteria in jejunal 
simulations of the pig gut fermentation (n=3) (starting media: 2.77 log10 CFU/mL; control: 5.31 log10 
CFU/mL) 
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Table 4. Data on the antimicrobial activity of carvacrol, thymol, eugenol and E-cinnamaldehyde in in 
vitro simulations of the pig gut fermentation in the dose-response study 
Bacterial group Carvacrol Thymol Eugenol Trans-
cinnamald. 
Gastric simulations 
  Total anaerobic bacteria 
  (4.54±0.54/4.22±0.29) (1) 
      MEC (2) 
      ∆ 0.5 log10 CFU/mL (3) 
      Bacteriostatic conc. (4) 
      R2 (5) 
Lactobacilli (4.00±0.65/3.78±0.65) 
      MEC 
      ∆ 0.5 log10 CFU/mL 
      Bacteriostatic conc. 
      R2 
 
 
 
159 
178 ± 76.5 
- 
0.19 
 
103 
398 ± 90.0 
- 
0.45 
 
 
 
186 
181 ± 84.0 
- 
0.21 
 
117 
433 ± 105.0 
- 
0.41 
 
 
 
360 
262 ± 102.7 
- 
0.13 
 
229 
> 600 
- 
0.30 
 
 
 
302 
321 ± 133.0 
- 
0.18 
 
83 
> 600 
- 
0.24 
Jejunal simulations 
  Total anaerobic bacteria 
  (5.01±0.72/6.05±0.51) 
      MEC 
      ∆ 1 log10 CFU/mL 
      Bacteriostatic conc. 
      R2 
  Coliform bacteria (2.77±1.02/5.31±0.84) 
      MEC 
      ∆ 1 log10 CFU/mL 
      Bacteriostatic conc. 
      R2 
  Streptococci  (3.05±0.64/4.68±0.33) 
      MEC 
      ∆ 1 log10 CFU/mL 
      Bacteriostatic conc. 
      R2 
  Lactobacilli (4.21±0.13/4.41±0.13) 
      MEC 
      ∆ 0.5 log10 CFU/mL 
      Bacteriostatic conc. 
      R2  
 
 
 
255 
447 ± 56.4  
457 ± 58.1 
0.87 
 
286 
371 ± 61.6 
535 ± 100.7 
0.92 
 
279 
487 ± 67.2 
> 600 
0.79 
 
232 
555 ± 55.5 
300 ± 24.0 
0.43 
 
 
 
258 
445 ± 57.4 
455 ± 59.1 
0.86 
 
323 
400 ± 74.6 
583 ± 125.9 
0.86 
 
261 
478 ± 46.0 
580 ± 61.5 
0.91 
 
154 
516 ± 40.0 
275 ± 17.2 
0.58 
 
 
 
223 
> 600 
> 600 
0.63 
 
207 
565 ± 68.4 
> 600 
0.73 
 
399 
> 600 
> 600 
0.63 
 
496 
> 600 
556 ± 55.0 
0.22 
 
 
 
56 
225 ± 28.2 
241 ± 30.1 
0.43 
 
96 
104 ± 44.4 
315 ± 77.4 
0.68 
 
274 
483 ± 79.0 
> 600 
0.68 
 
176 
> 600 
385 ± 25.2 
0.40 
(1) Viable counts (log10 CFU/mL) of starting media and control treatment (n=3), (2) MEC, Minimum Effect 
Concentration: concentration (mg/L) that equals an effect that is three times the mean square error giving a 
probability of 99.7% that the effect is different from zero, (3) Concentration (mg/L) that gives a mean reduction 
of y log10 CFU/mL compared to control ± standard deviation, (4) Concentration (mg/L) whereby a zero increase 
of viable counts (log10 CFU/mL) during incubation was observed ± standard deviation, (5) R2 of regression 
analysis using a quadratic function 
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Table 5. Effect of EO components on the production of bacterial metabolites in jejunal simulations of 
the pig gut fermentation (CAR=carvacrol; THY=thymol; EUG=eugenol and CIN=E-
cinnamaldehyde) (data 100 mg/L treatments and 100 + 100 mg/L combinations not shown) (n=3) 
Component or 
combination 
Concentrat. 
(mg/L) 
Lactic acid 
(mmol/L) (1) 
SCFA 
   Total 
(mmol/L) 
Molar % 
acetic acid 
 
Molar % 
propionic 
acid 
Molar % 
butyric acid 
Start. media 
Control 
CAR 
 
THY 
 
EUG 
 
CIN 
 
CAR+THY 
CAR+EUG 
CAR+CIN 
THY+EUG 
THY+CIN 
EUG+CIN 
RSD (2) 
- 
0 
300 
600 
300 
600 
300 
600 
300 
600 
250+250 
250+250 
250+250 
250+250 
250+250 
250+250 
1.26 
1.31 
1.21 
1.20 
1.21 
1.35 
1.24 
1.43 
1.22 
1.19 
1.31 
1.17 
1.15 
1.17 
1.31 
1.26 
0.19 
0.29 
0.51cd 
0.48bcd 
0.33ab 
0.43abcd 
0.32a 
0.45abcd 
0.38abc 
0.33ab 
0.32a 
0.33ab 
0.31a 
0.32a 
0.36ab 
0.32a 
0.32a 
0.10 
88.7 
89.7 
89.1 
84.0 
88.6 
84.6 
88.2 
85.3 
82.5 
84.2 
85.2 
84.6 
86.6 
86.7 
84.1 
81.9 
 
5.8 
4.0 
4.0 
5.5 
4.4 
5.3 
4.5 
4.5 
7.2 
5.6 
6.0 
5.5 
5.3 
5.3 
6.6 
7.0 
 
6.5 
6.3 
7.0 
10.6 
7.0 
10.1 
7.3 
10.1 
10.3 
10.2 
8.7 
9.9 
8.1 
7.9 
9.3 
11.1 
(1) GLM ANOVA was carried out for lactic acid and total SCFA, mean values per column bearing different 
superscripts are significantly different at P<0.05 (Duncan’s multiple range test), (2) RSD: Residual standard 
deviation. 
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DISCUSSION 
 
Validation of the in vitro incubation model 
 
The objective of this study was to characterise the antimicrobial activity against the pig gut flora of 
several promising EO components in an in vitro batch incubation model. In Fig. 1 it can be seen that 
for the control treatment in a jejunal simulation there is an initial lag phase followed by an 
exponential increase of the number of viable counts of total anaerobic bacteria. In the log growth 
phase the bacterial cells are highly metabolically active and are particularly sensitive to adverse 
conditions. In this way the model applied is well suited to evaluate the effect of antimicrobial agents. 
All EO components used show low water solubility but are well soluble in organic solvents. 
Therefore a solution of the respective component was made in absolute ethanol and added to the 
incubation medium and vigorously mixed. The final concentration of ethanol in the incubation 
medium never exceeded 2.4 mL/L. The addition of these small amounts of ethanol in the incubation 
medium had no or hardly any effect on the number of bacteria counted after incubation, even if 1000 
mg/L E-cinnamaldehyde was present. This shows that the addition of absolute ethanol does not affect 
the fermentation in this assay. The positive control treatment was therefore used as the control 
treatment in further incubations. 
It was concluded that the in vitro incubation model was satisfactory to evaluate the antimicrobial 
properties of the EO components. However, the microbial ecology of the pig gut is very diverse and 
complex. In our incubations the different bacterial groups considered did not show an equal rate of 
growth. In the starting media of the gastric and jejunal simulations (Table 3 and 4) the lactobacilli 
represented the most abundant group. After incubation they were outnumbered by the coliform 
bacteria. Coliform bacteria have shorter generation times and grow well in rich media like the 
incubation medium used. Surprisingly in the gastric simulations of the screening study, the number of 
lactobacilli did not increase while the number of coliform bacteria rose from 4.29 to 5.83 log10 
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CFU/mL. It has to be stressed that after addition of the artificial substrate and the inoculum to the 0.2 
mmol/L glycine buffer (pH 3) the pH of this medium rose up to 3.6 - 4.0 which further increased 
slightly during incubation. This explains why growth of coliform bacteria could occur. However in 
the gastric simulations of the dose-response study, no viable counts of coliform bacteria were 
detected neither in the starting nor after incubation.  
 
The antimicrobial properties of the isomers carvacrol and thymol 
 
Of the 4 tested monoterpenes (carvacrol, thymol, eucalyptol and terpinen-4-ol) only carvacrol and 
thymol showed interesting antimicrobial effects within the dose-range tested on the flora of the pig 
gut. Carvacrol and thymol are isomeric chemicals with a phenolic functional moiety. In the screening 
study carvacrol and thymol showed comparable antimicrobial properties (in all 3 types of 
simulations) which was confirmed in the dose-response study (equal estimated parameters of the 
quadratic function). They inhibited significantly and drastically the growth of all groups of bacteria at 
the highest dose in the first study (500 and 1000 mg/L for gastric and jejunal simulations 
respectively) (Table 3). For example, in jejunal simulations carvacrol and thymol at 1000 mg/L 
reduced the number of total anaerobic bacteria from 6.60 to 3.15 and 3.09 log10 CFU/mL 
respectively, which means a more than 3000-fold reduction. 
Two major conclusions can be drawn from the MEC and Δ y log10 CFU/mL values against all 
bacterial groups in jejunal simulations for both components (Table 4). Carvacrol and thymol display 
an important activity against all groups of bacteria equally and can therefore be considered as non-
selective, which is in line with the results of Cosentino et al. (1999), Griffin et al. (1999) and Van Zyl 
et al. (2006). However, Si et al. (2006b) found differences in sensitivity among a number of pig 
intestinal bacteria towards both carvacrol and thymol. On the other hand, these values illustrate the 
fact that these components have only obvious effects on the antimicrobial growth from a certain 
(critical) concentration on. This is clearly demonstrated by their highly concave quadratic curves for 
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the effect against coliform bacteria (Fig. 2). The estimated second order coefficients of the quadratic 
functions for carvacrol and thymol in this Fig. are 1.26 10-5 and 1.01 10-5 respectively. This important 
characteristic of the phenolic compounds carvacrol and thymol has also been described elsewhere 
(Juven et al., 1994). It looks like a minimum dose of carvacrol or thymol at the start is needed to 
inhibit bacterial metabolic activity in an sufficient way, which subsequently hampers bacterial 
reproduction and becomes bactericidal. Sub-bactericidal doses did however increase the lag phase 
(Fig. 1). Falcone et al. (2007) demonstrated that thymol was active on each phase of the growth cycle 
of 7 different hygiene-indicating and pathogenic bacteria. 
From Table 4 it can also be deduced that the concentration of carvacrol and thymol to reduce 
lactobacilli with 0.5 log10 CFU/mL was 28 and 16% higher in jejunal than in gastric incubations and 
that the MEC against total anaerobic bacteria and lactobacilli was lower in gastric incubations than in 
jejunal incubations. Their activity against the gut flora was therefore higher in gastric than in jejunal 
simulations. At low pH these molecules would be more undissociated and more hydrophobic, leading 
to a better binding to the hydrophobic areas of proteins and to a higher affinity for the lipid phase of 
prokaryotic membranes and enhancing membrane-associated events (Juven et al., 1994 and Sikkema 
et al., 1995).  
In caecal simulations, the 1000 mg/L treatments of carvacrol and thymol gave significant reductions 
compared to the control for all groups of bacteria, 100 mg/L was however not effective. No 
intermediate concentrations were tested here. Piva et al. (2002) found a 24% reduction of 
Enterobacteriaceae (4.1 vs 5.4 log10 CFU/mL) after 24 h of an in vitro caecal fermentation with 400 
mg/L carvacrol and Si et al. (2006b) found that both thymol (200 mg/L) and carvacrol (300 mg/L) 
reduced the number of coliforms, but only thymol had an effect on the number of lactobacilli in a 6 h 
caecal simulation. 
Interestingly, in our study the inhibitory effects of carvacrol and thymol on the production of total 
SCFA were clearly related to their antimicrobial effects against the coliform bacteria in jejunal 
simulations (Table 5). A shift to higher proportions of propionic and butyric acid was also observed. 
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The lactic acid concentration was not effected, which is quite surprising taking into account the 
effects against the lactic acid forming lactobacilli and streptococci.  
 
Minor antimicrobial effects by terpinen-4-ol, eucalyptol and E-anethole 
 
In contrast to other literature data we observed no clear antimicrobial activity of terpinen-4-ol (within 
the dose range tested). Terpinen-4-ol is a major component of the EO of tea tree (Melaleuca 
alternifolia). The tea tree EO is well recognized for its antiseptic characteristics. In natural sources of 
terpinen-4-ol, (+)-terpinen-4-ol is the predominant form (65%) (Leach et al., 1993), which was 
similar to the batch of tea tree EO used in this study. Therefore it was suspected that the different 
ratio between the enantiomers (1:1 for terpinen-4-ol) or synergistic effects between various 
components of the tea tree EO could interfere with the antimicrobial properties. However, the 
antimicrobial activity of tea tree EO here was equal or weaker than that of terpinen-4-ol, which has 
also been reported by Cox et al. (2001). Furthermore from the screening study it was concluded that 
eucalyptol (no significant effects) and the phenylpropene E-anethole (significant effect for total 
anaerobic bacteria in jejunal simulations and lactobacilli in caecal simulations at 1000 mg/L) did not 
give interesting and consistent effects.  
 
Selective antimicrobial activity of eugenol and E-cinnamaldehyde 
 
In our study the ranking of antimicrobial activity against both coliform bacteria and E. coli in jejunal 
simulations was E-cinnamaldehyde >> carvacrol > thymol > eugenol (Table 3 and 4). This is 
(partially) different from the results of Friedman et al. (2002) who found the following order in a 
microplate assay based on bactericidal activity 50%: carvacrol > cinnamaldehyde > thymol > 
eugenol. In the study of Helander et al. (1998), E. coli O157:H7 in a dilution assay, was nearly 
equally inhibited by thymol, carvacrol and cinnamaldehyde (MIC; respectively 450, 450 and 396 
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mg/L). It is therefore surprising that in our in vitro simulations E-cinnamaldehyde was a much more 
powerful antimicrobial against both coliform bacteria and E. coli than the other components. 
However, it has to be stressed that the dose effect of these agents against both coliform bacteria and 
E. coli differed among the agents. At low doses (< 400 mg/L) the effect of E-cinnamaldehyde 
exceeds the effect of the phenolic compounds carvacrol and thymol, while the effect at higher doses 
(600 mg/L) was comparable (different shapes of the quadratic function; Fig. 2). The quadratic 
function for E-cinnamaldehyde represents a convex curve, a progressive increase in the antibacterial 
effect takes place. Although our concept of MEC is not fully consistent with the more used concept 
of MIC, the MEC for E-cinnamaldehyde against E. coli (56 mg/L) (data not shown) was much lower 
than the MIC values against E. coli in the studies of Didry et al. (1993) (250 mg/L); Helander et al. 
(1998) (396 mg/L); Kamel (2001) (1000 mg/L); Olasupo et al. (2003) (615 mg/L); Kim et al. (2004) 
(250 mg/L against E. coli strains O157:H7 and O26 or 500 mg/L against strains ATCC11105 and 
O111) and Dal Sasso et al. (2006) (175 mg/L against E. coli strain ATCC or 125-245 mg/L against 
two other clinical isolates). There is no clear understanding for this strong activity against both 
coliform bacteria and E. coli at low doses in our studies. 
However, E-cinnamaldehyde at 100 mg/L had no effect on coliform bacteria in gastric simulations 
(Table 3) while it affected significantly the coliform bacteria in jejunal simulations (3.72 vs. 5.31 
log10 CFU/mL for control). Consequently E-cinnamaldehyde possesses a lower antimicrobial activity 
against the coliform bacteria at a lower pH. Possibly in more acidic and aerobic conditions this 
chemical with an α,β-unsaturated aldehyde structure is less active or more prone to oxidation, 
although synthetic antioxidants were present in the medium. Partial thermal oxidative decomposition 
of pure cinnamaldehyde (> 60°C) has been demonstrated by Friedman et al. (2000). Another 
remarkable feature is the lack of activity of eugenol in gastric conditions (highest dose 500 mg/L) 
while it had significant effects at 1000 mg/L against all bacterial groups in jejunal simulations and 
against coliform bacteria in caecal simulations. Si et al. (2006b) found that the antimicrobial activity 
of clove (containing eugenol) against two strains of E. coli and S. Typhymurium DT104 was 
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moderately reduced after a pre-treatment of eugenol at pH 2. These authors questioned the stability of 
eugenol at low pH. Generally, in our incubations, eugenol had a weaker effect on the pig gut flora 
than carvacrol, thymol and E-cinnamaldehyde. 
In contrast to carvacrol and thymol, E-cinnamaldehyde showed a clear selective antimicrobial 
spectrum. It was found to be highly inhibitory for coliform bacteria and E. coli while it hardly 
inhibited the growth of lactobacilli. The effect on streptococci was intermediate. In jejunal 
simulations a 10-fold reduction of coliform bacteria was achieved with a dose of 104 mg/L vs. 483 
mg/L for streptococci. More than 600 mg/L was needed to have an 0.5 log10 CFU/mL effect on 
lactobacilli. This explains also the higher MEC against total anaerobic bacteria in gastric than in 
jejunal simulations for E-cinnamaldehyde, as the lactobacilli were the predominant group after 
incubation and that no CFU of coliform bacteria were found on the EMB agar plates. Lee & Ahn 
(1998) also found that the growth-inhibiting activity of cinnamaldehyde was more pronounced in 
human intestinal Clostridium perfringens and Bacteroides fragilis, as compared to the bifidobacteria 
and Lactobacillus acidophilus. Lee et al. (2001) reported similar results, however they found clear 
differences in susceptibility of 3 different Bifidobacterium species. Cinnamaldehyde had no 
bactericidal effect on Lactobacillus sakei  up to 66000 mg/L  over a 1-h incubation (Gill & Holley, 
2004). The use of E-cinnamaldehyde in the jejunum (for example 100 mg/L) can therefore result in a 
shift in the microbial ecology in favour of lactic acid producing bacteria and reducing the number of 
(pathogenic) coliform bacteria.  
 
Little scope to improve the antimicrobial efficacy by making mixtures 
 
Synergism of antimicrobial agents could result in lower total doses needed and costs to obtain the 
same antimicrobial effect as the individual agents. In particular, effective combinations of these EO 
components could lower the risk for feed intake reduction caused by their pungent aromas and for 
residues in the meat. To analyse interactions (zero-interaction, antagonism or synergism) between 
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components, different approaches are available. The isobole method was chosen because this method 
is independent of the type of dose-response relation (linear, quadratic …) and the mode of action of 
the agents in the combination. A major drawback of this method is the fact that the analysis is based 
on the individual dose-response curves, which should be determined properly. As stated elsewhere, 
some important variation in data has occurred. This rendered the analysis for interaction a more 
difficult task. 
The combinations 250 mg/L carvacrol + 250 mg/L thymol and 400 mg/L carvacrol + 100 mg/L 
thymol were found to be synergistic against total anaerobic bacteria in jejunal simulations. The total 
dose of these combinations is 500 mg/L and this was between 5 and 11% lower than the calculated 
dose needed by the individual components to have the same effect, which indicates that the 
synergistic effect was rather small. Using a Fractional Inhibitory Concentration Index for the 
evaluation of the antimicrobial effect against respiratory pathogens of mixtures, Didry et al. (1993) 
found also that only the combination of carvacrol + thymol out of all binary mixtures of 
cinnamaldehyde, carvacrol and thymol showed synergism. Zhou et al. (2007) reported that several 
binary combinations of these EO components showed substantial synergistic effects against S. 
Typhymurium. In a study of Lambert et al. (2001) carvacrol and thymol were additive. In general, 
interaction effects differ and vary between experiments and reports. To conclude, there seems to be 
little scope here to improve the antimicrobial efficacy of these EO components by making mixtures. 
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CONCLUSION 
 
On the basis of the in vitro results presented in this paper, it can be concluded that the EO 
components carvacrol, thymol, E-cinnamaldehyde and to a lesser extent eugenol, have potential (in 
several ways) to modulate the flora and fermentation pattern in the GIT of pigs. Further research on 
the use of these components should focus on their kinetic behaviour in the gut and their potential for 
tolerance/resistance development. Therefore, reliable analytical methods should be developed to 
quantify these chemicals in feed and digesta. 
 
ACKNOWLEDGEMENTS 
 
Part of this work was financially supported by the Institute for the Promotion of Innovation by 
Science and Technology in Flanders (IWT), Brussels, Belgium. The advices and suggestions from L. 
Decombel and P. Gerard are sincerely appreciated. The authors are also grateful to A. Ovyn, C. 
Vermander, A. Maes and E. Turtelboom for skilful technical support. 
 - 107 - 
CHAPTER 3  
 
IN VITRO DEGRADATION AND IN VIVO PASSAGE KINETICS OF 
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CHAPTER 3  
 
IN VITRO DEGRADATION AND IN VIVO PASSAGE KINETICS OF 
CARVACROL, THYMOL, EUGENOL AND E-CINNAMALDEHYDE ALONG 
THE GASTROINTESTINAL TRACT OF PIGLETS 
 
 
ABSTRACT 
 
The EO carvacrol, thymol, eugenol and E-cinnamaldehyde have well-documented antimicrobial 
properties and offer therefore an alternative for the antimicrobial growth-promoters in pig feeds. The 
aim of this work was to determine the degradation and kinetics of these EO along the GIT of piglets 
which is necessary information for a correct application in pig feeds. None of these compounds was 
significantly degraded in in vitro simulations of the pig gastric fermentation. Carvacrol and thymol 
were not degraded in jejunal simulations, but significant losses up to 29% were found in caecal 
simulations. Eugenol and E-cinnamaldehyde showed a more pronounced degradation in jejunal and 
caecal simulations. A single dose mixed with feed (13.0, 13.2, 12.5 and 12.7 mg/kg body weight for 
carvacrol, thymol, eugenol and E-cinnamaldehyde respectively) was given orally to piglets. Half-
lives in total digestive tract ranged between 1.84 and 2.05 h, whereby E-cinnamaldehyde showed the 
fastest disappearance. All of these EO were mainly and nearly completely absorbed in the stomach 
and the proximal SI. Plasma concentrations (sum of free and conjugated compound) peaked at 1.39, 
1.35 and 0.83 h for carvacrol, thymol and eugenol respectively and this was accompanied by high 
concentrations in urine. The four compounds were in vitro poorly degraded in the proximal segments 
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of the GIT of piglets, but degradation is expected in more distal segments. In vivo, the EO were 
mainly and nearly completely absorbed in the stomach and the proximal SI. 
 
KEYWORDS: carvacrol, thymol, eugenol, E-cinnamaldehyde, degradation, absorption, kinetics, 
pigs 
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INTRODUCTION 
 
The use of antibiotics as AMGP in pig feeds has been banned in the EU from January 2006 
(regulation EC/1831/2003) and is under debate in other parts of the world. For decades the use of 
these AMGP in intensive pig production permitted higher growth rates and better feed conversion 
ratios in a nearly consistent way (Cromwell, 2002). Their mode of action is not fully understood but 
there is evidence that they work in part by decreasing the overall numbers and/or specific bacterial 
species or their metabolic activities in the GIT (Anderson et al., 1999; Corpet, 2000; Gaskins et al., 
2002; Visek, 1978). Moreover, in the EU antimicrobial inclusion levels of copper in piglet feed is 
foreseen to be reduced in the future. In this respect, EO with well documented antimicrobial 
properties like carvacrol, thymol, eugenol and E-cinnamaldehyde have gained renewed interest for 
use in animal feed. 
In previous work we were able to demonstrate in in vitro simulations of the pig gut fermentation that 
the minimum concentration of carvacrol, thymol, eugenol and E-cinnamaldehyde to reduce the 
number of total anaerobic bacteria compared to control with a probability of 99.7% was 255, 258, 
223 and 56 mg/L respectively (Michiels et al., 2009 – Chapter 2). Carvacrol and thymol were very 
effective against lactobacilli, streptococci and coliform bacteria while E-cinnamaldehyde inhibited 
mainly the growth of coliform bacteria. In caecal incubations carvacrol, thymol, eugenol and 
cinnamon oil showed a high efficacy against S. Typhimurium DT104, E. coli O157:H7 and E. coli 
K88 with little inhibition towards pig endogenous lactobacilli and bifidobacteria (Si et al., 2006). 
Therefore, these EO offer an alternative to maintain gut health and performance of young animals. 
However, no data are yet available about the stability and kinetics of these EO in the GIT of the pig 
when administered orally. This information is necessary for a correct application and dosage of these 
compounds in pig feeds and also with regard to potential resistance/tolerance development of gut 
bacteria against these EO. 
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This work focuses on the degradation and passage kinetics of these EO in the GIT of the piglet. First 
an accurate method to quantify these EO was developed. Secondly, in vitro incubations simulating 
the fermentation in different segments of the GIT were performed. Samples taken at the start and at 
the end of these incubations were analysed for their EO concentration. This allowed estimating the 
degradation of these compounds in the in vitro medium. Finally, a single dose of each of these EO 
mixed with feed was given to piglets. Following euthanasia at different times post-prandial, digesta 
and body fluids were sampled to obtain kinetic data. 
 
MATERIALS AND METHODS 
 
Chemicals 
 
Carvacrol (282197), thymol (T0501) and eugenol (E5,179-1) were obtained from Sigma-Aldrich 
nv/sa (Bornem, Belgium) and E-cinnamaldehyde (96320) was provided by Fluka (Bornem, 
Belgium). Ethyl ethanoate (Sigma-Aldrich; 154857) and 2-isopropylphenol (Fluka; 59720) were used 
in the GC-method to quantify the EO. The enzymes sulfatase (from Helix pomatia, Type H-1, EC 
3.1.6.1; Sigma-Aldrich; S9626) and β-glucuronidase (from bovine liver, Type B-1, EC 3.2.1.121; 
Sigma-Aldrich; G0251) were used for the hydrolysis of phase-II metabolites in plasma, bile and urine 
samples. 
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Analytical method to quantify carvacrol, thymol, eugenol and E-cinnamaldehyde in feed and 
distinct biological matrices 
 
EXTRACTION 
 
All extractions were performed in duplicate. The sample size for extraction was approximately 0.5 g 
(feed), 1.25 g (digesta from stomach, SI and caecum and faeces) or 1 mL (samples from other 
matrices: in vitro gastric, jejunal and caecal incubation media and pre-treated plasma, bile and urine). 
The extraction step was carried out in 15 mL vials, made out of glass and sealed with a cap with 
septum. Two mL aqua destillata was added. Thereafter, each sample was spiked with 50 μL absolute 
ethanol and 100 μL of a 2-isopropylphenol internal standard solution. The concentration of the 
internal standard solution was 2.5 mg 2-isopropylphenol per mL ethyl ethanoate for all matrices, 
except for pre-treated plasma and bile, for which it was 0.1 mg 2-isopropylphenol per mL ethyl 
ethanoate. Four mL ethyl ethanoate was added as extraction solvent. The extraction was performed 
by vigorous shaking for 30 s on a vortex apparatus followed by 30 min agitation on an orbital shaker. 
The samples were then left to equilibrate for 8 to 12 h followed by centrifugation (2000 g, 6 min) 
prior to transfer of the less dense ethyl ethanoate layer. Samples were extracted a second time with 4 
mL ethyl ethanoate. The combined ethyl ethanoate extracts were reduced to dryness with nitrogen at 
room temperature. The residue was redissolved in ethyl ethanoate (500 μL for all matrices except 100 
μL for pre-treated plasma and bile). Aliquots (1 μL) were used for GC-analysis. 
 
GC-ANALYSIS 
 
GC was performed using a capillary column 30 m x 0.25 mm ID x 0.25 μm film thickness fused 
silica. The phase composition was 2,3-di-O-methyl-6-O-tert-butyl dimethyl silyl beta cyclodextrin 
doped into 14% cyanopropylphenyl / 86% dimethyl polysiloxane (Restek Rt-βDEXsm; chiral 
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separation column; Bellefonte, USA). The average helium carrier gas flow was set to a constant 
velocity of 40 cm/s, equivalent to 1.90 mL/min. The split ratio of the column was 60:1. The injector 
temperature was set at 250°C. The column oven temperature started at 110°C for 2 min, then 
programmed to 170°C at 4°C per min and then to 230°C at 40°C per min, and maintained at 230°C 
for 4 min. The detector type was a FID, with a temperature of 280°C.  
 
VALIDATION 
 
The analytical method has been validated for linearity, specificity, repeatability and recovery of 
extraction/drying for each EO and matrix. The following criteria were evaluated (European 
Commission, 2002): [1] The method should give a linear peak response in the concentration range 5 
to 1000 mg/kg or mg/L for the matrices feed, in vitro incubation media, digesta, faeces and pre-
treated urine and in the range 0.25 to 500 mg/L for pre-treated plasma and bile (R2 > 0.99). For each 
matrix, 6 samples without EO (blank samples) were prepared. These samples were acidified to pH <2 
with 2% of 6 mol/L H2SO4 and then spiked with 50 µL of the EO diluted in absolute ethanol giving 6 
different final concentrations within the respective dose range. Subsequently, each sample was 
analysed as described in the previous sections (extraction and GC-analysis) in sixfold. The ratios 
peak area of EO / peak area of internal standard were calculated and used as dependent variable in 
linear regression analysis. In each series of analyses of unknown samples, numerous blank samples 
spiked with the EO were included to determine the response factors necessary for calculation of EO 
concentration in the unknown samples. [2] No peak signal interference should be observed 
(specificity). Therefore the signal-noise ratio of all peaks in the area ‘retention time of analyte ± 
2.5%’ must be lower than 3. For each matrix, 10 chromatograms obtained from blank samples were 
analysed. [3] Repeatability, expressed as coefficient of variation (CV; residual standard deviation 
relative to the mean) should be lower than %CVH = 2(1-0.5 logC) (Horwitz equation, whereby C is the 
mass fraction, expressed as the power of 10) and has been determined for three concentrations (low, 
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medium and high) (n=6). [4] The percentage of recovery for extraction/drying should range between 
-20 and +10%. Therefore the ratio peak area of EO / peak area of internal standard of a blank sample 
spiked with the EO before extraction/drying was compared to the ratio peak area of EO / peak area of 
internal standard of the respective EO added to an equal concentration after extraction/drying of a 
blank sample. Recovery has been measured for three concentrations (low, medium and high) (n=4). 
[5] The detection capability (CCβ), the smallest content of the substance that may be detected, 
identified and/or quantified in a sample with an error probability of β (= 5%), has been determined as 
well.  
 
Degradation of EO in in vitro simulations of the gut fermentation 
 
In order to study the degradation of these EO in the GIT, in vitro simulations of the fermentation in 
the GIT were carried out as described by Michiels et al. (2009) (Chapter 2). Briefly, incubations of 
gastric, jejunal and caecal contents with carvacrol, thymol, eugenol and E-cinnamaldehyde were 
performed. The in vitro incubation medium was composed of an artificial substrate, a buffer, a 
suspension of pig gut bacteria and a solution of the EO in absolute ethanol giving different final 
concentrations: 0, 10 and 100 mg/L  for all three types of simulation, 500 mg/L (gastric simulations) 
and 1000 mg/L (jejunal and caecal simulations). Incubation parameters closely resembled conditions 
prevailing in vivo. All incubations were carried in glass vessels and in triplicate. In Michiels et al., 
(2009) (Chapter 2) the effects of the EO against the gut bacteria in these in vitro simulations are 
described. In the current paper, samples from these incubations were taken to determine the 
degradation. Therefore, from each incubation vessel, 5 mL samples were taken at the start and at the 
end of the incubation and acidified to pH <2 with 2% of 6 mol/L H2SO4 to stop fermentation prior to 
storage at -20°C until analysis. Aliqouts (1 mL) were taken for quantification of EO as described 
above. The recovery (the concentration of EO after incubation relative to the concentration at the 
start of incubation; %) was calculated as a measure for degradation. The mean recovery of three 
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replicates was compared with a test value of 100% by means of an one-sample Student’s t-test (SPSS 
11.5 program software; SPSS Inc., Chicago IL, USA). 
 
In vivo absorption and passage kinetics of EO 
 
EXPERIMENTAL DESIGN 
 
Twelve piglets (19.8 ± 0.8 kg BW at the day of sampling, ((Landrace x Large White x Seghers 
synthetic line) x Piétrain) were individually housed and adapted to a synthetic diet (diet A in Table 1) 
containing 500 mg of each EO (carvacrol, thymol, eugenol and E-cinnamaldehyde) per kg feed over 
a period of 7 days. The feed was prepared by carefully mixing the EO in a fraction of the corn starch 
and this was further mixed with the other feed ingredients. Piglets were fed the dry meal twice a day, 
at 8 a.m. and 5 p.m. for a total of 900-1000 g (approximately 85% of ad libitum intake). Water was 
available ad libitum throughout the whole experimental period. The day before sampling, the animals 
were deprived of their evening meal. At 8 a.m. of the day of sampling (t = 0 h), all animals, except 
one pig (unfed), were given 300 g of the experimental feed (diet B in Table 1). Diet B was similarly 
prepared as diet A but contained 1000 mg/kg of each EO (intented dose),  and in addition 10 g/kg 
celite545 coarse and 1 g/kg C36H74. Animals were allowed to eat for 20 min. In 4 animals, the intake 
was lower than the given amount of 300 g. Residual feed and feed spoilage were carefully measured 
per animal. A corrected feed intake was calculated per pig, giving an average feed intake of 272 ± 25 
g (n=11). All piglets were slaughtered at different times post-prandial (t = 0.5, 1, 2, 3, 4, 5, 6, 8, 12, 
18 and 24 h). The unfed pig served as control to secure that digesta and body fluids were free of EO 
and indigestible markers at t = 0 h. 
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Table 1. Ingredient and analysed nutrient composition of the synthetic diet A (adaptation period) and 
B (sampling day) in the in vivo study (g/kg as fed) 
 Diet A Diet B 
Ingredient composition 
  Corn starch (1) 
  Potato protein (2) 
  Sucrose 
  Alphacel (3) 
  Soybean oil 
  Pectine NF pure citrus medium (4) 
  Monocalcium-phosphate 
  Limestone 
  Sodium chloride 
  L-lysine HCl 
  DL-methionine 
  L-tryptophane 
  Premix Vitamins Pigs 3/2.5 (5) 
  Premix Trace elem./min. Pigs ¾ (5) 
  Celite545 coarse (6) 
  C36H74 (7) 
  Carvacrol 
  Thymol 
  Eugenol 
  E-cinnamaldehyde 
Analysed nutrient composition 
  Dry matter 
  Ash 
  Crude protein 
  Ether extract 
  Crude fibre 
  4 mol/L HCl insoluble ash 
  C36H74 
  Carvacrol 
  Thymol 
  Eugenol 
  E-cinnamaldehyde 
 
550.55 
215.00 
91.00 
50.00 
35.00 
17.50 
14.00 
13.00 
6.50 
1.80 
0.90 
0.25 
1.30 
1.20 
- 
- 
0.50 
0.50 
0.50 
0.50 
 
919 
38 
171 
40 
11 
0.40 
0.00 
NA (8) 
NA 
NA 
NA 
 
537.55 
215.00 
91.00 
50.00 
35.00 
17.50 
14.00 
13.00 
6.50 
1.80 
0.90 
0.25 
1.30 
1.20 
10.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
922 
49 
168 
42 
12 
10.10 
0.97 
0.947 
0.958 
0.910 
0.926 
(1) Cargill, Ghent, Belgium; (2) Avebe b.a., Veendam, the Netherlands; (3) MP Biochemicals, LLC 900453, Brussels, 
Belgium; (4) Upjohn, Puurs, Belgium, Item nr. 00 160825 000 5; (5) Vitamex N.V., Drongen, Belgium ; (6) nr. 
22140, Fluka, Bornem, Belgium; (7) F-9504, Sigma-Aldrich, Bornem, Belgium ; (8) NA, not analysed 
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SAMPLE PREPARATION 
 
Piglets were electrically stunned and killed by exsanguination. Blood was collected in tubes provided 
with EDTA as anti-coagulant and was centrifuged at 3000 g for 15 min. Thereafter, plasma samples 
were immediately heat-treated in a water bath at 72°C for 5 min to hamper further enzymatic activity 
prior to storage at -20°C. An abdominal section was made and samples from the gall- and urinary 
bladder contents were taken and stored at -20°C. The GIT was removed and partitioned into the 
following digesta sampling sites: stomach, SI (divided into three segments of similar length and 
designated as S1, S2 and S3) and caecum. Digesta of each sampling site were quantitatively 
collected. Aliquots (6 g) of the fresh digesta were taken, acidified to pH <2 with 2% of 6 mol/L 
H2SO4 to stop fermentation and stored at -20°C until analysis. The remaining digesta were frozen, 
freeze-dried and finally ground to pass a 1 mm screen. Upon analysis, thawed plasma, bile and urine 
samples were pre-treated to hydrolyze phase-II metabolites. One mL of sample fluid was brought into 
a 10 mL vial and 0.5 mL β-glucuronidase solution (0.1 g in 50 mL 0.2 mol/L acetate buffer pH 5) and 
0.5 mL sulfatase solution (0.25 g in 50 mL cold 0.2% (w/v) NaCl solution, prepared immediately 
before use) were added. The vial was sealed and incubated overnight in a water bath at 37°C. After 
incubation, these samples were acidified to pH <2 with 2% of 6 mol/L H2SO4. 
 
ANALYSIS 
 
Quantification of EO in feed, fresh digesta and pre-treated plasma, bile and urine samples was 
performed as described above. The determined EO concentration in pre-treated plasma, bile and urine 
included the free and conjugated compound. Creatinine in urine was determined according to Yatzidis 
(1974). Diet A and B and freeze-dried samples from digesta were analysed for 4 mol/L HCl insoluble 
ash and C36H74 (Vulich et al., 1991). Weende components of feeds were determined as specified by 
Dierick et al. (2003). 
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CALCULATIONS AND STATISTICS 
 
Data on EO in different specimens (piglets) and sampling sites were reported as: [1] Concentration 
(mg/kg or mg/L); the concentration of the EO in urine is also expressed as the concentration of the 
EO relative to the concentration of creatinine (mg/g creatinine) in order to account for variation in 
urine volume. [2] Percentage of intake (%): (concentration of EO in digesta x amount of fresh digesta 
x 100) / total intake of EO. [3] Recovery (%): (concentration of marker in feed x concentration of EO 
in digesta x 100) / (concentration of marker in digesta x concentration of EO in feed). Two different 
indigestible markers were used: 4 mol/L HCl insoluble ash and C36H74. Presentations of data as [2] 
percentage of intake and [3] recovery were only applied for data on EO in digesta of the following 
sampling sites: stomach, S1, S2, S3 and caecum. The weighted sum of these sampling sites was 
assigned as total digestive tract. To describe gastric emptying and disappearance from total digestive 
tract, data (y) were plotted against time (t; h) using a first order model y = a . e-b.t; whereby a and b 
are estimated regression coefficients (Dänicke et al., 2004). The half-life t1/2 was calculated as ln2/b. 
Kinetics in other sampling sites were fitted to the following function using the non-compartmental 
model y = a . tb . e-c.t, whereby t = time and a, b and c are regression coefficients (Dänicke et al., 
2004). Regression coefficients were estimated iteratively using the least squares method in GraphPad 
Prism 5 software (GraphPad Software Inc., San Diego, USA). The following parameters were 
calculated from the estimated regression coefficients for the second model: tmax = b/c (time at 
maximum response, h); ymax = a . tmaxb . e-c.tmax (maximum response, weight unit or %) and t1/2 AUC = 
gammainv (0.5, b + 1, 1 / c) (time which corresponds to the half of the AUC, h). The areas under the 
time-response curves (AUC) for both models, calculated from t = 0 h to t whereby concentration is < 
CCβ or to t with the lowest measurable concentration (only for bile and urine), were estimated with 
the trapezoid rule using the same software program. Total plasma clearance with regard to 
bioavailability (ClT/F) was estimated with the following formula: ClT/F = dose/AUC0→inf. 
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RESULTS AND DISCUSSION 
 
Analytical method to quantify carvacrol, thymol, eugenol and E-cinnamaldehyde in feed and 
distinct biological matrices 
 
This work elaborated data on the degradation and passage kinetics of carvacrol, thymol, eugenol and 
E-cinnamaldehyde in the GIT of piglets. A prerequisite is the ability to quantify these compounds in 
feed and different biological matrices in a reliable and accurate manner. The method that was 
developed fulfilled all criteria that were specified (linearity, specificity, repeatability and recovery), 
with the exception of the quantification of E-cinnamaldehyde in in vitro caecal media, caecal digesta, 
faeces and pre-treated urine. The first criterion was linearity and this was tested by regression 
analysis. Intercepts were not significantly different from zero and R2 values were higher than 0.99 in 
the range of concentrations applied in this study, with the exception of E-cinnamaldehyde in in vitro 
caecal media, caecal digesta, faeces and pre-treated urine. In these 4 matrices, a significant negative 
intercept was found for E-cinnamaldehyde and the R2 were lower than 0.99. The ratios peak area of 
EO / peak area of internal standard were also remarkably lower compared to those of E-
cinnamaldehyde in the other matrices. In none of the cases interfering peaks were observed. All CV 
for repeatability were below %VCH and therefore satisfactory, except for E-cinnamaldehyde in pre-
treated urine. Excluding E-cinnamaldehyde in the 4 matrices mentioned above, the recoveries ranged 
between 80 and 95%. The CCβ for all EO in in vitro incubation media, digesta, faeces and pre-treated 
urine was in most cases approximately 0.5 mg/kg or mg/L. The CCβ for pre-treated plasma and bile 
was 0.2 mg/L. 
 
The unsatisfactory results for E-cinnamaldehyde in in vitro caecal media, caecal digesta, faeces and 
pre-treated urine points at possible important ‘matrix effects’. In these cases significant negative 
intercepts and recoveries below 50% were found, which  indicates that a considerable amount of this 
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compound is rapidly degraded or adsorption to or interaction with particles of the matrix is taking 
place once it was added to the acidified blank samples. E-cinnamaldehyde contains an oxidizable α,β-
unsaturated aldehyde function. Biochemical transformation of cinnamaldehyde as described by for 
example Haarmann & Reimer (2001) or Bock et al. (1988) can be excluded here due to the fact that 
before the addition of E-cinnamaldehyde, the blank samples were acidified to pH<2 hampering all 
enzymatic activity. No hydrolysis is possible for cinnamaldehyde, so it is expected to be stable in the 
aqueous incubation medium, although it may be slowly oxidized to cinnamic acid (Aromatic 
Consortium, 2005). Yuan et al., (1992) did not find any oxidation of cinnamaldehyde to cinnamic 
acid in aqueous solutions. In our study, in some cases peak signals for cinnamic acid were found on 
the chromatograms but the peak areas were far too low to explain all losses of E-cinnamaldehyde. 
Temperature-dependent and non-enzymatic oxidation and further decomposition to benzaldehyde and 
glyoxal has been reported by Friedman et al. (2000), but this occurred for pure cinnamaldehyde and 
at temperatures above 60°C. Through reaction with amino groups, cinnamaldehyde can form stable 
Schiff base intermediates (Yuan et al., 1992) that are insoluble in  ethyl ethanoate, the extraction 
solvent used in our method. Other nucleophilic addition reactions could also be involved. The exact 
reason for this analytical problem remains unclear and it is also not understood why these problems 
are found only in these 4 matrices. However, these matrices have in common that they are rich in 
microbial (in vitro caecal medium, caecal digesta and faeces) or animal (pre-treated urine) N-
containing degradation products increasing the likelihood for Schiff base formation to occur. It was 
concluded that the method was not satisfactory to quantify E-cinnamaldehyde in these 4 biological 
matrices. 
 
Degradation of EO in in vitro simulations of the gut fermentation 
 
The EO used are high-boiling liquids or solid in the case of thymol, so it was unlikely that there were 
any losses due to volatilization during the in vitro incubations at 37-39°C or during further handling 
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at room temperature. So recoveries below 100% are believed to be due to degradation during 
incubation. The recoveries for gastric incubations were not significantly different from 100% (Table 
2), so it is very likely that these EO will not be transformed in the proximal parts of the GIT. 
Carvacrol and thymol were not degraded in jejunal simulations but significant losses up to 29% were 
found in caecal simulations (Table 2). The recovery was also considerably higher at the higher dose, 
which is supported by literature data. At doses higher than in our study (1000-2500 mg/L), Varel 
(2002) found that carvacrol and thymol were stable in swine waste under anaerobic conditions 
(gassed with nitrogen) for 62 days, with 90 to 95% of the compound being recovered. Similarly, 
Broudiscou et al. (2007) found no degradation of thymol in an 24 h in vitro caprine ruminal 
fermentation at a dose of 2000 mg/L. However, carvacrol and thymol were found to be biodegraded 
under aerobic (Chamberlain & Dagley, 1968) and anaerobic conditions (Gibson & Harwood, 2002) 
mainly by soil bacteria and by a diverse array of pathways. Hence, it is interesting to note that here at 
the higher doses they are not or little degraded in conditions simulating the pig gut fermentation. 
Therefore bacterial resistance due to metabolization of these compounds is not anticipated, although 
long-term exposure to these compounds should be investigated. Indeed, various studies (Ultee et al., 
2000; Di Pasqua et al., 2006) highlighted the potential for induced bacterial tolerance in the presence 
of sub-lethal doses of several EO, which can compromise efficacy when applied in vivo. 
 
Significant degradation in jejunal simulations at 100 mg/L was found for both E-cinnamaldehyde 
(27%) and eugenol (8%) and at 1000 mg/L for E-cinnamaldehyde (11%) (Table 2). As discussed 
above, the GC-method could not be validated for quantification of E-cinnamaldehyde in the caecal 
incubation medium. However, there was no detectable response (<CCβ) for E-cinnamaldehyde for 
the 100 mg/L objects after caecal incubation, which could indicate that this compound was (totally) 
transformed under caecal conditions. The 1000 mg/L objects after incubation gave a moderate 
response but could neither be quantified. E-cinnamaldehyde has shown to be readily biodegradable. It 
was 100% biodegraded after 21 days in an OECD 301B test (Haarmann & Reimer, 2001). Bock et al. 
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(1988) described the reduction of cinnamaldehyde to the corresponding alcohol by the fungus 
Botrytis cinerea. Microbial degradation of eugenol and cinnamaldehyde involves oxidation of the 
side chain to carboxylic acid prior to hydroxylation and cleavage of the benzene ring (Shimoni et al., 
2002). For example, eugenol is microbially degraded to yield coniferyl alcohol, ferulic acid, vanillin 
and vanillic acid as intermediates (Tadasa, 1977). Likely, the higher biocatalytic capacity of the 
caecal bacteria compared to bacteria in the stomach and SI causes degradation of these EO to a larger 
extent. However, degradation pathways have been described mainly for soil microbes which are not 
present in the GIT of pigs and pure chemical transformation as discussed above in the case of E-
cinnamaldehyde, cannot be excluded. Interestingly Friedman et al. (2000) found that eugenol 
protected cinnamaldehyde against heat-induced destruction and Basketter (2000) reviewed the 
quenching effect of eugenol towards the skin sensitizing activity of cinnamaldehyde in human. In 
Michiels et al. (2009) (Chapter 2) we reported the effects of these EO against the gut bacteria in these 
in vitro simulations. It was shown that eugenol had a clear antimicrobial activity against coliform 
bacteria in jejunal simulations, while an antimicrobial effect in caecal simulations was not found. 
Possibly, the partial degradation caused this lack of activity in caecal simulations. E-cinnamaldehyde 
reduced significantly the number of coliform bacteria in jejunal simulations from 5.31 (control) to 
3.72 (100 mg/L) and 0.81 log10 CFU/mL (1000 mg/L) and in caecal simulations from 9.12 to 9.32 
and 6.43 log10 CFU/mL. It was also found that E-cinnamaldehyde had a much stronger effect against 
coliform bacteria in jejunal simulations as compared to carvacrol and thymol while in caecal 
simulations these 3 compounds showed a similar inhibition of bacterial growth. The lower activity of 
E-cinnamaldehyde in caecal simulations could be caused by microbial and/or chemical degradation 
of this compound. 
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Table 2. Recovery of EO from in vitro gastric, jejunal and caecal simulations of the fermentation in 
the GIT of pigs 
Dose of EO (mg/L) 
100  500-1000 (1) 
 
Recovery (%) 
(2) 
Significance 
(3) 
Recovery (%) Significance 
Gastric simulations 
  Carvacrol 
  Thymol 
  Eugenol 
  E-cinnamaldehyde 
 
91.9 
87.5 
91.7 
92.7 
 
NS 
NS 
NS 
NS 
 
100.6 
97.4 
100.1 
88.7 
 
NS 
NS 
NS 
NS 
Jejunal simulations 
  Carvacrol 
  Thymol 
  Eugenol 
  E-cinnamaldehyde 
 
106.1 
107.3 
92.1 
73.2 
 
NS 
NS 
** 
** 
 
107.9 
105.8 
99.9 
88.9 
 
NS 
NS 
NS 
* 
Caecal simulations 
  Carvacrol 
  Thymol 
  Eugenol 
  E-cinnamaldehyde 
 
71.0 
77.2 
78.4 
ND (4) 
 
* 
* 
* 
 
 
89.0 
83.1 
75.5 
ND (4) 
 
NS 
* 
* 
 
(1) 500 mg/L for gastric simulations and 1000 mg/L for jejunal and caecal simulations; (2) recovery = 
concentration of EO after incubation relative to concentration of EO at the start of incubation, %; (3) NS = 
not significantly different from 100%, *, ** = significantly different from 100% at 5% and 1% confidence 
level respectively (n=3); (4) ND, not detectable (see text) 
 
In vivo absorption and passage kinetics of EO 
 
To study the kinetics of carvacrol, thymol, eugenol and E-cinnamaldehyde in the GIT of piglets, an 
experimental layout was chosen wherein animals at the day of sampling were euthanized at different 
times after a single orally given dose. Each time point was represented by one piglet. Dänicke et al. 
(2004) argued that this seemed to be justified in the view of the regressive treatment of the data and 
the high experimental and analytical expenditure, which is also the case in this trial. At the day of 
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sampling, not all the piglets consumed the amount of feed offered. Residual feed and feed spoilage 
were carefully measured per animal and a corrected feed intake was calculated per piglet, giving an 
average feed intake of 272 ± 25 g (n=11). The CV for this corrected feed intake was lower than 10% 
and this was considered acceptable for further analysis. The EO concentration in feed was 
analytically verified and found to be slightly lower than the intended dose: 946.6, 957.8, 909.8 and 
926.4 mg/kg for carvacrol, thymol, eugenol and E-cinnamaldehyde respectively (Table 1). An 
average feed intake of 272 g corresponded therefore with a dose of 13.0, 13.2, 12.5 and 12.7 mg/kg 
BW for the same EO. All further calculations to determine kinetic data were based on the analytically 
verified EO concentration in feed. In the week before the day of sampling, animals were adapted to a 
diet containing the same mixture of EO (intended dose of 500 mg/kg), because preliminary 
experiments had shown that feed intake in piglets is very low the first day of offering these highly 
aromatic compounds.  
 
In Table 3 the passage kinetics in stomach and total digestive tract are presented. R2 were above 0.80, 
except for E-cinnamaldehyde. Half-lives of percentage of intake in total digestive tract ranged 
between 1.84 and 2.05 h. These values are only slightly higher than the respective values for 
percentage of intake in stomach, indicating that disappearance from the GIT was running almost 
parallel to disappearance from stomach. If we assume that the EO are not degraded in the proximal 
parts of the GIT (see above) disappearance from total digestive tract equals absorption. The half-lives 
(t1/2) and emptying rates (b) for percentage of intake in stomach of all EO were respectively lower 
and higher than the respective values of dry matter and markers (Table 3). It means that the EO 
disappeared faster from stomach as compared to dry matter, 4 mol/L HCl insoluble ash (marker for 
solid phase) and C36H74 (marker for lipophilic liquid phase). This might suggest that the EO were 
absorbed in the stomach and/or emptied with the aqueous phase of the digesta. Since plasma 
concentrations for carvacrol, thymol and eugenol (sum of free and conjugated compound; E-
cinnamaldehyde was not retrieved in plasma in none of the specimens) were high in specimen 0.5 h 
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post-prandial (Fig. 1) and peaked within 1.4 h (Table 4), it can be assumed that absorption occurred 
in the stomach. Absorption in stomach would depend on solubilisation of the EO. The dry matter 
content of gastric digesta ranged between 14 and 21% for specimens ≤ 3 h post-prandial. On the 
other hand, estimated t1/2 and emptying rates b for recovery in stomach relative to markers of the EO 
were respectively higher and lower than the respective values for percentage of intake in stomach 
(Table 3), which means that part of the EO was not absorbed from stomach. Indeed, stomach 
emptying coincided with increasing amounts in S1, as can be seen for all compounds in Fig. 1. 
Nevertheless, the amounts of EO that were recoverd in S1 represented only a minor fraction of the 
ingested quantity of EO. The AUC for percentage of intake in S1 (Table 4) relative to the AUC for 
percentage of intake in total digestive tract (Table 3) was 5.7, 6.1, 4.0 and 1.8% for carvacrol, thymol, 
eugenol and E-cinnamaldehyde respectively. Therefore, EO entering the duodenum must be rapidly 
absorbed. The thorough mixing with pancreatic juice and bile, should lead to 
solubilisation/emulsification, enhancing their absorption at this section of the SI. This is further 
substantiated by the prolonged high plasma levels until 4 h post-prandial and the comparable shape of 
curves for plasma concentration and percentage of intake in S1 (Fig. 1). It is reasonable to state that 
part of the EO had escaped from solubilisation and absorption in stomach due to adsorption to 
organic matter. It is well known that these compounds may interact with organic matter. Varel (2002) 
found that 90 to 95% of the recovered thymol in swine waste was found in the solid fraction. 
Veldhuizen et al. (2007) showed that carvacrol binds to albumin leaving less free unbound carvacrol 
and cinnamaldehyde reacted easily with proteins (Yuan et al., 1992; Kim et al., 2006). In our 
experiment the EO were mixed with corn starch before preparing the feed. Hence, a different 
preparation or formulation (e.g. encapsulation) can affect the rate of solubilisation and absorption. 
Here, E-cinnamaldehyde showed the fastest disappearance from total digestive tract (see half-life and 
emptying rate in Table 3), but it is unlikely that the higher water solubility of E-cinnamaldehyde 
compared to the other 3 compounds can explain this difference.  
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Small amounts were detected in S2 and S3 (Table 4), for example 1.9% of carvacrol intake (ratio 
AUCS3 to AUCtotal digestive tract) was found in S3 and the estimated maximum concentration in this 
sampling site was 9.6 mg/kg digesta. In the digesta of S1, S2 and S3 of the specimens 0.5, 1 and 2 h 
post-prandial considerable quantities of the markers were recovered (see also tmax values for 
percentage of intake of dry matter and markers in this sampling sites; Table 4). Obviously, gastro-
intestinal motility of the 24 h fasted animals caused a rapid shunt of part of the digesta (both solid 
and liquid phase) to the distal SI. Recovery of the EO in the SI could also be due to enterohepatic re-
cycling of free and conjugated compounds. This was certainly not the case for E-cinnamaldehyde 
since this compound was not detected in bile. Carvacrol, thymol and eugenol (sum of free and 
conjugated compound) were found in bile for specimens t = 0.5 to 6 h and surprisingly for the 24 h 
specimen. The concentration ranged between 1.40 and 6.93 mg/L and was independent from time 
post-prandial. Bile secretion is principally continuous but variable and in fasted animals bile can 
become more concentrated (Sambrook, 1981). An estimation of the contribution of enterohepatic re-
cycling was made based on calculated AUC values and an assumed 24 h bile secretion volume of 45 
mL/kg BW (Sambrook, 1981). The estimated percentages of intake recovered in bile were 3.2, 4.1 
and 2.5% for carvacrol, thymol and eugenol respectively. Probably, this is an overestimation because 
in specimens euthanized at later times post-prandial bile was more concentrated. The relative amount 
found in S1 (ratio AUCS1 to AUCtotal digestive tract) for carvacrol, thymol, eugenol and E-cinnamaldehyde 
was 5.7, 6.1, 4.0 and 1.8% respectively. Strikingly, the higher quantities found in S1 for carvacrol, 
thymol and eugenol as compared with E-cinnamaldehyde, the compound that was not detected in 
bile, nearly equals the estimated contribution of enterohepatic re-cycling. Therefore, enterohepatic re-
cycling for carvacrol, thymol and eugenol in piglets as such cannot be neglected, but more detailed 
studies are necessary to elucidate this phenomenon and its precise contribution to the kinetics in the 
GIT. It can be concluded that absorption of all EO was fast and occurred mainly and nearly 
completely in stomach and the proximal SI. This finding has relevance with regard to the formulation 
of effective inclusion levels in feeds. For example, in this trial with an inclusion level nearly as high 
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as 1000 mg per kg feed, the concentrations in gastric digesta were reduced by 50% in less than 3 h 
(Table 3) and none of the estimated maximum concentrations in S1 and S3 were higher than 75 
mg/kg and 10 mg/kg respectively (data not shown).   
 
E-cinnamaldehyde has not been detected in any of the plasma samples (< 0.2 mg/L). Yuan et al. 
(1993) retrieved cinnamaldehyde in plasma up to 2.5 mg/L in rat blood after oral gavage of 500 
mg/kg BW with a bioavailability of 18% (AUC after oral gavage relative to AUC after i.v. injection). 
At 50 mg/kg BW, a dose almost 4 times higher than in our study, the blood concentrations of 
cinnamaldehyde were below 0.1 mg/L at all sampling times, which is consistent with our results. It is 
concluded that absorbed E-cinnamaldehyde in piglets is also prone to rapid metabolization leaving 
undetectable amounts of the parent compound in plasma. The fate of E-cinnamaldehyde and its 
metabolites has not been investigated in this research but literature data indicates that with single 
dose administration recoveries in urine and faeces always exceeded 80% (for review on metabolic 
fate of cinnamaldehyde see Bickers et al. (2005) and Cocchiara et al. (2005)), so residues are not 
expected. However, 24 h after oral administration of a single dose of 14C-labelled (β-carbon atom) 
cinnamaldehyde (5-500 mg/kg BW) in rats, between 0.31 and 0.90% and between 0.13 and 0.26% of 
radioactivity was recovered in fat and muscle respectively (Sapienza et al., 1993). 
 
The calculated ClT/F was 15.6, 19.4 and 30.3 L/h for carvacrol, thymol and eugenol respectively. The 
data represent the clearance for the sum of free and conjugated parent compound with regard to 
bioavailability. They are much higher than the one found by Kohlert (2001) for thymol in human 
(1.21 L/h), but comparable or lower than values for other phenolic compounds (phenol, guaiacol and 
p-cresol) in humans (Ogata et al., 1995) or eugenol in rats (Guenette et al., 2007). Our data indicate 
that clearance of these phenols is fast, which is confirmed by the fact that tmax values for 
concentration in urine are only slightly higher than the ones in plasma (Table 4). A rapid renal 
excretion occurred since high amounts of the sum of free and conjugated carvacrol, thymol and 
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eugenol were found in urine (Table 4), which is obviously in agreement with other studies in rodents 
and humans for thymol and carvacrol (Takada et al., 1979 and Austgulen et al., 1987) and eugenol 
(Sutton et al., 1985). In these studies also a number of metabolites (e.g. oxidation products) have 
been detected, but for pig no data are available about the metabolic fate of these phenols. Guenette et 
al. (2007) found a t1/2AUC for eugenol in plasma, after repeated oral administrations of 40 mg/kg BW 
in rats of 14 h which is remarkably higher than the 2.1 h in our study (12.5 mg/kg BW). Probably, 
species, dose and frequency of administration can greatly influence metabolization and plasma levels. 
The estimated regression coefficients and kinetic parameters for concentration in plasma given in 
Table 4, show clearly that metabolization and elimination was faster for eugenol as compared to 
carvacrol and thymol. Estimated bioavailabilities (F) for these and related compounds range between 
16% (underestimated) and 100% (Ogata et al., 1995; Kohlert et al., 2002 and Bhattaram et al., 2002). 
It is very probable to state that the bioavailabities of carvacrol, thymol and eugenol in this trial must 
be high because the absorption was fast and nearly complete and large amounts in urine were found. 
Systemically available thymol (free and conjugated) can contribute to its pharmacological effects 
observed, for example for treatment of bronchitis and upper respiratory infections (Anonymous, 
1996). As Kohlert et al. (2002) did not find free thymol in plasma of humans, these authors proposed 
that cleavage of the sulphate conjugate at the level of alveoli is likely to happen so that free thymol 
could be effective in the target organ respiratory system. It should be stated that the single dose in 
that study was very low; 1.08 mg per human volunteer. Few studies reported data on residue analysis 
in body tissues or pork for these compounds. Zitterl-Eglseer et al. (2007) could not detect carvacrol 
in different tissues, including muscle and abdominal fat and indirectly, a sensory panel was unable to 
detect a flavour/aroma difference between control and treated (500 mg/kg oregano oleoresin in diet) 
pork (Janz et al., 2007). However, in both studies the orally administered dose was low compared to 
high inclusion rates used here and considered necessary when aiming at a modulation of the gut 
bacterial community (Michiels et al., 2009 – Chapter 2). 
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Table 3. Passage kinetics of carvacrol, thymol, eugenol and E-cinnamaldehyde in the total digestive tract and stomach according to a first  order 
model(1) after oral administration of respectively 13.0, 13.2, 12.5 and 12.7 mg/kg BW to piglets 
Regression coefficient ± SE (2) y 
a b 
t1/2 (h) (3) AUC (4) R2 RSD (5) 
Percentage of intake in total digestive tract (%) 
   Carvacrol 
   Thymol 
   Eugenol 
   E-cinnamaldehyde 
 
Concentration in stomach (mg/kg) 
   Carvacrol 
   Thymol 
   Eugenol 
   E-cinnamaldehyde 
 
Percentage of intake in stomach (%) 
   Dry matter 
   4 mol/L HCl insoluble ash 
   C36H74 
   Carvacrol 
   Thymol 
   Eugenol 
 
61.9 ± 9.4 
61.9 ± 9.3 
56.7 ± 9.8 
36.3 ± 9.5 
 
 
190 ± 18 
192 ± 18 
178 ± 23 
130 ± 31 
 
 
71.4 ± 9.5 
62.5 ± 11.7 
59.1 ± 12.6 
58.0 ± 8.8 
58.2 ± 8.7 
54.9 ± 9.4 
 
0.34 ± 0.09 
0.34 ± 0.09 
0.35 ± 0.11 
0.38 ± 0.17 
 
 
0.25 ± 0.05 
0.25 ± 0.04 
0.31 ± 0.07 
0.34 ± 0.14 
 
 
0.29 ± 0.07 
0.23 ± 0.08 
0.25 ± 0.10 
0.35 ± 0.09 
0.35 ± 0.09 
0.36 ± 0.11 
 
2.05 
2.02 
1.97 
1.84 
 
 
2.74 
2.78 
2.27 
2.01 
 
 
2.38 
3.04 
2.82 
1.99 
1.97 
1.90 
 
140 
138 
123 
71.9 
 
 
590 
604 
448 
281 
 
 
208 
203 
179 
127 
126 
114 
 
0.87 
0.88 
0.85 
0.71 
 
 
0.93 
0.93 
0.90 
0.74 
 
 
0.88 
0.74 
0.72 
0.88 
0.88 
0.85 
 
8.13 
7.91 
8.21 
7.64 
 
 
17.9 
18.1 
20.7 
26.2 
 
 
8.91 
12.1 
12.6 
7.44 
7.27 
7.74 
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   E-cinnamaldehyde 
 
Recovery in stomach rel. to 4 mol/L HCl ins. ash (%) 
   Carvacrol 
   Thymol 
   Eugenol 
   E-cinnamaldehyde 
 
Recovery in stomach rel. to C36H74 (%) 
   Carvacrol 
   Thymol 
   Eugenol 
   E-cinnamaldehyde 
39.2 ± 10.2 
 
 
111 ± 12 
111 ± 12 
107 ± 16 
73.9 ± 20.1 
 
 
119 ± 13 
119 ± 11 
116 ± 16 
78.4 ± 19.9 
0.38 ± 0.17 
 
 
0.27 ± 0.06 
0.27 ± 0.05 
0.31 ± 0.08 
0.34 ± 0.17 
 
 
0.25 ± 0.05 
0.25 ± 0.05 
0.31 ± 0.08 
0.33 ± 0.15 
1.82 
 
 
2.54 
2.57 
2.22 
2.06 
 
 
2.78 
2.82 
2.26 
2.08 
77.0 
 
 
309 
312 
258 
163 
 
 
362 
364 
291 
177 
0.72 
 
 
0.91 
0.92 
0.87 
0.69 
 
 
0.90 
0.92 
0.88 
0.72 
8.17 
 
 
11.7 
11.1 
14.3 
17.8 
 
 
12.7 
11.3 
14.7 
17.2 
(1) regression analysis according to model y = a . e-b.t where t = time (h) and a, b = regression coefficients; (2) SE = standard error of regression coefficient estimation; (3) t1/2 = 
half-life (= ln2/b); (4) area under the curve; (5) RSD = residual standard deviation of the regression  
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Table 4. Regression analysis of relating the time after a meal containing respectively 13.0, 13.2, 12.5 and 12.7 mg/kg BW of carvacrol, thymol, 
eugenol and E-cinnamaldehyde to the concentration in urine and plasma and percentage of intake in small intestine (S1, S2 and S3) according to 
a non-compartmental model(1) in piglets 
Regression coefficient ± SE (2) y 
a b c 
tmax (3) ymax (4) t1/2AUC  
(h) (5) 
AUC (6) R2 RSD (7) 
Concentration in urine 
(mg/g creatinine) 
   Carvacrol 
   Thymol 
   Eugenol 
   E-cinnamaldehyde (8) 
 
Concentr. in plasma (mg/L) 
   Carvacrol 
   Thymol 
   Eugenol 
   E-cinnamaldehyde (8) 
 
Percentage of intake in S1 (%) 
   Dry matter 
   4 mol/L HCl insoluble ash (9) 
   C36H74 
   Carvacrol 
 
 
284E2 ± 177E2 
359E2 ± 240E2 
135E3 ± 822E2 
 
 
 
5.77 ± 1.38 
3.99 ± 0.94 
4.85 ± 1.49 
 
 
 
21.3 ± 5.1 
 
31.9 ± 18.8 
6.41 ± 2.45 
 
 
8.00 ± 1.79 
8.60 ± 2.01 
8.99 ± 1.45 
 
 
 
0.69 ± 0.35 
0.50 ± 0.35 
0.45 ± 0.37 
 
 
 
0.66 ± 0.28 
 
1.42 ± 0.68 
1.84 ± 0.59 
 
 
3.99 ± 0.86 
4.30 ± 0.95 
4.73 ± 0.75 
 
 
 
0.49 ± 0.18 
0.37 ± 0.17 
0.54 ± 0.23 
 
 
 
0.69 ± 0.19 
 
1.21 ± 0.50 
1.07 ± 0.34 
 
 
2.00 
2.00 
1.90 
 
 
 
1.39 
1.35 
0.83 
 
 
 
0.96 
 
1.18 
1.71 
 
 
2470 
2550 
5370 
 
 
 
3.65 
2.80 
2.85 
 
 
 
2.66 
 
9.69 
2.74 
 
 
2.17 
2.15 
2.04 
 
 
 
2.78 
3.18 
2.10 
 
 
 
1.94 
 
1.74 
2.34 
 
 
5400 
5390 
9780 
 
 
 
17.1 
13.7 
8.79 
 
 
 
39.4 
 
26.9 
8.03 
 
 
0.93 
0.93 
0.96 
 
 
 
0.88 
0.84 
0.91 
 
 
 
0.95 
 
0.88 
0.89 
 
 
232 
245 
388 
 
 
 
0.63 
0.56 
0.44 
 
 
 
1.09 
 
1.58 
0.43 
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   Thymol 
   Eugenol 
   E-cinnamaldehyde 
 
Percentage of intake in S2 (%) 
   Dry matter 
   4 mol/L HCl insoluble ash 
   C36H74 
   Carvacrol 
   Thymol 
   Eugenol 
   E-cinnamaldehyde (9) 
 
Percentage of intake in S3 (%) 
   Dry matter 
   4 mol/L HCl insoluble ash 
   C36H74 
   Carvacrol 
   Thymol 
   Eugenol 
   E-cinnamaldehyde 
6.79 ± 2.53 
4.00 ± 1.57 
3.33 ± 1.15 
 
 
11.4 ± 0.7 
24.1 ± 4.8 
13.7 ± 7.6 
0.46 ± 0.11 
0.36 ± 0.11 
0.33 ± 0.04 
 
 
 
14.2 ± 2.9 
54.2 ± 12.7 
35.3 ± 10.8 
0.31 ± 0.13 
0.28 ± 0.09 
0.32 ± 0.11 
0.07 ± 0.03 
1.89 ± 0.58 
2.07 ± 0.65 
7.51 ±1.31 
 
 
0.47 ± 0.11 
0.53 ± 0.27 
0.34 ± 0.83 
0.62 ± 0.34 
1.04 ± 0.51 
0.54 ± 0.18 
 
 
 
0.00 ± 0.0 
1.59 ± 0.45 
1.71 ± 0.72 
5.32 ± 1.51 
1.38 ± 0.73 
6.95 ± 1.30 
4.64 ± 1.86 
1.10 ± 0.33 
1.15 ± 0.35 
3.46 ± 0.58 
 
 
0.38 ± 0.05 
0.47 ± 0.15 
0.28 ± 0.38 
0.45 ± 0.17 
0.56 ± 0.23 
0.40 ± 0.09 
 
 
 
0.17 ± 0.13 
0.77 ± 0.20 
0.68 ± 0.26 
1.68 ± 0.44 
0.52 ± 0.25 
2.29 ± 0.40 
1.50 ± 0.55 
1.72 
1.80 
2.17 
 
 
1.23 
1.13 
1.24 
1.37 
1.85 
1.33 
 
 
 
0.00 
2.06 
2.53 
3.17 
2.66 
3.04 
3.10 
2.86 
1.71 
0.62 
 
 
7.81 
15.1 
10.5 
0.30 
0.24 
0.22 
 
 
 
14.2 
34.7 
31.2 
0.70 
0.27 
0.70 
0.12 
2.34 
2.39 
2.37 
 
 
3.01 
2.58 
3.73 
2.87 
3.06 
3.02 
 
 
 
4.12 
2.93 
3.53 
3.57 
3.97 
3.33 
3.54 
8.35 
4.98 
1.30 
 
 
42.9 
60.8 
52.7 
1.28 
1.03 
1.00 
 
 
 
78.8 
138 
141 
2.63 
1.38 
2.00 
0.40 
0.89 
0.88 
0.98 
 
 
0.98 
0.90 
0.26 
0.88 
0.79 
0.96 
 
 
 
0.79 
0.88 
0.72 
0.89 
0.69 
0.95 
0.84 
0.43 
0.27 
0.04 
 
 
0.48 
2.00 
5.40 
0.05 
0.06 
0.02 
 
 
 
2.65 
5.30 
7.28 
0.09 
0.08 
0.06 
0.02 
(1) regression analysis according to model 2, y = a . tb . e-c.t where t = time (h) and a, b and c = regression coefficients; (2) SE = standard error of regression coefficient 
estimation; (3) tmax = b/c (time at maximum response, h); (4) ymax = a . tmaxb . e-c.tmax (maximum response, weight unit or %); (5) t1/2 AUC = gammainv (0.5, b + 1, 1 / c) (time which 
corresponds to the half of the AUC, h); (6) area under the curve; (7) RSD = residual standard deviation of the regression; (8) E-cinnamaldehyde was not detected (<CCβ) in urine 
and plasma in any of the specimens; (9) regression not converged. 
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Fig. 1. Percentage of intake in stomach (─▲─ ) and S1 (• ;  small intestine 1) (left ordinate) and 
concentration in plasma (-◊-;  free and conjugated compound) (right ordinate) for carvacrol (A), 
thymol (B), eugenol (C) and E-cinnamaldehyde (D) in relation to time after oral administration of 
respectively 13.0, 13.2, 12.5 and 12.7 mg/kg BW to piglets. 
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CONCLUSION 
 
An analytical method to quantify carvacrol, thymol, eugenol and E-cinnamaldehyde in different 
biological matrices was developed and validated. However, ‘matrix’ effects rendered the method 
unreliable for dosing E-cinnamaldehyde in in vitro caecal media, caecal digesta, faeces and pre-
treated urine. These matrices have in common that they are rich in microbial (in vitro caecal medium, 
caecal digesta and faeces) or animal (pre-treated urine) N-containing degradation products increasing 
the likelihood for Schiff base formation to occur, but this should be further investigated. The four 
compounds were in vitro poorly degraded in the proximal segments of the GIT, but degradation is 
expected in more distal segments. In vivo, the EO were mainly and nearly completely absorbed in the 
stomach and the proximal SI. The latter finding must be taken into account when designing feed 
additives based on these EO. 
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CHAPTER 4A  
 
EFFECT OF DOSE OF THYMOL AND FLAVOURS ON PALATABILITY IN 
A CHOICE-FEEDING STUDY WITH PIGLETS 
 
 
ABSTRACT 
 
The objectives in this choice-feeding study were: [1] to determine the effect of dose of thymol on 
palatability (experiment I) and [2] to study the possibility of added flavours to mitigate the aversive 
effects of high thymol inclusion rates on palatability (experiment II). Twenty-four fully weaned 
piglets were divided into 8 groups of 3 animals. Each group was housed in a separated pen equipped 
with two troughs; a reference diet was offered in one through and a test diet in the second trough. 
Piglets had free access to both troughs and could therefore choose between the two diets offered. 
Each experiment had two experimental periods that lasted for 4 consecutive days whereby feed 
intake was recorded daily. Feed intake of the test diet was expressed as the proportion of the total 
intake and tested by means of a one-sample Student’s t-test against a set value of 50% (n=16). The 
preference of the piglets for feed supplemented with 125, 500 and 2000 mg/kg thymol was 53.0 ± 
14.0 % (P>0.05), 47.5 ± 19.6 % (P>0.05) and 9.9 ± 9.2 % (P<0.001) respectively (experiment I). 
Definitely, 125 and 500 mg/kg thymol did not affect palatability, while the piglets almost completely 
refused to eat feed with 2000 mg/kg thymol. Two test diets were included in experiment II; feed 
supplemented with 2000 mg/kg thymol with either flavour A (intended to mask the pungent taste of 
thymol) or flavour B (designed to mask both taste and smell of thymol) and opposed against a control 
diet. The relative intake of the test diets was 19.5 ± 10.5 % (P<0.001) and 14.0 ± 15.7 % (P<0.001), 
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respectively, which means that the flavours could partially alleviate the aversive effects of 2000 
mg/kg thymol. Alternatively, animals were offered one of these test diets and a reference diet 
containing 2000 mg/kg thymol. In accordance to the former results, animals had a preference for the 
feed with 2000 mg/kg thymol + flavour A (67.6 ± 18.9 %; P<0.01). However, the results for the feed 
with 2000 mg/kg thymol + flavour B (28.9 ± 13.1 %; P<0.001) did not confirm the previous 
observations.  
 
KEYWORDS: thymol, flavour, aroma, palatability, feed intake, pig
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INTRODUCTION 
 
The sensorial qualities of a feedstuff are mainly defined by its aroma, texture and flavour (Laitat et 
al., 2003) and determine in part its palatability (reflected by ingestive response). Aroma is 
appreciated by olfactive (smell) and nasal sensations, while flavour perception can be ascribed to 
taste and olfactive and thermo-mechanical stimulation like hot or from chemical origin (e.g. spicy). 
The pig’s sense of smell is very performant and 2000 times superior to that of human. Generally, pigs 
accept well acidified feed, are indifferent for salt content, reject feedstuffs with a bitter taste and have 
a strong preference for sweet substances, in particular sucrose. It has been shown that pigs have 
preference for specific flavours, and which, when added to feed  were able to enchance feed intake in 
the first weak post-weaning (not in the following weeks) (McLaughlin et al., 1983). However, it is 
still a matter of debate to what extent flavours can positively influence feed intake. 
 
Flavours are added to feeds to affect the sensorial characteristics of the feed. The objective can be 
either: [1] to improve the palatability of the feed in order to enhance feed intake, or [2] to mask off-
flavours or [3] to standardise the flavour of the feed, because the amount and type of feedstuffs 
included is changing over time. EO have a distinctive, marked flavour and are traditionally used in 
feeds as flavour or aroma (e.g. Laitat et al., 2004 and list of Sensory additives – flavouring 
compounds in Community Register of Feed Additives pursuant to Regulation (EC) No 1831/2003; 
accessed Dec. 2008, http://ec.europa.eu/food/food/animalnutrition/feedadditives - Notified and 
authorised feed additives). Windisch et al. (2007) stated that choice-feeding studies are to be 
compiled to test palatability. Indeed, a higher feed intake in growth trials can reflect the higher 
consumption capacity of animals grown larger due to better nutrient utilization compared with 
untreated controls. In a choice-feeding study, animals have free access to two or more feeds and their 
preference for one feed can be determined. It is assumed that, when animals can choose between 
diets that differ only in flavour, their preferred feed reflects the most palatable feed. The number of 
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published choice-feeding studies with EO is very limited. A dose-related depression of palatability in 
pigs fed EO from fennel and caraway has been shown (Schöne et al., 2006); as well as from the herbs 
thyme and oregano (Jugl-Chizzola et al., 2006).  
 
The objectives in this choice-feeding study were: [1] to determine the effect of dose of thymol on 
palatability and [2] to study the possibility of added flavours to mitigate the aversive effects of high 
thymol inclusion rates on palatability. Thymol was selected for this trial, because in a preliminary 
latin-square experiment we observed that thymol had the least depressive effect on appetite compared 
to the other EO (unpublished results). In that experiment, feed intake was recorded for 6 h after 
supplying an experimental feed (2000 mg/kg carvacrol, thymol, eugenol and E-cinnamaldehyde or 
control feed), which was preceded by giving control feed and temporarily fasting. For humans, 
thymol has the characteristic, agreeable odor of thyme and a bitter, aromatic and sometimes burning 
sensation mediated by receptor mechanisms in the nose and tongue. Hereby, it was shown that this 
compounds activate TRPA1 (Lee et al., 2007a) and TRPV3 (Xu et al., 2006). This trial was 
performed to explore the effects of thymol on appetite (enhanced of decreased palatability) in 
advance to further in vivo trials (see Chapter 4B). 
 
MATERIALS AND METHODS 
 
Animals and housing 
 
Twenty-four weaned male castrated piglets (24 d; Belgian Landrace x Large White) with an initial 
weight of 6.91 ± 0.71 kg were divided into 8 groups of 3 animals with a similar average live weight. 
Each group of 3 animals was housed in a floor slatted pen (1.20 x 1.25m) equipped with two identical 
troughs. During the first 10 days post-weaning all animals were offered the basal diet ad libitum in 
both troughs. At 10 days post-weaning the experiments were started. Water was provided ad libitum 
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by two nipple drinkers at the opposite side of the troughs. Pens were cleaned daily to avoid fecal 
contamination of the pen floor. Average live weight at the start of experiment I and II was 8.04 ± 
1.31 kg and 13.06 ± 2.36 kg respectively. 
 
Feed 
 
The composition of the basal diet is given in Table 1. The basal diet was given to all animals until 
start of experiment I. The basal diet was used to prepare the experimental diets as shown in Table 2. 
For experiment I the following diets were prepared: a basal diet (CO1), and the basal diet 
supplemented with thymol at 125 mg/kg (THY125), at 500 mg/kg (THY500) and at 2000 mg/kg 
(THY2000A). Thymol was added to the feed after adsorption on a cellulose carrier (Alphacel non-
nutritive bulk; nr. 900453; MP Biochemicals, LLC, Brussels, Belgium). First 100 g of thymol 
(T0501; Sigma-Aldrich nv/sa, Bornem, Belgium) was dissolved in 250 mL methanol. Thereafter, 100 
g of the carrier was added to the mixture and further blended for 1 h. The mixture was dried in a 
rotavapor apparatus (waterbath, 30°C) followed by exposure to the air until a dry preparation was 
obtained. Finally, it was ground and passed through a sieve with 500 µm pores. The preparation of 
thymol on alphacel contained 48.8 % thymol in the final product. Alphacel was then added to the 
diets in order to obtain equal amounts of the basal diet in all experimental diets. In experiment II, the 
diets used were: a basal diet (CO2), and the basal diet supplemented with 2000 mg/kg thymol 
(THY2000B), with 2000 mg/kg thymol and 4000 mg/kg flavour A (THY2000B+FA) and with 2000 
mg/kg thymol and 40000 mg/kg flavour B (THY2000B+FB). The same thymol preparation as in 
experiment I was used. Flavour A (active principles not disclosed) was provided by Scentarom n.v. 
(Merchtem, Belgium) and was intended to mask the pungent taste of thymol. Dextrose was the carrier 
for the active ingredients of this flavour. Flavour B (active principles not disclosed; Scentarom n.v., 
Merchtem, Belgium) was designed to mask both the taste and smell of thymol. Dextrose was the 
 - 146 - 
main carrier for the active ingredients of flavour B. All experimental diets were prepared in the week 
before starting the respective experiment. 
 
Table 1. Ingredient and analysed and calculated nutrient composition of the basal diet 
Ingredient composition (g/kg) 
  Corn 
  Soybean meal 43% 
  Soybean oil 
  DL-methionine 
  L-lysine HCl 
  L-threonine 
  L-tryptophane 
  Sodium chloride 
  Monocalcium-phosphate 
  Limestone 
  Premix Vitamins Pigs 3/2.5 (1) 
  Premix Trace elem. Pigs ¾ (1) 
Calculated composition as is (2) 
  Dry matter (g/kg) 
  Crude protein (g/kg) 
  Ether extract (g/kg) 
  NEv97 (3) (MJ/kg) 
  dLYS (g/kg) 
  dMET+CYS (g/kg) 
  dTHR (g/kg) 
  dTRY (g/kg) 
 
665.6 
282.4 
10.32 
1.36 
3.63 
0.80 
0.39 
6.50 
12.50 
14.00 
1.30 
1.20 
 
878.6 
176.7 
40.70 
9.86 
10.30 
6.10 
5.90 
1.90 
(1) Vitamex N.V., Drongen, Belgium – see also Table 1, Chapter 4B; (2) 
CVB Table 1998, Centraal Veevoederbureau, Lelystad, The Netherlands; (3) 
Net energy for pigs, CVB 1998  
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Table 2. Composition of the experimental diets (g/kg) 
Thymol preparation and 
carrier (1) 
Flavour and carrier Experimental diet Basal diet 
Thymol 
preparation 
Alphacel Flavour A Flavour B Carrier A Carrier B 
Experiment I 
 CO1 
 THY125 
 THY500 
 THY2000A 
 
995.90 
995.90 
995.90 
995.90 
 
 
0.25 
1.00 
4.10 
 
4.10 
3.85 
3.10 
 
    
Experiment II 
 CO2 
 THY2000B 
 THY2000B+FA 
 THY2000B+FB  
 
951.90 
951.90 
951.90 
951.90 
 
 
4.10 
4.10 
4.10 
 
4.10 
 
 
 
4.00 
 
 
 
 
 
40.00 
 
4.00 
4.00 
 
4.00 
 
40.00 
40.00 
40.00 
(1) The thymol preparation contained 48.8% thymol and alphacel was used as carrier 
 
 
Choice-feedings experiments 
 
Two choice-feedings experiments were conducted. As a rule, a reference diet was offered in one 
trough and a test diet was offered in the second trough. Piglets had free access to both troughs and 
could therefore choose between the two diets offered. Experiment I was started at day 10 post-
weaning and tested the palatability of feed supplemented with increasing concentrations of thymol. 
Four treatments (test diet vs. reference diet) were included: CO1 vs. CO1, THY125 vs. CO1, 
THY500 vs. CO1 and THY2000A vs. CO1. Each treatment was assigned to two pens in both periods 
(Table 3). Each experimental period lasted for 4 consecutive days and was preceded by 3 days 
offering the CO1 diet to all pens in both troughs. At 7.30 a.m. the weighed portions of both diets 
were offered and 24 h later the residues from both the troughs were weighed. Immediately thereafter, 
the new portions were offered. Regarding local preferences for the left or right trough, the diets in 
both troughs were changed every day. The 24-h intake of the test diet was related to the total feed 
intake. Data from the 4 days were used for statistical analysis which means that there was no 
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adaptation period to the offered experimental diets. Feed troughs were designed to minimize feed 
moistening; throughout the whole study moistening was at minimum and not taken into account in 
further data processing. In case of contamination with urine or feces, feed intake for the respective 
pen and day was withdrawn from the dataset. Feed intake (kg per day per animal) given in the results 
section refers to total fresh feed intake. In experiment I each treatment was tested in 4 out of 8 pens 
for a total of 16 days. 
 
In experiment II the hypothesis was tested whether flavours had the ability to alleviate the depressive 
effect on palatability of high doses of thymol. Therefore flavours were added to feeds containing 
2000 mg/kg thymol. Treatments (test diet vs. reference diet) were: THY2000B+FA vs. CO2, 
THY2000B+FB vs. CO2, THY2000B+FA vs. THY2000B and THY2000B+FB vs. THY2000B. 
Similarly to experiment II, each treatment was assigned to two pens in both periods (Table 3). 
Further protocol details are identical to experiment I. 
 
Table 3. Study design with four treatments (test diet vs. reference diet) allocated to two pens per 
period in each choice-feeding experiment (1) 
Experiment I Experiment II Pen 
Period 1 (1) Period 2 Period 3 Period 4 
1 
2 
3 
4 
5 
6 
7 
8 
THY500/CO1 
THY125 /CO1 
CO1/CO1 
THY2000A/CO1 
THY2000A/CO1 
THY500/CO1 
CO1/CO1 
THY125/CO1 
CO1/CO1 
THY2000A/CO1 
THY125/CO1 
THY500/CO1 
THY500/CO1 
CO1/CO1 
THY125/CO1 
THY2000A/CO1 
THY2000B+FA/THY2000B 
THY2000B+FB/CO2 
THY2000B+FA/CO2 
THY2000B+FB/THY2000B 
THY2000B+FB/THY2000B 
THY2000B+FA/THY2000B 
THY2000B+FA/CO2 
THY2000B+FB/CO2 
THY2000B+FB/CO2 
THY2000B+FA/THY2000B 
THY2000B+FB/THY2000B 
THY2000B+FA/CO2 
THY2000B+FA/CO2 
THY2000B+FB/CO2 
THY2000B+FB/THY2000B 
THY2000B+FA/THY2000B 
(1) Each experimental period lasted for 4 consecutive days and was preceded by 3 days offering the respective control 
diet to all animals. 
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Statistical methods 
 
Total feed intake per pen and day were recorded. The intake of the test diet was expressed as the 
proportion of the total feed intake. Data were analysed for normal distribution using the Kolmogorov-
Smirnov procedure in the SPSS 15.0 program (SPSS Inc., Chicago IL, USA). Data of experiment I 
were analysed by the GLM procedure. Three factors were included in the model: period (2) and day 
(4) as random factors and treatment (4) as fixed factor. In case a factor was not significant (P>0.05) it 
was deleted from the model. Treatments means were compared by the Tukey test. If animals have no 
preference for one of the two diets offered, it can be expected that the relative intake of the test diet 
equals 50%. Therefore the null hypothesis was that neither of the diets would be preferred and this 
was tested by means of a one-sample Student’s t-test (set value = 50%). The same hypothesis was put 
forward for analysis of data of experiment II. In this experiment two treatments had the CO2 diet as 
reference diet. Mean values for relative feed intake of the test diets of these two treatments were 
compared by a two-sample Student’s t-test. The same approach was used for the two treatments 
whereby THY2000B can be regarded as reference diet. 
 
RESULTS AND DISCUSSION 
 
In experiment I, animals had no preference for one of the two CO1 diets in the treatment CO1 vs. 
CO1 (Table 4). This means that feed intake from both troughs was equal which is a prerequisite in a 
choice-feeding study. Further, variance analysis showed that the effects of day and period for relative 
intake of test diet were not significant. Significant interaction of these factors with the factor 
treatment was lacking. Therefore it is reasonable to state that there was no learning or habituation to 
the applied thymol or influence of the preceding treatment. In this study, thymol was prepared on 
alphacel as an inert carrier. Hereby, the pungent flavour of thymol was preserved, and hence its effect 
on palatability could be tested. The supplementation with 125 and 500 mg/kg thymol did not affect 
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the palatability of the diet as is illustrated by P-values > 0.05 in the one-sample the Student’s t-test 
(Table 4). However, animals clearly preferred the CO1 diet to a diet with 2000 mg/kg thymol. The 
animals almost completely refused to eat feed with 2000 mg/kg thymol. In addition, total feed intake 
was numerically lower for the treatment THY2000A vs. CO1 compared to the other treatments. The 
reason for this was that in the first two days of the trial the amount offered of each diet was lower 
than the total feed intake of that day so that animals were limited in their uptake if they wanted to 
choose for one diet. Probably, this has led to an overestimation of the relative intake of the test diet in 
this treatment. 
 
From experiment II it can clearly be observed that the animals preferred the CO2 diet compared to 
the diets supplemented with 2000 mg/kg thymol and either of the two flavours. The relative intake 
for THY2000B+FA and THY2000B+FB was respectively 19.5 ± 10.5 and 14.0 ± 15.7 % which was 
higher than the relative intake of THY2000A in experiment I (9.9 ± 9.2 %; overestimated). So, it can 
be assumed that the flavours were able to partially reduce the aversive effect of 2000 mg/kg thymol 
on palatability. However, an age effect cannot be ruled out since the animals in experiment II were 
two weeks older than in experiment I. It is well known that the susceptibility for flavours declines 
with age (McLaughlin et al., 1983). The relative intake of 67.6 ± 18.9 % for THY2000B+FA 
compared to the reference diet THY2000B confirms the masking effect of flavour A. The opposite 
can be said for flavour B, because the animals ate more from the reference diet than from the test diet 
in treatment THY2000B+FB vs. THY2000B. It can further be questioned whether differences in 
dextrose content (THY2000B+FB will have the lowest dextrose content) could have interfered with 
the differences in palatability of the experimental diets. The relative intake for THY2000A in 
experiment I was 9.9 ± 9.2 % (overestimated), which means that the animals almost completely 
refused to eat this feed. From this point, it can be understood that it is difficult for flavours to mask 
substantially the flavour of thymol because the animals rejected feed with 2000 mg/kg in this 
experiment. Probably, it would have been more appropriate to test flavour addition to a diet 
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containing for example 1000 mg/kg thymol. This thymol inclusion rate has not been tested here, but 
from Table 4 it can be expected that the preference for such a diet must be between 9.9 and 47.5%. 
At least, it can be stated that flavour A, which was intented to mask only taste was more effective 
than flavour B (intented to mask both taste and smell) in reducing the aversive effects of 2000 mg/kg 
thymol. 
 
Table 4. Feed intake and relative intake of test diets in two choice-feeding experiments 
Intake of test diet (2) Treatment Total feed intake 
(g per day per animal) (1) (3) relative intake (%) (1) (3) P-value (4) 
  Experiment I 
 
 CO1/CO1 
THY125/CO1 
THY500/CO1 
THY2000A/CO1 
 
 
599a ± 193 (307-987) 
570ab ± 128 (340-780) 
581ab ± 134 (400-920) 
487b ± 148 (280-727) 
 
 
53.7a ± 16.4 (26.0-85.3) 
53.0a ± 14.0 (29.2-87.5) 
47.5a ± 19.6 (12.0-76.7) 
9.9b ± 9.2 (2.1-29.5) 
 
 
0.382 
0.428 
0.616 
<0.001 
 
  Experiment II 
 
THY2000B+FA/CO2 
THY2000B+FB/CO2 
 
THY2000B+FA/THY2000B 
THY2000B+FB/THY2000B 
 
 
 
892 ± 166 (600-1267) 
866 ± 299 (520-1380) 
 
876 ± 273 (580-1360) 
931 ± 263 (540-1413) 
 
 
 
19.5 ± 10.5 (3.4-39.1) 
14.0 ± 15.7 (0-44.4) 
 
67.6a ± 18.9 (35.8-96.7) 
28.9b ± 13.1 (14.2-55.9) 
 
 
 
<0.001 
<0.001 
 
0.003 
<0.001 
(1) Mean ± standard deviation (min-max), n=16; (2) Tests diets in experiment I are CO1, THY125, THY500 and 
THY2000A; in experiment II, THY2000B+FA and THY2000B+FB were assigned as test diets; (3) Values with 
different superscripts in the same experiment and column part represent significant differences, P<0.05; (4) The null 
hypothesis was that the test diet was not preferred and this was tested by means of a one-sample Student’s t-test (set 
value = 50%; n = 16). 
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CONCLUSION 
 
When piglets had free choice between a control diet and a diet with thymol; they had no preference 
for thymol at 125 mg/kg, neither for thymol at 500 mg/kg. However; palatability was drastically 
negatively affected when 2000 mg/kg was included in the diet. Addition of flavours was able to 
partially overcome the reduced intake; especially a flavour that was aimed to mask the pungent taste 
of thymol. 
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CHAPTER 4B  
 
EFFECT OF DOSE AND FORMULATION OF CARVACROL AND THYMOL 
ON GUT BACTERIA AND GUT FUNCTION IN PIGLETS AFTER WEANING  
 
 
ABSTRACT 
 
Two trials were conducted to study the effect of dose and formulation of carvacrol and thymol on gut 
bacterial counts and metabolites and gut function in weaned piglets. In experiment I, 25 piglets (28 d, 
6.59 ± 0.48 kg) were allocated to five dietary treatments: a control diet and the same diet 
supplemented with either carvacrol or thymol at doses of 500 and 2000 mg/kg. The EO were 
dissolved in the soybean oil fraction, prior to mixing with the basal diet. In experiment II, 35 piglets 
(28 d, 7.99 ± 0.73 kg) were assigned to seven dietary treatments: the same control diet as in 
experiment I and this diet supplemented with thymol in one of three formulations (on celite, on 
alphacel or microencapsulated) at doses of 500 and 2000 mg/kg. Microencapsulation was applied in 
order to delay the release of the active ingredient in the gastro-intestinal tract. All diets were given ad 
libitum. At 11/12 days post-weaning piglets were euthanized, and digesta from stomach, proximal 
and distal SI were sampled for bacteriological (plating onto selective media for total anaerobic 
bacteria, coliforms, streptococci and lactobacilli) and biochemical analysis. Small intestinal tissue 
was sampled for histo-morphological determinations. Feed intake was higher for animals fed 500 
mg/kg carvacrol and thymol, with the exception of the microencapsulation treatment (between +12.4 
and +44.7% as compared to control), and likewise villi at the distal SI were larger compared to 
control (between +4.9 and +7.5% as compared to control; P>0.05). In experiment I, the villus/crypt 
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ratio at the distal SI for the experimental diets (1.30-1.32) was higher than for the control diet (1.24) 
(P<0.05). Thymol fed animals in experiment II had a lower number of intra-epithelial lymphocytes at 
the proximal (P<0.05) and at the distal (P<0.1) SI as compared to the control animals. Concurrently, 
the villus/crypt ratio at the distal SI tended to be higher in the experimental diets (P<0.1). Mean EO 
concentration in stomach and proximal SI for the 2000 mg/kg diets ranged between 475 and 647 and 
between 5 and 24 mg/kg fresh digesta, respectively. Cumulative absorption in proximal SI was 
higher than 90% for all treatments. These data suggest that EO can enhance feed intake at 500 mg/kg 
and improve gut health, but conclusive evidence for clear antimicrobial effects towards the major 
culturable bacteria of the pig gut is limited. 
 
KEYWORDS: carvacrol, thymol, gut bacteria, gut function, weaning piglets 
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INTRODUCTION 
 
Pigs post-weaning are subject to growth-check and vulnerable for gastro-intestinal disorders and 
infections, often leading to diarrhoea and consequently economic losses. In the past decades, the 
preventive use of antibiotics and metals (copper and zinc) as AMGP has proven its benefits. The 
AMGP have proven to elicit their effects through modulation or reduction of the bacterial 
metabolism and load in the gastrointestinal tract of monogastrics, resulting in improved gut 
functionality and health and animal performance (Decuypere et al., 1991; Visek, 1978; Gaskins et al., 
2002). Recent limitations on the use of antibiotics are believed to worsen the challenges for the 
young pig during the critical period post-weaning. Moreover, in the EU antimicrobial levels of 
copper are foreseen to be reduced in the near future. 
 
Plant-based products have gained interest as alternative. In a recent review by Windisch et al. (2008) 
it is concluded that reported effects on pig performance gives a rather scattered picture, and that the 
mode of action of plant-based compounds is not always well understood. Most attention has been 
directed to compounds with antimicrobial activities, like oregano oil, thyme oil and their components 
carvacrol and thymol. The antimicrobial properties of carvacrol and thymol have been shown in 
standard assays (e.g. Karapinar and Aktug, 1987; Didry et al., 1993) and against commensal bacteria 
and pathogens in in vitro simulations of the pig gut fermentation (Michiels et al., in press – Chapter 
2; Si et al., 2006). Michiels et al. (in press) (Chapter 2) showed that carvacrol and thymol equally 
inhibited the main culturable bacterial groups present. However, they only exerted a bactericidal 
effect above a certain (critical) concentration. It was found that 400 and 400-550 mg/kg digesta 
would be necessary to induce a substantial reduction in number of coliforms and lactobacilli, 
respectively. Si et al. (2006) found, in a 6 h caecal incubation, that carvacrol (300 mg/L) and thymol 
(200 mg/L) inhibited growth of coliforms, but only thymol was effective against lactobacilli. The 
number of in vivo trials with these pure compounds is however limited (Piva et al., 2007b; Trevisi et 
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al., 2007). Up to date there is no solid evidence that these compounds exert an antimicrobial effect in 
vivo towards gut bacteria in pigs. Besides, both compounds have been shown to possess antioxidant 
properties (e.g. Youdim and Deans, 2000), to affect the immune response by intracellular Ca2+ 
mobilization in monocytic cells (Chan et al., 2005), and to inhibit the release of elastase (Braga et al., 
2006) and of cyclooxygenase activity (Marsik et al. 2005). Further, Michiels et al. (2008) 
demonstrated that carvacrol and thymol were mainly and nearly completely absorbed in the stomach 
and proximal SI after oral administration of a single dose mixed with feed (13.0 and 13.2 mg/kg BW 
for carvacrol and thymol) to piglets. Fast absorption is likely to reduce lumen concentrations and 
consequently the effectiveness of the EO. Hence, the type of formulation of these compounds in feed 
might affect the outcome. For example, microencapsulation is assumed to protect the active 
ingredient from absorption, resulting in a more gradual release in the GIT. However, a variety of 
techniques to encapsulate active ingredients are available and information on the rate and extent of 
release of microencapsulated active ingredients applied in pig nutrition is still scarce (Piva et al., 
1997; Piva et al., 2007a).  
 
The aim of the present study was to test the hypothesis that carvacrol and thymol could reduce the 
bacterial load and improve indices of gut functionality in weaned piglets. Two dose levels (500 and 
2000 mg/kg) were applied, and in addition different formulations types, including 
microencapsulation, were tested. 
 
MATERIALS AND METHODS 
Animals and feed 
 
In experiment I, 25 newly weaned male-castrated piglets (28 d, BW 6.59 ± 0.48 kg, Belgian Landrace 
x Large White) were allocated according to live weight to five dietary treatments (pens) of five 
animals each. Feed was offered ad libitum as dry meal. Water was available by nipple drinkers. In 
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experiment II, 35 newly weaned male-castrated piglets (28 d, BW 7.99 ± 0.73 kg; Hypor hybrid x 
Piétrain) were allocated according to live weight to seven dietary treatments (pens) of five piglets 
each. The same basal diet based on wheat and peas was used for both trials (Table 1). Celite 545 
coarse (22140, Sigma-Aldrich nv/sa, Bornem, Belgium) was included as source of 4 mol/L HCl 
insoluble ash. Experiment I consisted of a control (CON) diet (=basal diet) and four experimental 
diets: CON + 500 mg/kg carvacrol (28219-7, Sigma-Aldrich nv/sa) (CAR500), CON + 500 mg/kg 
thymol (T0501, Sigma-Aldrich nv/sa) (THY500), CON + 2000 mg/kg carvacrol (CAR2000) and 
CON + 2000 mg/kg thymol (THY2000). The analytically verified concentration of carvacrol or 
thymol of the feeds was 0 (CON), 506 (CAR500), 494 (THY500), 1883 (CAR2000) and 1870 
(THY2000) mg/kg. The EO were dissolved in the soybean oil fraction and then further mixed with 
the basal diet, without soybean oil. In experiment II, two thymol inclusion rates and three formulation 
types were tested. The diets were: CON, CON + 500 mg/kg thymol on celite 545 coarse as carrier 
(CE500), CON + 500 mg/kg thymol on alphacel non-nutritive bulk (nr. 900453, MP Biochemicals, 
LLC, Brussels, Belgium) as carrier (AL500), CON + 500 mg/kg microencapsulated (SODA Feed 
Ingredients, Monaco) thymol (ME500), CON + 2000 mg/kg thymol on celite 545 coarse as carrier 
(CE2000), CON + 2000 mg/kg thymol on alphacel non-nutritive bulk as carrier (AL2000) and CON 
+ 2000 mg/kg microencapsulated (SODA Feed Ingredients, Monaco) thymol (ME2000). The 
analytically verified concentration of thymol of the diets was 0 (CON), 474 (CE500), 485 (AL500), 
340 (ME500), 2164 (CE2000), 2080 (AL2000) and 1783 (ME2000) mg/kg. Experimental diets were 
prepared by equally diluting the basal diet with the preparation containing thymol and with alphacel 
non-nutritive bulk if necessary. For the preparation of thymol on a carrier, firstly 100 g of thymol was 
dissolved in 250 mL methanol. Thereafter, 100 g of the respective carrier was added to the mixture 
and further blended for 1 h. The mixture was dried in a rotavapor apparatus (water bath, 30°C) 
followed by exposure to the air until a dry preparation was obtained. This was ground and passed 
through a sieve with 500 µm pores. Microencapsulation was applied in order to protect the active 
ingredient from absorption, resulting in a more gradual release in the gastro-intestinal tract (GIT) 
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(Piva et al., 1997; Piva et al., 2007a). The microencapsulated thymol was manufactured by complex 
coacervation in which a double coating protects the thymol. The inner coating was a hydrogenated 
vegetable oil matrix and the outer layer was made from a pig skin gelatine protein. The preparation of 
thymol on celite 545 coarse, on alphacel non-nutritive bulk and microencapsulated thymol contained 
479, 478 and 197 g/kg thymol respectively. The analytical recovery of thymol in the preparations 
exceeded 90%. 
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Table 1. Ingredient and analysed and calculated nutrient composition of basal diet used in the two 
experiments with weaned piglets. 
 Experiment I Experiment II 
Ingredient composition (g/kg as fed) 
  Pea 
  Wheat 
  Wheat gluten 
  Soybean oil 
  Sucrose 
  DL-Methionine 
  L-Lysine HCl 
  L-Threonine 
  L-Tryptophane 
  L-Valine 
  Sodium chloride 
  Monocalcium-phosphate 
  Limestone 
  Premix Vitamins Pigs 3/2.5 (1) 
  Premix Trace elem. Pigs ¾ (2) 
  Celite 545 coarse 
Analysed nutrient composition (g/kg as fed) 
  Dry matter 
  Ash 
  Crude protein 
  Ether extract 
  Crude fibre 
  4 mol/L HCl insoluble ash 
Calculated nutrient composition (3) 
  NEv97 (4) (MJ/kg) 
  CP (g/kg) 
  dLYS (g/kg) 
  dMET+CYS (g/kg) 
  dTHR (g/kg) 
  dTRY (g/kg) 
 
120.00 
660.24 
120.00 
30.00 
20.00 
2.26 
7.50 
2.50 
0.50 
1.00 
4.50 
9.00 
10.00 
1.30 
1.20 
10.00 
 
898 
46 
206 
41 
27 
7.9 
 
10.28 
202.12 
10.25 
8.48 
6.78 
2.08 
 
120.00 
660.24 
120.00 
30.00 
20.00 
2.26 
7.50 
2.50 
0.50 
1.00 
4.50 
9.00 
10.00 
1.30 
1.20 
10.00 
 
913 
44 
196 
53 
28 
9.6 
 
10.28 
202.12 
10.25 
8.48 
6.78 
2.08 
(1) Vitamex N.V., Drongen, Belgium (Vit A, 17355 IE/kg as fed; Vit D3, 2314 IE/kg; Vit E, 55250 µg/kg; Vit 
K3, 1888 µg/kg; Vit B1, 1739 µg/kg; Vit B2, 6240 µg/kg; Vit B3, 20768 µg/kg; Vit B6, 3380 µg/kg; Vit B12, 496 
µg/kg and antioxidants (BHT and ethoxyquin), 23400 µg/kg); (2) Vitamex N.V., Drongen, Belgium (Fe, 122400 
µg/kg as fed; Cu, 10008 µg/kg; Zn, 99960 µg/kg; Mn, 80040 µg/kg; I, 967 µg/kg; Co, 1008 µg/kg and Se, 350 
µg/kg); (3) CVB Table (1997), Centraal Veevoederbureau, Lelystad, The Netherlands; (4) Net energy for pigs, 
CVB (1997)   
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Experimental design and sampling strategy 
 
The experiments lasted for 12 days in a temperature-controlled facility (27-28°C). Faeces and health 
condition of the piglets was visually checked daily and coded per pen. Animals were weighed 
individually at arrival, at day six and before euthanasia. Feed intake was recorded per pen for the 
periods 0 to 6 days and 7 to 12 days. Fresh faeces were collected from each pen at day 6 and 12. 
After freeze-drying, excreta were pooled per diet group. In experiment I, 15 and 10 piglets were 
sacrificed on day 11 and 12 respectively, without previous fasting. In experiment II, 21 and 14 piglets 
were sacrificed on day 11 and 12 respectively. Piglets were electrically stunned and killed by 
exsanguination. Blood was collected in tubes provided with EDTA as anti-coagulant for EO analysis. 
An abdominal section was made and samples from the urinary bladder contents were taken and 
stored at -20°C. Subsequently the GIT was removed and partitioned into the following digesta 
sampling sites: stomach, proximal SI (S1, 0 to 3m distal from pylorus) and distal SI (S2, 3 to 0 m 
proximal to caecum). Digesta of each segment were quantitatively collected and pH was determined. 
One g of fresh digesta was taken and processed for bacteriological analysis. Aliquots of the fresh 
digesta were taken, acidified to pH<2 with 2% of 6 mol/L H2SO4 to stop fermentation and stored at -
20°C pending analysis for EO and bacterial metabolites. The remaining digesta were frozen, freeze-
dried and finally ground to pass a 1 mm sieve. From proximal (3m distal to pylorus, J1) and distal 
(3m proximal to caecum, J2) SI, segments (10 cm of length) were taken, flushed with 0.9% saline 
and fixed in neutral buffered formalin for 24 h pending further measurements of histo-morphological 
parameters. 
 
Chemical, bacteriological and histo-morphological analyses 
 
Quantification of the EO in formulations, feed, fresh digesta, plasma and urine samples was 
performed as described by Michiels et al. (2008) (Chapter 3). Briefly, samples were extracted twice 
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with ethyl ethanoate whereby 2-isopropylphenol was used as internal standard. The combined ethyl 
ethanoate extracts were reduced to dryness with nitrogen at room temperature and the residue was re-
dissolved in ethyl ethanoate. Aliquots (1 μL) were used for GC-analysis. Plasma and urine samples 
were pre-treated with β-glucuronidase and sulfatase to hydrolyze phase-II metabolites. Thus, the 
analyzed content of the EO in plasma and urine includes the free and conjugated parent compound. 
Creatinine in urine was determined according to Yatzidis (1974).  
Bacterial counts (viable counts; log10 CFU/g fresh digesta) in digesta of stomach, S1 and S2 were 
done using the ring-plate technique (Van Der Heyde and Henderickx, 1963). Serial 10-fold dilutions 
were made from 1 g aliquots of fresh digesta, using a sterilized peptone solution (1 g peptone + 0.4 g 
agar + 8.5 g NaCl in 1 L aq. dest.) and plated onto selective media in duplicate. Selective media were 
used for counting the following bacterial groups: total anaerobic bacteria (Reinforced Clostridial 
Agar, CM0151, Oxoid, Basingstoke, UK + 0.001% hemin; incubated for 48 h at 37°C under 90% N2 
and 10% CO2), coliform bacteria (Eosin Methylene Blue Agar, CM0069, Oxoid; incubated for 24 h 
at 37°C aerobically), streptococci (Slanetz & Bartley Medium, CM0377, Oxoid; incubated for 48 h at 
37°C aerobically) and lactobacilli (Rogosa Agar, CM0627, Oxoid + 0.132% acetic acid; incubated 
for 48 h at 37°C under 90% N2 and 10% CO2). Bacterial metabolites were determined in digesta of 
S2. Short chain fatty acids (SCFA) and lactic acid were analysed by a GC method described by 
Jensen et al. (1995) and ammonia was determined as specified by Van Nevel et al. (2003). Diet and 
freeze-dried samples from gastric digesta, pooled (per pen) digesta of S1, pooled (per pen) digesta of 
S2 and pooled (per pen) excreta were used to quantify 4 mol/L HCl insoluble ash as indigestible 
marker to calculate apparent digestibility coefficients. This marker was also used to calculate the 
apparent digestibility (%) of carvacrol and thymol in the stomach and SI by the formula: 100 – 
(EOcomp x Mfeed) / (EOfeed x Mcomp) x 100, in which EOcomp and Mcomp are the concentration of 
respectively the compound and the marker in the respective section of the GIT and EOfeed and Mfeed 
are the concentration of respectively the compound and the marker in the feed. Since Michiels et al. 
(2008) showed that degradation of both EO in stomach and SI is not anticipated, the calculated 
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digested fraction represents the amount that is absorbed. Analysis of dry matter, ether extract, 
nitrogen and crude fibre of diets, pooled digesta of S2 and pooled excreta were determined according 
to the standard methods as indicated by Van Nevel et al. (2003). Measurement of the histo-
morphological parameters villus length (V) and crypt depth (C) and enumeration of intra-epithelial 
lymphocytes (IEL) were carried as described by Van Nevel et al. (2003). 
 
Statistical analysis 
 
The effect of diet was tested using the one-way ANOVA procedure. Animal was used as the 
experimental unit, which was in agreement with other authors (see e.g. Manzanilla et al., 2004; 
Mikkelsen and Jensen, 2004). Orthogonal contrasts were applied in order to explore the effect of 
treatments. All calculations were carried out using the SPSS 15.0 program for Windows (SPSS 
Inc.,Chicago IL,USA). 
 
RESULTS 
 
Experiment I 
 
During the whole trial all animals showed a good health condition and severe diarrhoea was not 
observed. Animals fed CAR2000 showed a lower average daily gain compared to CON (12.6 vs. 75.3 
g/day, P<0.05). Animals fed CAR500 and THY500 had a higher feed intake on pen level as 
compared to CON, +12.4 and +21.9% respectively, although growth was not different from CON 
(P>0.05). The digesta from S2 of animals fed THY2000 had a higher dry matter content compared to 
CON (P<0.05, Table 2). Bacteriological counts in the digesta of stomach, S1 and S2 were in none of 
the cases significantly lower for the experimental diets compared to CON (Table 2). THY2000 had 
higher numbers of streptococci (S2) (P<0.05) and tended to have more lactobacilli (S1 and S2) 
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(P<0.1) than in CON. The orthogonal contrast 500 mg/kg vs. 2000 mg/kg for streptococci and 
lactobacilli counts in S2 was significant, whereby the 2000 mg/kg treatments showed the highest 
numbers of these lactic acid bacteria. Regarding the same bacterial groups in S2, supplementation 
with carvacrol gave lower counts than with thymol (orthogonal contrast III). At J2, the ratio V/C for 
the experimental diets (1.30 - 1.32) was higher than for CON (1.24) (orthogonal contrast of all 
experimental diets vs. CON, P<0.05, data not shown). This altered ratio V/C was due to enlarged 
villi (+7.5%; for both CAR500 and THY500, P>0.05) or to shortened crypts (-12.5 and -4.4% for 
CAR2000 and THY2000 respectively, P>0.05). The concentrations of carvacrol and thymol (2000 
mg/kg) were on average 521 and 544 mg/kg fresh digesta in stomach and 5 and 16 mg/kg digesta in 
S1 (Table 3). For stomach, S1, plasma and urine, the concentration of EO was affected by dose level 
(orthogonal contrast III), but not for S2. More thymol was retrieved in S1 (P<0.05) and in S2 (P<0.1) 
than carvacrol. Using 4 mol/L HCl insoluble ash as a marker, it was found that between 25 and 39% 
(no differences between treatments) and between 50 and 66% of the EO had disappeared (absorbed) 
from gastric and S1 digesta respectively (Figure 1).  
 
Experiment II 
 
Mild diarrhoea was seen in the pens fed the ME diets from day 5 to 10, but health status of all 
animals was not compromised. No medical interventions were done during the trial. Feed intake on 
pen level was not reduced by supplementation of 2000 mg/kg thymol, except for the CE2000 
treatment (-20.0%). The diets CE500, AL500, ME500 and AL2000 showed respectively a 44.7, 16.7, 
0.4 and 18.3% higher feed intake vs. CON (167.4 g/day). For the whole trial none of the 
experimental diets altered the average daily gain compared to CON (84.2 g/day), although the 
average daily gain of animals fed CE2000 tended to be reduced (P<0.1). Differences in dry matter 
weight of gastric (P<0.1), proximal small intestinal (P<0.1) and distal small intestinal (P<0.05) 
digesta between the 500 mg/kg and the 2000 mg/kg treatments were found (orthogonal contrast II, 
 - 166 - 
Table 4). Diet ME2000 showed a lower dry matter weight of gastric digesta compared to CON 
(P<0.05), while the same diet and diets ME500 and AL2000 showed more fill of the distal small 
intestinal segment as compared to CON (P<0.05). ME2000 had a lower gastric pH (P<0.1) than 
CON, while the pH of digesta in the S2 segment of animals fed CE2000 was higher than CON 
(P<0.05). In Table 4 bacteriological counts are shown as well. Diet CE500 (total anaerobic bacteria 
in S1) and diet CE2000 (total anaerobic bacteria in S1, streptococci in S1 and S2 and lactobacilli in 
S2) showed lower numbers of bacteria in the SI as compared to CON (P<0.05) and also in 
comparison to the other formulation types (see orthogonal contrast III and IV). The number of 
coliforms in S2 was higher in the experimental diets vs. CON (P<0.05), especially for CE500, 
AL500 and AL2000, and higher for the 500 mg/kg vs. 2000 mg/kg diets (P<0.05). Diet ME2000 
gave in all three sampling sites the lowest number of coliform bacteria and the highest number of 
streptococci and in S2 the number of lactobacilli was higher on this diet compared to the other diets; 
however these effects were non-significant. The lower numbers of lactic acid bacteria in S2 can 
explain the lower lactate concentration (P<0.05) as observed for treatment CE2000 (Table 4). At J2, 
the experimental diets tended to have smaller crypts and an increased V/C ratio (orthogonal contrast 
I, Table 5). In general, experimental diets gave lower number of IEL at J1 (P<0.05) and at J2 (P<0.1) 
compared to CON. The number of IEL at J1 and J2 for both diets CE500 and ME2000 were 
significantly lower compared to CON. 
 
The mean thymol concentration in gastric contents for the 2000 mg/kg treatments ranged between 
475 and 647 mg/kg (Table 6). Within each dose level, the thymol content in gastric digesta was lower 
for the ME treatments than for the other formulation types (orthogonal contrast III and IV). This can 
be explained by the fact that the analytically verified dose of thymol in the ME diets was lower than 
in the other diets. Conversely, in the SI, there were no significant differences in the thymol 
concentration within dose. An equal cumulative absorption in the different segments of the GIT for 
all treatments was observed (Figure 1). Cumulative absorption in S2 was for all treatments above 
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98.1%. Therefore it is reasonable to state that the type of formulation did not affect the kinetics of EO 
along the GIT. Thymol concentration (sum of free and conjugated compound) in plasma and urine 
were comparable to the results of experiment I.  
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Fig. 1. Cumulative absorption of carvacrol and thymol in stomach, proximal SI (S1) and distal SI 
(S2) in experiment I and II with weaned piglets. 
- Abbreviations are: CAR = carvacrol; THY = thymol; CE = thymol on celite 545 coarse as carrier; 
AL = thymol on alphacel non-nutritive bulk as carrier; ME = microencapsulated thymol, number 
indicate dose in mg/kg as fed; 
- 4 mol/L HCl insoluble ash was used as indigestible marker; no significant (P>0.05) differences 
were found between treatments for absorption in stomach in both experiments; determination of 
absorption in S1 and S2 was based on pooled digesta. 
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Table 2. Effects of dose (mg/kg) and EO on pH, absolute dry matter weight (g), dry matter content (g/kg), bacteriological counts (log10 CFU/g 
fresh digesta) and bacterial metabolites (µmol/g) of digesta of stomach, proximal (S1) and distal small intestine (S2) in experiment I with weaned 
piglets.  
 CON 500 2000 SE Significance (1) (2) (3) 
  CAR THY CAR THY  I II III 
Stomach 
  pH 
  Dry matter 
  Dry matter content 
  Total anaerobic bacteria 
  Coliform bacteria 
  Streptococci 
  Lactobacilli 
S1 
  pH 
  Dry matter 
  Dry matter content 
  Total anaerobic bacteria 
  Coliform bacteria 
  Streptococci 
  Lactobacilli 
S2 
  pH 
 
3.5 
97.0 
292.1 
7.95 
3.63 
7.75 
8.49 
 
6.0 
4.2 
88.0 
6.70 
2.67 
6.50 
7.17 
 
6.7 
 
3.4 
88.5 
308.7 
8.12 
4.67 
8.06 
8.45 
 
6.0 
5.2 
91.5 
6.73 
2.42 
6.70 
7.25 
 
6.7 
 
3.4 
77.6 
273.0 
7.85 
2.95 
7.81 
8.38 
 
5.8 
3.4 
85.8 
6.70 
3.53 
6.43 
7.32 
 
6.3§ 
 
3.5 
93.9 
303.5 
8.06 
5.05 
7.99 
8.39 
 
6.1 
3.1 
78.1 
6.69 
2.99 
5.99 
6.96 
 
6.3 
 
3.2 
106.2 
288.2 
7.91 
4.99 
8.07 
8.50 
 
6.0 
4.0 
111.4 
6.84 
2.57 
6.83 
7.72(§) 
 
6.4 
 
0.4 
17.6 
35.2 
0.22 
1.30 
0.36 
0.13 
 
0.2 
1.4 
34.8 
0.56 
0.81 
0.80 
0.43 
 
0.4 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
* 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
 
n.s. 
n.s. 
n.s. 
* 
n.s. 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
* 
 
n.s. 
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  Dry matter 
  Dry matter content 
  Total anaerobic bacteria 
  Coliform bacteria 
  Streptococci 
  Lactobacilli 
  Acetate 
  Propionate 
  Butyrate 
  Lactate 
  Ammonia 
6.6 
58.0 
7.31 
3.77 
7.62 
8.11 
3.56 
0.28 
0.22 
32.8 
5.57 
8.2 
93.7 
7.23 
2.93 
7.29 
7.71(§) 
4.23 
0.33 
0.25 
32.0 
7.56 
4.6 
61.7 
7.21 
4.52 
7.64 
8.13 
3.31 
0.33 
0.24 
50.3 
5.30 
4.7 
63.0 
7.76 
4.18 
7.67 
8.29 
4.75 
0.30 
0.25 
54.9 
5.94 
8.9 
113.3§ 
7.57 
4.13 
8.42§ 
8.52(§) 
4.30 
0.36§ 
0.18 
55.6 
5.26 
3.4 
51.0 
0.57 
0.88 
0.54 
0.35 
1.53 
0.12 
0.04 
24.7 
3.37 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
* 
** 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
T 
* 
T 
n.s. 
n.s. 
T 
n.s. 
n.s. 
Abbreviations are: CON = control diet ; CAR = carvacrol; THY = thymol and SE = standard error. 
(1) n.s. = non-significant (P>0.1); T = trend (P<0.1); * = P<0.05; ** = P<0.01; *** = P<0.001; (2) I = orthogonal contrast of all experimental diets vs. CON; II = orthogonal 
contrast 500 mg/kg vs. 2000 mg/kg and III = orthogonal contrast carvacrol vs. thymol; (3) orthogonal contrast of each experimental diet vs. CON, mean values of 
experimental diet with superscript (§) and § are significantly different from CON at respectively P<0.1 (trend) and P<0.05. 
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 Table 3. Effects of dose (mg/kg) and EO on concentration of EO in samples of gastric, proximal small intestinal (S1) and distal small intestinal 
(S2) digesta, in plasma and in urine in experiment I with weaned piglets (1). 
 500 2000 SE Significance (2) (3) 
 CAR THY CAR THY  I II III IV 
Digesta (mg/kg fresh digesta) 
  Stomach 
  S1 
  S2 
Plasma (µg/mL) 
Urine (µg/mg creatinine) 
 
118 
3.49 
2.00 
3.10 
158 
 
115 
3.49 
1.64 
2.10 
210 
 
521 
5.02 
1.78 
10.2 
665 
 
544 
16.4 
5.51 
8.76 
983 
 
53.2 
6.72 
2.87 
2.97 
299 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
* 
T 
n.s. 
n.s. 
 
*** 
* 
n.s. 
*** 
*** 
 
n.s. 
T 
n.s. 
n.s. 
n.s. 
Abbreviations are: CON = control diet ; CAR = carvacrol; THY = thymol and SE = standard error. 
(1) carvacrol and thymol were only found in the sampling sites of the respective diets and were not detected in the control treatment; determined concentration in plasma and 
urine includes both the free and conjugated parent compound; (2) n.s. = non-significant (P>0.1); T = trend (P<0.1); * = P<0.05; ** = P<0.01; *** = P<0.001; (3) I = 
orthogonal contrast CAR500 vs. THY500; II = orthogonal contrast CAR2000 vs. THY2000; III = orthogonal contrast 500 mg/kg vs. 2000 mg/kg and IV = orthogonal contrast 
carvacrol vs. thymol. 
 - 171 - 
 - 172 - 
Table 4. Effects of dose (mg/kg) of thymol and formulation type on pH, absolute dry matter weight (g), dry matter content (g/kg), bacteriological 
counts (log10 CFU/g fresh digesta) and bacterial metabolites (µmol/g) of digesta of stomach, proximal (S1) and distal small intestine (S2) in 
experiment II with weaned piglets. 
 CON 500 2000 SE Significance (1) (2) (3) 
  CE AL ME CE AL ME  I II III IV V 
Stomach 
  pH 
  Dry matter 
  Dry matter content 
  Total anaerobic bacteria 
  Coliform bacteria 
  Streptococci 
  Lactobacilli 
S1 
  pH 
  Dry matter 
  Dry matter content 
  Total anaerobic bacteria 
  Coliform bacteria 
  Streptococci 
  Lactobacilli 
S2 
  pH 
 
3.9 
123.5 
301.2 
8.72 
4.17 
7.78 
8.43 
 
5.9 
4.4 
85.2 
7.86 
4.26 
6.87 
7.65 
 
5.9 
 
3.8 
105.2 
285.2 
8.69 
3.92 
7.88 
8.49 
 
5.8 
5.8 
81.2 
7.08§ 
4.69 
6.45 
7.49 
 
6.2 
 
3.9 
118.5 
320.4 
9.09§ 
4.92 
8.08 
8.57 
 
5.7 
3.5 
97.8 
7.70 
4.70 
6.90 
7.73 
 
6.1 
 
3.9 
103.9 
305.6 
8.67 
3.99 
7.47 
8.73 
 
5.9 
2.6 
84.3 
7.70 
5.13 
6.58 
7.74 
 
6.2 
 
4.0 
85.9(§) 
301.9 
9.00 
4.76 
7.38 
8.46 
 
6.0 
3.4 
89.0 
7.26§ 
5.03 
6.07§ 
7.62 
 
6.5§ 
 
3.9 
101.6 
319.0 
8.71 
4.69 
7.73 
8.56 
 
5.7 
10.0 
128.5 
7.53 
5.67 
6.66 
7.65 
 
6.0 
 
3.6(§) 
69.5§ 
304.0 
8.48 
3.30 
8.12 
8.27 
 
5.8 
5.3 
114.6 
7.72 
3.21 
7.20 
7.59 
 
6.1 
 
0.3 
28.2 
30.6 
0.29 
1.28 
0.43 
0.42 
 
0.2 
1.8 
42.0 
0.45 
1.76 
0.58 
0.65 
 
0.4 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
 
n.s. 
T 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
T 
* 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
* 
n.s. 
T 
n.s. 
 
n.s. 
 
n.s. 
n.s. 
n.s. 
* 
n.s. 
n.s. 
n.s. 
 
T 
n.s. 
n.s. 
* 
n.s. 
* 
n.s. 
 
n.s. 
 
n.s. 
n.s. 
n.s. 
* 
T 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
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  Dry matter 
  Dry matter content 
  Total anaerobic bacteria 
  Coliform bacteria 
  Streptococci 
  Lactobacilli 
  Acetate 
  Propionate 
  Butyrate 
  Lactate 
  Ammonia 
6.0 
125.7 
8.99 
5.21 
7.96 
8.86 
11.2 
0.30 
0.00 
89.5 
3.49 
8.0 
83.1(§) 
8.99 
7.87§ 
7.92 
8.74 
11.1 
1.03 
0.00 
76.1 
3.18 
5.8 
72.2§ 
9.19 
8.27§ 
8.02 
9.06 
12.1 
0.00 
0.00 
87.2 
3.07 
11.4§ 
118.0 
8.92 
7.94 
7.40 
8.62 
3.60 
0.31 
0.00 
69.6 
4.25 
8.3 
103.1 
8.55 
6.76 
6.90§ 
8.01§ 
9.88 
0.00 
0.00 
24.6§ 
2.71 
13.9§ 
129.3 
9.22 
7.98§ 
7.56 
8.98 
18.9 
0.00 
0.00 
90.3 
3.82 
10.8§ 
106.2 
9.08 
5.16 
8.14 
9.09 
4.85 
0.00 
0.00 
79.0 
4.25 
3.0 
35.4 
0.48 
1.70 
0.70 
0.49 
11.8 
0.94 
- 
38.7 
1.08 
* 
n.s. 
n.s. 
* 
n.s. 
n.s. 
n.s. 
n.s. 
- 
n.s. 
n.s. 
* 
T 
n.s. 
* 
n.s. 
n.s. 
n.s. 
n.s. 
- 
n.s. 
n.s. 
n.s. 
n.s. 
T 
n.s. 
n.s. 
** 
n.s. 
n.s. 
- 
* 
n.s. 
T 
n.s. 
n.s. 
n.s. 
n.s. 
* 
n.s. 
n.s. 
- 
n.s. 
* 
n.s. 
n.s. 
n.s. 
* 
n.s. 
n.s. 
* 
n.s. 
- 
n.s. 
n.s. 
Abbreviations are: CON = control diet ; CE = thymol on celite 545 coarse as carrier; AL = thymol on alphacel non-nutritive bulk as carrier; ME = microencapsulated thymol 
and SE = standard error. 
(1) n.s. = non-significant (P>0.1); T = trend (P<0.1); * = P<0.05; ** = P<0.01; *** = P<0.001; (2) I = orthogonal contrast of all experimental diets vs. CON; II = orthogonal 
contrast 500 mg/kg vs. 2000 mg/kg; III = orthogonal contrast CE vs. AL; IV = orthogonal contrast CE vs. ME and V = orthogonal contrast AL vs. ME; (3) orthogonal contrast 
of each experimental diet vs. CON, mean values of experimental diet with superscript (§) and § are significantly different from CON at respectively P<0.1 (trend) and P<0.05. 
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Table 5. Effects of dose of thymol (mg/kg) and formulation type on histo-morphological parameters at 3m distal to pylorus (J1) and 3m proximal 
to caecum (J2) in experiment II with weaned piglets. 
 CON 500 2000 SE Significance (1) (2) (3) 
  CE AL ME CE AL ME  I II III IV V 
J1 
  V (µm) 
  C (µm) 
  ∆VC (µm) 
  V/C 
  IEL (#/100 enterocytes) 
J2 
  V (µm) 
  C (µm) 
  ∆VC (µm) 
  V/C 
  IEL (#/100 enterocytes) 
 
449.9 
250.2 
700.1 
1.84 
26.8 
 
428.8 
244.3 
673.1 
1.80 
26.2 
 
454.4 
245.4 
699.8 
1.89 
24.0§ 
 
449.6 
248.7 
698.3 
1.85 
24.5§ 
 
430.3 
229.2 
659.5 
1.97 
25.8 
 
451.8 
222.6 
674.4 
2.08§ 
25.1 
 
430.9 
230.0 
660.9 
1.93 
26.6 
 
413.6 
221.8 
635.4 
1.91 
24.7 
 
425.1 
229.5 
654.6 
1.89 
26.9 
 
402.8 
227.8 
630.6 
1.82 
26.1 
 
464.1 
248.5 
712.7 
1.91 
24.9 
 
421.6 
220.7(§) 
642.3 
2.01(§) 
24.8 
 
496.2 
252.4 
748.6 
2.01 
21.9§ 
 
424.0 
218.2(§) 
642.2 
1.99(§) 
24.7§ 
 
58.9 
27.1 
81.2 
0.19 
1.9 
 
42.3 
21.1 
57.7 
0.16 
2.6 
 
n.s. 
n.s. 
n.s. 
n.s. 
* 
 
n.s. 
T 
n.s. 
T 
T 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
T 
n.s. 
** 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
T 
n.s. 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
Abbreviations are: CON = control diet ; CE = thymol on celite 545 coarse as carrier; AL = thymol on alphacel non-nutritive bulk as carrier; ME = microencapsulated thymol; 
V = villus height; C = crypt depth; IEL = intra-epithelial lymphocytes and SE = standard error. 
(1) n.s. = non-significant (P>0.1); T = trend (P<0.1); * = P<0.05; ** = P<0.01; *** = P<0.001; (2) I = orthogonal contrast of all experimental diets vs. CON; II = orthogonal 
contrast 500 mg/kg vs. 2000 mg/kg; III = orthogonal contrast CE vs. AL; IV = orthogonal contrast CE vs. ME and V = orthogonal contrast AL vs. ME; (3) orthogonal contrast 
of each experimental diet vs. CON, mean values of experimental diet with superscript (§) and § are significantly different from CON at respectively P<0.1 (trend) and P<0.05. 
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Table 6. Effects of dose of thymol (mg/kg) and formulation type on concentration of thymol in samples of gastric, proximal small intestinal (S1) 
and distal small intestinal (S2) digesta, in plasma and in urine in experiment II with weaned piglets (1). 
 500 2000 SE Significance (2) (3) 
 CE AL ME CE AL ME  I II III IV 
Digesta (mg/kg fresh digesta) 
  Stomach 
  S1 
  S2 
Plasma (µg/mL) 
Urine (µg/mg creatinine) 
 
138 
2.96 
1.63 
2.63 
137 
 
151 
3.04 
1.80 
2.37 
151 
 
105 
3.33 
1.12 
2.42 
94.8 
 
614 
13.0 
4.41 
8.03 
432 
 
647 
23.8 
4.55 
7.87 
763 
 
475 
21.3 
7.47 
7.91 
531 
 
75.6 
8.81 
3.78 
2.91 
260 
 
*** 
*** 
** 
*** 
*** 
 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
 
* 
n.s. 
n.s. 
n.s. 
n.s. 
 
** 
n.s. 
n.s. 
n.s. 
n.s. 
Abbreviations are: CON = control diet ; CE = thymol on celite 545 coarse as carrier; AL = thymol on alphacel non-nutritive bulk as carrier; ME = microencapsulated thymol 
and SE = standard error. 
 (1) thymol was not detected in the control treatment; determined concentration in plasma and urine includes both the free and conjugated parent compound; (2) n.s. = non-
significant (P>0.1); T = trend (P<0.1); * = P<0.05; ** = P<0.01; *** = P<0.001; (3) I = orthogonal contrast 500 mg/kg vs. 2000 mg/kg; II = orthogonal contrast CE vs. AL; 
III = orthogonal contrast CE vs. ME and IV = orthogonal contrast AL vs. ME.  
 - 176 - 
DISCUSSION 
 
EO concentration in digesta and antibacterial effects 
 
The gastric EO concentration (Table 4 and 6) was higher than the critical concentration indicated by 
Michiels et al. (in press) (Chapter 2) or antimicrobial doses used by Si et al. (2006) and therefore 
antimicrobial effects were anticipated. However, the 2000 mg/kg diets did not reduce the number of 
any bacterial group compared to CON in this segment (Table 2 and 4). Further analysis of the data 
showed that there were large differences between animals, with a 1.5 and more than 2-fold range in 
the concentrations in gastric digesta for experiment I and II, respectively. Pearson correlation 
coefficients between concentration and number of bacteria in gastric digesta were calculated for each 
experiment. No significant (negative) correlations were found, so there are no indications for any 
antimicrobial activity in the stomach. Probably, the higher dry matter content of the gastric digesta as 
compared to the in vitro medium used in the study of Michiels et al. (in press) (Chapter 2) (app. 300 
vs. 100 g/kg), can explain this lack of effect. The detrimental effect of dry matter on the antibacterial 
activity of EO was evidenced in food matrices (Smith-Palmer et al., 2001). The mean EO 
concentration in S1 and S2 for the 2000 mg/kg treatments did not exceed 24 mg/kg, which is 
considered far too low to provoke a direct antimicrobial effect. Nevertheless, in the SI of animals fed 
CE2000 the bacterial load was reduced. These animals showed a lower feed intake (pen level) and 
smaller growth rates (P<0.1), which is obviously in contradiction to the effects usually observed in 
animals fed antimicrobial growth-promoters. A reduction in the number of bacteria in the other 2000 
mg/kg and 500 mg/kg treatments has not been observed. Additionally, adaptation of bacteria could 
also have contributed to the lack of effect. Bacteria became tolerant to these EO when grown at sub-
lethal concentrations (Di Pasqua et al., 2006; Ultee et al., 2000) and perhaps this might have been 
affecting the microbial ecology in our experiments. To conclude, based on our findings there is no 
conclusive evidence that these feed inclusion rates of carvacrol and thymol can reduce the bacterial 
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load (main bacterial groups quantified by plating onto selective media) in the foregut of piglets. Few 
data are available in literature; trials have been performed with pure compounds, mixtures and herbal 
extracts with lower and higher doses than in our trials. In none of these experiments a significant 
reduction of the foregut bacteria was observed (herbal extracts, 7500 mg/kg, Namkung et al., 2004; 
Xtract, 150-300 mg/kg, Manzanilla et al., 2004; herbal extract mixture, 700-1400-2100 mg/kg, 
Oetting et al., 2006). Very recently Janczyk et al. (2008) found that supplementation of pig diet with 
thymol (10,000 mg/kg) caused clear changes in the small intestinal microbial community, as assessed 
by PCR. 
 
Obviously, the low concentrations of the EO in the gut digesta found in our trials, were due to fast 
absorption in the proximal GIT, as can been seen in Fig. 1. However it has to be said, that there were 
large differences between animals. Absorption in the stomach was influenced by the dry matter 
content of the gastric digesta, since we found for both experiments a negative correlation between 
these two variables (exp. 1; r=-0.62, P<0.01 and exp. 2; r=-0.47, P<0.01). More fluid gastric contents 
can enhance the solubilization and emulsification of the EO and consequently absorption and/or 
gastric emptying with the liquid phase. It was found that formulation type (experiment II) did not 
affect the kinetics of the EO in the GIT. In the study of Piva et al. (2007a) animals were fed either an 
unprotected or a microencapsulated mixture of sorbic acid and vanillin. They reported the ratio 
concentration in stomach (on DM basis) to concentration in proximal and distal SI. For animals fed 
the microencapsulated ingredients, these ratios were 0.44-0.48 and 0.35-0.55 for proximal and distal 
SI respectively. In animals fed the unprotected ingredients, these fractions were below 0.02. In our 
study, these ratios were similar for all treatments and below 0.1. There is no explanation why the 
microencapsulation did not retard the release (and absorption) of thymol in experiment II. A single 
batch of microencapsulated thymol was made for this trial and likely the technical preparation was 
not fully successful. The application of appropriate in vitro techniques to test the release properties of 
formulations in advance to in vivo research is prompted. 
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Improving gut health 
 
In experiment II, thymol fed animals showed lower number of IEL in the small intestinal mucosa (for 
some treatments with significance, P<0.05; see also orthogonal contrast I in Table 5). IEL are T-
lymphocytes, with the majority of the cytotoxic CD8+ phenotype. Thymol has shown to reduce the 
biosynthesis of prostaglandins through its cyclooxygenase inhibitory activity. The IC50 value against 
cyclooxygenase-1 was 0.03 mg/L and was comparable to that of indomethacin (Marsik et al., 2005). 
Prostaglandins are mediators of inflammatory responses, hence thymol might have downregulated 
mucosal inflammatory responses and concomittantly the recruitment and migration of T-lymphocytes 
to the villus epithelium. The reduction in number of IEL did not depend on formulation type and 
dose. Presumably, the thymol small intestinal concentrations as observed for all treatments (Table 6) 
were high enough to provoke this effect. A reduced number of IEL can be assumed to be a beneficial 
effect as a positive relationship between the number of IEL in the small intestinal mucosa and its 
turnover rate has been reported (Guy-Grand et al., 1998). Concurrently, the V/C ratio at S2 was 
higher in carvacrol and thymol fed animals (exp I, P<0.05; exp II, P<0.1). A higher V/C ratio is 
associated with a slower enterocyte migration rate and concomitant turnover rate of the epithelia. 
This situation can result in improved digestive and absorptive capacities of the SI as fully mature 
enterocytes have a higher activity of brush border enzymes. This change in V/C ratio was 
accompanied with enlarged villi or reduced crypts. Especially, for the 500 mg/kg treatments it was 
seen that villi at J2 were longer, although not significant. Obviously, there is a clear relationship 
between the 12 days post-weaning feed intake - all but one (ME500) of the 500 mg/kg treatments 
gave a higher feed intake compared to CON (from +12.4 to +44.7% on pen level) - and the length of 
villi at day of slaughter. It is well established that immediate post-weaning feed intake and the 
presence of digesta in the gut per se stimulate the development/adaptation of gut histo-morphology 
and consequently leads to a less severe villi atrophy or better recovery of villi structure (Pluske et al., 
1997). Further, thymol supplementation notably resulted in more appetite compared to carvacrol as is 
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evidenced in experiment I. This difference was also observed in a previous unpublished latin-square 
experiment wherein the 6 h feed intake after supplying an experimental feed (2000 mg/kg carvacrol, 
thymol or control feed), preceded by giving control feed and temporarily fasting of the animals, was 
followed up. Adverse effects of 2000 mg/kg EO on appetite were greater for carvacrol than for 
thymol. 
 
In addition, different results indicate that gut health was improved in treatments THY2000 and 
ME2000. Higher numbers of both streptococci and lactobacilli were found in S1 and S2 for 
THY2000. ME2000 had lower numbers of coliforms in all three sampling sites and higher numbers 
of streptococci in all three sampling sites and lactobacilli in S2. Hence, it is fair to postulate that these 
treatments resulted in a higher ratio of lactic acid bacteria/coliforms in the SI. This ratio is considered 
to be an indicator of a healthy gut and pathogen resistance (Reid and Hillman, 1999). Lactic acid 
bacteria produce lactic acid which results in lower pH values (Jensen and Mikkelsen, 1998), possibly 
suppressing the proliferation of potentially pathogenic G- bacteria. In case the number of total 
anaerobic bacteria are unaltered (as observed for most treatments here) or reduced, a shift in the ratio 
lactic acid bacteria to coliforms in favour of the former group can be considered as a positive effect. 
It was seen that the gastric pH for the treatments THY2000 and ME2000 was substantially lower than 
the respective CON diet (Table 2 and 4). A lower gastric pH would increase the barrier function of 
the stomach towards acid susceptible bacteria like coliforms and favour the growth of acid tolerant 
bacteria like lactic acid bacteria, a phenomenon that can be observed even more caudally in the SI 
(Canibe and Jensen, 2003). So, the higher ratio lactic acid bacteria/coliform found in S2 for both diets 
can be due to the lower pH in the stomach rather than a direct effect of thymol on bacteria in S2. An 
increased retention time of gastric digesta can eventually result in a lowered pH. This was 
hypothesised in the trial of Manzanilla et al. (2004). The authors argued that capsaicin was 
responsible for the slower gastric emptying, and this resulted finally in a higher ratio 
lactobacilli/coliforms in the distal SI. Relaxant effects on smooth and skeletal muscle have been 
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found for carvacrol (Aydin et al., 2007; Boskabady and Jandagh, 2003) and thymol (Beer et al., 
2007;  Szentandrassy et al., 2003) and this could suggest a role in gastric motility. However, in our 
trial the gastric dry matter weight of all treated animals was comparable (or lower) compared to 
control animals, although having similar BW. This would indicate that gastric emptying was not 
affected (or enhanced) in the treated animals. Likewise, an effect on gastric motility cannot be 
confirmed here. In both experiments, a significant (P<0.01) positive correlation between gastric fresh 
weight content and pH (exp. 1; r=0.57 and exp. 2; r=0.73) has been found. It indicates that smaller 
amounts in stomach became more acidified. Probably, here gastric pH was more related to gastric fill 
than to other factors, like retention time and feed buffering capacity. Why this was only observed for 
THY2000 and ME2000 is not clear. 
 
CONCLUSION 
 
Supplementing feeds for newly weaned piglets with 500 mg/kg carvacrol and thymol may enhance 
post-weaning feed intake and result in longer villi (non-significant). These two EO at both 500 and 
2000 g/kg feed did not reduce the number of bacteria or their metabolites in the foregut, probably as a 
result of the high dry matter content of gastric digesta and the fast absorption in the proximal SI. 
Formulation type (soybean oil, inert carriers and microencapsulation) did not alter the release and 
absorption of the EO in the GIT. Carvacrol and thymol diets reduced to a variable extent the number 
of IEL and concurrently the V/C ratio at the distal SI was higher. Both effects indicate that gut health 
was improved. In view of the limited number of animals in these trials, confirmation of these findings 
is warranted. 
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EFFECT OF THE ESSENTIAL OILS THYMOL, E-ANETHOLE AND E-
CINNAMALDEHYDE ON ACTIVE NUTRIENT ABSORPTION AND 
STIMULATED CHLORIDE SECRETION IN THE ISOLATED PIG GUT 
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CHAPTER 5  
 
EFFECT OF THE ESSENTIAL OILS THYMOL, E-ANETHOLE AND E-
CINNAMALDEHYDE ON ACTIVE NUTRIENT ABSORPTION AND 
STIMULATED CHLORIDE SECRETION IN THE ISOLATED PIG GUT 
 
 
ABSTRACT 
 
The essential oils thymol, E-anethole and E-cinnamaldehyde have been shown to exert antimicrobial 
properties against commensal and pathogenic bacteria of the porcine gut. Therefore, they have gained 
interest for use in animal feeds. However, distinct biological activities are reported which can 
interfere with the absorptive and secretory functions of the gut epithelia. Hence, we studied the effect 
of these compounds on sodium-dependent D-glucose and L-alanine absorption and stimulated 
chloride secretion. Stripped mid-jejunal tissue of fully weaned piglets was mounted in modified 
Ussing chambers. The increase in short-circuit current (∆Isc) to mucosal addition of 16 mmol/L D-
glucose and 16 mmol/L L-alanine, with or without pre-incubation with 0.2 and 1.0 mmol/L thymol or 
E-cinnamaldehyde and 0.2 and 0.5 mmol/L E-anethole was determined. Accordingly, the effect on 
stimulated chloride secretion by secretagogues was measured. Thymol and E-cinnamaldehyde 
reduced the Isc response to nutrients and secretagogues in a dose-dependent manner. ∆Isc to D-
glucose for thymol at 0.2 and 1.0 mmol/L was respectively 73.7 ± 7.9 (P>0.05) and 23.8 ± 7.4 
(P<0.001) compared to 80.1 ± 7.4 µA/cm2 for control and to L-alanine respectively 20.6 ± 2.3 
(P=0.01) and 5.9 ± 2.4 (P<0.001) compared to 33.7 ± 2.6 µA/cm2 for control. E-cinnamaldehyde 
showed only significant effects at 1 mmol/L. Pre-incubation with 0.5 mmol/L E-anethole did not alter 
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the response to mucosal D-glucose. The inhibitory activity of thymol and E-cinnamaldehyde on 
active nutrient absorption could compromise intestinal digestive functions. The reduction in secretory 
response to cAMP/cGMP mediated VIP and theophylline was greater than for Ca2+ mediated 5-HT 
and carbachol. Chloride secretion induced by 5-HT and theophylline was also affected by 0.5 
mmol/L E-anethole. A reduction of induced secretion might be beneficial in cases of excessive 
chloride secretion. Additional investigations are urged to confirm these findings and eventually 
elucidate the mechanisms behind. 
 
KEYWORDS: Essential oils, Ussing chamber, sodium-dependent nutrient absorption, chloride 
secretion, diarrhoea, pig 
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INTRODUCTION 
 
Essential oils (EO) with well documented antimicrobial properties like thymol, E-cinnamaldehyde 
and to a lesser extent E-anethole (e.g. Michiels et al., 2009 – Chapter 2) have gained renewed interest 
for application in animal feed, mainly due to constraints on the use of antibiotics and metals as 
AMGP. The mode of action of the AMGP is not fully understood but there is evidence that they work 
in part by decreasing the overall numbers and/or specific bacterial species or their metabolic 
activities in the GIT (Anderson et al., 1999; Corpet, 2000;  Decuypere et al., 1991; Gaskins et al., 
2002; Visek, 1978). 
In particular, Dierick et al. (1981) showed in an isolated loop pig model that Virginiamycin (50 mg/L 
in solution) improved the absorption of free amino acids. This feature of Virginiamycin may partly 
explain the observed higher ileal nutrient digestibility and the improved feed conversion in pigs 
(Decuypere et al., 1991). Little is known about the effects of EO on nutrient absorption and secretion. 
Kreydiyyeh et al. (2003) demonstrated in a rat perfusion model that 0.05% aniseed EO (76.7% E-
anethole) significantly increased jejunal glucose absorption and this coincided with the stimulation of 
the Na+-K+-ATPase activity, the driving force for secondary active transport, in jejunal homogenates. 
On the contrary, eugenol (app. 5.2 mmol/L) and cinnamaldehyde (app. 7.5 mmol/L) reduced 
significantly the L-alanine absorption, which was attributed to the inhibition of basolateral Na+-K+-
ATPase activity (Kreydiyyeh et al., 2000). In the Ussing chamber model, Beesley et al. (1996) 
showed that mucosal peppermint oil (1 and 5 mg/mL) inhibited sodium-dependent glucose 
absorption, but not acetylcholine stimulated chloride secretion. In contrast, serosal peppermint oil at 
1 mg/mL reduced chloride secretion induced by acetylcholine without affecting the effect of glucose.  
 
Taking together, these results for EO are quite conflicting and were in fact solely obtained in rat 
models. Any effect on active nutrient absorption might interfere with feed digestibility; obviously an 
improved capacity for nutrient absorption can be considered beneficial. The preventive effect of zinc 
 - 188 - 
on diarrhoea in newly weaned piglets is partially due to the attenuation of chloride secretion caused 
by bacterial toxins (Carlson et al., 2004 and Carlson et al., 2006). So, a reduction of chloride 
secretion stimulated by secretagogues, as examplified by Beesley et al. (1996) with peppermint oil, 
could be indicative for a similar mode of action. This led us to conclude that it is of high interest to 
study the effect of thymol, E-anethole and E-cinnamaldehyde on active nutrient absorption and 
induced chloride secretion in the pig intestine, as these compounds may come into contact with the 
intestinal mucosa after oral application. Moreover, cytotoxic and apoptotic effects by EO against 
intestinal Caco-2 and IPEC-1 cell cultures were found by respectively Dusan et al. (2006) and 
Bimczok et al. (2008), which could compromise the epithelial absorptive and secretory function. In 
the research presented here, the Ussing chamber technique was used. 
 
MATERIALS AND METHODS 
 
Animals and tissue 
 
Each of the series of experiments included 5 to 6 fully weaned piglets with an average live weight ± 
standard deviation of 16.1 ± 2.5; 15.9 ± 1.7; 18.1 ± 0.1; 15.6 ± 0.7 and 15.6 ± 1.1 kg for series 1, 2, 3, 
4 and 5 respectively. Piglets ((Landrace x Large White x Seghers Hybrid synthetic line) x Piétrain) 
were weaned at 25 days of age. After weaning piglets received a weaner (2 weeks) and a starter diet 
ab libitum until day of euthanisation. Both diets were without AMGP. The composition of the starter 
diet was (in g/kg): 667 maize, 283 soybean meal, 10.3 soybean oil, 3.6 HCl-lysine, 0.8 DL-threonine, 
0.4 L-tryptophane, 6.5 sodium chloride, 12.5 monocalcium phosphate, 14.3 calciumcarbonate and 2.5 
vitamin and trace element mixture. Water was available ad libitum. The euthanasia procedure 
included electric stunning followed by exsanguination. Immediately thereafter, a midline abdominal 
incision was made and the complete GIT was removed. A segment of 20 cm, distal from mid-small 
intestine was taken, rinsed with a Ringer’s buffer solution and then placed in an oxygenated Ringer’s 
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buffer solution at 38°C. The Ringer’s solution (pH 7.4) contained (in mmol/L): 115 NaCl, 25 
NaHCO3, 0.4 NaH2PO4.H2O, 2.4 Na2HPO4.2H2O, 5 KCl, 1.2 CaCl2.2H2O, MgCl2.6H2O and 6 D-
glucose. The segment was opened longitudinally along the mesenteric border. The epithelium was 
stripped of its serosal and muscle layers and then mounted in 6 modified Ussing chambers (acrylate 
polymer) (Dipl.-Ing. Muβler Scientific Instruments, Aachen, Germany). To confirm correct tissue 
preparations, histological assessments were performed according to Van Nevel et al. (2003). Edge 
damage was minimised by placing silicon sheets on both sides of the tissue. The Ussing chambers 
had an opening area of 1.07 cm2. All tissues were mounted within 15 minutes following 
euthanisation. A volume of 6.5 mL of the following buffer solution (pH 7.4) was added at the serosal 
side of the epithelium (in mmol/L): 115 NaCl, 25 NaHCO3, 0.4 NaH2PO4.H2O, 2.4 Na2HPO4.2H2O, 
5 KCl, 1.2 CaCl2.2H2O, MgCl2.6H2O and 12 D-glucose. On the mucosal side, 12 mmol/L D-glucose  
was replaced by 12 mmol/L mannitol. The temperature of buffer solutions was held constant at 38°C 
and mixed and gassed with a 95% O2 and 5% CO2 mixture by a gas lift system. 
 
Measurement of electrophysiological parameters 
 
Electrical measurements were obtained by a six-channel microcomputer-controlled voltage/current 
clamp (Dipl.-Ing. Muβler Scientific Instruments, Aachen, Germany). Two 3 mmol/L KCL agar 
bridges were positioned near each surface of the tissue (< 3mm) and connected to Ag/AgCl 
electrodes by 3 mmol/L KCl solution for the measurement of the transepithelial potential difference 
(PD). Two distant 3 mmol/L KCL agar bridges were connected with Ag/AgCl electrodes by 3 
mmol/L KCl solution for passing current through the tissue. Before mounting the epithelial tissue in 
Ussing chambers, the voltage/current clamp was corrected for fluid resistance. The 
electrophysiological measurements were started under open circuit conditions. The transepithelial 
resistance (Rt; Ω.cm2) was determined from voltage deflections (PD; mV) in response to bipolar 50 
µA current pulses generated for 200 ms. The measured PD and corresponding Rt, calculated by the 
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Ohm’s law were given every 6 s. After an equilibration period of 15 minutes, tissues were short-
circuited. The short-circuit current (Isc; µA/cm2) was assumed to be an indirect measure of net 
transcellular electrolyte movement. The Isc was recorded continuously and data were transferred to a 
computer with the software package Clamp version 2.14 (Dipl.-Ing. Muβler Scientific Instruments, 
Aachen, Germany). 
 
Experimental design 
 
Thirty-five minutes after mounting the tissues, experimental protocols were started. A stock solution 
of the respective EO was added to the mucosal side with increasing final concentrations in the 
bathing media; 0, 0.2 and 0.5 (only E-anethole; 117870, Sigma-Aldrich nv/sa, Bornem, Belgium) or 
1.0 mmol/L (thymol; T0501, Sigma-Aldrich nv/sa and E-cinnamaldehyde; 96320, Fluka, Bornem, 
Belgium). Stock solutions (5 µL) were prepared in absolute ethanol and added to each chamber. 
Preliminary experiments showed that the addition of 5 µL absolute ethanol had no effect on basal 
values. The highest concentration tested for E-anethole was 0.5 mmol/L, since this corresponds 
approximately to its maximum water solubility (Terpene Consortium, 2002). Each concentration was 
tested in two chambers. Five minutes after EO addition the change in basal Rt (∆RtBASAL; Ω.cm2) and 
basal Isc (∆IscBASAL, µA/cm2) were recorded. In series 1, 2 and 3, respectively thymol, E-anethole 
and E-cinnamaldehyde were tested for their effect on D-glucose absorption and stimulated chloride 
secretion by 5-HT (5-hydroxytryptamine or serotonine; H9523, Sigma-Aldrich nv/sa) and 
theophylline (T1633, Sigma-Aldrich nv/sa). Therefore, at 55 min, 16 mmol/L D-glucose was added 
to the mucosal side and simultaneously 16 mmol/L mannitol was added to the serosal side in all 
chambers. Twenty minutes later, 5-HT (0.1 mmol/L) was added to the serosal side. Finally, 20 min 
after adding 5-HT, 5 mmol/L theophylline was added bilaterally. In series 4 and 5, thymol and E-
cinnamaldehyde respectively were tested for their effect on L-alanine absorption and stimulated 
chloride secretion by VIP (vasoactive intestinal peptide; V3628, Sigma-Aldrich nv/sa), carbachol 
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(LANSL06674.06; VWR, Leuven, Belgium) and theophylline. At 55 min, 16 mmol/L L-alanine was 
added to the mucosal side and simultaneously 16 mmol/L mannitol was added to the serosal side in 
all chambers. Twenty minutes later, VIP (0.1 µmol/L) was added to the serosal side, followed at an 
equal time interval before serosal addition of carbachol (1 mmol/L). Finally, 20 min after adding 
carbachol, 5 mmol/L theophylline was added bilaterally. The change in Isc (∆Isc; µA/cm2) due to 
addition of nutrient and secregatogues was calculated by subtracting the Isc before stimulation from 
the peak response after stimulation. 
In two experiments (one with thymol and one with E-cinnamaldehyde); after termination of the 
experiment, tissues were pinned on cork, transferred to buffered formalin and processed for 
histological survey (Van Nevel et al., 2003). In three experiments with thymol at 1.0 mmol/L from 
series 1, samples from the mucosal and serosal compartment (6 chambers) were taken at the end of 
the experiment (sampling 80 min after thymol addition) and the thymol concentration herein was 
determined (Michiels et al., 2008 – Chapter 3). 
 
Statistical analysis 
 
Statistical analysis was carried out by the General Linear Model in SPSS (SPSS 15.0 program 
software; SPSS Inc., Chicago IL, USA) whereby EO concentration (αi; i=0, 0.2 and 0.5 or 1.0 
mmol/L) was included as fixed factor and animal (βj; 5 to 6 piglets per series) as random factor. The 
model represents: 
y = µ + αi + βj + αi . βj + εij 
where y is the dependent variable, µ is the overall mean and εij the residual error. If the interaction 
term αi . βj was not significant (P>0.05) it was excluded from the model. The type of sum of squares 
in the procedure was chosen to correct for unbalanced data. Treatment means (concentration) were 
compared with the LSD test. Results are presented as adjusted means ± standard error. 
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RESULTS 
 
Histological assessments and thymol concentration 
 
Histological investigations of the mounted jejunal tissue showed an appropriate stripping of the outer 
muscle layers and preservation of submucosa (data not shown). Post-experimental examination of 
tissues (two experiments), showed a similar appearance with maintenance of epithelial layer integrity 
in all treatments. Minimal sloughing of villus cells and oedema in the lamina propria could be 
observed in most tissues. In Fig. 1 a control tissue and a tissue bathed in 1 mmol/L E-
cinnamaldehyde is shown. The mean mucosal thymol concentration, 80 minutes after thymol 
application (1.0 mmol/L; mucosal side) was 0.46 ± 0.03 mmol/L (n=6 chambers), which corresponds 
to approximately half of the initial concentration. The concentration in the serosal buffer was lower 
than 1.5 µmol/L.  
 
Fig. 1. Examples of histological sections of jejunal tissue after an experiment in the Ussing chambers 
(115 min) and stained with haematoxylin-eosin; A: control treatment, B: E-cinnamaldehyde, 1 
mmol/L. 
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Effect on basal short-circuit current and tissue resistance 
 
Table 1 represents the results of the Ussing chamber study. An example of electrical recordings is 
given in Fig. 2. Thymol (series 1 and 4) and E-cinnamaldehyde (series 3 and 5) at 0.2 mmol/L 
showed a significantly higher ∆IscBASAL compared to the control (P<0.05). It means that the basal 
short-circuit current was affected after addition of the EO. The Isc increase at 1.0 mmol/L was not 
different from the control. The addition of E-cinnamaldehyde to the mucosal buffer provoked a slight 
increase in tissue resistance (Rt) at both doses compared to the control (P<0.05). 
 
 
 
Fig. 2. Example of short-circuit current (Isc) and tissue resistance (Rt) recordings in response to 
mucosal addition of 16 mmol/L D-glucose at the mucosal side, 0.1 mmol/L 5-HT at the serosal side 
and 5 mmol/L theophylline bilaterally. The recordings of two Ussing chambers from Series 3 are 
shown: control treatment (CON, black lines) and pre-incubation with 1.0 mmol/L E-cinnamaldehyde 
added to the mucosal buffer (CIN, grey lines) 
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Effect on active nutrient absorption 
 
Changes in short-circuit current after addition of D-glucose and L-alanine are a measure of sodium-
coupled nutrient absorption. Neither, E-anethole at 0.2 and 0.5 mmol/L, nor thymol and E-
cinnamaldehyde at 0.2 mmol/L affected sodium-dependent D-glucose absorption (Table 1). Thymol 
at 0.2 mmol/L reduced ∆IscL-ALANINE by almost 40% compared to the control (P<0.05). The highest 
concentration of thymol and E-cinnamaldehyde had clearly a great impact on active nutrient 
absorption (P<0.05). The Isc response to D-glucose for the thymol and E-cinnamaldehyde treatment 
was respectively 29.7 and 61.0% compared to that of the control, while the Isc response to L-alanine 
dropped further down to respectively 17.5 and 51.5%. The inhibitory effect of thymol exceeded by 
far the effect of E-cinnamaldehyde. 
 
Effect on induced chloride secretion 
 
All three EO reduced to a variable extent the Isc response to the secretagogues (Table 1). The 
chloride secretory response to neurotransmitters VIP and acetylcholine (and its mimetic carbachol) is 
mediated by elevated cAMP and intracellular Ca2+ levels respectively, which in turn activates 
chloride channels at the apical membrane resulting in chloride secretion (Barrett & Keely, 2000). 
Anion secretion induced by 5-HT is also via a calcium-dependent mechanism through binding to 5-
HT2 receptors located on enterocytes. However, in vivo this peptide also evokes the release of 
acetylcholine and non-adrenergic, non-cholinergic neutrotransmitters (most likely VIP) from enteric 
nerve endings. These effects may be quantitatively more important in the overall secretory response 
of 5-HT. Theophylline is a cAMP and cGMP phosphodiesterase inhibitor and will therefore 
inevitably result in an increase of intracellular levels of these second-messengers and subsequently 
chloride secretion. It is striking that for both thymol and E-cinnamaldehyde at 1.0 mmol/L the 
reduction in the Isc response as compared to the control was greater for the cAMP/cGMP mediated 
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secretagogues VIP (49.2 and 63.5% compared to control, respectively) and theophylline (39.2 and 
65.0%; taken from series 1 and 3) than for the Ca2+ mediated secretagogues 5-HT (64.2 and 79.6%) 
and carbachol (64.3 and 91.8%). So, the inhibitory effect seems to depend on the intracellular 
signalling pathway. The lower response to theophylline found in series 4 and 5 as compared to series 
1, 2 and 3 is most likely caused by the action of VIP, that already triggered cAMP in advance or due 
to secondarily down-regulation of chloride secretion by carbachol and is in accordance to Carlson et 
al. (2006). 
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Table 1. Response of tissue resistance (Rt, Ω.cm2) and short-circuit current (Isc, µA/cm2) to increasing mucosal concentrations (mmol/L) of the 
EO thymol, E-anethole and E-cinnamaldehyde. Data are presented as adjusted means ± standard error (1) 
 Thymol (2) E-anethole E-cinnamaldehyde 
 0 0.2 1.0 0 0.2 0.5 0 0.2 1.0 
 Series 1 Series 2 Series 3 
RtBASAL 
∆RtBASAL 
IscBASAL 
∆IscBASAL 
∆IscGLUCOSE 
∆Isc5-HT 
∆IscTHEOPHYLLINE 
47.3 ± 3.1 
0.3 ± 0.5 
5.5 ± 3.3 
0.9 ± 1.2a 
80.1 ± 7.4a 
12.0 ± 0.9a 
25.0 ± 1.6a 
48.6 ± 3.5 
0.2 ± 0.6 
13.0 ± 4.1 
5.9 ± 1.5b 
73.7 ± 7.9a 
8.3 ± 1.1b 
16.2 ± 1.8b 
51.2 ± 3.3 
0.5 ± 0.5 
7.0 ± 3.3 
3.5 ± 1.2ab 
23.8 ± 7.4b 
7.7 ± 1.0b 
9.8 ± 2.2c 
57.9 ± 2.9 
0.6 ± 0.3 
-1.5 ± 2.2 
1.3 ± 0.5 
76.7 ± 6.7 
14.8 ± 0.7a 
25.4 ± 1.2aA 
59.3 ± 3.1 
0.6 ± 0.3 
-0.2 ± 2.5 
1.1 ± 0.5 
72.8 ± 7.0 
13.0 ± 0.8ab 
21.8 ± 1.3abB 
60.5 ± 3.3 
0.5 ± 0.4 
-0.6 ± 2.6 
0.5 ± 0.5 
69.4 ± 7.8 
11.9 ± 0.8b 
19.9 ± 1.4bB 
58.2 ± 3.4 
-0.2 ± 0.5a 
12.4 ± 5.0 
0.8 ± 1.1A 
69.0 ± 5.4a 
10.3 ± 1.1ab 
22.3 ± 1.5a 
54.0 ± 3.0 
2.2 ± 0.4b 
6.2 ± 4.8 
3.7 ± 1.1B 
77.1 ± 4.9a 
12.0 ± 1.0a 
20.9 ± 1.5a 
60.4 ± 3.1 
2.8 ± 0.4b 
12.5 ± 4.6 
2.9 ± 1.0AB 
42.1 ± 5.4b 
8.2 ± 1.2b 
14.5 ± 1.5b 
 Series 4  Series 5 
RtBASAL 
∆RtBASAL 
IscBASAL 
∆IscBASAL 
∆IscL-ALANINE 
∆IscVIP 
∆IscCARBACHOL 
∆IscTHEOPHYLLINE 
55.7 ± 2.7 
-1.0 ± 0.5 
8.6 ± 3.0 
0.5 ± 0.4a 
33.7 ± 2.6a 
6.5 ± 0.7a 
27.7 ± 1.9a 
12.7 ± 0.7a 
56.3 ± 2.4 
-0.2 ± 0.5 
7.2 ± 3.0 
3.3 ± 0.5b 
20.6 ± 2.3b 
6.9 ± 0.7a 
23.6 ± 1.9a 
11.3 ± 0.8a 
55.2 ± 3.2 
-0.7 ± 0.5 
4.4 ± 3.0 
0.5 ± 0.5a 
5.9 ± 2.4c 
3.2 ± 0.6b 
17.8 ± 1.8b 
7.2 ± 0.7b 
   51.4 ± 3.3 
-0.1 ± 0.4a 
1.1 ± 3.9 
0.4 ± 0.8a 
41.0 ± 2.8a 
6.3 ± 0.7A 
41.9 ± 2.9A 
13.4 ± 0.9 
51.0 ± 2.9 
1.7 ± 0.4b 
3.5 ± 3.7 
4.6 ± 0.8b 
35.1 ± 2.6a 
5.5 ± 0.8AB 
33.7 ± 2.9B 
11.4 ± 0.9 
49.9 ± 3.5 
2.2 ± 0.4b 
8.1 ± 4.5 
1.8 ± 0.9a 
21.1 ± 2.8b 
4.0 ± 0.9B 
38.5 ± 2.9AB 
11.3 ± 0.9 
(1) The number of animals used per series was 5 to 6 with 2 tissues per animal and concentration; (2) Values per EO within a row with different superscripts are significantly 
different at P<0.1 (A,B,C) or P<0.05 (a,b,c) 
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DISCUSSION 
 
We investigated the effects of thymol, E-anethole and E-cinnamaldehyde on active nutrient 
absorption and induced chloride secretion in the pig Ussing chamber model. In the Ussing chamber 
technique, substances can be added to the buffers in order to assess the direct effect on the 
physiology of the mounted tissue; however limitations of the model have to be taken into account 
(Boudry, 2005) and viability of the tissue is limited (Söderholm et al., 1998). Surprisingly, when the 
thymol concentration in both buffers at the end of the experiment was determined, no thymol was 
retrieved in the serosal buffer and approximately half of the initial concentration was found in the 
mucosal buffer. In an Ussing chamber study with chicken jejunal tissue, it was shown that with 
increasing mucosal addition of thymol (0.013, 0.067 and 0.133 mmol/L) the amount retrieved in the 
serosal buffer relative to the total amount retrieved declined (from 17 to 1%) (Haselmeyer, 2007). In 
our study, the applied doses were higher and the fact that thymol was not detected in the serosal 
compartement is then in line with the data of Haselmeyer (2007).  
 
We demonstrated that thymol and E-cinnamaldehyde affected sodium-coupled D-glucose and L-
alanine absorption in a dose-dependent manner. To a variable extent, chloride secretion induced by 
several secretagogues was reduced as well. Cloride is taken up into the cell across the basolateral 
membrane via the Na+, K+, 2Cl--cotransporter, geared by the basolateral Na+-K+-ATPase that 
establishes an inwardly directed sodium concentration gradient. So far, we found that all Na+-K+-
ATPase driven processes investigated here were significantly inhibited. Inhibition was noticed by 
pre-incubation with 1.0 mmol/L thymol and E-cinnamaldehyde and with 0.2 mmol/L thymol; only 
for L-alanine, 5-HT and theophylline. Presumably, the effects in our study can be ascribed to a direct 
inhibitory effect towards the activity of the basolateral Na+-K+-ATPase. It should be stressed that the 
EO are lipophilic and therefore can enter epithelial cells in a passive manner and therefore can reach 
the basolateral membrane. Consequently, all the cellular activities and processes that are driven by 
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the sodium gradient established by the Na+-K+-ATPase are expected to be impaired at the enterocyte 
level. This assumption is in agreement with the work of Kreydiyyeh et al. (2000), at least in the case 
of E-cinnamaldehyde. These authors showed that cinnamaldehyde inhibited the activity of rat 
intestinal Na+-K+-ATPase in a concentration-dependent manner (IC50; 1.1 mg/mg protein jejunal 
homogenate). Accordingly, they found that cinnamaldehyde (app. 7.5 mmol/L) reduced significantly 
L-alanine absorption in a rat jejunal perfusion experiment (app. 40% of control). Despite the fact that 
we used a different model, another species and lower concentrations, our results for E-
cinnamaldehyde do well agree with those results. Nevertheless, other mechanisms could be involved 
as well. An alteration of enterocyte membrane fluidity could compromise the efficacy of membrane-
embedded transport proteins. In particular, the phenolic thymol and its isomer carvacrol have been 
shown to accumulate in bacterial membranes and affect their fluidity and permeability (e.g. Ultee et 
al., 1999) and this would be consistent with the more pronounced effect of thymol as compared to E-
cinnamaldehyde. Another possibility can be a direct interaction of the compounds with the apical 
transporters: the co-transporter SGLT-1 (sodium-glucose linked co-transporter 1) for D-glucose, the 
respective neutral amino acid transporter for L-alanine and distinct chloride channels; the 
cAMP/cGMP-dependent CFTR (cystic fibrosis transmembrane conductance regulator) and calcium-
dependent CaCC (calcium-activated chloride channel). A competitive type of inhibition of SGLT-1 
by quercitin glucosides and green tea polyphenols has been suggested by Ader et al. (2001) and 
Kobayashi et al. (2000) respectively. Data for thymol or E-cinnamaldehyde are lacking. A direct 
interaction with these transport proteins is however unlikely, because the apical transport of D-
glucose, L-alanine and chloride is mediated by several different proteins. E-anethole (0.2 and 0.5 
mmol/L) did not alter the rate of D-glucose absorption. On the contrary, Kreydiyyeh et al. (2003) 
demonstrated in a rat perfusion model that aniseed EO significantly increased jejunal D-glucose 
absorption. These authors used aniseed EO, which contained 76.6% E-anethole, at a concentration of 
0.05%. The concentration of E-anethole in the perfusate approximates then 2.58 mmol/L. Therefore, 
discrepancy between the study of Kreydiyyeh et al. (2003) and ours can be related to concentration, 
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the contribution of other components in the aniseed EO, the model applied or species difference. 
Finally, in our study only active nutrient absorption was measured, while in in vivo sodium-
dependent and independent glucose absorption takes place. Shortly after a meal, brush border 
membrane GLUT2 (glucose transporter 2) levels are increased and serves as a means of sodium-
independent glucose absorption to cope with high luminal glucose concentrations (Kellett & 
Helliwell, 2000). Kreydiyyeh et al. (2003) argued that their observation could be explained by the 
stimulation  of the basolateral Na+-K+-ATPase, the transporter that drives sodium-dependent glucose 
absorption. Perhaps, an effect on sodium-independent glucose absorption was involved as well. 
 
Boudry & Perrier (2008) found a dose-dependent (0-0.1 mmol/L) increase in Isc after addition of 
thymol and cinnamaldehyde. This rise in Isc immediately followed EO addition and returned rapidly 
to basal values; it means that these EO provoke a transient secretory response of electrolytes. They 
found that the ionic basis was different; thymol induced Cl- and HCO3- secretion via a nervous 
pathway, likely by nicotinic receptor stimulation and cinnamaldehyde induced only HCO3- secretion, 
probably by direct activation of epithelial nicotinic receptors. In our study, we applied higher doses 
and the changes in Isc after addition of 0.2 mmol/L thymol and E-cinnamaldehyde were smaller and 
also much less then the effects of secretagogues. We determined the change in Isc five minutes after 
EO addition, because an immediate Isc increase as in the study of Boudry & Perrier (2008) was not 
observed here. The change in Isc for the higher concentration (1.0 mmol/L) was in none of the cases 
significantly different from control. We assume that at the higher concentration a stimulation of anion 
secretion is counteracted by the inhibitory effects as mentioned above. Interestingly, the addition of 
E-cinnamaldehyde to the mucosal buffer provoked a consistent slight increase in tissue resistance. 
Tissue resistance has been related to tight junction integrity and paracellular permeability (Lallès et 
al., 2004). Therefore, an increased tissue resistance can enhance the epithelial barrier function 
towards entry of luminal antigens and invading bacteria. It was suggested that the lateral enterocyte 
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space may be the preferential site of entry for several pathogenic bacterial strains (e.g. Wells et al., 
1998). Although the effect of E-cinnamaldehyde was rather small, it deserves further attention. 
 
Thymol and E-cinnamaldehyde inhibited the secretory response to all 4 secretagogues, while E-
anethole at 0.5 mmol/L reduced the response to 5-HT and theophylline. This could imply that the EO 
would be beneficial in cases of excessive chloride secretion that results in the clinical picture of 
diarrhoea, e.g. in response to toxins such as the cholera toxin or ETEC enterotoxins whose 
mechanisms of action involve the neurocrine mediators (Barrett & Keely, 2000). This is of particular 
importance for piglets post-weaning as they show a higher sensitiveness to secretagogues (Montagne 
et al., 2007). Hence, thymol and E-cinnamaldehyde show a more or less similar anti-secretory effect 
to zinc as was shown in the Ussing chamber model by Carlson et al. (2006). However, chloride and 
water secretion cannot solely be considered as a patho-physiological event. Limited secretion also 
has a physiological function as it comprises the more thorough mixing of the digesta with fluid and 
enzymes and guarantees a continuous rinsing of the intestinal surface counteracting the colonization 
of (pathogenic) bacteria (Lodemann et al., 2006). Therefore, it can expected that these EO will 
interfere with this basal function of chloride secretion as well.  
 
In addition, EO have been shown to affect intestinal cell viability and causing apoptosis and necrosis. 
However, the concentration range for these effects varies according the report. Bimczok et al. (2008) 
found a IC50 of carvacrol towards pig intestinal IPEC-1 cells of 0.53 mmol/L (MTT assay), while 
according to Roselli et al. (2007), the highest non-toxic concentration towards the same cell line was 
5.00 mmol/L (assessed by cell permeability) for both carvacrol and cinnamaldehyde. Carvacrol, 
thymol and eugenol at 0.37, 0.17 and 0.52 mmol/L had no cytotoxic effects after 24 h against 
differentiated Caco-2 cells, while at the higher dose (1.83, 0.80 and 2.5 mmol/L, respectively) the 
EO, except for thymol, led to general damage of the cells (apoptosis and necrosis) and loss of 
monolayer adhesion (Dusan et al., 2006). Apoptosis could be a result of the binding of EO to the cell 
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surface hydrophobically and thereby triggering an oxygen burst (Suzuki et al., 1985) or by their 
effect on mitochondrial membranes resulting in an impairment of the electron chain reactions and a 
pro-oxidant activity; as proposed by Bakkali et al. (2008). From these literature data; 0.20 mmol/L 
should be non-cytotoxic. Regarding 1.0 mmol/L, it cannot be decisively concluded whether this dose 
in our Ussing chamber study could have induced loss of cell viability and consequently interfered 
with the epithelial absorptive and secretory capacity. In the Results section, it was shown that there 
was minimal sloughing of villus cells (also in control treatment). Probably, exfoliation of these cells 
was preceeded by deteoration of cell function and concomitant absorptive and secretory capacity and 
this process was aggrevated by EO addition. The fact that thymol was not retrieved in the serosal 
buffer also points at possible cytotoxic effects. 
 
 
CONCLUSION 
 
We demonstrated that thymol and E-cinnamaldehyde impaired sodium-dependent absorption of D-
glucose and L-alanine in vitro in a dose-dependent manner. Pre-incubation with 0.5 mmol/L E-
anethole did not alter response to mucosal D-glucose. The reduction by thymol and E-
cinnamaldehyde in secretory response to cAMP/cGMP mediated secretagogues VIP and theophylline 
was greater than for the Ca2+ mediated secretagogues 5-HT and carbachol. E-anethole, at 0.5 mmol/L 
affected chloride secretion induced by 5-HT and theophylline. Inhibition of the basolateral sodium-
potassium pump (E-cinnamaldehyde) and modification of membrane fluidity (thymol) might be 
involved but additional investigations are necessary to confirm these findings and eventually 
elucidate the exact mode of action. 
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EO for use in pig nutrition has deserved a lot of attention during the last decade, with special 
emphasis to their antimicrobial properties. Despite an overwhelming amount of in vitro data 
concerning the latter, few in vivo trials with pure compounds have been published. Moreover, results 
varied according to experiment and a substantial reduction of the bacterial load in the foregut, like 
with other alternatives for AMGP (e.g. Dierick et al., 2002b), has not been demonstrated yet. 
Therefore, it was of great interest to study the effect of these EO on gut bacteria and functionality in 
the pig and to understand possible pitfalls that arise when they are applied in vivo. In this thesis, 5 
pure components were selected based on literature data and were investigated. It was preferred to 
work with pure compounds rather that plant EO, because: [1] biological activities observed can then 
inherently be related to the compound applied; [2] the composition of a plant EO can differ a lot 
according to factors specified in Chapter 1 and [3] requirements for authorisation (technical dossier 
to EFSA) are mainly addressed to single substances; registration of complex mixtures, in casu plant 
EO, can be problematic because of quality demands for composition whereby all active substances, 
impurities/contaminants and excipients should be quantitatively reported. 
 
Antimicrobial activity and stability 
 
The in vitro antimicrobial activity against the main components of the pig gut flora was established 
by means of simulations of the fermentation present in the different sections of the GIT (Chapter 2). 
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Samples from these experiments were taken to determine the stability/degradation in the respective 
section of the GIT (Chapter 3). Fig. 1 resumes these findings. 
 
The isomers carvacrol and thymol showed similar antimicrobial activities and can be considered to 
be non-selective. In addition, they will not be degraded along the proximal GIT. From former 
research at our laboratory we concluded that a concentration that gives 1 log10 CFU/mL reduction in 
this type of in vitro batch incubations can result in appreciable reductions of the gut flora in vivo 
(Dierick et al., 2002b). Considering the results for carvacrol and thymol, this would equal a dose of 
approximately 400 mg/L to reduce the coliforms in the SI and 400-550 mg/L to reduce the 
lactobacilli in the stomach and the SI. These concentrations are well below their water solubility and 
are somewhat in the same order of MIC values against various bacteria (Table 2, Chapter 1) and in 
line with the results of Si et al. (2006b). As both compounds were most effective against the 
dominant flora components like lactobacilli and streptococci in the proximal sections of the GIT and 
in an acidic environment, they must be well suited to reduce total bacterial load cranially and thus act 
as a growth-promoter. Nevertheless, the doses needed to obtain these effects are still rather high (> 
400 mg/L). In two in vivo trials, we supplemented weaned piglets with 500 and 2000 mg/kg carvacrol 
or thymol (Chapter 4B). A higher inclusion level was not tested because of adverse effects on 
palatability (clearly illustrated in the choice-feeding study, Chapter 4A). With this dose, acute oral 
toxicity is not expected. If, for example piglets weigh 10 kg and consume 300 g feed a day, then an 
inclusion of 2000 mg/kg EO gives a daily EO intake of 60 mg/kg BW. This is well below the LD50 
values for rodents (p58, Chapter 1). Theoretically, if the diluting effect of water, saliva and gut 
secretions is taking into account, 2000 mg/kg will result in gastric and small intestinal concentrations 
of approximately 600 and 200 mg/kg, respectively. This 600 mg/kg for stomach coincided more or 
less with what we found in vivo, but antibacterial effects were not present. This can be explained by 
the higher dry matter content of gastric digesta as compared to the in vitro medium used. Smith-
Palmer et al. (2001) already demonstrated that a high dry matter content can abolish antibacterial 
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effects. The recovery in the SI was lower than theoretically deduced, due to absorption (see below). 
Probably, single phenolic EO - when administered in an economical and technical acceptable dose - 
will not be able to reduce the bacterial load in vivo and therefore act as a real growth-promoter. A 
realistic opportunity is to maximise synergism with organic acids or with antimicrobial peptides 
(endogenous or exogenous) (see also Chapter 1, 2.3). Both types of antimicrobial molecules 
stress/disrupt the integrity of the microbial membranes, as do phenolic EO. Therefore, their mode of 
action is not exclusive, rather they should work in conjunction as they have the same target site. More 
research should focus on this. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Scheme representing the antimicrobial activity and stability of selected EO in in vitro 
simulations of the pig gut fermentation (for further details see Chapter 2 and 3). 
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Eugenol and especially E-cinnamaldehyde showed a selective antimicrobial spectrum and should 
induce a shift in the ratio lactobacilli/coliforms. The former was notably only active in jejunal 
simulations; and thus not in an acidic (stomach) and anaerobic (caecum) environment. No 
explanation can be given. E-cinnamaldehyde, at 100 mg/L, reduced substantially coliforms, which 
are mainly present in the distal SI. Coliforms are sometimes considered as indicator organisms for the 
presence of opportunistic pathogens. So, E-cinnamaldehyde holds promise to combat the pathogen 
load and secure intestinal health of pigs. We have not carried out in vivo trials with this compound, 
and only one preliminary report was found in literature (Andrés Elias et al., 2007). Contrary to 
carvacrol and thymol, few studies have addressed the relationship between the biological activity and 
cinnamaldehyde structurally related compounds (Brackman et al., 2008; Lee et al., 2001; Lee et al., 
2007 and Lee et al., 2008). Lee et al. (2001) found that some cinnamic acid derivates were equally 
effective as E-cinnamaldehyde against E. coli, but in contrast to the latter they did not affect the 
growth of Bifodobacterium spp. and Lactobacillus spp. In conclusion, these compounds were even 
more selective than E-cinnamaldehyde and could therefore balance the intestinal microbes further 
towards a healthy community (pathogen resistance, Reid & Hillman, 1999). More exploration of 
these findings is absolutely warranted. Interestingly, Niu et al. (2006) and Brackman et al. (2008) 
showed that E-cinnamaldehyde interfered with quorum sensing of bacteria. Evidence for quorum 
sensing mechanisms have been found for the rumen (Erickson et al., 2002), but not for monogastrics. 
This needs further attention, and if so, again E-cinnamaldehyde is the molecule of choice. 
 
However, as the compound owes its many biological functions to its reactive α,β-unsaturated 
aldehyde configuration (nucleophilic addition reactions), this provides the molecule also a low 
stability. Especially, thermal breakdown to benzaldehyde (Friedman et al., 2000 and Gholivand & 
Ahmadi, 2008) should be of great concern for feed processing. In our research, it was partially 
degraded in in vitro small intestinal fermentations and its fate in caecal simulations could not be 
quantified due to analytical problems. It was clear that E-cinnamaldehyde showed weaker 
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antimicrobial activities in caecal simulations as could be predicted from its effect in jejunal 
simulations. Probably, it reacted here with matrix elements or was (bio)chemically transformed. We 
found cinnamic acid peaks on the chromatograms. However, detailed studies with more advanced 
analytical tools (for example, GC-MS) are necessary to understand its kinetics in the GIT. It is 
surprising, as E-cinnamaldehyde seems to be an interesting compound to modify ruminal 
fermentation patterns, that no data are available about its stability or appearance of metabolites in the 
rumen. This knowledge is needed to evaluate its efficacy and safety for the animal and its products. 
We found in the Ussing chamber model that E-cinnamaldehyde had a dose-dependent adverse effect 
on sodium-dependent nutrient absorption. However, these data can be questioned to some extent, 
since it is not known if this model is suited to test lipophilic compounds (although the concentration 
did not exceed its water-solubility). A study using a model more close to the in vivo situation 
(perfusion model) to confirm this finding is thus required. Nevertheless, Kreydiyyeh et al. (2000) 
already demonstrated that this compound was able to inhibit enterocyte Na+-K+-ATPase activity; the 
driving force for sodium-dependent nutrient absorption. Notably, many contemporary studies focus 
on elucidating the role of TRP channels in the animal’s body and hence the full relevance of E-
cinnamaldehyde as a potent agonist of TRPA1 is not understood. For example, Nozawa et al. (2009) 
showed that TRPA1 is highly expressed in enterochromaffin cells (EC) and that TRPA1 agonists 
activated EC function, such as the release of 5-HT. At least, this property of cinnamaldehyde (TRPA1 
stimulation), explains partially its adverse effects on palatability in pigs fed high doses of this 
compound, which was clearly observed in preliminary trials at the laboratory. 
 
There is a strong conviction that cinnamaldehyde-related compounds having the same (or even 
better) antimicrobial (and/or anti-quorum sensing) potential, without showing the disadvantages of 
the parent compound, are there to be found. 
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Fast absorption in the ’open system’ GIT 
 
An important observation in this thesis was that these EO were mainly and nearly completely 
absorbed in the stomach and the proximal SI when ingested (Fig. 1., Chapter 3 and Fig. 1., Chapter 
4B). Fast absorption and rapid clearance of these compounds has also been reported in studies with 
humans and rodents. Hence, we found rather low luminal availabilities and lack of substantial 
antimicrobial activity in two in vivo trials with carvacrol and thymol (Chapter 4B). The highest 
concentration in the proximal and distal SI that we found in these trials was 40.8 mg/kg thymol (pig 
on diet AL2000) and 15.9 mg/kg thymol (pig on diet CE2000), respectively. Both pigs here were fed 
2000 mg/kg thymol. It is surprising that many pig trials have been performed with particularly low 
inclusion rates of EO (see Table 5., Chapter 1); in only one study the dose was higher than in our 
research (Trevisi et al., 2007). In none of these studies were the active ingredients dosed in the 
digesta. Nonetheless, the use of kinetic data of these agents is essential in order to predict effective 
feed inclusion rates and also to assess risks for tolerance/resistance development against these agents. 
Indeed various studies (Ultee et al., 2000; Di Pasqua et al., 2006) highlighted the potential for 
induced bacterial tolerance in the presence of sub-lethal doses of several EO. The bacteria lowered 
their membrane fluidity due to changes in the fatty acid and head-group composition of 
phospholipids. Adaptation of the gut microbiota was observed by Cardozo et al. (2004) and Report 
(2006). Many (soil)organisms can use these EO as carbon and energy source (Liotori, 1999), so they 
are biodegradable. It is not known whether and which gut bacteria can metabolise these EO. We 
found substantial degradation in caecal simulations, but did not research for underlying mechanisms. 
It  might be possible that analogous mechanisms interfered with our observations made in the in vivo 
trials. The use of the EO in vivo should be well designed to avoid a continuous exposure of the gut 
flora to low levels of these compounds which will result eventually in microbial adaptation or 
important biodegradation and hence loss of efficacy or eventually favouring some microbes. 
Molecular techniques (e.g. PCR-DGGE) can be used to detect changes in the microbial population of 
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the gut. For example, in thymol fed animals (10000 mg/kg), the G- bacterium Actinobacillus minor 
was absent and in contrast, the G- enterobacterium Citrobacter freundii was present in most animals 
fed thymol (Janczyk et al., 2008).  
 
The notion that fast absorption can compromise an antibacterial effect gets particular relevance in 
cases where the bacterium is to be targeted in the ileum and caecum, e.g. the zoonotic pathogen 
Salmonella enterica. In the study of the kinetics of the EO in the GIT (Chapter 3), the estimated 
maximum concentration in the ileal digesta was 10, 4, 9 and 2 mg/kg for carvacrol, thymol, eugenol 
and E-cinnamaldehyde respectively (data not shown). The minimum reported MIC value against 
Salmonella enterica was 150, 57, 100 and 400 µg/mL for the same EO (Table 2., Chapter 1). It can 
be calculated that at least a 15, 14, 11 and 200-fold dosis in the feed than the one applied in the study 
might be necessary to achieve a concentration corresponding to the lowest MIC value. The feed 
inclusion level in the study for the EO was between 910 and 958 mg/kg. An alternative for higher 
feed inclusion levels is the application of appropriate release techniques. Active ingredients may be 
coated or microencapsulated (e.g. Meunier et al., 2006 and Piva et al., 2007) in order to delay the 
release of the active ingredients, but this makes it also more costly. Surprisingly, in our in vivo trial 
and for unknown reasons, micro-encapsulation of thymol did not give higher small intestinal 
concentrations compared to control. Another approach would be to covalently bind the compounds, 
for example as glycosides (which are actually present in plants in case of the phenolic compounds), 
but isolation or artificial synthesis is low-yielding and very costly. Additionaly, these technical 
formulations might provide more advantages: [1] protection from loss during feed processing and 
storage; [2] less distinct flavour and [3] less interaction with feed particles. 
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Effect on palatability and gut bacterial ecology and function 
 
EO are frequently added to feed as flavours with the aim to affect the sensorial characteristics of the 
feed, mainly taste and smell. It means that they can affect palatability. We carried out a choice-
feeding study to explore the effect of thymol and masking flavours on the animal’s preference 
(Chapter 4A). 2000 mg/kg had a huge negative effect on appetite, but this was not so clear 
considering the ADFI in the two in vivo trials (Chapter 4B). A dose of 10000 mg/kg did reduce feed 
intake post-weaning (Trevisi et al., 2007). There was an analogous difference with regard to 500 
mg/kg thymol; no preference for this diet in the choice-feeding study but a higher ADFI in the in vivo 
trials was found. It seems that the results of the two studies do not exactly match. Interestingly, added 
flavours were able to mask partially the reduced preference for 2000 mg/kg in the choice-feeding 
study. So, if high inclusion rates are used, appropriate flavours can be helpful.  
 
Effects on gut bacteria and function, as we found in and ex vivo are summarised in Fig. 2. Most 
AMGP target G+ bacteria (mainly lactic acid producing species) without affecting for example 
coliforms. A similar effect was shown for high doses of ZnO (Hojberg et al., 2005). These additives 
have proven to be beneficial in terms of animal performance. From our observations - and in contrast 
to what we could expect based on the in vitro data – the EO carvacrol and thymol did not show a 
similar effect. Rather, they improved several indices that are related to a better gut health balance. 
Animals fed thymol showed lower numbers of IEL in the small intestinal mucosa, irrespective of 
formulation type or dose (for some treatments with significance, P<0.05; see also orthogonal contrast 
I in Table 5, Chapter 4B). It can be considered as a beneficial effect since a positive relationship 
between the number of IEL and mucosal turnover exists. Faster renewal of enterocytes lining the villi 
results in less mature enterocytes with less brush-border enzyme and absorptive activities and higher 
maintenance costs to restore epithelial integrity. A similar effect was demonstrated by Manzanilla et 
al. (2004), although they applied a low-dosed mixture containing carvacrol, cinnamaldehyde and 
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capsicum oleoresin. IEL are T-lymphocytes, with the majority of the cytotoxic CD8+ phenotype. The 
number of IEL is increased by microbial colonisation (bacterial antigenic load) and to a lesser extent 
by dietary immunogenic factors. Research with germ-free animals showed underdeveloped intestinal 
lymphoid tissues, substantially decreased numbers of lymphocytes and low antibody concentrations; 
all which converted to the normal state when germ-free animals were associated with intestinal 
bacteria. Here, the same basal diet was used in all treatments, hence a dietary effect can be ruled out. 
Two hypotheses to explain the reduction in IEL by thymol are put forward: 
[1] here, culturable bacterial groups were quantified on selective media and substantial 
changes in the number of gut bacteria were not detected. However, it is well established that 
with this approach the overwhelming diversity of the gut bacterial community cannot be fully 
characterised. Therefore, we speculate that it is not unlikely that thymol supplementation 
affected the growth of bacteria (e.g. Janczyk et al., 2008) which was not detected here, but 
could possibly trigger the intestinal immune system differently. More investigations are 
needed to understand which immunogenic bacteria could have been affected by these EO, and 
 [2] carvacrol and thymol might have reduced the biosynthesis of prostaglandins through their 
COX inhibitory activity and hence downregulated (partially) inflammatory responses. 
Consequently, the (excessive) recruitment and migration of T-lymphocytes to the villus 
epithelium was restrained. 
Overall, the fact that these EO can affect the immune response of the GIT warrants further attention.  
 
Supplementation with carvacrol and thymol also resulted in a higher V/C ratio at the distal small 
intestine. A increased V/C ratio is associated with a slower enterocyte migration rate and concomitant 
turnover rate of the epithelium. For almost all 500 mg/kg diets a higher feed intake was found and 
this offers the opportunity to optimise the weaning transition period. The attenuating effect on 
stimulated (excessive) chloride secretion needs confirmation. Presumably, these EO are more useful 
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when animals are subject to gastro-intestinal disorders and/or unfavourable hygiene conditions 
(pathogen load).  
 
These observations will contribute to our knowledge about the ‘mode of action’ of these EO, but 
many questions remain without answer. Based on the obtained data in this thesis and according to my 
opinion the following topics should be investigated with priority to better understand the interaction 
with gut bacteria and physiology: 
[1] effects on gut microbiota (by plating and molecular techniques) and immune function 
(anti-inflammatory effects) by these EO and related compounds (especially cinnamaldehyde) 
in controlled-release formulations; 
[2] effect on gut motility (see evidence for inhibitory effect on smooth muscle contractility); 
[3] anti-oxidant effect (dose-response studies) towards feed components and gut tissue 
(phenolic compounds) and 
[4] interaction with absorptive and secretory functions of the epithelium (confirmation of 
obtained results in perfusion model and eventually study of underlying mechanisms). 
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Fig. 2. Summary of in and ex vivo negative (-) and positive (+) effects of EO on palatability, feed intake and gut bacteria and function (for further 
details see Chapter 4A, 4B and 5). Some effects indicate that the gut health balance might be improved. Effects indicated with (?) need confirmation. 
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Potential risks and legal aspects 
 
EO were studied here for their potential as alternative for the AMGP. The in-feed antibiotics were 
banned in the EU, for reasons of antimicrobial resistance, residue issues and negative consumer 
perception. Let’s face these three topics for the EO; firstly antimicrobial resistance. There is evidence 
that bacteria can adapt to and degrade the EO (discussed above), but acquired genetic resistance has 
not been demonstrated. So far their efficacy is not ensured, but it is unclear whether this poses a risk 
for human health since their antimicrobial use for humans is limited. Intriguing is the work of 
Pumbwe et al. (2007). They demonstrated that sub-lethal cinnamaldehyde selected for multiple 
antibiotic resistance in B. fragilis. It means that there is a possibility that misuse of this EO can lead 
to bacterial resistance towards antibiotics. This has to be checked in vivo. With regard to the second 
point, residue issues are not anticipated (rapid metabolic conversion and clearance), but such research 
with high doses for pig has not been performed. In this respect, precaution is recommended. Thirdly, 
a major advantage of EO is that their consumer acceptance is high. People see this more as a ‘natural 
remedie’. However, this is definitely not an alibi to declare that they are safe or not harmful. 
 
Herbs and their extracts are increasingly being used (and informally marketed) not only as sensory 
additives, but also for other purposes, for example better growth or feed conversion, improved meat 
quality, and for prophylactic purposes. There are strong indications that such use will further increase 
in the future. As mentioned in Chapter 1, herbal extracts, flavours and EO now fall within the scope 
of EC Regulation 1831/2003. It means that for authorisation on the EU market, applications have to 
go through a set procedure. A key element hereby, is the evaluation of the technical dossier by the 
EFSA which should include proof of the claim and safety according to toxicological and tolerance 
tests. According to the claims made by the applicant and based on substantial proof of efficacy, 
herbal extracts will be classified either as technological (main action outside the animal) or as 
zootechnical (main action inside animal) feed additives. In both cases, for xenobiotic active 
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principles, a full toxicological data set will be required in order to guarantee safety for the animal, 
user, consumer and environment.  
 
Essential oils??? 
 
To conclude, the in vitro studies showed the huge potential of carvacrol, thymol and E-
cinnamaldehyde to modulate the composition of the gut bacteria of the pig. Contrary, in two trials 
with weaned piglets the supplementation with carvacrol and thymol at the doses applied did not 
reduce the bacterial load, most likely due to fast absorption of the active ingredient in the stomach 
and the proximal small intestine. Some effects indicate that the gut health balance might be 
improved, however the Ussing chamber study showed deleterious effects on active nutrient 
absorption. AMGP were an essential element of the enormous expansion and intensification of pig 
production systems during the last five decades. Essential oils might replace these AMGP partially, 
but in contrast to what their name suggests, they will not be essential. Besides, an essential oil is 
essential in the sense that it carries the distinctive scent, or essence, of the plant where it is derived 
from. 
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The use of antibiotics as antimicrobial growth-promoters (AMGP) in pig feeds has been banned in 
the EU from January 2006 (regulation EC/1831/2003) and is under debate in other parts of the world. 
For decades the use of these AMGP in intensive pig production permitted higher growth rates and 
better feed conversion ratios in a nearly consistent way. Their mode of action is not fully understood 
but there is evidence that they work in part by decreasing the overall numbers and/or specific 
bacterial species or their metabolic activities in the gastro-intestinal tract (GIT). However, others 
believe that the growth-promoting effect can be attributed to a direct effect on host cells, in particular 
inflammatory cells. Furthermore, in the EU antimicrobial inclusion levels of copper in piglet feed is 
foreseen to be reduced in the future. In this respect, essential oils (EO) with well documented 
antimicrobial properties like carvacrol and E-cinnamaldehyde have gained renewed interest for use in 
animal feed. The specific objectives of the present study were: [1] to characterise the antimicrobial 
activities of EO against piglet intestinal bacteria; [2] to study the stability and kinetics of EO in the 
GIT of piglets and [3] to study the effect of EO on the functionality of the gut in piglets. Concerning 
the experimental work, effects were mainly quantified related to the weaning period of pigs, because 
in current pig production systems, the weaning period is one of the main critical points for growth 
and survival of the animal. 
 
In Chapter 1, a literature review is presented. It comprises relevant data of carvacrol, thymol, 
anethole, eugenol and cinnamaldehyde, with special emphasis on the antimicrobial activities and the 
reported effects on pig gut bacteria and physiology and animal performance. 
 
The antimicrobial activity of 7 EO against the major culturable components of the pig gut flora has 
been characterised by means of an in vitro incubation model simulating the fermentation in different 
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sections of the pig GIT (Chapter 2). In a first study, these compounds were screened for their 
antimicrobial properties. Dose-response equations were established for the 4 compounds with the 
highest potential in a second study. Binary combinations were tested as well, and the interaction 
effects were evaluated following the isobole method. The results of both studies indicated that 
carvacrol, thymol, eugenol and E-cinnamaldehyde give opportunities to modulate the flora and 
fermentation pattern of the GIT of pigs, while eucalyptol, terpinen-4-ol and E-anethole were found 
not to have interesting effects on modifying the composition of the pig gut flora. The minimum 
concentration for carvacrol, thymol, eugenol and E-cinnamaldehyde in jejunal simulations needed to 
reduce the number of total anaerobic bacteria compared to control with a probability of 99.7% was 
255, 258, 223 and 56 mg/L respectively. This strong activity of E-cinnamaldehyde was due to its 
progressively increasing effect against coliform bacteria; a dose of 104 mg/L gave a reduction of 1 
log10 CFU/mL vs. 371, 400 and 565 mg/L for carvacrol, thymol and eugenol respectively. However, 
E-cinnamaldehyde showed clearly less inhibitory activity towards lactobacilli than carvacrol and 
thymol. Therefore, the use of E-cinnamaldehyde (for example 100 mg/L) and to a lesser extent 
eugenol could result in a shift in the microbial ecology in favour of lactic acid producing bacteria and 
reducing the number of coliform bacteria. Carvacrol and thymol showed very similar and non-
selective antimicrobial properties. Their effect was more pronounced in acidic media and 
demonstrated a rapidly increasing bactericidal effect from a certain concentration on (400-500 mg/L 
in jejunal simulations). The inhibition of the production of total SCFA in jejunal simulations by these 
4 candidates was related to their effect against coliform bacteria, however they did not alter the lactic 
acid and ammonia concentrations. Few combinations demonstrated synergism; most mixtures 
showed zero interaction or antagonism. Carvacrol + thymol (ratio ≥1) was synergistic against total 
anaerobic bacteria in jejunal simulations, however this effect was rather small. In caecal simulations, 
carvacrol, thymol and E-cinnamaldehyde were equally effective while eugenol had only an effect on 
coliforms. 
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Data on the stability and kinetics of carvacrol, thymol, eugenol and E-cinnamaldehyde in the GIT of 
pigs were determined in a subsequent study (Chapter 3). Samples of in vitro incubations were 
analysed for their EO content, and the recovery was calculated as a measure for stability/degradation. 
None of these compounds was significantly degraded in in vitro simulations of the pig gastric 
fermentation. Carvacrol and thymol were not degraded in jejunal simulations, but significant losses 
up to 29% were found in caecal simulations. Eugenol and E-cinnamaldehyde showed a more 
pronounced degradation in jejunal and caecal simulations. A single dose mixed with feed (13.0, 13.2, 
12.5 and 12.7 mg/kg BW for carvacrol, thymol, eugenol and E-cinnamaldehyde respectively) was 
given orally to piglets. Half-lives in total digestive tract ranged between 1.84 and 2.05 h, whereby E-
cinnamaldehyde showed the fastest disappearance. All of these EO were mainly and nearly 
completely absorbed in the stomach and the proximal SI. Plasma concentrations (sum of free and 
conjugated compound) peaked at 1.39, 1.35 and 0.83 h for carvacrol, thymol and eugenol 
respectively and this was accompanied by high concentrations in urine.  
 
The objectives in a choice-feeding study were: [1] to determine the effect of dose of thymol on 
palatability (experiment I) and [2] to study the possibility of added flavours to mitigate the aversive 
effects of high thymol inclusion rates on palatability (experiment II) (Chapter 4A). Twenty-four fully 
weaned piglets were divided into 8 groups of 3 animals. Each group was housed in a separated pen 
equipped with two troughs; a reference diet was offered in one trough and a test diet in the second 
trough. Piglets had free access to both troughs and could therefore choose between the two diets 
offered. Feed intake of the test diet was expressed as the proportion of the total intake and tested by 
means of a one-sample Student’s t-test against a set value of 50% (n=16). The preference of the 
piglets for feed supplemented with 125, 500 and 2000 mg/kg thymol was 53.0 ± 14.0 % (P>0.05), 
47.5 ± 19.6 % (P>0.05) and 9.9 ± 9.2 % (P<0.001) respectively (experiment I). Definitively, 125 and 
500 mg/kg thymol did not affect palatability, while the piglets almost completely refused to eat feed 
with 2000 mg/kg thymol. Two test diets were included in experiment II; feed supplemented with 
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2000 mg/kg thymol with either flavour A (intended to mask the pungent taste of thymol) or flavour B 
(designed to mask both the taste and smell of thymol) and opposed against a control diet. The relative 
intake of test diets was 19.5 ± 10.5 % (P<0.001) and 14.0 ± 15.7 % (P<0.001), respectively, which 
means that the flavours could partially alleviate the aversive effects of 2000 mg/kg thymol. 
Alternatively, animals were offered one of these test diets and a reference diet containing 2000 mg/kg 
thymol. In accordance to the former results, animals had a preference for the feed with 2000 mg/kg 
thymol + flavour A (67.6 ± 18.9 %; P<0.01). However, the results for the feed with 2000 mg/kg 
thymol + flavour B (28.9 ± 13.1 %; P<0.001) did not confirm the previous observations.  
 
Two trials were conducted to study the effect of dose and formulation of carvacrol and thymol on gut 
bacterial counts and metabolites and gut function in weaned piglets. In experiment I, 25 piglets (28 d, 
6.59 ± 0.48 kg) were allocated to five dietary treatments: a control diet and the same diet 
supplemented with either carvacrol or thymol at doses of 500 and 2000 mg/kg. The EO were 
dissolved in the soybean oil fraction, prior to mixing with the basal diet. In experiment II, 35 piglets 
(28 d, 7.99 ± 0.73 kg) were assigned to seven dietary treatments: the same control diet as in 
experiment I and this diet supplemented with thymol in one of three formulations (on celite, on 
alphacel or microencapsulated) at doses of 500 and 2000 mg/kg. Microencapsulation was applied in 
order to delay the release of the active ingredient in the gastro-intestinal tract. All diets were given ad 
libitum. At 11/12 days post-weaning piglets were euthanized, and digesta from stomach, proximal 
and distal SI were sampled for bacteriological (plating onto selective media for total anaerobic 
bacteria, coliforms, streptococci and lactobacilli) and biochemical analysis. Small intestinal tissue 
was sampled for histo-morphological determinations. Feed intake was higher for animals fed 500 
mg/kg carvacrol and thymol, with the exception of the microencapsulation treatment (between +12.4 
and +44.7% as compared to control), and likewise villi at the distal SI were larger compared to 
control (between +4.9 and +7.5% as compared to control; P>0.05). In experiment I, the villus/crypt 
ratio at the distal SI for the experimental diets (1.30-1.32) was higher than for the control diet (1.24) 
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(P<0.05). Thymol fed animals in experiment II had a lower number of intra-epithelial lymphocytes at 
the proximal (P<0.05) and at the distal (P<0.1) SI as compared to the control animals. Concurrently, 
the villus/crypt ratio at the distal SI tended to be higher in the experimental diets (P<0.1). Mean EO 
concentration in stomach and proximal SI for the 2000 mg/kg diets ranged between 475 and 647 and 
between 5 and 24 mg/kg fresh digesta, respectively. Cumulative absorption in proximal SI was 
higher than 90% for all treatments. These data suggest that EO can enhance feed intake at 500 mg/kg 
and improve gut health, but conclusive evidence for clear antimicrobial effects towards the major 
culturable bacteria of the pig gut is limited. 
 
Chapter 5 presents a detailed study of the effects of thymol, E-anethole and E-cinnamaldehyde on 
active epithelial absorption of D-glucose and L-alanine and induced chloride secretion in the Ussing 
chamber model. Stripped mid-jejunal tissue of fully weaned piglets was mounted in modified Ussing 
chambers. The increase in short-circuit current (∆Isc) to mucosal addition of 16 mmol/L D-glucose 
and 16 mmol/L L-alanine, with or without pre-incubation with 0.2 and 1.0 mmol/L thymol or E-
cinnamaldehyde and 0.2 and 0.5 mmol/L E-anethole was determined. Accordingly, the effect on 
stimulated chloride secretion by secretagogues was measured. Thymol and E-cinnamaldehyde 
reduced the Isc response to nutrients and secretagogues in a dose-dependent manner. ∆Isc to D-
glucose for thymol at 0.2 and 1.0 mmol/L was respectively 73.7 ± 7.9 (P>0.05) and 23.8 ± 7.4 
(P<0.001) compared to 80.1 ± 7.4 µA/cm2 for control and to L-alanine respectively 20.6 ± 2.3 
(P=0.01) and 5.9 ± 2.4 (P<0.001) compared to 33.7 ± 2.6 µA/cm2 for control. E-cinnamaldehyde 
showed only significant effects at 1 mmol/L. Such effects in vivo could compromise intestinal 
absorption of nutrients. The reduction in secretory response to cAMP/cGMP mediated VIP and 
theophylline was greater than for Ca2+ mediated 5-HT and carbachol. Pre-incubation with 0.5 
mmol/L E-anethole did not alter response to mucosal D-glucose, but affected chloride secretion 
induced by 5-HT and theophylline. This could imply that the EO would be beneficial in cases of 
excessive chloride secretion that results in the clinical picture of diarrhoea, e.g. in response to toxins 
 - 226 - 
such as the cholera toxin or ETEC enterotoxins whose mechanisms of action involve the neurocrine 
mediators. 
 
Finally, a general discussion (Chapter 6) aims at interrelating all data. Data are viewed in the 
perspective of these EO as alternatives for the AMGP and future prospects are discussed. To 
conclude, the in vitro studies showed the huge potential of carvacrol, thymol and E-cinnamaldehyde 
to modulate the composition of the gut bacteria of the pig. Contrary, in two trials with weaned piglets 
the supplementation with carvacrol and thymol at the doses applied did not reduce the bacterial load, 
most likely due to fast absorption of the active ingredient in the stomach and the proximal small 
intestine. Some effects indicate that the gut health balance might be improved, however the Ussing 
chamber study showed deleterious effects on active nutrient absorption. It is argued that there is still 
scope to improve the efficacy of these EO to aid the development and function of the GIT in piglets. 
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Het gebruik van antibiotica als antimicrobiële groeibevorderaar (AMGB) in de voeding van varkens 
is sinds 2006 in de EU verboden (Verordening EC/1831/2003) en staat ter discussie in de rest van de 
wereld. De toepassing van deze AMGB’s in de intensieve varkensproductie gedurende de laatste 
decennia gaf aanleiding tot een betere groei van de dieren en een verlaagde voederconversie. De 
werkingswijze waarbij dit gebeurde is niet volledig opgehelderd maar er is genoeg wetenschappelijk 
bewijs om aan te nemen dat het gunstig effect toe te schrijven is aan een remmende werking op de 
bacteriën en hun metabolisme in het maag-darmkanaal. Alhoewel andere auteurs het 
groeibevorderend effect van de AMGB’s eerder in verband brengen met een direct effect op de cellen 
van de gastheer, in het bijzonder de ontstekingscellen. Verder wordt verwacht dat de toegelaten 
antimicrobiële dosis van koper in de biggenvoeding in de EU in de toekomst zal teruggebracht 
worden. Omdat van sommige essentiële oliën (EO), zoals de componenten carvacrol en 
kaneelaldehyde bekend is dat ze antimicrobiële eigenschappen bezitten, is er aldus interesse om EO 
te gebruiken in diervoeders. De specifieke doelstellingen van het huidige proefschrift waren: [1] de 
antimicrobiële eigenschappen van deze EO tegenover de darmbacteriën van het varken te 
karakteriseren, [2] de stabiliteit en de kinetiek van de EO in het maag-darmkanaal te onderzoeken en 
[3] het effect van deze componenten op de functionaliteit van de darm bij biggen te bepalen. In deze 
studie werden de effecten nagegaan bij gespeende biggen, omdat in de huidige productiesystemen, de 
speenfase één van de meest kritieke fasen is voor de groei en overleving van het dier. 
 
Hoofdstuk 1 bevat een overzicht van de bestaande literatuur. Het behandelt relevante gegevens met 
betrekking tot carvacrol, thymol, anethol, eugenol en kaneelaldehyde, met bijzondere aandacht voor 
hun antimicrobiële eigenschappen en waargenomen effecten op de bacteriën van het maag-
darmkanaal, de darmfysiologie en de prestaties van biggen. 
 
De antimicrobiële activiteit ten aanzien van de belangrijkste cultiveerbare groepen darmbacteriën bij 
het varken van 7 EO werd gekarakteriseerd door middel van in vitro simulaties van de fermentatie in 
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de verschillende delen van het maag-darmkanaal (Hoofdstuk 2). In een eerste studie werd een 
screening uitgevoerd. Daarna werden dosis-respons relaties opgesteld van de 4 componenten met het 
grootste potentieel. Binaire combinaties werden eveneens getest, en de interactie werd geëvalueerd 
door middel van de isobool methode. De resultaten van beide studies toonden aan dat carvacrol, 
thymol, eugenol en E-kaneelaldehyde mogelijkheden bieden om de groei van de bacteriën en het 
fermentatiepatroon in het maag-darmkanaal van varkens te moduleren. Eucalyptol, terpinen-4-ol en 
E-anethol vertoonden geen interessante effecten. De minimale concentratie van carvacrol, thymol, 
eugenol en E-kaneelaldehyde nodig om de aantallen bacteriën in simulaties van de dunne darm 
fermentatie te reduceren met een probabiliteit van 99.7% was respectievelijk 255, 258, 223 and 56 
mg/L. E-kaneelaldehyde vertoonde een uitgesproken activiteit ten aanzien van coliforme bacteriën, 
een dosis van 104 mg/L gaf een reductie van 1 log10 KVE (kolonievormende eenheden)/mL vs. 371, 
400 en 565 mg/L voor respectievelijk carvacrol, thymol en eugenol. Daartegenover staat dat E-
kaneelaldehyde minder effectief was tegen lactobacillen dan carvacrol en thymol. De toepassing van 
E-kaneelaldehyde en in mindere mate eugenol kan dus resulteren in een verschuiving van de 
microbiële ecologie ten gunste van melkzuurproducerende bacteriën en ten nadele van coliformen. 
Carvacrol en thymol hadden vergelijkbare en niet-selectieve antimicrobiële eigenschappen. Hun 
effect was het meest uitgesproken in een zuur medium en ze vertoonden een sterk toenemend 
bactericidaal effect eens een bepaalde kritieke concentratie (400-500 mg/L in simulaties van dunne 
darm) werd overschreden. De reductie door de 4 componenten van de kort-keten vetzuurproductie 
was gerelateerd aan het effect ten aanzien van de coliforme bacteriën, ze hadden geen effect op de 
melkzuur en ammonium concentraties in het medium. Een beperkt aantal combinaties was 
synergetisch, de meeste mengsels resulteerden in geen interactie of antagonisme. Carvacrol + thymol 
(ratio ≥1) vertoonde synergisme tegen totaal anaërobe bacteriën in simulaties van de dunne darm, 
maar het effect was beperkt. In caecum simulaties waren carvacrol, thymol en E-kaneelaldehyde even 
effectief, terwijl eugenol enkel een effect op de coliformen had. 
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Gegevens met betrekking tot de stabiliteit en de kinetiek in het maag-darmkanaal van carvacrol, 
thymol, eugenol en E-kaneelaldehyde werden bepaald in een volgende studie (Hoofstuk 3). De 
concentratie van de EO in het medium van in vitro incubaties werd gekwantificeerd, en de terugwinst  
na incubatie werd berekend als een maat voor stabiliteit/degradatie. Geen enkele van deze 
componenten werd significant afgebroken in in vitro simulaties van de maag fermentatie. Voor 
carvacrol en thymol werden evenmin significante verliezen in dunne darm simulaties vastgesteld, 
maar wel in caecum simulaties (tot 29%). Belangrijke degradatie van eugenol en E-kaneelaldehyde 
trad op in dunne darm en caecum simulaties. Aan biggen werd oraal één enkele dosis van carvacrol, 
thymol, eugenol en E-kaneelaldehyde gemengd met het voeder (respectievelijk 13.0, 13.2, 12.5 en 
12.7 mg/kg lichaamsgewicht) toegediend. Halfwaardetijden voor het totale maag-darmkanaal lagen 
tussen 1.84 en 2.05 u, waarbij de snelste verdwijning optrad voor E-cinnamaldehdye. Al deze stoffen 
werden snel en nagenoeg volledig geabsorbeerd in de maag en het duodenum, met als gevolg dat lage 
concentraties werden aangetroffen in de meer distale delen. Plasma concentraties (som van de vrije 
en geconjugeerde component) piekte na 1.39, 1.35 en 0.85 u voor respectievelijk carvacrol, thymol 
en eugenol en dit ging gepaard met hoge concentraties in de urine.   
 
De doelstellingen in een choice-feeding studie waren: [1] het bepalen van het effect van de dosis van 
thymol op de smakelijkheid (experiment I) en [2] het bestuderen van de mogelijkheid van 
toegevoegde smaakstoffen om de negatieve effecten van een hoge dosis thymol te maskeren 
(experiment II) (Hoofdstuk 4A). Vierentwintig volledige gespeende biggen werden verdeeld in 8 
groepen van 3 dieren. Elke groep werd gehuisvest in een afzonderlijk hok dat voorzien was van twee 
identieke voederbakken. Een referentie voeder werd verstrekt in de ene voederbak en een test voeder 
in de andere voederbak. De dieren hadden toegang tot beide voederbakken en konden dus vrij kiezen 
tussen de twee voeders. De voederopname van het testvoeder werd uitgedrukt als de proportie van de 
totale opname. Door middel van een one-sample Student’s t-test werd nagegaan of deze relatieve 
opname statistisch verschillend was van 50% (n=16). De voorkeur van de biggen voor het voeder met 
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125, 500 en 2000 mg/kg thymol was 53.0 ± 14.0 % (P>0.05), 47.5 ± 19.6 % (P>0.05) en 9.9 ± 9.2 % 
(P<0.001) respectievelijk (experiment I). Het betekent dat 125 en 500 mg thymol per kg voeder geen 
effect had op de smakelijkheid, terwijl de biggen haast volledig het voeder met 2000 mg/kg thymol 
links lieten liggen. In experiment II werden twee testvoeders gebruikt; een voeder dat 
gesupplementeerd was met 2000 mg/kg thymol met ofwel smaakstof A (bedoeld om de smaak van 
thymol te maskeren) of met smaaktstof B (om smaak en geur van thymol te maskeren). Deze werden 
getest tegenover een controle voeder. De relatieve opname van het testvoeder was respectievelijk 
19.5 ± 10.5 % (P<0.001) en 14.0 ± 15.7 % (P<0.001), wat erop duidt dat de smaakstoffen de afkeer 
ten aanzien van 2000 mg/kg thymol gedeeltelijk konden reduceren. Vervolgens werden de dieren 
gevoederd met dezelfde testvoeders, maar als referentievoeder werd hier een voeder met 2000 mg/kg 
thymol verstrekt. In overeenstemming met de vorige resultaten, verkozen de dieren het voeder met 
2000 mg/kg thymol + smaakstof A (67.6 ± 18.9 %; P<0.01). Het resultaat voor 2000 mg/kg thymol + 
smaaktstof B (28.9 ± 13.1 %; P<0.001) bevestigde evenwel niet de vorige bevindingen.  
 
In twee proeven met gespeende biggen werden de voeders gesupplementeerd met carvacrol en 
thymol, en dit bij dosissen van 500 en 2000 mg/kg voeder (Hoofdstuk 4B). Het effect op de aantallen 
darmbacteriën en metabolieten en de darmfunctie werd onderzocht. In experiment I werden 25 
gespeende biggen (28 d, 6.59 ± 0.48 kg) verdeeld over 5 voederbehandelingen: een controle voeder 
en hetzelfde voeder waaraan carvacrol of thymol hetzij aan een dosis van 500 of 2000 mg/kg werd 
toegevoegd. De EO werden opgelost in de sojaolie, vooraleer het werd gemengd met de rest van het 
voeder. In experiment II werden 35 gespeende biggen (28 d, 7.99 ± 0.73 kg) verdeeld over 7 
behandelingen: een controle voeder en hetzelfde voeder gesupplementeerd met thymol in één van 
drie formulaties (op celite, op alphacel of na microencapsulatie) en dit bij 500 en 2000 mg/kg. 
Microencapsulatie werd toegepast met als bedoeling de vrijstelling van de actieve component in het 
maag-darmkanaal te vertragen. De voeders werden ad libitum verstrekt. Na 11/12 dagen werden de 
dieren geëuthanaseerd en de digesta van de maag, de proximale en distale dunne darm werden 
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bemonsterd voor bacteriologische (uitplaten op selectieve media voor totaal anäerobe bacteriën, 
coliformen, streptococcen en lactobacillen) en biochemische analyses. Stalen van dunne darmweefsel 
werden genomen voor histo-morfologische bepalingen. De voederopname was hoger bij dieren 
gevoederd met 500 mg/kg carvacrol en thymol, met uitzondering van de microencapsulatie 
behandeling (tussen +12.4 en +44.7% in vergelijking met controle), en bijgevolg waren de darmvilli 
ter hoogte van de distale dunne darm ook groter dan bij de controle dieren (tussen +4.9 en +7.5%; 
P>0.05). In experiment I was de verhouding villushoogte/cryptediepte ter hoogte van distale dunne 
darm hoger voor de experimentele voeders (1.30-1.32) dan voor het controle voeder (1.24) (P<0.05). 
Dieren gevoederd met thymol in experiment II vertoonden een lager aantal intra-epitheliale 
lymfocyten in de proximale (P<0.05) en de distale (P<0.1) dunne darm in vergelijking met controle 
dieren. Deze laatste bevinding kan in verband gebracht worden met de tendens tot een verhoogde 
verhouding villushoogte/cryptediepte ter hoogte van distale dunne darm bij de experimentele voeders 
(P<0.1). De gemiddelde concentratie van de EO in de verse digesta van maag en proximale dunne 
darm voor de behandelingen met 2000 mg/kg thymol varieerde tussen 475 en 647 en tussen 5 en 24 
mg/kg respectievelijk. De gecumuleerde absorptie in de proximale dunne darm was voor alle 
behandelingen hoger dan 90%. De resultaten uit deze proeven suggeren dat deze EO de 
voederopname kunnen verhogen bij 500 mg/kg en daarnaast de darmgezondheid positief 
beïnvloeden, maar duidelijke antimicrobiële effecten tegenover de belangrijkste cultiveerbare 
darmbacteriën werden niet gevonden. 
 
In het Ussing kamer model werd het effect van thymol, E-anethol en E-kaneelaldehyde op actieve 
nutriënt absorptie en secretie nagegaan (Hoofdstuk 5). Gestript weefsel afkomstig van mid-jejunum 
van volledig gespeende biggen werd gemonteeerd in gemodificeerde Ussing kamers. De stijging in 
de stroom bij kortsluiten (∆Isc, short-ciruit current) na mucosale additie van 16 mmol/L D-glucose en 
16 mmol/L L-alanine, al of niet na pre-incubatie met 0.2 en 1.0 mmol/L thymol of E-kaneelaldehyde 
en 0.2 en 0.5 mmol/L E-anethol werd onderzocht. Op dezelde manier werd het effect op 
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gestimuleerde chloride secretie door middel van secretagogen opgemeten. Thymol en E-
kaneelaldehyde reduceerden op een dosis afhankelijke wijze de absorptie van D-glucose en L-alanine 
en gestimuleerde secretie van chloride. ∆Isc voor D-glucose met thymol aan 0.2 en 1.0 mmol/L was 
respectievelijk 73.7 ± 7.9 (P>0.05) en 23.8 ± 7.4 (P<0.001) in vergelijking met 80.1 ± 7.4 µA/cm2 
voor de controle en voor L-alanine respectievelijk 20.6 ± 2.3 (P=0.01) en 5.9 ± 2.4 (P<0.001) 
tegenover 33.7 ± 2.6 µA/cm2 voor de controle. Enkel bij 1 mmol/L vertoonde E-kaneelaldehyde 
significante effecten. Indien dergelijke effecten zich in vivo zouden voordoen, kan dit de actieve 
absorptie van nutriënten in gevaar brengen. De reductie van de geïnduceerde chloride secretie via 
cAMP/cGMP gemedieerde VIP en theophylline was groter dan voor Ca2+ gemedieerde 5-HT en 
carbachol. Pre-incubatie met 0.5 mmol/L E-anethol gaf geen effect op de de Isc respons na mucosale 
additie van D-glucose, maar wel op chloride secretie door 5-HT en theophylline. Het feit dat deze EO 
de respons op secretagogen reduceren kan positief zijn in gevallen van overmatige chloride secretie 
dat aanleiding geeft tot klinische diarree; bijvoorbeeld in respons tot toxines afkomstig van 
enterotoxische E. coli. Echter, in dit onderzoek werden ook aanwijzingen gevonden die erop kunnen 
wijzen dat cytotoxische effecten een rol hebben gespeeld. 
 
In het laatste hoofdstuk worden de bekomen resultaten verder bediscussieerd en geïnterpreteerd en dit 
in licht van deze EO als alternatief voor de AMGB’s. Als conclusie kan gesteld worden dat het in 
vitro onderzoek het enorme potentieel van carvacrol, thymol en kaneelaldehyde om de samenstelling 
van de darmbacteriën bij het varken te moduleren heeft aangetoond. Echter, in twee proeven met 
gespeende biggen werd vastgesteld dat de supplementatie met carvacrol en thymol, bij de dosissen 
die werden toegepast geen reductie van de aantallen bacteriën opleverde. Dit was hoogst 
waarschijnlijk te wijten aan de snelle absorptie van de actieve component in de maag en de proximale 
dunne darm. Sommige effecten duidden op een verbeterde darmgezondheidheidstoestand, maar de 
Ussing kamer studie toonde aan dat deze stoffen een nefast effect hadden op de actieve absorptie van 
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nutriënten. Niettemin wordt aangetoond dat er perspectieven zijn om de effectiviteit van deze 
componenten te verbeteren. 
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Toen ik op de Hogeschool Gent terecht kwam wist ik eigenlijk niet wat me te wachten stond. Op het 
sollicitatie gesprek was het duidelijk geworden dat het onderzoek iets met varkens zou zijn. Echte 
affectie met die dieren had ik niet, mijn ouders hadden melkkoeien en die varkens die stinken altijd. 
De eerste gesprekken met mijn promotoren verliepen vlot, en ze kwamen met het idee op de proppen 
om te onderzoeken wat essentiële oliën zouden kunnen betekenen voor biggen. Natuurlijk spitste ik 
mijn oren want essentiële oliën dat zijn aroma’s en aangename geuren en al vlug legde ik de link met 
die varkens. Achteraf bleek natuurlijk dat ze daar andere bedoelingen mee hadden. 
 
Ik bleef niet bij de pakken zitten en ging te rade bij echte specialisten ter zake. In leerde Philippe 
Gerard van de Primrose Academy kennen. Philippe, een echte merci. Je hebt me ingeleid in de 
fascinerende wereld van de fytotherapie, aromatherapie … Veel suggesties en ideeën voor onderzoek 
heb ik bij jou opgedaan, en de cursussen die ik bij je volgde waren echt boeiend. De eerste keer dat 
we een essentiële olie mochten extraheren in je labo vergeet ik nooit. 
 
Zo was mijn ontdekkingstocht gestart, en beetje bij beetje leerde ik meer over onze varkens. Heel 
veel kon ik opsteken van mijn promotoren: Noël Dierick, Stefaan De Smet en Dirk Fremaut. Noël, je 
hebt me van dichtbij begeleid in het onderzoek. Zo vele malen stond ik aan je bureau met vragen en 
twijfels over het proefprotocol en steeds hielp je me vooruit. Je encyclopedische kennis over 
verteringsfysiologie, grondstoffen en additieven is onuitgegeven. Je kritische kijk op mijn onderzoek 
en resultaten en het minitieus doornemen van de manuscripten waardeer ik ten zeerste. Ik wil je 
hiervoor oprecht van harte bedanken. Stefaan, je was een aandachtige toeschouwer van het werk. Bij 
besprekingen had je altijd een klare kijk op de zaak en kwam je met verrassende opmerkingen uit de 
hoek. Bovendien gaf je jou mening eerlijk te kennen, zowel als het goed of slecht was. Bedankt voor 
de leerrijke samenwerking de voorbije jaren. Dikwijls was Dirk de eerste persoon die ik op het werk 
tegenkwam. We hebben dan ook veel gepraat, pittige verhalen verteld, gediscussieerd en over nieuwe 
ideeën nagedacht. Je informeerde altijd hoe het ervoor stond en dit was steeds een stimulans om 
verder te doen. Bedankt Dirk. Mijn promotoren wil ik ook bedanken voor de nodige vrijheid die ze 
me gaven bij het uitvoeren van mijn taken; zowel bij het doctoraatsonderzoek als bij de 
lesopdrachten. Ik wil hierbij ook nog speciaal Chris Van Nevel bedanken. Bedankt voor je hulp en 
suggesties bij het onderzoek en de levenswijsheid die jij ons, jonge onderzoekers altijd meegaf. 
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I also would like to thank sincerely all the members of the examination committee for reading the 
manuscript and for all suggestions to improve my thesis. Especially, the attendance of the  
researchers from abroad is greatly appreciated.  
 
De voorbije jaren waren een continu zwerven tussen Lanupro en BIOT. De experimenten gingen 
door op Lanupro, in het labo ‘beneden’. Daar heb ik een fantastische tijd gehad, wat alleen maar 
mogelijk was door de collega’s daar; Cyriel, Anneke, Annick en Erwin. Bedankt voor jullie eindeloze 
inzet en hulp bij alle labowerk en proeven, en bij de opkuis die ik liet staan. Het ene moment was het 
een geoliede machine, het andere moment was er tijd voor gebrul en gelach. Het was bijzonder 
aangenaam om jullie één voor één beter te leren kennen. Cyriel, je verhalen over je fietstochten 
waren aanstekelijk (natuurlijk was ik altijd jaloers). Bedankt voor alle praktische hulp. Ann, vele 
protocols heb ik met jou doorgenomen en veelal nam jij de leiding bij de slachtproeven. En je had 
altijd tijd voor een babbel. Merci voor de aangename tijd in het labo (en nu ben ik echt serieus!). 
Annick, merci voor de vele analyses, de uitplatingen en de oprechte babbels tussendoor. Tenslotte is 
er nog Erwin, die steeds de voeders maakte, voor de dieren zorgde, maar eigenlijk een man van alle 
werk is. Merci voor al je werk, en natuurlijk ook de leute, onvergetelijk zijn die sneeuwman en het 
strippen. 
 
De bureau op Lanupro moest ik delen met een andere Joris, wat soms tot hilarische situaties leidde. 
Joris, in het begin was je de cel-en-genner die het wel zou weten. Al gauw moest ik mijn mening 
herzien. We leerden elkaar gaandeweg beter kennen en respecteren. We hadden ook veel dezelfde 
interesses (hell yeah). Je was een supertoffe kameraad. Aan je enthousiasme heb ik me heel dikwijls 
kunnen optrekken. Bedankt voor de vele wetenschappelijke discussies en de hulp in het labo. Op 
moeilijke momenten konden we over alles praten. Een grote merci voor al die jaren en de 
vriendschap; merci ook aan Elke. 
 
Uiteraard wil ik ook al de andere collega’s van Lanupro en BIOT die op één of andere manier mij 
geholpen hebben bedanken. Waardering voor het werk van Charlotte. Jouw tabelletje met richtlijnen 
en bijhorend tijdschema voor wie in de laatste rechte lijn van zijn lange tocht is belandt geeft me veel 
gemoedsrust bezorgd. En voorts al degenen die ik leerde kennen op studiedagen of bezoeken en mijn 
blik op essentiële oliën en varkens verruimden of mijn praktisch hielpen bij de voorbereiding van de 
proeven. 
 
Dank aan Paul Vandecasteele, alias “the simplisitie of the measerment is its bjoetie, de result is de 
interpreteisjen of tat simpel measerment and noting seems to be wat it reely is” voor de vele uren, 
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belangeloze hulp bij de Ussing kamers. Het was zwoegen en hard nadenken om het telkens weer 
allemaal in orde te krijgen. We hebben beide veel bijgeleerd en je was een bijzondere verschijning in 
ons labo. Merci dat ik op jou kon rekenen. 
 
Een pluim voor Luc Decombel, je hebt me dikwijls uit de nood geholpen met statistische problemen, 
ook na de uren bij jullie thuis. Het gedoe met de gaschromatograaf was niet mogelijk geweest zonder 
de hulp van Peter Maene en Yvan De Bock. Problemen hebben we genoeg gehad; de gastoevoer die 
stilviel, de naald die brak, de septa van de vialtjes die niet geschikt bleken te zijn …. Altijd heb je 
meegezocht naar oplossingen, en met een gepaste dosis voor humor kon je alles relativeren. Bedankt 
voor die steun.  
 
Een dikke merci ook aan alle toffe collega’s op Lanupro en BIOT voor de veel te lange koffiepauzes, 
voor de babbels over de promoties van de macro en nonsens, de roddels, de traktaties, de 
geanimeerde recepties, de natte sportdagen, maar vooral, vooral voor de steun, de interesse en de 
vriendschap. Katrien en Nicolas, bedankt om van onze bureau een leuke plek te maken! Ik wil graag 
ook alle collega’s die nog onderweg zijn, veel moed toewensen. 
 
Mijn ouders wil ik bedanken voor de kansen die ze me gaven, voor de interesse en steun. 
 
Sabine, het meeste heb ik aan jou te danken. Zonder je geduld, begrip en steun was het nooit gelukt. 
Als het teveel werd voor mij, trokken we er samen op uit en je zorgde voor rust. Oef, waarschijnlijk 
ben je net zo content als ik dat het erop zit. Bedankt voor al die jaren samen, merci voor alles. 
 
Joris 
7 mei 2009 
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“See my dreams; they're not like anyone's, anyone's” (PL X) 
 
“Could there be, something that your world depends on in me... 
Could it be, nothing that you learned from ash and debris?” (PL IR) 
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